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Foreword
When	the	U.S.	Congress	passed	the	Occupational	Safety	and	Health	Act	of	1970	(Public	Law	91–
596),	it	established	the	National	Institute	for	Occupational	Safety	and	Health	(NIOSH).	Through	
the	Act,	Congress	charged	NIOSH	with	recommending	occupational	safety	and	health	standards	
and	describing	exposure	limits	that	are	safe	for	various	periods	of	employment.	These	limits	in-
clude	but	are	not	limited	to	the	exposures	at	which	no	worker	will	suffer	diminished	health,	func-
tional	capacity,	or	life	expectancy	as	a	result	of	his	or	her	work	experience.	By	means	of	criteria	
documents,	NIOSH	communicates	these	recommended	standards	to	regulatory	agencies	(includ-
ing	the	Occupational	Safety	and	Health	Administration	[OSHA]),	health	professionals	in	academic	
institutions,	industry,	organized	labor,	public	interest	groups,	and	others	in	the	occupational	safety	
and	health	community.	Criteria	documents	contain	a	critical	review	of	the	scientific	and	techni-
cal	information	about	the	prevalence	of	hazards,	the	existence	of	safety	and	health	risks,	and	the	
adequacy	of	control	methods.
This	criteria	document	is	derived	from	reviews	of	 information	from	human	and	animal	studies	
of	the	toxicity	of	refractory	ceramic	fibers	(RCFs)	and	is	intended	to	describe	the	potential	health	
effects	of	occupational	exposure	to	airborne	fibers	of	this	material.	RCFs	are	amorphous	synthetic	
fibers	produced	by	the	melting	and	blowing	or	spinning	of	calcined	kaolin	clay	or	a	combination	of	
alumina,	silica,	and	other	oxides.	RCFs	belong	to	the	class	of	synthetic	vitreous	fibers	(SVFs)—ma-
terials	that	also	include	fibers	of	glass	wool,	rock	wool,	slag	wool,	and	specialty	glass.	RCFs	are	used	
in	commercial	applications	requiring	lightweight,	high-heat	insulation	(e.g.,	furnace	and	kiln	insu-
lation).	Commercial	production	of	RCFs	began	in	the	1950s	in	the	United	States,	and	production	
increased	dramatically	in	the	1970s.	Domestic	production	of	RCFs	in	1997	totaled	approximately	
107.7	million	lb.	Currently,	total	U.S.	production	has	been	estimated	at	80	million	lb	per	year,	
which	constitutes	1%	to	2%	of	SVFs	produced	worldwide.	In	the	United	States,	approximately	
31,500	workers	have	the	potential	for	occupational	exposure	to	RCFs	during	distribution,	handling,	
installation,	and	removal.	More	than	800	of	these	workers	are	employed	directly	in	the	manufactur-
ing	of	RCFs	and	RCF	products.	With	increasing	production	of	RCFs,	concerns	about	exposures	to	
airborne	fibers	prompted	animal	inhalation	studies	that	have	indicated	an	increased	incidence	of	
mesotheliomas	in	hamsters	and	lung	cancer	in	rats	following	exposure	to	RCFs.	Studies	of	workers	
who	manufacture	RCFs	have	shown	a	positive	association	between	increased	exposure	to	RCFs	and	
the	development	of	pleural	plaques,	skin	and	eye	irritation,	and	respiratory	symptoms	and	con-
ditions	(including	dyspnea,	wheezing,	and	chronic	cough).	In	addition,	current	and	former	RCF	
production	workers	have	shown	decrements	in	pulmonary	function.	
After	evaluating	this	evidence,	NIOSH	proposes	a	recommended	exposure	limit	(REL)	for	RCFs	
of	0.5	fiber	per	cubic	centimeter	 (f/cm3)	of	air	as	a	 time-weighted	average	(TWA)	concentra-
tion	for	up	to	a	10-hr	work	shift	during	a	40-hr	workweek.	Limiting	airborne	RCF	exposures	to	
this	concentration	will	minimize	the	risk	for	 lung	cancer	and	irritation	of	the	eyes	and	upper	
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respiratory	system	and	is	achievable	based	on	a	review	of	exposure	monitoring	data	collected	from	
RCF	manufacturers	and	users.	However,	because	a	residual	risk	of	cancer	(lung	cancer	and	pleural	
mesothelioma)	may	still	exist	at	the	REL,	continued	efforts	should	be	made	toward	reducing	expo-
sures	to	less	than	0.2	f/cm3.	Engineering	controls,	appropriate	respiratory	protection	programs,	and	
other	preventive	measures	should	be	implemented	to	minimize	worker	exposures	to	RCFs.	NIOSH	
urges	employers	to	disseminate	this	information	to	workers	and	customers.	NIOSH	also	requests	
that	professional	and	trade	associations	and	labor	organizations	inform	their	members	about	the	
hazards	of	exposure	to	RCFs.	
John	Howard,	M.D.	
Director,	National	Institute	for	
					Occupational	Safety	and	Health	
Centers	for	Disease	Control	and	Prevention
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Executive Summary
lung	cancer.	However,	studies	of	worker	popu-
lations	with	occupational	exposure	to	airborne	
RCFs	have	shown	an	association	between	ex-
posure	 and	 the	 formation	of	pleural	plaques,	
increased	prevalence	of	respiratory	symptoms	
and	 conditions	 (dyspnea,	 wheezing,	 chronic	
cough),	decreases	in	pulmonary	function,	and	
skin,	eye,	and	upper	respiratory	tract	irritation	
[Lemasters	et	al.	1994,	1998;	Lockey	et	al.	1996].	
Increased	decrements	 in	pulmonary	 function	
among	workers	exposed	to	RCFs	who	are	cur-
rent	 or	 former	 cigarette	 smokers	 indicate	 an	
apparent	 synergistic	 effect	 between	 smoking	
and	RCF	exposure	[Lemasters	et	al.	1998].	This	
finding	is	consistent	with	studies	of	other	dust-
exposed	populations.	The	 implementation	of	
improved	engineering	controls	and	work	prac-
tices	in	RCF	manufacturing	processes	and	end	
uses	have	led	to	dramatic	declines	in	airborne	
fiber	exposure	concentrations	[Rice	et	al.	1996,	
1997;	Maxim	et	al.	2000a],	which	in	turn	have	
lowered	 the	 risk	 of	 symptoms	 and	 health	 ef-
fects	for	exposed	workers.		
In	2002,	the	Refractory	Ceramic	Fibers	Coali-
tion	(RCFC)	established	the	Product	Steward-
ship	 Program	 (PSP),	 which	was	 endorsed	 by	
the	 Occupational	 Safety	 and	 Health	 Admin-
istration	(OSHA).	Contained	in	the	PSP	were	
recommendations	for	an	RCF	exposure	guide-
line	of	0.5	fiber	per	cubic	centimeter	(f/cm3)	of	
air	as	a	time-weighted	average	(TWA)	based	on	
the	contention	that	exposures	at	 this	concen-
tration	 could	 be	 achieved	 in	most	 industries	
that	manufactured	or	used	RCFs.	At	this	time,	
the	 available	 health	 data	 do	 not	 provide	 suf-
ficient	evidence	 for	deriving	a	precise	health-
based	 occupational	 exposure	 limit	 to	 protect	
The	National	Institute	for	Occupational	Safety	
and	Health	(NIOSH)	has	reviewed	data	char-
acterizing	 occupational	 exposure	 to	 airborne	
refractory	ceramic	fibers	(RCFs)	and	informa-
tion	 about	 potential	 health	 effects	 obtained	
from	experimental	and	epidemiologic	studies.	
From	this	review,	NIOSH	determined	that	oc-
cupational	exposure	to	RCFs	is	associated	with	
adverse	respiratory	effects	as	well	as	 skin	and	
eye	irritation	and	may	pose	a	carcinogenic	risk	
based	on	the	results	of	chronic	animal	inhala-
tion	studies.
In	 chronic	 animal	 inhalation	 studies,	 expo-
sure	to	RCFs	produced	an	increased	incidence	
of	mesotheliomas	 in	hamsters	 [McConnell	 et	
al.	 1995]	 and	 lung	 cancer	 in	 rats	 [Mast	 et	 al.	
1995a,b].	The	potential	role	of	nonfibrous	par-
ticulates	generated	during	inhalation	exposures	
in	the	animal	studies	complicates	the	issue	of	
determining	the	exact	mechanisms	and	doses	
associated	with	the	toxicity	of	RCFs	in	produc-
ing	carcinogenic	effects	[Mast	et	al.	2000].	The	
induction	of	mesotheliomas	and	 sarcomas	 in	
rats	 and	 hamsters	 following	 intrapleural	 and	
intraperitoneal	 implantation	 of	 RCFs	 pro-
vided	additional	evidence	for	the	carcinogenic	
potential	 of	RCFs	 [Wagner	 et	 al.	 1973;	Davis	
et	al.	1984;	Smith	et	al.	1987;	Pott	et	al.	1987].	
Lung	 tumors	have	 also	been	observed	 in	 rats	
exposed	 to	 RCFs	 by	 intratracheal	 instillation	
[Manville	Corporation	1991].
In	contrast	to	the	carcinogenic	effects	of	RCFs	
observed	in	experimental	animal	studies,	epide-
miologic	studies	have	found	no	association	be-
tween	occupational	exposure	to	airborne	RCFs	
and	an	excess	rate	of	pulmonary	fibrosis	or	
Executive Summary
vi	 Refractory Ceramic Fibers
against	 lung	 cancer.	 However,	 given	 what	 is	
known	 from	 the	 animal	 and	 epidemiological	
data,	 NIOSH	 supports	 the	 intent	 of	 the	 PSP	
and	 concurs	 that	 a	 recommended	 exposure	
limit	(REL)	of	0.5	f/cm3	as	a	TWA	for	up	to	
a	10-hr	work	shift		during	a	40-hr	workweek	
will	lower	the	risk	for	developing	lung	cancer.	
Keeping	 exposures	below	 the	REL	 should	 re-
duce	 the	 risk	 of	 lung	 cancer	 to	 estimates	 be-
tween	0.073/1,000	and	1.2/1,000	(based	on	ex-
trapolations	of	 risk	models	 from	Moolgavkar	
et	al.	[1999]	and	Yu	and	Oberdörster	[2000]).	
Keeping	worker	exposures	below	the	REL	will	
also	reduce	the	risk	of	irritation	of	the	eyes	and	
upper	respiratory	system.	
The	 risk	 for	mesothelioma	 at	 0.5	 f/cm3	 is	 not	
known	 but	 cannot	 be	 discounted.	 Evidence	
from	epidemiologic	studies	showed	that	higher	
exposures	in	the	past	resulted	in	pleural	plaques	
in	workers,	indicating	that	RCFs	do	reach	pleu-
ral	tissue.	Both	implantation	studies	in	rats	and	
inhalation	studies	in	hamsters	show	that	RCFs	
can	cause	mesothelioma.	Because	of	limitations	
in	 the	hamster	data,	 the	 risk	of	mesothelioma	
cannot	be	quantified.	However,	the	fact	that	no	
mesothelioma	has	been	 found	 in	workers	 and	
that	pleural	plaques	appear	 to	be	 less	 likely	 in	
workers	with	lower	exposures	suggests	a	 lower	
risk	for	mesothelioma	at	the	REL.	
Because	 residual	 risks	 of	 cancer	 (lung	 cancer	
and	pleural	mesothelioma)	and	irritation	may	
still	 exist	 at	 the	REL,	NIOSH	 further	 recom-
mends	 that	 all	 reasonable	 efforts	 be	made	 to	
work	toward	reducing	exposures	to	less	than	
0.2	f/cm3.	At	this	concentration,	the	risks	of	lung	
cancer	are	estimated	to	be	between	0.03/1,000	
and	0.47/1,000	(based	on	extrapolations	of	risk	
models	from	Moolgavkar	et	al.	[1999]	and	Yu	
and	Oberdörster	[2000]).
Maintaining	airborne	RCF	concentrations	be-
low	 the	REL	 requires	 a	 comprehensive	 safety	
and	 health	 program	 that	 includes	 provisions	
for	the	monitoring	of	worker	exposures,	instal-
lation	and	routine	maintenance	of	engineering	
controls,	and	the	training	of	workers	 in	good	
work	practices.	Industry-led	efforts	have	like-
wise	 promoted	 these	 actions	 by	 establishing	
the	PSP.	NIOSH	believes	that	maintaining	ex-
posures	 below	 the	REL	 is	 achievable	 at	most	
manufacturing	operations	and	many	user	ap-
plications,	 and	 that	 the	 incorporation	 of	 an	
action	level	(AL)	of	0.25	f/cm3	in	the	exposure	
monitoring	strategy	will	help	employers	deter-
mine	when	workplace	exposure	concentrations	
are	approaching	the	REL.	The	AL	concept	has	
been	an	integral	element	of	occupational	stan-
dards	recommended	in	NIOSH	criteria	docu-
ments	 and	 in	 comprehensive	 standards	 pro-
mulgated	by	OSHA	and	 the	Mine	Safety	and	
Health	Administration	(MSHA).	
NIOSH	also	recommends	that	employers	im-
plement	additional	measures	under	a	compre-
hensive	 safety	 and	health	program,	 including	
hazard	communication,	respiratory	protection	
programs,	 smoking	 cessation,	 and	 medical	
monitoring.	 These	 elements,	 in	 combination	
with	efforts	to	maintain	airborne	RCF	concen-
trations	below	the	REL,	will	further	protect	the	
health	of	workers.
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 Abbreviations
ACGIH	 American	Conference	of	Governmental	Industrial	Hygienists
ACS	 American	Cancer	Society
Al	 aluminum
AL	 action	level
A1
2
O
3	
alumina
Al
2
Si
2
O
5
[OH]
4	
siliceous	kaolin
AM	 arithmetic	mean
APF	 assigned	protection	factor
ATSDR	 Agency	for	Toxic	Substances	Disease	Registry
B
2
O
3	
boron	oxide
BAL	 bronchoalveolar	lavage
°C	 degree(s)	Celsius
CaO	 calcium	oxide
CFR	 Code	of	Federal	Regulations
CI	 confidence	interval
DECOS	 Dutch	Expert	Committee	on	Occupational	Standards
dG	 2-deoxyguanosine
DNA	 deoxyribonucelic	acid
EDXA	 energy	dispersive	X-ray	analyzer
e.g.	 for	example
EID	 Education	and	Information	Division
EPA	 U.S.	Environmental	Protection	Agency
°F	 degree(s)	Fahrenheit
f/cm3	 fibers	per	cubic	centimeter	of	air
Fe	 iron
FEF
25–75
	 forced	expiratory	flow	(liter/second)	between	25%	and	75%	of	the	
	 				forced	vital	capacity	
Fe
2
O
3
	 ferric	oxide
FEV
1
	 forced	expiratory	volume	in	one	second
FEV
1
/FVC	 ratio	of	forced	expiratory	volume	in	one	second	to	forced	vital	
		 				capacity
FJC	 functional	job	category
FVC	 forced	vital	capacity
g/cm3	 grams	per	cubic	meter	of	air
GM	 geometric	mean
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Abbreviations
GM
D
	 geometric	mean	diameter
GM
L	
geometric	mean	length
GSD	 geometric	standard	deviation	
GSH	 glutathione
γ-GT	 γ-glutamyltransferase	
HEPA	 high-efficiency	particulate	air
HHE	 Health	Hazard	Evaluation
hr	 hour(s)
HTE	 hamster	tracheal	epithelial
IARC	 International	Agency	for	Research	on	Cancer
i.e.	 that	is
IgG	 immunoglobulin
IJT	 industry	job	title
ILO	 International	Labor	Office
ILs	 interleukins
K
2
O	 potassium	oxide
lb	 pound(s)
LDH	 lactose	dehydrogenase
LOAEL	 lowest	observable	adverse	effect	level
LOD	 limit	of	detection
MAC	 maximum	achievable	concentration
MAN	 Manville	RCF
mg/m3	 milligrams	per	cubic	meter
MgO		 magnesium	oxide
min	 minute(s)
ml	 milliliter(s)
MLE	 maximum	likelihood	estimate
mm	 millimeter(s)
MMC	 metal	matrix	composites
MMMF	 man-made	mineral	fiber
MMVF	 man-made	vitreous	fiber
MSDS	 material	safety	data	sheet
MSHA	 Mine	Safety	and	Health	Administration
MTD	 maximum	tolerated	dose
MVK	 Moolgavkar-Venzon-Knudson
n	 number
Na
2
O	 sodium	oxide
ng	 nanogram(s)
NIEHS	 National	Institute	of	Environmental	Health	Sciences
NIOSH	 National	Institute	for	Occupational	Safety	and	Health
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Abbreviations
nl	 nanoliter(s)
NOAEL	 no	observable	adverse	effect	level
NTP	 National	Toxicology	Program
ODC	 ornithine	decarboxylase
OM	 Osborne	Mendel
OR	 odds	ratio
OSHA	 Occupational	Safety	and	Health	Administration
P	 probability
PA	 posteroanterior
PCM		 phase	contrast	optical	microscopy
PEL	 permissible	exposure	limit
PFT	 pulmonary	function	test
PG	 prostaglandin
PPE	 personal	protective	equipment
PSP	 Product	Stewardship	Program
RCF	 refractory	ceramic	fiber
RCFC	 Refractory	Ceramic	Fibers	Coalition
REL	 recommended	exposure	limit
ROM	 reactive	oxygen	metabolite
ROS	 reactive	oxygen	species
RPM	 rodent	pleural	mesothelial
SAED	 selected	area	electron	diffraction
SD	 standard	deviation
SEM	 scanning	electron	microscopy
Si	 silicon
SiO
2	
silicon	dioxide
SMR	 standardized	mortality	ratio
SVF	 synthetic	vitreous	fiber
TEM	 transmission	electron	microscopy
TIMA	 Thermal	Insulation	Manufacturers	Association
TiO
2	
titanium	dioxide
TLV	 threshold	limit	value
TNF	 tumor	necrosis	factor
TWA	 time-weighted	average
UCL	 upper	confidence	limit
UICC	 Union	Internationale	Contre	le	Cancer
UJT	 uniform	job	titles
WHO	 World	Health	Organization
ZrO
2
		 zirconium	dioxide
µm	 micrometer
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Glossary
Action level (AL):	A	statistically	derived	concept	used	to	permit	an	employer	to	have	confidence	(e.g.,	
95%)	that	if	a	measured	exposure	concentration	is	below	the	AL,	then	only	a	small	probability	exists	
that	the	actual	concentration	is	above	the	exposure	limit. Often	established	as	half	of	the	exposure	
limit,	the	AL	should	be	designated	for	determining	when	additional	controls	are	needed	or	adminis-
trative	actions	should	be	taken	to	reduce	exposures.	The	purpose	of	using	this	reference	is	to	indicate	
when	worker	exposures	to	hazardous	substances	may	be	approaching	the	exposure	limit.	
After-service refractory ceramic fiber (RCF):	RCF	that	has	been	subjected	to	greater	than	1,800	oF	
(~1,000	oC)	and	has	partially	converted	to	the	silica	polymorph	cristobalite.	In	experimental	stud-
ies,	this	fiber	is	also	called	RCF4.
Aspect ratio:	The	length	to	width	ratio	of	a	fiber.
Costophrenic angle:	Location	on	a	chest	radiograph	where	the	ribs	and	the	diaphragm	appear	to	
meet.
Dyspnea grade 1:	Shortness	of	breath	on	exertion,	classified	as	less	severe	than	grade	2.
Dyspnea grade 2:	Shortness	of	breath	on	exertion,	excluding	shortness	of	breath	associated	
with	hurrying	on	the	level	or	walking	up	a	slight	hill,	and	classified	as	more	severe	than	dys-
pnea	grade	1.
FEF
25–75
:	Forced	expiratory	flow	(liter/second)	 that	 is	between	25%	and	75%	of	 the	 forced	vital	
capacity.	
FEV
1
:	Forced	expiratory	volume	in	one	second,	or	the	maximum	volume	of	air	that	can	be	forcibly	
expired	during	the	first	second	of	expiration	following	a	maximal	inspiration.
Fiber counting rules:	Criteria	for	identifying	and	counting	fibers	during	air	sampling	and	exposure	
assessment.	The	three	main	conventions	 for	fiber	counting	are	described	below	(and	 in	Section	
4.2.1	and	Appendix	A).
■	 NIOSH “A” rules—any	particle	>5	µm	long	with	an	aspect	ratio	(length	to	width)	greater	
than	3:1	is	considered	a	fiber.
■	 NIOSH “B” rules—any	particle	>5	µm	long	with	an	aspect	ratio	equal	to	or	greater	than	5:1	
and	a	diameter	<3	µm	is	considered	a	fiber.	
■	 World Health Organization (WHO) reference method for man-made mineral fiber—any	
particle	>5	µm	long	with	an	aspect	ratio	equal	to	or	greater	than	3:1	and	a	diameter	<3	µm	is	
considered	a	fiber.
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Glossary
FVC:	Forced	vital	capacity	or	the	maximum	volume	of	air	(in	liters)	that	can	be	forcibly	expired	
from	the	lungs	following	a	maximal	inspiration.	
High-efficiency particulate air (HEPA) filter:	A	dry-type	filter	used	to	remove	airborne	particles	
with	an	efficiency	equal	to	or	greater	than	99.97%	for	0.3-µm	particles.	The	lowest	filtering	effi-
ciency	of	99.97%	is	associated	with	0.3-µm	particles,	which	is	approximately	the	most	penetrating	
particle	size	for	particulate	filters.	
Inspirable dust:	The	fraction	of	airborne	particles	that	would	be	inspired	through	the	mouth	and	
nose	of	a	worker.
MAN:	A	refractory	ceramic	fiber	produced	by	the	Johns	Manville	Company.	
Occupational medical monitoring (incorporating medical screening, surveillance):	The	periodic	
medical	evaluation	of	workers	to	identify	potential	health	effects	and	symptoms	related	to	occupa-
tional	exposures	or	environmental	conditions	in	the	workplace.	An	occupational	medical	monitor-
ing	program	is	a	secondary	prevention	method	based	on	two	processes,	screening	and	surveillance.	
Occupational	medical	screening	focuses	on	early	detection	of	health	outcomes	for	individual	work-
ers.	Screening	may	involve	an	occupational	history	assessment,	medical	examination,	and	medical	
tests	to	detect	the	presence	of	toxicants	or	early	pathologic	changes	before	the	worker	would	nor-
mally	seek	clinical	care	for	symptomatic	disease.	Occupational	medical surveillance	involves	the	
ongoing	evaluation	of	the	health	status	of	a	group	of	workers	through	the	collection	and	analysis	of	
health	data	for	the	purpose	of	disease	prevention	and	for	evaluating	the	effectiveness	of	interven-
tion	programs.
Pleural plaques:	Discrete	areas	of	thickening	that	are	generally	on	the	parietal	pleura	and	are	most	
commonly	 located	at	 the	midcostal	and	posterior	costal	areas,	 the	dome	of	 the	diaphragm,	and	
the	mediastinal	pleura.	Presence	of	plaques	is	an	indication	of	exposure	to	a	fibrous	silicate,	most	
frequently	asbestos.
Radiographic opacity:	A	shadow	on	a	chest	X-ray	film	generally	associated	with	a	fibrogenic	re-
sponse	to	dust	retained	in	the	lungs	[Morgan	1995].	Opacities	are	classified	by	size,	shape,	location,	
and	profusion	according	to	guidelines	established	by	the	International	Labor	Office	[ILO	2000]	
www.ilo.org/public/english/support/publ/books.htm).	
Refractory ceramic fiber (RCF):	An	amorphous,	synthetic	fiber	(Chemical	Abstracts	Services	No.	
142844–00–6)	produced	by	melting	and	blowing	or	spinning	calcined	kaolin	clay	or	a	combina-
tion	of	alumina	(Al
2
O
3
)	and	silicon	dioxide	(SiO
2
).	Oxides	may	be	added	such	as	zirconia,	ferric	
oxide,	titanium	oxide,	magnesium	oxide,	calcium	oxide,	and	alkalies.	The	percentage	(by	weight)	
of	components	is	as	follows:	alumina,	20%	to	80%;	silicon	dioxide,	20%	to	80%;	and	other	oxides	
in	smaller	amounts.
Respirable-sized fiber:	Particles	>5	µm	long	with	an	aspect	ratio	>3:1	and	diameter	≤1.3	µm.	
Shot:	Nonfibrous	particulate	that	is	generated	during	the	production	of	RCFs	from	the	original	
melt	batch.
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Glossary
Standardized mortality ratio (SMR):	The	ratio	of	the	observed	number	of	deaths	(from	a	specified	
cause)	to	the	expected	number	of	deaths	(from	that	same	cause)	that	has	been	adjusted	to	account	
for	demographic	differences	(e.g.,	age,	 sex,	 race)	between	the	study	population	and	the	referent	
population.	
Synthetic vitreous fiber (SVF):	Any	of	a	number	of	manufactured	fibers	produced	by	the	melting	
and	subsequent	fiberization	of	kaolin	clay,	sand,	rock,	slag,	etc.	Fibrous	glass,	mineral	wool,	ceramic	
fibers,	and	alkaline	earth	silicate	wools	are	the	major	types	of	SVF,	also	called	man-made	mineral	
fiber	(MMMF)	or	man-made	vitreous	fiber	(MMVF).
Thoracic-sized fiber:	Particles	>5	µm	long	with	aspect	ratio	>3:1	and	a	diameter	<3	to	3.5	µm.	
Thoracic	refers	to	particles	penetrating	to	the	thorax	(50%	cut	at	10-µm	aerodynamic	diameter).	
Mineral	and	vitreous	fibers	with	diameters	3	to	3.5	µm	have	an	aerodynamic	diameter	of	approxi-
mately	10	µm.
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1 Recommendations for a Refractory Ceramic Fiber (RCF) Standard
mesothelioma,	 and	 other	 adverse	 respiratory	
health	 effects	 (including	 irritation	 and	 com-
promised	pulmonary	function)	associated	with	
excessive	RCF	exposure	in	the	workplace.	Lim-
iting	exposures	will	also	protect	workers’	eyes	
and	skin	from	the	mechanical	irritation	asso-
ciated	with	exposure	to	RCFs.	In	most	manu-
facturing	operations,	it	is	currently	possible	to	
limit	airborne	RCF	concentrations	to	0.5	f/cm3	
or	less.	Exceptions	may	occur	during	RCF	fin-
ishing	 operations	 and	 during	 the	 installation	
and	removal	of	RCF	products,	when	the	nature	
of	 job	activities	presents	a	challenge	to	meet-
ing	 the	REL.	For	 these	operations,	 additional	
protective	measures	 are	 recommended.	 Engi-
neering	and	administrative	controls,	respirator	
use,	and	other	preventive	measures	should	be	
implemented	to	minimize	exposures	for	work-
ers	 in	 RCF	 industry	 sectors	 where	 airborne	
RCF	 concentrations	 exceed	 the	 REL.	NIOSH	
urges	employers	 to	disseminate	 this	 informa-
tion	to	workers	and	customers,	and	RCF	man-
ufacturers	 should	 convey	 this	 information	 to	
downstream	users.	NIOSH	 also	 requests	 that	
professional	 and	 trade	 associations	 and	 labor	
organizations	inform	their	members	about	the	
hazards	of	exposure	to	RCFs.
1.2  Definitions and 
 Characteristics
1.2.1 Naturally Occurring Mineral Fibers
Many	types	of	mineral	fibers	occur	naturally.	
Asbestos	 is	 the	 most	 prominent	 of	 these	 fi-
bers	because	of	its	industrial	application.	The	
The	National	Institute	for	Occupational	Safety	
and	Health	 (NIOSH)	 recommends	 that	 expo-
sure	to	airborne	refractory	ceramic	fibers	(RCFs)	
be	controlled	in	the	workplace	by	implementing	
the	 recommendations	 presented	 in	 this	 docu-
ment.	These	recommendations	are	designed	to	
protect	the	safety	and	health	of	workers	for	up	to	
a	10-hr	work	shift	during	a	40-hr	workweek	over	
a	40-year	working	lifetime.	Observance	of	these	
recommendations	should	prevent	or	greatly	re-
duce	the	risks	of	eye	and	skin	irritation	and	ad-
verse	respiratory	health	effects	(including	lung	
cancer)	 in	 workers	 with	 exposure	 to	 airborne	
RCFs.	 Preventive	 efforts	 are	 primarily	 focused	
on	 controlling	 and	minimizing	 airborne	 fiber	
concentrations	 to	which	workers	 are	 exposed.	
Exposure	monitoring,	hazard	communication,	
training,	 respiratory	protection	programs,	 and	
medical	 monitoring	 are	 also	 important	 ele-
ments	of	a	comprehensive	program	to	protect	
the	health	of	workers	 exposed	 to	RCFs.	These	
elements	 are	 described	 briefly	 in	 this	 chapter	
and	in	greater	detail	in	Chapter	9.
1.1  Recommended Exposure 
 Limit (REL)
NIOSH	recommends	that	occupational	expo-
sures	to	airborne	RCFs	be	limited	to	0.5	fiber	
per	cubic	centimeter	(f/cm3)	of	air	as	a	 time-
weighted	average	(TWA)	concentration	for	up	
to	a	10-hr	work	shift	during	a	40-hr	workweek,	
measured	 according	 to	NIOSH	Method	7400	
(B	rules)	[NIOSH	1998].	
This	 recommended	 exposure	 limit	 (REL)	 is	
intended	 to	 reduce	 the	 risk	 of	 lung	 cancer,	
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asbestos	minerals	include	both	the	serpentine	
asbestos	(chrysotile)	and	the	amphibole	min-
eral	 fibers,	 including	 actinolite,	 amosite,	 an-
thophyllite,	 crocidolite,	 and	 tremolite	 [Peters	
and	 Peters	 1980].	 Since	 ancient	 times,	 min-
eral	fibers	have	been	mined	and	processed	for	
use	as	insulation	because	of	their	high	tensile	
strength,	 resistance	 to	 heat,	 durability	 in	 ac-
ids	and	other	chemicals,	and	light	weight.	The	
predominant	 forms	 of	 asbestos	 mined	 and	
used	 today	are	 chrysotile	 (~95%),	 crocidolite	
(<5%),	and	amosite	(<1%).	
For	 the	purposes	of	 this	document,	naturally	
occurring	 mineral	 fibers	 are	 distinguishable	
from	synthetic	vitreous	fibers	(SVFs)	based	on	
the	crystalline	structure	of	the	mineral	fibers.	
This	property	causes	the	mineral	fibers	to	frac-
ture	longitudinally	when	subjected	to	mechan-
ical	 stresses,	 thereby	 producing	 more	 fibers	
of	decreasing	diameter.	By	 contrast,	 SVFs	are	
amorphous	and	fracture	transversely,	resulting	
in	more	 fibers	 of	 decreasing	 length	 until	 the	
segments	are	no	longer	of	sufficient	length	to	
be	considered	fibers.	Naturally	occurring	min-
eral	fibers	are	generally	more	durable	and	less	
soluble	 than	 SVFs,	 a	 property	 that	 accounts	
for	 the	biopersistence	and	toxicity	of	mineral	
fibers	in	vivo.
1.2.2  RCFs
RCFs	are	a	 type	of	SVF;	 they	are	amorphous	
synthetic	 fibers	 produced	 from	 the	 melting	
and	 blowing	 or	 spinning	 of	 calcined	 kaolin	
clay	or	a	combination	of	alumina	(Al
2
O
3
)	and	
silicon	dioxide	(SiO
2
).	Oxides	such	as	zirconia,	
ferric	 oxide,	 titanium	 oxide,	 magnesium	 ox-
ide,	calcium	oxide,	and	alkalies	may	be	added.	
The	percentage	of	components	(by	weight)	 is	
as	follows:	alumina,	20%	to	80%;	silicon	diox-
ide,	20%	to	80%;	and	other	oxides	 in	smaller	
amounts.	 Like	 the	 naturally	 occurring	 min-
eral	 fibers,	RCFs	possess	 the	desired	qualities	
of	 heat	 resistance,	 tensile	 strength,	 durability,	
and	 light	 weight.	 On	 a	 continuum,	 however,	
RCFs	are	less	durable	(i.e.,	more	soluble)	than	
the	least	durable	asbestos	fiber	(chrysotile)	but	
more	durable	than	most	fibrous	glass	and	oth-
er	types	of	SVFs.
1.2.3 SVFs
SVFs	include	a	number	of	manmade	(not	natu-
rally	occurring)	fibers	that	are	produced	by	the	
melting	and	subsequent	fiberization	of	kaolin	
clay,	sand,	rock,	slag,	and	other	materials.	The	
major	types	of	SVFs	are	fibrous	glass,	mineral	
wool	(slag	wool,	rock	wool),	and	ceramic	fibers	
(including	RCFs).	SVFs	are	also	frequently	re-
ferred	to	as	manmade	mineral	fibers	(MMMFs)	
or	manmade	vitreous	fibers	(MMVFs).
1.3 Sampling and Analysis
Employers	 shall	 perform	 air	 sampling	 and	
analysis	to	determine	airborne	concentrations	
of	RCFs	according	to	NIOSH	Method	7400	(B	
rules)	[NIOSH	1998],	provided	in	Appendix	A	
of	this	document.
1.4 Exposure Monitoring
Employers	shall	perform	exposure	monitoring	
as	follows:
■	 Establish	a	workplace	exposure	monitor-
ing	 program	 for	 worksites	 where	 RCFs	
or	RCF	products	are	manufactured,	han-
dled,	used,	installed,	or	removed.
■	 Include	in	this	program	routine	area	and	
personal	 monitoring	 of	 airborne	 fiber	
concentrations.	
■	Design	a	monitoring	strategy	that	can	be	
used	to	
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—	evaluate	a	worker’s	exposure	to	RCFs,
—	assess	the	effectiveness	of	engineering	
controls,	 work	 practices,	 and	 other	
factors	 in	 controlling	 airborne	 fiber	
concentrations,	and	
—	identify	 work	 areas	 or	 job	 tasks	 in	
which	worker	exposures	are	routinely	
high	 and	 thus	 require	 additional	 ef-
forts	to	reduce	them.
1.4.1 Sampling Surveys 
Employers	shall	conduct	exposure	monitoring	
surveys	to	ensure	that	worker	exposures	(mea-
sured	by	full-shift	samples)	do	not	exceed	the	
REL.	Because	adverse	respiratory	health	effects	
may	occur	at	the	REL,	it	is	desirable	to	achieve	
lower	concentrations	whenever	possible.	When	
workers	 are	 potentially	 exposed	 to	 airborne	
RCFs,	employers	shall	conduct	exposure	mon-
itoring	surveys	as	follows:
■	 Collect	 representative	 personal	 samples	
over	the	entire	work	shift	[NIOSH	1997a].
■	 Perform	 periodic	 sampling	 at	 least	 an-
nually	 and	whenever	 any	major	process	
change	takes	place	or	whenever	another	
reason	 exists	 to	 suspect	 that	 exposure	
concentrations	may	have	changed.
■	 Collect	 all	 routine	 personal	 samples	 in	
the	breathing	zones	of	the	workers.	
■	 If	workers	are	exposed	to	concentrations	
above	 the	 REL,	 perform	more	 frequent	
exposure	 monitoring	 as	 engineering	
changes	 are	 implemented	 and	 until	 at	
least	 two	 consecutive	 samples	 indicate	
that	exposures	no	longer	exceed	the	REL	
[NIOSH	1977a].
■	Notify	all	workers	of	monitoring	results	
and	of	any	actions	taken	to	reduce	their	
exposures.	
■	When	developing	an	exposure	sampling	
strategy,	consider	variations	in	work	and	
production	 schedules	 as	 well	 as	 the	 in-
herent	variability	in	most	area	sampling	
[NIOSH	1995a].	
1.4.1.1 Focused sampling
When	sampling	to	determine	whether	worker	
RCF	 exposures	 are	 below	 the	REL,	 a	 focused	
sampling	strategy	may	be	more	practical	than	
a	random	sampling	approach.	A	focused	sam-
pling	 strategy	 targets	workers	perceived	 to	be	
exposed	to	the	highest	concentrations	of	a	haz-
ardous	substance	[Leidel	and	Busch	1994].	This	
strategy	is	most	efficient	for	identifying	expo-
sures	 above	 the	REL	 if	maximum-risk	work-
ers	and	time	periods	are	accurately	identified.	
Short	 tasks	 involving	 high	 concentrations	 of	
airborne	fibers	 could	 result	 in	 elevated	expo-
sure	over	full	work	shifts.	
Sampling	strategies	such	as	those	used	by	Corn	
and	Esmen	[1979],	Rice	et	al.	[1997],	and	Max-
im	et	al.	[1997]	have	been	developed	and	used	
specifically	in	RCF	manufacturing	facilities	to	
monitor	airborne	fiber	concentration.	In	these	
strategies,	 representative	 workers	 are	 selected	
for	 sampling	 and	 are	 grouped	 according	 to	
dust	 zones,	 uniform	 job	 titles,	 or	 functional	
job	categories.	These	approaches	are	intended	
to	reduce	the	number	of	required	samples	and	
increase	the	confidence	of	identifying	workers	
at	similar	risk.		
1.4.1.2 Area sampling
Area	sampling	may	be	useful	in	exposure	mon-
itoring	to	determine	sources	of	airborne	RCFs	
and	 to	 assess	 the	 effectiveness	 of	 engineering	
controls.	
1.4.2 Action Level
An	action	level	(AL)	at	half	the	REL	(0.25	f/cm3)	
shall	 be	 used	 to	 determine	 when	 additional	
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controls	 are	 needed	 or	 when	 administrative	
actions	should	be	taken	to	reduce	exposure	to	
RCFs.	The	purpose	of	an	AL	is	to	indicate	when	
worker	exposures	to	hazardous	substances	may	
be	 approaching	 the	 REL.	 	When	 air	 samples	
contain	concentrations	at	or	above	the	AL,	the	
probability	 is	 high	 that	 worker	 exposures	 to	
the	hazardous	substance	exceed	the	REL.	
The	AL	is	a	statistically	derived	concept	permit-
ting	the	employer	to	have	confidence	(e.g.,	95%)	
that	if	results	from	personal	air	samples	are	be-
low	the	AL,	the	probability	is	small	that	worker	
exposures	are	above	the	REL.	NIOSH	has	con-
cluded	 that	 the	use	of	 an	AL	permits	 the	 em-
ployer	 to	monitor	hazardous	workplace	 expo-
sures	without	daily	 sampling.	The	AL	concept	
has	served	as	the	basis	for	defining	the	elements	
of	 an	 occupational	 standard	 in	 NIOSH	 crite-
ria	 documents	 and	 comprehensive	 standards	
promulgated	 by	 the	 Occupational	 Safety	 and	
Health	Administration	 (OSHA)	 and	 the	Mine	
Safety	and	Health	Administration	(MSHA).	
1.5 Hazard Communication
Employers	shall	take	the	following	measures	to	
inform	workers	about	RCF	hazards:	
■	 Establish	 a	 safety	 and	 health	 training	
program	 for	 all	 workers	 who	manufac-
ture,	use,	handle,	install,	or	remove	RCF	
products	or	perform	other	activities	that	
bring	them	into	contact	with	RCFs.
■	 Inform	 employees	 and	 contract	 work-
ers	 about	hazardous	 substances	 in	 their	
work	areas.
■	 Instruct	workers	about	how	to	get	infor-
mation	 from	material	 safety	data	 sheets	
(MSDSs)	for	RCFs	and	other	chemicals.
■	 Provide	 MSDSs	 onsite	 and	 make	 them	
easily	accessible.
■	 Inform	 workers	 about	 adverse	 respira-
tory	 health	 effects	 associated	 with	 RCF	
exposures.	
■	 In	work	involving	the	removal	of	refrac-
tory	 insulation	materials,	make	workers	
aware	 of	 the	 potential	 for	 exposure	 to	
respirable	crystalline	silica,	the	health	ef-
fects	related	to	this	exposure,	and	meth-
ods	for	reducing	exposures.	
■	Make	 workers	 who	 smoke	 cigarettes	
or	 use	 other	 tobacco	products	 aware	 of	
their	 increased	 risk	 of	 developing	RCF-
induced	respiratory	symptoms	and	con-
ditions	(see	Sections	1.12	and	9.6	for	rec-
ommendations	about	smoking	cessation	
programs).
1.6 Training
Employers	shall	provide	the	following	training	
for	workers	exposed	to	RCFs:
■	 Train	workers	to	detect	hazardous	situa-
tions.
■	 Inform	 workers	 about	 practices	 or	 op-
erations	 that	 may	 generate	 high	 air-
borne	fiber	concentrations	(e.g.,	cutting	
and	sanding	RCF	boards	and	other	RCF	
products).	
■	 Train	workers	how	to	protect	themselves	
by	 using	 proper	 work	 practices,	 engi-
neering	controls,	and	personal	protective	
equipment	(PPE).
1.7 Product Formulation
One	 factor	 recognized	 as	 contributing	 to	 the	
toxicity	 of	 an	 inhaled	 fiber	 is	 its	 durability	
and	 resistance	 to	 degradation	 in	 the	 respira-
tory	tract.	Chemical	characteristics	place	RCFs	
among	the	most	durable	SVFs.	As	a	result,	an	
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inhaled	RCF	that	is	deposited	in	the	alveolar	re-
gion	of	the	lung	will	persist	longer	in	the	lungs	
than	 a	 less	 durable	 fiber.	 Therefore,	 NIOSH	
recommends	 substituting	 a	 less	 durable	 fiber	
for	 RCFs	 or	 reformulating	 the	 chemistry	 of	
RCFs	toward	this	end	to	reduce	the	hazard	for	
exposed	workers.	As	part	of	product	steward-
ship	efforts,	several	RCF	producers	within	the	
Refractory	 Ceramic	 Fibers	 Coalition	 (RCFC)	
have	developed	new	and	 less	biopersistent	fi-
bers	termed	alkaline	earth	silicate	wools	[Max-
im	et	al.	1999b].	Newly	developed	fibers	should	
undergo	 industry-sponsored	 testing	 before	
their	selection	and	commercial	use	to	exclude	
possible	adverse	health	effects	from	exposure.	
1.8  Engineering Controls 
and Work Practices
1.8.1  Engineering Controls
Employers	shall	use	and	maintain	appropriate	
engineering	controls	to	keep	airborne	concen-
trations	of	RCFs	at	or	below	 the	REL	during	
the	 manufacture,	 use,	 handling,	 installation,	
and	 removal	 of	 RCF	 products.	 Engineering	
controls	for	controlling	RCFs	include	the	fol-
lowing:		
■	 Local	exhaust	ventilation	or	dust	collec-
tion	 systems	 at	 or	 near	 dust-generating	
systems
—	Band	saws	used	in	RCF	manufactur-
ing	 and	 finishing	 operations	 have	
been	 fitted	 with	 such	 engineering	
controls	 to	 capture	 fibers	 and	 dust	
during	 cutting	 operations,	 thereby	
reducing	exposures	for	the	band	saw	
operator	[Venturin	1998].
—	Disc	sanders	fitted	with	similar	 local	
exhaust	ventilation	systems	effectively	
reduce	 airborne	 RCF	 concentrations	
during	the	sanding	of	vacuum-formed	
RCF	products	[Dunn	et	al.	2004].
■	 Enclosed	 processes	 used	 during	 manu-
facturing	 to	 keep	 airborne	 fibers	 con-
tained	and	separated	from	workers	
■	Water	 knives,	 which	 are	 high-pressure	
water	jets	that	effectively	cut	and	trim	the	
edges	of	RCF	blanket	while	 suppressing	
dust	 and	 limiting	 the	generation	of	 air-
borne	fibers	
1.8.2  Work Practices
Employers	 shall	 implement	appropriate	work	
practices	to	help	keep	worker	exposures	at	or	
below	the	REL	for	RCFs.	The	 following	work	
practices	 are	 recommended	 to	 help	 reduce	
concentrations	of	airborne	fibers:
■	 Limit	the	use	of	power	tools	unless	they	
are	equipped	with	 local	exhaust	or	dust	
collection	systems.
—	Be	aware	that	manually	powered	hand	
tools	generate	less	dust	and	fewer	air-
borne	 fibers,	 but	 they	 often	 require	
additional	 physical	 effort	 and	 time	
and	may	increase	the	risk	of	muscu-
loskeletal	disorders.	
—	The	additional	physical	effort	required	
by	 hand	 tools	may	 also	 increase	 the	
rate	and	depth	of	breathing	and	con-
sequently	 affect	 the	 inhalation	 rate	
and	deposition	of	fibers	in	the	lungs.	
■	Use	 ergonomically	 correct	 tools	 and	
proper	workstation	design	to	reduce	the	
risk	of	musculoskeletal	disorders.	
■	Use	high-efficiency	particulate	air-filtered	
(HEPA-filtered)	vacuums.
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■	Use	 wet	 sweeping	 to	 suppress	 airborne	
fiber	 and	 dust	 concentrations	 during	
cleanup.
■	When	removing	after-service	RCF	prod-
ucts,	dampen	insulation	with	a	light	wa-
ter	spray	to	prevent	fibers	and	dust	from	
becoming	 airborne.	 (However,	 use cau-
tion when dampening refractory linings 
during installation,	since	water	can	dam-
age	 refractory-lined	 equipment,	 causing	
the	generation	of	steam	and	possible	ex-
plosion	during	heating.)	
■	 Clean	work	areas	regularly	using	a	HEPA-
filtered	vacuum	or	wet	sweeping	to	mini-
mize	accumulation	of	debris.	
■	 Ensure	 that	 workers	 wear	 long-sleeved	
clothing,	gloves,	and	eye	protection	when	
performing	 potentially	 dusty	 activities	
involving	 RCFs	 or	 RCF	 products.	 For	
some	 activities,	 disposable	 clothing	 or	
coveralls	may	be	preferred.
1.9 Respiratory Protection
Respirators	 shall	 be	 used	 while	 performing	
any	 task	 for	 which	 the	 exposure	 concentra-
tion	 is	unknown	or	has	been	documented	 to	
be	higher	than	the	NIOSH	REL	of	0.5	f/cm3	as	
a	TWA.	However,	respirators	shall	not	be	used	
as	the	primary	means	of	controlling	worker	ex-
posures.	
When	 possible,	 use	 other	methods	 for	mini-
mizing	worker	exposures	to	RCFs:
■	 Product	substitution
■	 Engineering	controls
■	 Changes	in	work	practices
Use	 respirators	 when	 available	 engineering	
controls	and	work	practices	do	not	adequately	
control	 worker	 exposures	 below	 the	 REL	 for	
RCFs.	NIOSH	recognizes	 that	 controlling	ex-
posures	to	RCFs	is	a	particular	challenge	during	
the	finishing	stages	of	RCF	product	manufac-
turing	and	during	the	installation	and	removal	
of	refractory	materials
1.9.1 Respiratory Protection Program
When	 respiratory	 protection	 is	 needed,	 em-
ployers	 shall	 establish	a	comprehensive	respi-
ratory	protection	program	as	described	in	the	
OSHA	 respiratory	 protection	 standard	 [29	
CFR*	1910.134].	Elements	of	a	respiratory	pro-
tection	program	must	be	 established	and	de-
scribed	in	a	written	plan	that	is	specific	to	the	
workplace.	The	plan	must	include	the	follow-
ing	elements:	
■	 Procedures	for	selecting	respirators
■	Medical	evaluations	of	workers	required	
to	wear	respirators
■	 Fit-testing	procedures
■	 Routine-use	 procedures	 and	 emergency	
respirator-use	procedures
■	 Procedures	 and	 schedules	 for	 cleaning,	
disinfecting,	storing,	inspecting,	repairing,	
discarding,	and	maintaining	respirators
■	 Procedures	 for	 ensuring	 adequate	 air	
quality	for	supplied-air	respirators
■	 Training	in	respiratory	hazards
■	 Training	 in	 the	proper	use	 and	mainte-
nance	of	respirators
■	 Program	evaluation	procedures
■	 Procedures	for	ensuring	that	workers	who	
voluntarily	 wear	 respirators	 (excluding	
filtering	facepieces	known	as	dust	masks)	
*Code of Federal Regulations.		See	CFR	in	references.
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comply	with	the	medical	evaluation	and	
cleaning,	 storing,	 and	 maintenance	 re-
quirements	of	the	standard
■	 A	designated	program	administrator	who	
is	qualified	to	administer	the	respiratory	
protection	program
Employers	shall	update	the	written	program	as	
necessary	to	account	for	changes	in	the	work-
place	 that	 affect	 respirator	 use.	 In	 addition,	
employers	 are	 required	 to	 provide	 at	 no	 cost	
to	workers	all	equipment,	training,	and	medi-
cal	evaluations	required	under	the	respiratory	
protection	program.		
1.9.2  Respirator Selection
When	conditions	of	exposure	to	airborne	RCFs	
exceed	the	REL,	proper	respiratory	protection	
shall	be	selected	as	follows:	
■	 Select,	 at	 a	minimum,	 a	 half-mask,	 air-
purifying	respirator	equipped	with	a	100	
series	 particulate	 filter.	 This	 respirator	
has	an	assigned	protection	factor	(APF)	
of	10.
■	 Provide	a	higher	level	of	protection	and	
prevent	 facial	 or	 eye	 irritation	 from	
RCF	 exposure	 by	 using	 a	 full-facepiece,	
air-purifying	 respirator	 equipped	 with	
a	 100-series	 filter;	 or	 use	 any	 powered,	
air-purifying	respirator	equipped	with	a	
tight-fitting	facepiece	(full-facepiece).
■	 Consider	 providing	 a	 supplied-air	 res-
pirator	with	a	 full	 facepiece	 for	workers	
who	remove	after-service	RCF	insulation	
(e.g.,	 furnace	 insulation)	 and	 are	 there-
fore	 exposed	 to	 high	 and	unpredictable	
concentrations	 of	 RCFs.	 These	 respira-
tors	provide	a	greater	level	of	respiratory	
protection.	Use	them	whenever	the	work	
task	involves	potentially	high	concentra-
tions	of	airborne	fibers.	
■	 Always	 perform	 a	 comprehensive	 as-
sessment	of	workplace	exposures	 to	de-
termine	 the	 presence	 of	 other	 possible	
contaminants	(such	as	silica)	and	to	en-
sure	that	proper	respiratory	protection	is	
used.
■	Use	only	respirators	approved	by	NIOSH	
and	MSHA.
For	information	and	assistance	in	establishing	
a	respiratory	protection	program	and	selecting	
appropriate	respirators,	see	the	OSHA	Respira-
tory Protection Advisor	on	the	OSHA	Web	site	
at	 www.osha.gov.	 Additional	 information	 is	
also	 available	 from	 the	NIOSH Respirator Se-
lection Logic	[NIOSH	2004],	the	NIOSH Guide 
to Industrial Respiratory Protection	 [NIOSH	
1987b],	and	the	NIOSH Guide to the Selection 
and Use of Particulate Respirators Certified un-
der 42 CFR 84	[NIOSH	1996].
1.10 Sanitation and Hygiene
Employers	shall	take	the	following	measures	to	
protect	workers	potentially	exposed	to	RCFs:
■	Do	not	permit	smoking,	eating,	or	drink-
ing	in	areas	where	workers	may	contact	
RCFs.
■	 Provide	 showering	 and	 changing	 areas	
free	 from	contamination	where	workers	
can	 store	work	 clothes	 and	 change	 into	
street	 clothes	 before	 leaving	 the	 work	
site.	
■	 Provide	 services	 for	 laundering	 work	
clothes	so	that	workers	do	not	take	con-
taminated	clothes	home.
■	 Protect	 laundry	 workers	 handling	 RCF-
contaminated	clothes	from	airborne	con-
centrations	that	are	above	the	REL.	
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Workers	 shall	 take	 the	 following	 protective	
measures:
■	Do	not	smoke,	eat,	or	drink	in	areas	po-
tentially	contaminated	with	RCFs.
■	 If	fibers	get	on	the	skin,	wash	with	warm	
water	and	mild	soap.
■	 Apply	skin-moisturizing	cream	or	lotion	
as	 needed	 to	 avoid	 irritation	 caused	 by	
frequent	washing.
■	Wear	 long-sleeved	 clothing,	 gloves,	 and	
eye	protection	when	performing	poten-
tially	dusty	activities	involving	RCFs.
■	 Vacuum	this	clothing	with	a	HEPA-filtered	
vacuum	before	leaving	the	work	area.
■	Do	not	use	 compressed	air	 to	 clean	 the	
work	area	or	clothing	and	do	not	shake	
clothing	to	remove	dust.	These	processes	
will	 create	 a	 greater	 respiratory	 hazard	
with	airborne	dust	and	fibers.	
■	Do	not	wear	work	 clothes	or	protective	
equipment	 home.	 Change	 into	 clean	
clothes	before	leaving	the	work	site.
1.11 Medical Monitoring
Medical	 monitoring	 (in	 combination	 with	
resulting	 intervention	 strategies)	 represents	
secondary	prevention	and	 should	not	 replace	
primary	prevention	efforts	to	control	airborne	
fiber	 concentrations	 and	 worker	 exposures	
to	 RCFs.	However,	 compliance	with	 the	 REL	
for	RCFs	 (0.5	 f/cm3)	does	not	 guarantee	 that	
all	workers	will	be	free	from	the	risk	of	RCF-
induced	 respiratory	 irritation	 or	 respiratory	
health	 effects.	 Therefore,	medical	monitoring	
is	 especially	 important,	 and	 employers	 shall	
establish	a	medical	monitoring	program	as	fol-
lows:
■	 Collect	 baseline	 data	 for	 all	 employees	
before	they	begin	work	with	RCFs.
■	 Continue	 periodic	 medical	 screening	
throughout	their	lifetime.	
■	Use	medical	surveillance,	which	involves	
the	 aggregate	 collection	 and	 analysis	 of	
medical	 screening	 data,	 to	 identify	 oc-
cupations,	activities,	and	work	processes	
in	need	of	additional	primary	prevention	
efforts.
■	 Include	 all	 workers	 potentially	 exposed	
to	 RCFs	 (in	 both	 manufacturing	 and	
end-use	 industries)	 in	 an	 occupational	
medical	monitoring	program.
■	 Provide	workers	with	information	about	
the	purposes	of	medical	monitoring,	the	
health	benefits	of	 the	program,	 and	 the	
procedures	involved.	
■	 Include	 the	 following	 workers	 (who	
could	 receive	 the	 greatest	 benefits	 from	
medical	screening)	in	the	medical	moni-
toring	program:	
—	Workers	 exposed	 to	 elevated	 fiber	
concentrations	 (e.g.,	 all	 workers	 ex-
posed	 to	 airborne	 fiber	 concentra-
tions	above	 the	AL	of	0.25	F/cm3,	as	
described	in	Section	9.3)
—	Workers	 in	 areas	 or	 in	 specific	 jobs	
and	activities	(regardless	of	airborne	
fiber	concentration)	in	which	one	or	
more	workers	have	symptoms	or	re-
spiratory	 changes	 apparently	 related	
to	RCF	exposure
—	Workers	 who	may	 have	 been	 previ-
ously	 exposed	 to	 asbestos	 or	 other	
recognized	 occupational	 respiratory	
hazards	 that	 place	 them	 at	 an	 in-
creased	risk	of	respiratory	disease		
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1.11.1 Oversight of the Program
Assign	 oversight	 of	 the	 medical	 monitor-
ing	program	to	a	qualified	physician	or	other	
qualified	health	care	provider	 (as	determined	
by	appropriate	State	laws	and	regulations)	who	
is	informed	and	knowledgeable	about	the	fol-
lowing:
■	 Administering	 and	managing	 a	medical	
monitoring	 program	 for	 occupational	
hazards
■	 Establishing	 a	 respiratory	 protection	
program	based	 on	 an	understanding	 of	
requirements	 of	 the	 OSHA	 respiratory	
protection	 standard	 and	 types	 of	 respi-
ratory	protection	devices	available	at	the	
workplace
■	 Identifying	 and	 managing	 work-related	
respiratory	effects	or	illnesses
■	 Identifying	 and	 managing	 work-related	
skin	diseases
1.11.2 Elements of the Medical 
Monitoring Program 
Include	 the	 following	 elements	 in	 a	 medical	
monitoring	 program	 for	 workers	 exposed	 to	
RCFs:	(1)	an	initial	medical	examination,	(2)	pe-
riodic	medical	examinations	at	regularly	sched-
uled	 intervals,	 (3)	more	 frequent	 and	detailed	
medical	examinations	as	needed	on	the	basis	of	
the	findings	from	these	examinations,	(4)	work-
er	training,	(5)	written	reports	of	medical	find-
ings,	(6)	quality	assurance,	and	(7)	evaluation.	
These	 elements	 are	described	 in	 the	 following	
subsections.	
1.11.2.1  Initial (baseline) examination 
Perform	an	initial	(baseline)	examination	as	near	
as	possible	to	the	date	of	beginning	employment	
(within	3	months)	and	include	the	following:
■	 A	 physical	 examination	 of	 all	 systems	
with	an	emphasis	on	the	respiratory	sys-
tem	and	the	skin
■	 A	spirometric	 test	 (note	 that	anyone	ad-
ministering	spirometric	testing	as	part	of	
the	medical	monitoring	program	should	
have	completed	a	NIOSH-approved	train-
ing	course	in	spirometry	or	other	equiva-
lent	training)	
■	 A	chest	X-ray	(all	chest	X-ray	films	should	
be	 interpreted	 by	 a	 certified	 NIOSH	 B	
Reader	 using	 the	 standard	 International 
Classification of Radiographs of Pneumo-
conioses	 [ILO	 2000,	 or	 the	 most	 recent	
equivalent])	
■	Other	medical	tests	as	deemed	appropri-
ate	by	the	responsible	health	care	profes-
sional
■	 A	standardized	respiratory	symptom	ques-
tionnaire,	such	as	the	American	Thoracic	
Society	 respiratory	 questionnaire	 [Ferris	
1978,	or	the	most	recent	equivalent]	
■	 A	standardized	occupational	history	ques-
tionnaire	 that	gathers	 information	about	
all	past	jobs	with	(1)	special	emphasis	on	
those	with	potential	exposure	to	dust	and	
mineral	fibers,	(2)	a	description	of	all	du-
ties	and	potential	exposures	for	each	job,	
and	 (3)	 a	 description	 of	 all	 protective	
equipment	the	worker	has	used
1.11.2.2  Periodic examinations
Administer	 periodic	 examinations	 (includ-
ing	 a	physical	 examination	of	 the	 respiratory	
system	and	the	skin,	spirometric	testing,	a	re-
spiratory	symptom	update	questionnaire,	and	
an	occupational	history	update	questionnaire)	
at	regular	intervals	determined	by	the	medical	
monitoring	 program	 director.	 Determine	 the	
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frequency	 of	 the	 periodic	 medical	 examina-
tions	according	to	the	following	guidelines:
■	 For	workers	with	fewer	than	10	years	since	
first	 exposure	 to	RCFs,	 conduct	periodic	
examinations	at	least	once	every	5	years.
■	 For	workers	with	10	or	more	years	since	
first	exposure	to	RCFs,	conduct	periodic	
examinations	at	least	once	every	2	years.	
A	chest	X-ray	and	spirometric	testing	are	im-
portant	 on	 initial	 examination	 and	may	 also	
be	appropriate	medical	screening	tests	during	
periodic	 examinations	 for	 detecting	 respira-
tory	 system	 changes,	 especially	 in	 workers	
with	more	than	10	years	since	first	exposure	to	
RCFs.	A	qualified	health	care	provider	should	
consult	with	the	worker	to	determine	whether	
the	 benefits	 of	 periodic	 chest	X-rays	warrant	
the	additional	exposure	to	radiation.	
1.11.2.3 More frequent evaluations
Workers	may	need	to	undergo	more	frequent	
and	detailed	medical	evaluations	if	the	attend-
ing	physician	determines	that	he	or	she	has	any	
of	the	following	indications:
■	New	or	worsening	respiratory	symptoms	
or	findings	(e.g.,	chronic	cough,	difficult	
breathing,	wheezing,	reduced	lung	func-
tion,	or	radiographic	indications	of	pleu-
ral	plaques	or	fibrosis)
■	History	of	exposure	to	other	respiratory	
hazards	(e.g.,	asbestos)
■	 Recurrent	or	chronic	dermatitis
■	Other	medically	significant	reason(s)	for	
more	detailed	assessment
1.11.2.4 Worker training
Provide	 workers	 with	 sufficient	 training	 to	
recognize	 symptoms	 associated	 with	 RCF	
exposures	(e.g.,	chronic	cough,	difficult	breath-
ing,	wheezing,	skin	irritation).	Instruct	work-
ers	to	report	these	symptoms	to	the	designated	
medical	monitoring	program	director	or	other	
qualified	health	care	provider	 for	appropriate	
diagnosis	and	treatment.	
1.11.2.5   Written reports of medical 
findings
Following	initial	and	periodic	medical	exami-
nations,	the	physician	or	other	qualified	health	
care	provider	shall	give	each	worker	a	written	
report	containing
—	results	of	any	medical	tests	performed	
on	the	worker,
—	a	medical	 opinion	 in	plain	 language	
about	 any	 medical	 condition	 that	
would	 increase	 the	 worker=s	 risk	 of	
impairment	 from	 exposure	 to	 air-
borne	RCFs,
—	recommendations	 for	 limiting	 the	
worker=s	 exposure	 to	 RCFs	 (which	
may	 include	 the	 use	 of	 appropriate	
PPE,	as	warranted),	and
—	recommendations	 for	 further	 evalu-
ation	 and	 treatment	 of	 any	medical	
conditions	detected.	
Following	initial	and	periodic	medical	exami-
nations,	the	physician	or	other	qualified	health	
care	provider	shall	also	give	a	written	report	to	
the	employer	containing
—	occupationally	 pertinent	 results	 of	
the	medical	evaluation,
—	a	 medical	 opinion	 about	 any	 medi-
cal	condition	that	would	increase	the	
worker=s	risk	of	impairment	from	ex-
posure	to	airborne	RCFs,
—	recommendations	 for	 limiting	 the	
worker=s	 exposure	 to	 RCFs	 or	 other	
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agents	 in	 the	workplace	 (which	may	
include	the	use	of	appropriate	PPE	or	
reassignment	to	another	job),	and
—	a	statement	to	indicate	that	the	work-
er	 has	 been	 informed	 about	 the	 re-
sults	of	the	medical	examination	and	
about	 any	medical	 condition(s)	 that	
should	 have	 further	 evaluation	 or	
treatment.	
Findings,	test	results,	or	diagnoses	that	have	no	
bearing	 on	 the	worker=s	 ability	 to	work	with	
RCFs	shall	not	be	included	in	the	report	to	the	
employer.	Safeguards	to	protect	the	confiden-
tiality	 of	 the	 worker=s	 medical	 records	 shall	
be	 enforced	 in	accordance	with	all	 applicable	
regulations	and	guidelines.	
1.11.2.6  Quality assurance
Employers	shall	do	the	following	to	ensure	the	
effective	 implementation	 of	 a	medical	moni-
toring	program:
■	 Ensure	that	workers	follow	the	qualified	
health	care	provider’s	recommended	ex-
posure	 restrictions	 for	 RCFs	 and	 other	
workplace	hazards.	
■	 Ensure	that	workers	use	appropriate	PPE	
if	 they	 are	 exposed	 to	 RCF	 concentra-
tions	above	the	REL.	
■	 Encourage	workers	 to	participate	 in	 the	
medical	monitoring	program	and	to	re-
port	any	symptoms	promptly	to	the	pro-
gram	director.
■	 Provide	any	medical	evaluations	that	are	
part	of	the	medical	monitoring	program	
at	no	cost	to	the	workers.	
■	When	 implementing	 job	 reassignments	
recommended	 by	 the	 medical	 program	
director,	ensure	that	workers	do	not	lose	
wages,	benefits,	or	seniority.
■	 Ensure	that	the	medical	monitoring	pro-
gram	 director	 communicates	 regularly	
with	 the	 employer’s	 safety	 and	 health	
personnel	 (e.g.,	 industrial	hygienists)	 to	
identify	work	areas	that	may	require	con-
trol	measures	 to	minimize	 exposures	 to	
workplace	hazards.	
1.11.2.7  Evaluation
Employers	 shall	evaluate	 their	medical	moni-
toring	programs	as	follows:
■	 Periodically	 have	 standardized	 medical	
screening	data	aggregated	and	evaluated	
by	 an	 epidemiologist	 or	 other	 knowl-
edgeable	 person	 to	 identify	 patterns	 of	
worker	health	that	may	be	linked	to	work	
activities	 and	 practices	 requiring	 addi-
tional	primary	preventive	efforts.	
■	 Combine	 routine	 aggregate	 assessments	
of	 medical	 screening	 data	 with	 evalu-
ations	 of	 exposure	 monitoring	 data	 to	
identify	needed	changes	in	work	areas	or	
exposure	conditions.	
1.12  Labeling and Posting
Employers	shall	post	warning	labels	and	signs	
as	follows:
■	 Post	warning	labels	and	signs	describing	
the	health	risks	associated	with	RCFs	at	
entrances	to	work	areas	and	inside	work	
areas	 where	 airborne	 concentrations	 of	
RCFs	may	exceed	the	REL.	
■	Depending	 on	 work	 practices	 and	 the	
airborne	 concentrations	 of	 RCFs,	 state	
on	the	signs	the	need	to	wear	protective	
clothing	and	the	appropriate	respiratory	
protection	for	RCF	exposures	above	the	
REL.	
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■	 If	respiratory	protection	is	required,	post	
the	following	statement:	
Employers	shall	encourage	smoking	cessation	
among	RCF-exposed	workers	as	follows:
■	 Establish	smoking	cessation	programs	to	
inform	workers	about	the	increased	haz-
ards	 of	 cigarette	 smoking	 and	 exposure	
to	RCFs.
■	 Provide	 assistance	 and	 encouragement	
for	workers	who	want	to	quit	smoking.	
■	 Prohibit	smoking	in	the	workplace.	
■	Disseminate	 information	 about	 health	
promotion	 and	 the	 harmful	 effects	 of	
smoking.
■	Offer	 smoking	 cessation	 programs	 to	
workers	at	no	cost	to	participants.
■	 Encourage	activities	that	promote	physi-
cal	 fitness	 and	 other	 healthy	 lifestyle	
practices	 affecting	 respiratory	 and	 car-
diovascular	health	(e.g.,	through	training	
programs,	employee	assistance	programs,	
and	health	education	campaigns).
NIOSH	 recommends	 that	 all	 workers	 who	
smoke	 and	 are	 potentially	 exposed	 to	 RCFs	
participate	in	smoking	cessation	programs.
RESPIRATORY PROTECTION 
REQUIRED IN THIS AREA
■	 Print	all	labels	and	warning	signs	in	both	
English	 and	 the	 predominant	 language	
of	workers	who	do	not	read	English.
■	 Verbally	 inform	workers	 about	 the	haz-
ards	and	instructions	printed	on	the	 la-
bels	and	signs	if	they	are	unable	to	read	
them.
1.13  Smoking Cessation
NIOSH	recognizes	a	synergistic	effect	between	
exposure	to	RCFs	and	cigarette	smoking.	This	
effect	increases	the	risk	of	adverse	respiratory	
health	 effects	 induced	 by	RCFs.	 In	 studies	 of	
workers	exposed	to	various	airborne	contami-
nants,	 combined	 exposures	 to	 smoking	 and	
airborne	dust	have	been	shown	to	contribute	
to	 the	 increased	 risk	of	occupational	 respira-
tory	 diseases,	 including	 chronic	 bronchitis,	
emphysema,	 and	 lung	 cancer	 [Morgan	 1994;	
Barnhart	1994].
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2 Background and Description of RCFs
2.1  Scope
Information	about	RCFs	was	collected	and	re-
viewed	for	this	document	to	assess	the	health	
hazards	associated	with	occupational	exposure	
to	this	airborne	fiber.	Chapter	2	describes	the	
background	 for	 studying	 the	health	effects	of	
workplace	 exposures	 to	 RCFs.	 Information	
is	 presented	 about	 the	 physical	 and	 chemical	
properties	 of	 RCFs,	 including	 the	 morphol-
ogy,	dimensions,	 and	durability	of	fibers	 that	
make	 up	 RCF-containing	 products.	 Chapter	
3	 discusses	 the	 production	 and	uses	 of	RCFs	
as	a	high-temperature	insulation	material;	the	
chapter	also	describes	the	number	of	workers	
with	potential	for	exposure	to	RCFs.	Chapter	4	
presents	a	review	of	the	literature	on	potential	
workplace	exposures	to	airborne	RCFs	during	
manufacturing	and	end	uses	of	RCF	products.	
Chapter	5	describes	the	effects	of	exposure	to	
RCFs—first	with	reviews	of	animal	studies	and	
then	with	a	description	of	epidemiologic	stud-
ies	 of	 RCFs,	 focusing	 on	 U.S.	 and	 European	
workers	 in	 the	 RCF	manufacturing	 industry.	
Recent	 quantitative	 risk	 assessments	 of	 RCFs	
are	 also	 summarized	 in	 this	 chapter.	Chapter	
6	contains	a	discussion	of	fiber	characteristics	
and	the	parameters	(dose,	dimensions,	and	du-
rability)	that	determine	fiber	toxicity.	Chapter	
7	summarizes	existing	standards	and	guidelines	
for	occupational	 exposure	 to	RCFs.	Chapter	8	
provides	the	basis	and	rationale	for	the	NIOSH	
REL.	Chapters	 1	 and	 9	 provide	 recommenda-
tions	and	guidelines	for	minimizing	exposures	
to	 airborne	 fibers	 of	 RCFs	 in	 the	 workplace.	
Finally,	Chapter	10	discusses	 future	areas	 for	
research	relating	to	fiber	toxicity	and	occupa-
tional	exposures.
2.2  Background
In	 1977,	NIOSH	 reviewed	 health	 effects	 data	
on	occupational	exposure	to	fibrous	glass	and	
determined	the	principal	adverse	health	effects	
to	be	skin,	eye,	and	upper	respiratory	tract	ir-
ritation	as	well	as	the	potential	for	nonmalig-
nant	respiratory	disease.	At	that	time	NIOSH	
recommended	the	following:
Occupational	exposure	to	fibrous	glass	shall	be	
controlled	so	that	no	worker	is	exposed	at	an	
airborne	concentration	greater	than	3,000,000	
fibers	per	cubic	meter	of	air	(3	fibers	per	cubic	
centimeter	of	air);	.	.	.	airborne	concentrations	
determined	as	total	fibrous	glass	shall	be	lim-
ited	to	a	TWA	of	5	milligrams	per	cubic	meter	
of	air	[NIOSH	1977].
NIOSH	 also	 stated	 that	 until	more	 informa-
tion	 became	 available,	 this	 recommendation	
should	be	applied	to	other	MMMFs,	also	called	
SVFs.	Since	then,	additional	data	have	become	
available	from	studies	in	animals	and	humans	
exposed	to	RCFs.	The	purpose	of	this	report	is	
to	review	and	evaluate	these	studies	and	other	
information	about	RCFs.
2.3  Chemical and Physical 
Properties of RCFs
RCFs	(Chemical	Abstracts	Service	No.	142844–
00–6)	are	amorphous	fibers	that	belong	to	the	
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larger	class	of	SVFs,	which	also	includes	fibers	
of	 glass	 wool,	 mineral	 wool,	 slag	 wool,	 and	
specialty	glass.	SVFs	vary	according	to	chemi-
cal	 and	 physical	 properties,	 making	 them	
suitable	 for	 different	 uses.	 Like	 the	 naturally	
occurring	 mineral	 fibers	 defined	 in	 Section	
1.2,	RCFs	possess	desired	qualities	of	heat	re-
sistance,	 tensile	 strength,	durability,	 and	 light	
weight.	 The	 maximum	 end-use	 temperature	
for	RCFs	ranges	 from	approximately	1,050	to	
1,425	oC	(1,920	to	2,600	oF),	depending	on	the	
exact	 chemistry	 of	 the	 fiber.	Unlike	 naturally	
occurring	mineral	fibers,	however,	 SVFs	 such	
as	RCFs	and	fibrous	glass	are	noncrystalline	in	
structure	 and	 fracture	 transversely,	 retaining	
the	same	diameter	but	creating	shorter	fibers.	
In	contrast,	the	crystalline	structure	of	mineral	
fibers	such	as	asbestos	causes	the	fibers	to	frac-
ture	 along	 the	 longitudinal	 plane	 under	me-
chanical	stresses,	resulting	in	more	fibers	with	
the	same	 length	but	 smaller	diameters.	These	
differences	 in	 morphology	 and	 cleavage	 pat-
terns	suggest	that	work	with	SVFs	is	less	likely	
to	generate	high	concentrations	of	airborne	fi-
bers	 than	work	with	asbestos	 for	 comparable	
operations,	 since	 large-diameter	 fibers	 settle	
out	 in	 the	 air	 faster	 than	 small-diameter	 fi-
bers	[Assuncao	and	Corn	1975;	Cherrie	et	al.	
1986;	Lippmann	1990].	During	 the	manufac-
turing	of	RCFs,	approximately	50%	of	product	
(by	weight)	is	generated	as	fiber,	and	50%	is	a	
byproduct	made	up	of	nonfibrous	particulate	
material	 called	 shot.	 Selected	physical	 charac-
teristics	of	RCFs	are	presented	in	Table	2–1.
RCFs	are	produced	by	the	blowing	or	spinning	of	
furnace-melted	siliceous	kaolin	(Al
2
Si
2
O
5
[OH]
4
)	
clay	or	blends	of	kaolin,	silica,	and	zircon.	RCFs	
are	also	referred	to	as	alumina-based	or	kaolin-
based	ceramic	fibers	because	they	are	produced	
from	 a	 50:50	 mixture	 of	 alumina	 and	 silica	
[IARC	 1988].	 Other	 oxides	 (including	 those	
of	boron,	titanium,	and	zirconium)	are	added	
as	stabilizers	to	alter	the	physical	properties	of	
RCFs	 [RCFC	1996].	The	 addition	of	 stabiliz-
ers	and	binders	alters	 the	properties	of	dura-
bility	and	heat	resistance	for	RCFs.	Generally,	
three	 types	of	RCFs	are	manufactured,	 and	a	
fourth	after-service	 fiber	 (often	 recognized	 in	
the	literature)	is	distinguished	according	to	its	
unique	chemistry	and	morphology.	Table	2–2	
presents	the	chemistries	of	the	four	fiber	types,	
numbered	RCF1	through	RCF4.	RCF1	is	a	ka-
olin	 fiber;	 RCF2	 is	 an	 alumina/silica/zirconia	
fiber;	 RCF3	 is	 a	 high-purity	 (alumina/silica)	
fiber;	and	RCF4	is	an	after-service	fiber,	charac-
terized	by	devitrification	(i.e.,	formation	of	the	
silica	 polymorph	 cristobalite),	 which	 occurs	
during	 product	 use	 over	 an	 extended	 period	
of	 time	 at	 temperatures	 exceeding	 1,050	 to	
1,100	oC	(>1,900	oF).	Another	fiber	subcategory	
is	RCF1a,	prepared	from	commercial	RCFs	us-
ing	a	less	aggressive	method	than	that	used	to	
prepare	 RCF1	 for	 animal	 inhalation	 studies	
[Brown	 et	 al.	 2000].	 RCF1a	 is	 distinguished	
from	RCF1	used	in	chronic	animal	inhalation	
studies,	the	former	having	a	greater	concentra-
tion	of	longer	fibers	and	fewer	nonfibrous	par-
ticles.	The	lower	ratio	of	respirable	nonfibrous	
particles	 to	 fibers	 in	 RCF1a	 compared	 with	
RCF1	 has	 been	 shown	 to	 affect	 lung	 deposi-
tion	and	clearance	in	animal	inhalation	studies	
[Brown	et	al.	2000;	Bellman	et	al.	2001].	Chap-
ter	5	presents	additional	discussion	of	animal	
studies	and	test	fiber	characteristics.
2.3.1  Fiber Dimensions
Fibers	of	biological	importance	are	those	that	
become	airborne	and	have	dimensions	within	
inhalable,	thoracic,	and	respirable	size	ranges.	
Thoracic-sized	fibers	 (<3	 to	3.5	μm	in	diam-
eter)	 and	 respirable-sized	 fibers	 (<1.3	 μm	 in	
diameter)	 with	 lengths	 up	 to	 200	 μm	 [Tim-
brell	 1982;	 Lippmann	 1990;	 Baron	 1996]	 are	
capable	 of	 reaching	 the	 portion	 of	 the	 respi-
ratory	 system	 below	 the	 larynx.	 Respirable-
sized	fibers	 are	of	biological	 concern	because	
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they	are	capable	of	reaching	the	lower	airways	
and	gas	exchange	regions	of	the	lungs	when	in-
haled.	Longer	or	thicker	airborne	fibers	gener-
ally	settle	out	of	suspension	or,	if	inhaled,	are	
generally	 filtered	 out	 in	 the	 nasal	 passage	 or	
deposited	in	the	upper	airways.	Thoracic-sized	
fibers	that	are	inhaled	and	deposited	in	the	up-
per	respiratory	tract	are	generally	cleared	more	
readily	from	the	lung,	but	they	have	the	poten-
tial	to	cause	irritation	and	produce	respiratory	
symptoms.	Fiber	dimensions	are	a	 significant	
factor	 in	determining	 their	deposition	within	
the	lung,	biopersistence,	and	toxicity.	
RCFs	and	other	SVFs	are	manufactured	to	meet	
specified	nominal	diameters	according	to	the	fi-
ber	type	and	intended	use.	RCFs	are	produced	
with	nominal	diameters	of	1.2	to	3	μm	[Esmen	
et	al.	1979;	Vu	1988;	TIMA	1993].	Typical	di-
ameters	for	an	individual	RCF	(as	measured	in	
Table 2–1 .  Selected physical characteristics of RCFs
Characteristic Description
Softening	point 1,700	to	1,800	˚C
Refractive	index 1.55	to	1.57
Specific	gravity	(density) 2.6	to	2.7	g/cm3
Shot	content	(nonfibrous	particulate)		 20%	to	50%	by	weight
Nominal	diameter	(bulk) 1.2	to	3	μm
Length	(bulk) 2	to	254	μm
Dissolution	rate	(at	pH=7.4) 1	to	10	ng/cm2/hr
Sources:	RCFC	[1996],	TIMA	[1993],	and	IARC	[1988].
Table 2–2 . The chemistry of stock RCFs (% oxide)
Oxide component RCF1 RCF2 RCF3 RCF4
Silicon	dioxide	(SiO
2
) 47.7 50 50.8 47.7
Alumina	(Al
2
O
3
) 48 35 48.5 48
Ferric	oxide	(Fe
2
O
3
) 0.97 <0.05 0.16 0.97
Titanium	dioxide	(TiO
2
) 2.05 0.04 0.02 2.05
Zirconium	dioxide	(ZrO
2
) 0.11 15 0.23 0.11
Calcium	oxide	(CaO) 0.07 0.05 0.04 0.07
Magnesium	oxide	(MgO) 0.98 0.01 <0.01 0.08
Sodium	oxide	(Na
2
O) 0.54 <0.3 0.19 0.54
Potassium	oxide	(K
2
O) 0.16 <0.01 <0.01 0.16
Adapted	from	Mast	et	al.	[1995a].
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RCF-containing	 products)	 range	 from	 0.1	 to	
20	μm,	with	 lengths	ranging	from	5	to	200	μm	
[IARC	1988].	In	bulk	samples	taken	from	three	
RCF	 blanket	 insulation	 products,	 more	 than	
80%	 of	 the	 fibers	 counted	 by	 phase	 contrast	
optical	microscopy	(PCM)	were	<3	μm	in	di-
ameter	[Brown	1992].	This	result	is	consistent	
with	 those	 from	 another	 study	 of	 bulk	 sam-
ples	 of	 RCF	 insulation	 materials	 [Christensen	
et	al.	1993],	which	found	the	fibers	to	have	geo-
metric	 mean	 diameters	 (GM
D
)	 ranging	 from	
1.5	 to	 2.8	μm	(arithmetic	mean	 [AM]	diam-
eter	 range=2.3	 to	 3.9	 μm;	median	 diameter	
range=1.6	to	3.3	μm).
Studies	of	 airborne	fiber	 size	distributions	 in	
RCF	 manufacturing	 operations	 indicate	 that	
these	fibers	meet	the	criteria	for	thoracic-	and	
respirable-sized	fibers.	One	early	study	of	three	
domestic	RCF	production	facilities	found	that	
approximately	 90%	 of	 airborne	 fibers	 were	
<3	μm	in	diameter,	and	95%	of	airborne	fibers	
were	 <4	 μm	 in	 diameter	 and	 <50	 μm	 long	
[Esmen	 et	 al.	 1979].	 The	 study	 showed	 that	
diameter	and	length	distributions	of	airborne	
fibers	 in	 the	 facilities	 were	 consistent,	 with	 a	
GM
D
	of	0.7	μm	and	a	geometric	mean	length	
(GM
L
)	 of	 13	μm.	Another	 study	 [Lentz	 et	 al.	
1999]	 used	 these	 data	 in	 combination	 with	
monitoring	 data	 from	 two	 additional	 studies	
[MacKinnon	 et	 al.	 2001;	Maxim	 et	 al.	 1997]	
at	RCF	manufacturing	plants	 to	 review	char-
acteristics	of	fibers	sized	from	118	air	samples	
covering	20	years	(1976–1996).	Fibers	with	di-
ameters	 <1	μm	 (n=3,711)	were	measured	 by	
transmission	 electron	microscopy	 (TEM).	Of	
these,	 52%	had	diameters	<0.4	μm,	75%	had	
diameters<0.6	 μm,	 and	 89%	 had	 diameters	
<0.8	μm.	Fiber	lengths	ranged	from	<0.6	to	>20	
μm,	with	68%	of	fibers	measuring	2.4	to	20	μm	
long	and	19%	of	 the	fibers	>20	μm	long.	On	
the	basis	of	the	results	of	TEM	analysis	of	3,357	
RCFs	observed	on	98	air	samples	collected	in	
RCF	manufacturing	sites,	Allshouse	[1995]	re-
ported	that	99.7%	of	the	fibers	had	diameters	
<3	μm	and	64%	had	lengths	>10	μm.	Measure-
ments	of	airborne	fibers	in	the	European	RCF	
manufacturing	industry	are	comparable:	Rood	
[1988]	 reported	 that	 all	 fibers	 observed	were	
in	the	thoracic	and	respirable	size	range	(i.e.,	di-
ameter	<3	to	3.5	μm),	with	median	diameters	
ranging	from	0.5	to	1.0	μm	and	median	lengths	
from	8	to	23	μm.
Cheng	 et	 al.	 [1992]	 analyzed	 an	 air	 sample	
for	fibers	during	removal	of	after-service	RCF	
blanket	insulation	from	a	refinery	furnace.	Fi-
ber	diameters	ranged	from	0.5	to	6	μm,	with	a	
median	diameter	of	1.6	μm.	The	length	of	fi-
bers	 ranged	 from	5	 to	220	μm.	Of	100	fibers	
randomly	 selected	 and	 analyzed	 from	 the	 air	
sample,	87%	were	within	the	thoracic	and	re-
spirable	size	range.	Another	study	of	exposures	
to	 airborne	 fibers	 in	 industrial	 furnaces	 dur-
ing	installation	and	removal	of	RCF	materials	
found	GM
D
	values	of	0.38	and	0.57	μm,	respec-
tively	[Perrault	et	al.	1992].	
2.3.2 Fiber Durability
Fiber	durability	can	affect	the	biologic	activity	
of	fibers	inhaled	and	deposited	in	the	respira-
tory	system.	Durable	fibers	are	more	biopersis-
tent,	thereby	increasing	the	potential	for	caus-
ing	a	biological	effect.	Durability	of	a	fiber	 is	
measured	by	 the	 amount	 of	 time	 it	 takes	 for	
the	fiber	to	fragment	mechanically	into	short-
er	fibers	or	dissolve	 in	biological	fluids.	RCFs	
tested	 in	 vitro	with	 a	 solution	 of	 neutral	 pH	
(modified	 Gamble’s	 solution)	 had	 a	 dissolu-
tion	rate	of	1	to	10	ng/cm2	per	hr	[Leineweber	
1984].	This	test	is	biologically	relevant	because	
of	the	similarity	of	the	solution	to	the	condi-
tions	 of	 the	 pulmonary	 interstitial	 fluid.	 By	
comparison,	other	SVFs	(glass	and	slag	wools)	
are	more	soluble,	with	dissolution	rates	in	the	
100s	 of	 ng/cm2	 per	 hr	 [Scholze	 and	Conradt	
1987].	Along	a	 continuum	of	fiber	durability	
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determined	in	tests	using	simulated	lung	flu-
ids	at	pH	7.4,	the	asbestos	fiber	crocidolite	has	
a	dissolution	rate	of	<1	ng/cm2	per	hr,	RCF1	
and	MMVF32	(E	glass)	have	dissolution	rates	
of	1	to	10	ng/cm2	per	hr,	MMVF21	has	a	dis-
solution	rate	of	15	to	25	ng/cm2	per	hr,	other	
fibrous	glass	and	slag	wools	have	dissolution	
rates	in	the	range	of	50	to	400	ng/cm2	per	hr,	
and	the	alkaline	earth	silicate	wools	have	dis-
solution	 rates	 ranging	 from	 approximately	
60	to	1,000	ng/cm2	per	hr	[Christensen	et	al.	
1994;	Maxim	et	al.	1999b;	Moore	et	al.	2001].	
Chrysotile,	which	is	considered	the	most	sol-
uble	form	of	asbestos,	has	a	dissolution	rate	of	
<1	to	2	ng/cm2	per	hr.
RCFs	dissolve	more	rapidly	than	chrysotile,	even	
though	RCFs	have	a	thicker	diameter	(by	an	or-
der	of	magnitude)	than	chrysotile.	The	rate	of	
dissolution	is	an	important	fiber	characteristic	
that	 affects	 the	 clearance	 time	 and	 biopersis-
tence	of	the	fiber	in	the	lung.	The	significance	of	
fiber	dimension,	clearance,	and	dissolution	(i.e.,	
breakage,	solubility)	is	discussed	in	Chapter	6.
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3.1 Production
RCF	 production	 in	 the	 United	 States	 began	
in	 1942	 on	 an	 experimental	 basis,	 but	RCFs	
were	 not	 commercially	 available	 until	 1953.	
Sales	of	RCFs	were	modest	initially,	but	they	
began	to	expand	when	the	material	gained	ac-
ceptance	as	an	economical	alternative	insula-
tion	for	high-temperature	kilns	and	furnaces.	
Commercial	production	of	RCFs	first	reached	
significant	levels	in	the	1970s	as	oil	shortages	
necessitated	 reductions	 in	 energy	 consump-
tion.	The	growing	demand	for	RCFs	has	also	
been	strongly	 influenced	by	the	recognition	
of	health	effects	associated	with	exposure	to	
asbestos-containing	materials	and	the	increas-
ingly	stringent	regulation	of	these	products	in	
the	United	States	and	many	other	countries.	
Annual	domestic	production	of	RCFs	was	an	
estimated	85.7	million	lb	in	1990;	in	1997,	pro-
duction	 of	RCFs	 in	 the	United	 States	 totaled	
107.7	million	 lb	annually	 [RCFC	1998].	Cur-
rently,	total	U.S.	production	is	estimated	to	be	
80	million	lb	per	year,	representing	about	1%	
to	 2%	 of	 the	 worldwide	 production	 of	 SVFs	
[RCFC	2004].	RCFs	are	also	produced	in	Mex-
ico,	 Canada,	 Brazil,	 Venezuela,	 South	 Africa,	
Australia,	 Japan,	China,	Korea,	Malaysia,	 Tai-
wan,	 and	 several	 countries	 in	 Europe	 [RCFC	
1996].	 In	 the	United	 States	 and	 Puerto	 Rico,	
the	 primary	 producers	 of	 RCFs	 include	 A.P.	
Green	 Industries	 (Pryor,	 OK),	 Unifrax	 Cor-
poration	 (Niagara	Falls,	NY,	 formerly	Carbo-
rundum),	 Thermal	 Ceramics	 (Augusta,	 GA),	
and	 Vesuvius	 (King	 of	 Prussia,	 PA,	 formerly	
Premier	Refractories	and	Chemicals).	The	lat-
ter	 three	 producers	 account	 for	 an	 estimated	
90%	of	domestic	production	and	are	members	
of	the	RCFC,	which	has	been	active	in	moni-
toring	exposures,	developing	product	steward-
ship	programs,	and	funding	research	to	study	
RCF	hazards	and	safe	work	practices	for	RCF	
manufacturing	and	use.		
3.2  Potential for Worker 
 Exposure
Approximately	 31,500	 workers	 in	 the	 United	
States	are	potentially	exposed	to	RCFs	during	
manufacturing,	processing,	or	end	use.	A	simi-
lar	number	of	workers	are	potentially	exposed	
to	RCFs	in	Europe.	Of	these	workers,	about	800	
(3%)	are	employed	in	the	actual	manufactur-
ing	of	RCFs	and	RCF	products	[Maxim	et	al.	
1997;	RCFC	2004].
3.3  RCF Manufacturing 
 Process
The	manufacture	of	RCFs	(Figure	3–1)	begins	
by	blending	raw	materials,	which	may	include	
kaolin	 clay,	 alumina,	 silica,	 and	 zirconia	 in	
a	 batch	house.	The	batch	mix	 is	 then	 trans-
ferred	 either	manually	 or	 automatically	 to	 a	
furnace	to	be	melted	at	temperatures	exceed-
ing	1,600		oC.	On	reaching	a	specified	temper-
ature	and	viscosity	in	the	furnace,	the	molten	
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Fibers are produced
by blowing or spinning
molten materials drained
from furnace.
Bulk fiber is packaged.
Felt or blanket is cured
in tempering oven.
Product is shipped,
stored, or fabricated
into specialty product.
Figure 3–1. Process flow chart for RCF production.
Batch is melted in 
furnace at >1600˚C.
Lubricants are added
and fibers are processed
by needle-felting machine.
Fibers settle into
collection chamber.
Blanket is cut to
specifications
and packaged.
Raw materials (AI2O3,
SiO2, TiO2, MgO, CaO,
Na2O, K2O, etc.) are
added to batch mix.
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batch	mixture	drains	from	the	furnace	and	is	
fiberized,	either	through	exposure	to	pressur-
ized	air	or	by	flowing	through	a	series	of	spin-
ning	wheels	[Hill	1983].	Fans	are	used	to	create	
a	partial	vacuum	that	pulls	the	fibers	into	a	col-
lection	or	settling	chamber.	RCFs	may	then	be	
conveyed	pneumatically	 to	a	bagging	area	 for	
packaging	as	bulk	fiber.	Some	bulk	fiber	may	
be	used	directly	in	this	form,	or	it	may	be	pro-
cessed	 to	 form	textiles,	 felts,	boards,	cements,	
and	 other	 specialty	 items.	 Other	 RCFs	 are	
formed	into	blankets	as	bulk	fiber	in	the	collec-
tion	chamber	settles	onto	a	conveyor	belt.	The	
blanket	 passes	 through	 a	 needle	 felting	 ma-
chine	that	interlocks	the	fibers	and	compresses	
the	blanket	to	a	specified	thickness.	From	the	
needler,	 the	blanket	 is	 conveyed	 to	 a	 temper-
ing	oven	to	remove	 lubricants	 that	were	add-
ed	in	the	settling	chamber.	The	lubricants	are	
burned	off,	and	the	blanket	is	cut	to	desired	size	
and	packaged.	As	with	the	bulk	fiber,	the	RCF	
blanket	may	undergo	additional	fabrication	to	
create	 other	 specialty	 products.	 Many	 of	 the	
processes	are	automated	and	are	monitored	by	
machine	 operators.	 Postproduction	 processes	
such	as	cutting,	sanding,	packaging,	handling,	
and	shipping	are	more	labor	intensive,	but	the	
potential	exists	for	exposure	to	airborne	fibers	
throughout	production.
3.4  RCF Products and Uses
RCFs	may	be	used	in	bulk	fiber	form	or	as	one	
of	 the	RCF	 specialty	products	 in	 the	 form	of	
mats,	paper,	 textiles,	 felts,	 and	boards	 [RCFC	
1996].	Because	of	its	ability	to	withstand	tem-
peratures	 exceeding	 1,000	 °C,	 RCFs	 are	 used	
predominantly	 in	 industrial	 applications,	 in-
cluding	 insulation,	 reinforcement,	 and	 ther-
mal	 protection	 for	 furnaces	 and	 kilns.	 RCFs	
can	 also	 be	 found	 in	 automobile	 catalytic	
converters,	 in	 consumer	 products	 that	 oper-
ate	at	high	temperatures	(e.g.,	toasters,	ovens,	
woodstoves),	 and	 in	 space	 shuttle	 tiles.	 RCFs	
have	been	formed	into	noise-control	blankets	
[Thornton	et	al.	1984]	and	used	as	a	replace-
ment	 for	 refractory	 bricks	 in	 industrial	 kilns	
and	 furnaces	[RCFC	1996].	RCFs	have	 found	
increasing	 application	 as	 reinforcements	 in	
specialized	metal	matrix	 composites	 (MMC),	
especially	 in	 the	 automotive	 and	 aerospace	
industries	 [Stacey	 1988].	A	 summary	of	RCF	
products	and	applications	are	provided	here.
3.4.1  Examples of Products 
■	 Blankets—high-temperature	 insulation	
produced	from	spun	RCFs	in	the	form	of	
a	mat	or	blanket
■	 Boards—high-temperature	insulation	pro-	
duced	from	bulk	fibers	in	the	form	of	a	
compressed	 rigid	 board	 (boards	 have	
a	 higher	 density	 than	 blankets	 and	 are	
used	as	core	material	or	in	sandwich	as-
semblies)
■	 Bulk RCFs—fibers	with	qualities	of	high-
temperature	resistance	to	be	used	as	feed-
stock	in	manufacturing	processes	or	other	
applications	for	which	product	consisten-
cy	is	critical—typically	in	the	manufacture	
of	other	ceramic-fiber-based	products
■	 Ropes and braids—high-temperature	 in-
sulation	 produced	 by	 textile	 operations	
and	 used	 for	 packing,	 seals,	 and	 wicking	
applications
■	 Woven textiles—high-temperature	 in-
sulation	produced	by	textile	processes	in	
the	form	of	cloth,	tape,	or	sleeves
■	 Papers and felts—flexible	high-temper-
ature	insulation	produced	by	papermak-
ing	processes	and	used	for	seals,	gaskets,	
and	other	automotive	and	aerospace	ap-
plications
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■	 Vacuum cast shapes—high-temperature	
insulation	produced	by	forming	special-
ized	shapes	on	prefabricated	molds	with	
wet	fibers	and	then	drying	them	by	vacu-
um	and	heat,	thereby	transforming	bulk	
fiber	into	rigid,	shaped	products
■	 Specialties—forms	(i.e.,	mixes,	cements,	
and	 caulking	 compounds)	 that	 contain	
wet,	 inorganic	 binder	 and	 are	 used	 as	
protective	 coating	putties	 as	well	 as	 ad-
hesives	and	heat	and	fire	barriers	in	high-
temperature	applications
■	 Modules—packaged	functional	assembly	
of	 blanket	 insulation	 with	 hardware	 for	
attaching	to	the	surfaces	of	 furnaces	and	
kilns
3.4.2  Examples of Applications
■	 Insulation	linings	of	high-temperature	in-
dustrial	furnaces	and	related	equipment
■	 Hot	 spot	 repair	 of	 industrial	 furnace	
linings
■	 Industrial	 furnace	curtains,	gaskets,	and	
seals
■	 Insulation	of	pipes,	ducts,	and	cables	as-
sociated	 with	 high-temperature	 indus-
trial	furnaces
■	 Fire	 protection	 for	 industrial	 process	
equipment
■	 Aircraft	and	aerospace	heat	shields
■	 Commercial	and	consumer	appliances	con-	
sisting	of	prefabricated	chimneys,	pizza	ov-
ens,	self-cleaning	ovens,	and	wood-burning	
stoves
■	 Automobile	 applications	 consisting	 of	
brake	pads,	clutch	facings,	catalytic	con-
verters,	 air	 bags,	 shoulder	 belt	 controls,	
and	passenger	compartment	heat	shields
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4 Assessing Occupational Exposure
4.1  Air Sampling and 
Analytical Methods
The	 conventional	 method	 used	 to	 assess	 the	
characteristics	 and	 concentrations	 of	 expo-
sures	 to	 airborne	 fibers	 is	 to	 collect	 personal	
and	environmental	(area)	air	samples	for	labo-
ratory	analysis.
Personal	samples	are	the	preferred	method	for	
estimating	 the	 exposure	 characteristics	 of	 a	
worker	performing	specific	tasks.	For	personal	
sampling,	 a	 worker	 is	 equipped	 with	 the	 air	
sampling	 equipment,	 and	 the	 collection	me-
dium	is	positioned	within	the	worker’s	breath-
ing	zone.	Area	sampling	is	performed	to	evalu-
ate	exposure	characteristics	associated	with	an	
area	or	process.	Sampling	equipment	for	area	
sampling	is	stationary,	in	contrast	to	personal	
sampling,	which	allows	for	mobility	by	accom-
panying	 the	worker	 throughout	 the	 sampling	
period.
4.2  Sampling for Airborne 
Fibers
The	two	NIOSH	methods	for	the	sampling	and	
analysis	of	airborne	fibers	of	asbestos	and	oth-
er	fibrous	materials	are	as	follows:	
■	Method	7400	describes	air	sampling	and	
analysis	by	PCM
■	Method	7402	describes	air	sampling	and	
analysis	by	TEM
Both	methods	 (listed	 in	 the	NIOSH Manual 
of Analytical Methods	[NIOSH	1998]	and	pro-
vided	in	Appendix	A)	involve	using	an	air	sam-
pling	pump	connected	 to	a	cassette.	The	cas-
sette	 consists	 of	 a	 conductive	 cowl	 equipped	
with	a	25-mm	cellulose	ester	membrane	filter	
(0.45-	to	1.2-µm	pore	size).	The	pump	is	used	
to	draw	air	through	the	sampling	cassette	at	a	
constant	flow	rate	between	0.5	and	16	L/min.	
Airborne	 fibers	 and	 other	 particulates	 are	
trapped	on	the	filter	for	analysis	using	micro-
scopic	methods.	Methods	7400	and	7402	can	
be	 used	 to	 count	 the	 number	 of	 fibers	 (and	
therefore	calculate	concentration	based	on	the	
volume	of	air	sampled)	and	measure	the	fiber	
dimensions.	Fiber	concentration	is	reported	as	
the	number	of	fibers	per	 cubic	 centimeter	of	
air	(f/cm3).	Although	the	two	methods	differ	in	
preparation	of	the	sampling	media	for	analy-
sis,	the	major	distinction	between	them	is	the	
resolving	capabilities	of	the	microscope.	With	
PCM,	0.25	µm	is	approximately	 the	diameter	
of	the	thinnest	fibers	that	can	be	observed	[De-
ment	and	Wallingford	1990].	TEM	has	a	lower	
resolution	limit	well	below	the	diameter	of	the	
smallest	RCF	(~0.02	 to	0.05	µm)	 [Middleton	
1982].	TEM	also	 allows	 for	qualitative	 analy-
sis	 of	 fibers	 using	 an	 energy-dispersive	X-ray	
analyzer	(EDXA)	to	determine	elemental	com-
position	and	selected	area	electron	diffraction	
(SAED)	 for	 comparing	 diffraction	 patterns	
with	reference	patterns	for	identification.	
4.2.1 NIOSH Fiber-Counting Rules 
The	appendix	to	NIOSH	Method	7400	speci-
fies	 two	 sets	of	fiber-counting	 rules	 that	vary	
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according	to	the	parameters	used	to	define	a	fi-
ber.	Under	the	A	rules,	any	particle	>5	µm	long	
with	an	aspect	ratio	(length	to	width)	>3:1	is	
considered	 a	 fiber.	 No	 upper	 limit	 exists	 on	
the	fiber	diameter	 in	the	A	counting	rules.	In	
the	B	 rules,	a	fiber	 is	defined	as	being	>5	µm	
long	with	an	aspect	ratio	≥5:1	and	a	diameter	
<3	µm.	The	upper-diameter	limit	in	the	B	rules	
restricts	the	measurement	to	thoracic	and	re-
spirable	fibers.	It	is	important	to	note	which	set	
of	fiber-counting	criteria	is	used	when	report-
ing	analytical	results.	NIOSH	recommends	us-
ing	Method	 7400	with	 the	B	 rules	 for	 evalu-
ating	 exposures	 to	 airborne	 RCFs.	 NIOSH	
Method	7402	specifies	use	of	the	A rules,	with	a	
lower-diameter	limit	of	0.25	µm	to	allow	com-
parison	 with	 results	 obtained	 from	 NIOSH	
Method	7400.	Method	7402	can	also	be	used	to	
compare	 fiber	 counts	 obtained	 from	Method	
7400	(B	rules).	TEM	permits	the	identification	
and	counting	of	fibers	<0.25	µm	in	diameter;	
0.25	µm	is	the	approximate	resolution	limit	for	
PCM.
4.2.2 European Fiber-Counting Rules
In	 Europe,	 a	 slightly	 different	 fiber-counting	
convention	is	used.	The	World	Health	Organi-
zation	(WHO)	reference	method	for	MMMFs	
[WHO/EURO	Technical	Committee	for	Mon-
itoring	and	Evaluating	Airborne	MMMF	1985]	
recognizes	a	fiber	as	>5	µm	long	with	a	diameter	
<3	µm	and	an	aspect	ratio	≥3:1.	Several	studies	
comparing	fiber	 counts	determined	with	dif-
ferent	counting	conventions	have	found	good	
agreement	in	air	sampling	for	RCF	exposures.	
Buchta	et	al.	[1998]	compared	fiber	counts	of	
air	samples	for	RCF	exposures	as	analyzed	us-
ing	 the	NIOSH	A	 and	B	 rules;	both	methods	
produced	 similar	 results,	 with	 no	 statistically	
significant	difference	in	fiber	density	measure-
ments	 on	 sample	 filters.	Maxim	 et	 al.	 [1997]	
found	 that	 fiber	 counts	 made	 using	 NIOSH	
Method	7400	B	rules	are	equal	to	approximately	
95%	of	the	counts	determined	using	the	WHO	
reference	method.	In	studies	with	other	SVFs,	
Lees	 et	 al.	 [1993]	 also	 found	 that	fiber	 expo-
sure	 estimates	 were	 slightly	 higher	 using	 the	
A rules	but	were	comparable	to	the	values	ob-
tained	using	B	 rules.	Breysse	 et	 al.	 [1999]	 re-
ported	a	similar	finding	when	comparing	RCF	
fiber	counts	determined	by	both	A	and	B	rules:	
the	ratio	of	A	to	B	counts	was	1.33.	These	re-
sults	suggest	that	for	airborne	RCF	exposures,	
most	fibers	with	a	>3:1	aspect	ratio	also	meet	
the	≥5:1	aspect	ratio	criterion	and	are	<3	µm	
in	diameter.	
4.3  Sampling for Total or 
Respirable Airborne 
Particulates
Airborne	 exposures	 generated	 during	 work	
with	RCFs	may	also	be	estimated	by	sampling	
for	general	dust	concentrations.	Sampling	for	
particulates	 not	 otherwise	 regulated	 is	 de-
scribed	in	NIOSH	Method	0500	for	total	dust	
concentrations	 and	 in	 NIOSH	Method	 0600	
for	the	respirable	fraction	[NIOSH	1998].	Both	
methods	(also	included	in	Appendix	A)	use	a	
sampling	pump	to	pull	air	through	a	filter	that	
traps	suspended	particulates.	NIOSH	Method	
0600	uses	 a	 size-selective	 sampling	 apparatus	
(cyclone)	to	separate	the	respirable	fraction	of	
airborne	material	from	the	nonrespirable	frac-
tion.	The	mass	of	airborne	particulates	on	the	
filter	 is	 measured	 using	 gravimetric	 analysis,	
and	 airborne	 concentration	 is	 determined	 as	
the	ratio	of	the	particulate	mass	to	the	volume	
of	air	sampled,	reported	as	mg/m3	(or	µg/m3).	
This	method	does	not	distinguish	fibers	from	
nonfibrous	airborne	particles.	No	NIOSH	REL	
exists	for	either	total	or	respirable	particulates	
not	 otherwise	 regulated.	 The	 OSHA	 permis-
sible	exposure	limit	(PEL)	for	particulates	not	
otherwise	regulated	is	15	mg/m3	for	total	par-
ticulates	and	5	mg/m3	for	respirable	particulates	
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as	 8-hr	 TWA	 concentrations.	 The	 American	
Conference	 of	 Governmental	 Industrial	 Hy-
gienists	(ACGIH)	threshold	limit	value	(TLV)	
for	particles	(insoluble	or	poorly	soluble)	not	
otherwise	 specified	 is	10	mg/m3	 for	 inhalable	
particles	and	3	mg/m3	 for	 respirable	particles	
as	8-hr	TWA	concentrations	[ACGIH	2005].	
4.4  Sampling for Airborne 
Silica
Because	silica	is	a	major	constituent	of	RCFs,	
the	potential	exists	for	exposure	to	silica	dur-
ing	work	with	RCFs	(e.g.,	in	manufacturing	or	
during	 removal	 of	 after-service	 RCF	 furnace	
insulation).	 As	 with	 sampling	 for	 respirable	
particulates,	 sampling	 for	 respirable	 silica	 in-
volves	 using	 a	 pump	 to	 draw	 air	 through	 a	
cyclone	 before	 collecting	 respirable	 airborne	
particles	on	a	filter.	Qualitative	and	quantita-
tive	 analysis	 of	 the	 sample	 for	 silica	 content	
can	be	performed	using	the	following	analyti-
cal	methods:
■	 X-ray	powder	diffraction	(NIOSH	Meth-
od	7500)
■	 Visible	 absorption	 spectrophotometry	
(NIOSH	Method	7601)
■	 Infrared	 absorption	 spectrophotometry	
(NIOSH	Method	7602)	
The	NIOSH	REL	for	respirable	crystalline	sili-
ca	is	0.05	mg/m3	as	a	TWA	for	up	to	10	hr/day	
during	a	40-hr	workweek	[NIOSH	1974].	The	
ACGIH	TLV	for	crystalline	silica	is	0.05	mg/m3	
as	an	8-hr	TWA	[ACGIH	2005].
4.5  Industrial Hygiene 
Surveys and Exposure 
Assessments
Assessments	 of	 occupational	 exposures,	 in-
cluding	quantitative	measurement	of	airborne	
fiber	concentrations	associated	with	manufac-
turing,	 handling,	 and	 using	 RCFs,	 have	 been	
performed	 using	 industrial	 hygiene	 surveys	
and	air	sampling	techniques	at	multiple	work-
sites.	Sources	of	monitoring	data	that	charac-
terize	occupational	exposures	to	RCFs	include	
the	following:
■	University	of	Pittsburgh	studies	of	expo-
sures	at	RCF	manufacturing	sites	 in	 the	
1970s	[Corn	and	Esmen	1979;	Esmen	et	
al.	1979]
■	 An	 ongoing	 University	 of	 Cincinnati	
epidemiologic	 study	 with	 exposure	 as-
sessments	that	use	historical	monitoring	
data	 and	 current	 monitoring	 strategies	
[Rice	et	al.	1994,	1996,	1997]
■	 A	5-year	consent	agreement	between	the	
RCFC	and	 the	U.S.	Environmental	Pro-
tection	Agency	(EPA)	to	monitor	worker	
exposures	 in	RCF	manufacturing	plants	
and	in	secondary	users	of	RCFs	and	RCF	
products	 [RCFC	 1993;	 Everest	 1998;	
Maxim	et	al.	1994,	1997,	2000a]
■	 Studies	 of	 exposure	 to	 airborne	 fibers	
during	 the	 installation	 and	 removal	 of	
RCF	 insulation	 in	 industrial	 furnaces	
[Gantner	 1986;	 Cheng	 et	 al.	 1992;	 van	
den	Bergen	et	al.	1994;	Sweeney	and	Gil-
grist	1998;	Maxim	et	al.	1999b]
■	 International	 (Canadian,	 Swedish,	 Aus-
tralian)	industrial	hygiene	surveys	of	oc-
cupational	 exposures	 to	 RCFs	 [Perrault	
et	al.	1992;	Krantz	et	al.	1994;	Rogers	et	
al.	1997]
■	 A	study	of	end-user	exposures	to	RCF	in-
sulation	products	by	researchers	at	Johns	
Hopkins	University	[Corn	et	al.	1992]	
■	NIOSH	Health	Hazard	Evaluations	(HHEs)	
of	occupational	exposures	to	RCFs
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4.5.1 University of Pittsburgh Survey 
of Exposures During RCF 
Manufacturing
In	the	mid	1970s,	researchers	from	the	Univer-
sity	 of	 Pittsburgh	 conducted	 environmental	
monitoring	to	assess	worker	exposures	to	air-
borne	fibers	 at	 domestic	RCF	manufacturing	
facilities.	 This	 research	 effort	 was	 one	 of	 the	
pioneering	studies	in	the	use	of	workplace	ex-
posure	groupings	or	dust zones	for	establishing	
a	 sampling	 strategy	 [Corn	 and	Esmen	1979].	
In	a	series	of	industrial	hygiene	surveys,	Esmen	
et	al.	[1979]	collected	215	full-shift	air	samples	
at	three	RCF	manufacturing	plants.	Table	4–1	
summarizes	 the	 sampling	 data	 for	 the	 three	
facilities	 (A,	 B,	 and	 C)	 by	 fiber	 concentra-
tion	 of	 total	 airborne	 dust.	 Although	 a	 wide	
range	of	values	for	individual	samples	existed	
(<0.01	to	16	f/cm3),	average	(AM)	concentra-
tions	ranged	from	0.05	to	2.6	f/cm3.	The	high-
est	exposure	concentrations	were	measured	in	
manufacturing	 and	 finishing	 operations	 dur-
ing	which	sanding,	cutting,	sawing,	and	drill-
ing	operations	were	performed	and	ventilation	
was	 lacking.	A	 large	 number	 of	 these	 opera-
tions	were	noted	in	plant	A,	which	is	reflected	
by	 the	elevated	fiber	and	dust	 concentrations	
for	 this	plant.	When	data	were	 compared	 for	
similar	 operations	 and	 dust	 zones,	 exposure	
concentrations	 were	 consistent	 across	 plants.	
Analyses	of	air	samples	also	included	measure-
ment	of	fiber	dimensions.	Approximately	95%	
of	the	airborne	fibers	measured	were	<4.0	µm	
in	diameter	and	<50	µm	long	with	a	GM
D
	of	
0.7	µm	and	a	GM
L
	of	13	µm.
4.5.2  University of Cincinnati Study 
of Exposures During RCF 
Manufacturing
In	1987,	researchers	from	the	University	of	Cin-
cinnati	 initiated	 an	 industry-wide	 epidemio-
logic	study	of	workers	who	manufacture	RCFs.	
One	aim	of	the	study	was	to	characterize	current	
and	former	exposures	to	RCFs	and	silica	in	U.S.	
RCF	manufacturing	facilities.	Data	from	initial	
surveys	 conducted	 at	 five	RCF	manufacturing	
plants	 indicated	 airborne	 RCFs	 with	 a	 GM
D
	
ranging	from	0.25	to	0.6	µm	and	a	GM
L
	ranging	
from	3.8	 to	11.0	µm	[Lockey	et	al.	1990].	The	
airborne	 TWA	 fiber	 concentrations	 for	 these	
five	plants	ranged	from	<0.01	to	1.57	f/cm3.	Af-
ter	the	first	two	rounds	of	quarterly	sampling,	
Rice	et	al.	[1994]	had	collected	data	from	484	
fiber	count	samples	(382	samples	with	values	
greater	 than	 the	 analytic	 limit	 of	 detection	
[LOD],	 39	overloaded	 samples,	 36	 samples	
with	 values	 below	 the	 LOD,	 and	 27	 samples	
voided	because	of	tampering	or	pump	failure).	
They	 also	 collected	 35	 samples	 from	persons	
working	with	raw	materials	that	were	analyzed	
quantitatively	 and	 qualitatively	 for	 respirable	
mass	and	for	silica	polymorphs	(quartz,	tridy-
mite,	and	cristobalite).	A	sampling	strategy	was	
developed	 by	 identifying	 more	 than	 100	job	
Table 4–1 . Industrial hygiene survey data for three RCF* manufacturing plants†
AM total airborne dust AM fiber concentration 
Plant No . samples mg/m3 Range f/cm3 Range
A 76 	 6.05 	0.37–100.00 							2.6 			0.02–16.0
B 67 	 1.6 	0.19–9.73 							0.63 			0.04–6.7
C 72 	 0.85 	0.05–2.34 							0.05 			<0.01–0.29
Source:	Esmen	et	al.	[1997].
*Abbreviations:	AM=arithmetic	mean;	RCF=refractory	ceramic	fiber.
†Fibers	were	defined	as	having	an	aspect	ratio	>3:1.	Transmission	electron	microscopy	was	used	to	measure	fibers	≤1 µm	in	diameter.
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functions	 across	 5	 facilities.	 These	 job	 func-
tions	were	consolidated	into	industry	job	titles	
based	on	similarities	of	function,	proximity	to	
certain	processes,	and	exposure	characteristics	
within	designated	dust	zones.	Table	4–2	pres-
ents	median	TWA	exposures	to	airborne	con-
centrations	of	RCFs	by	job	title	at	plants	sam-
pled	in	1987.	TWA	fiber	concentrations	ranged	
from	below	the	analytical	LOD	to	1.04	f/cm3	for	
workers	in	20	different	industry	job	titles.	Fiber	
concentrations	obtained	by	rinsing	the	walls	of	
the	sampling	cowl,	where	a	significant	number	
of	 fibers	 accumulated	 during	 sampling	 [Cor-
nett	et	al.	1989;	Breysse	et	al.	1990],	ranged	from	
below	the	analytical	LOD	to	1.54	f/cm3.	Of	the	
35	samples	analyzed	for	the	silica	polymorphs,	
quantifiable	silica	was	found	in	5	samples:	4	of	
the	 samples	 contained	 cristobalite	 in	 concen-
trations	ranging	from	20	to	78	µg/m3,	and	1	of	
the	 samples	 contained	 70	 µg/m3	 quartz.	 The	
measurable	 silica	 exposures	 occurred	 among	
workers	employed	as	raw	material	handlers	and	
furnace	operators.	
As	 the	 study	progressed,	approximately	1,820	
work	 history	 interviews	 were	 conducted	 and	
evaluated	 to	 refine	 uniform	 job	 titles	 and	 to	
identify	 dust	 zones	 according	 to	 the	 meth-
od	of	Corn	and	Esmen	[1979].	Four	years	of	
sampling	data	(1987–1991)	were	merged	with	
historic	 sampling	 data	 to	 construct	 exposure	
estimates	for	81	job	titles	in	7	facilities	for	spec-
ified	 time	 periods	 [Rice	 et	 al.	 1997].	 Overall	
exposures	decreased.	The	maximum	exposure	
estimated	was	10	f/cm3	in	the	1950s	for	carding	
in	 a	 textile	 operation;	 subsequent	 changes	 in	
engineering,	 process,	 and	 ventilation	 reduced	
exposure	estimates	for	all	20	job	titles	to	near	
or	below	1	f/cm3	[Rice	et	al.	1996,	1997].	The	
study	reported	that	at	more	recent	operations	
(1987–1991),	exposure	estimates	ranged	from	
below	the	analytic	LOD	to	0.66	f/cm3.
Subsequently,	Rice	et	al.	[2005]	published	the	
results	from	an	analysis	of	exposure	estimates	
for	10	years	of	follow-up	sampling	(1991−2001)	
at	5	of	7	facilities	(2	facilities	had	closed	before	
1991).	The	researchers	found	the	following	es-
timates	for	122	job	titles	still	active	in	2001:
Number and % Exposure estimate 
   of job titles           (f/cm3)
				97	(79%) 	. . . . . . . . . . 	≤0.25	
				17	(14%) 	. . . . . . . . . . 	>0.25	to	0.5	
						8	(		7%).	.	.	.	.	.	.	.	.	.	. 	>0.5
The	study	shows	that	exposures	decreased	for	
25%	 of	 job	 titles,	 remained	 stable	 for	 53%,	
and	 increased	 for	22%.	Of	 the	 job	 titles	with	
increased	exposure	estimates,	9	estimates	were	
>0.1	f/cm3	(range	=	0.1	to	0.21	f/cm3),	and	19	
estimates	 were	 <0.1	 f/cm3.	 The	 exposure	 es-
timates	 for	 this	 study	 do	 not	 include	 adjust-
ments	for	respirator	use.
4.5.3  RCFC/EPA Consent Agreement 
Monitoring Data
In	1993,	the	RCFC	and	the	EPA	entered	into	a	ne-
gotiated	5-year	consent	agreement	to	determine	
the	magnitude	of	RCF	exposures	in	the	primary	
RCF	manufacturing	 industry	 and	 in	 secondary	
RCF-use	 industries	 [RCFC	 1993;	Maxim	 et	 al.	
1994,	 1997;	 Everest	 1998].	Another	 purpose	 of	
this	consent	agreement	was	to	document	changes	
in	RCF	exposures	during	the	5	years	of	the	agree-
ment	(1993–1998).	The	Quality	Assurance	Proj-
ect	Plan	 in	 the	consent	agreement	contains	 the	
analytical	 protocols,	 statistical	 design,	 descrip-
tion	of	the	program	objectives,	and	timetables	for	
meeting	the	objectives	[RCFC	1993].
During	 each	 year	 of	 the	 consent	 agreement,	 a	
minimum	 of	 720	 personal	 air	 samples	 (mea-
sured	 as	 8-hr	 TWAs)	 were	 collected	 according	
to	a	 stratified	random	sampling	plan.	Of	 these,	
320	 samples	 were	 collected	 in	 RCF	 manufac-
turing	 and	 processing	 (primary)	 facilities.	 The	
remaining	 400	 samples	 were	 collected	 in	 RCF	
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customer	 facilities	 referred	 to	 as	 end-use	 (sec-
ondary)	facilities.	The	researchers	collected	a	to-
tal	of	4,576	samples.	A	number	of	end-use	facili-
ties	were	randomly	selected	from	a	list	of	known	
purchasers	of	RCF	products.	The	remainder	con-
sisted	of	facilities	that	volunteered	for	sampling	
once	they	learned	of	the	consent	agreement.	The	
strata	from	which	the	720	samples	were	collected	
consist	of	eight	functional	job	categories	derived	
so	that	results	could	be	aggregated	for	compari-
son	 across	 industries,	 facilities,	 and	 similar	 job	
functions	[RCFC	1993].	This	categorization	was	
based	 on	 the	 approach	 instituted	 by	Corn	 and	
Esmen	[1979].	Appendix	B	lists	definitions	and	
major	 work	 tasks	 for	 each	 functional	 job	 cat-
egory.	TWA	and	task-length	average	air	sampling	
data	were	gathered	according	to	NIOSH	Meth-
od	7400	(B	rules)	and	analyzed	using	PCM	and	
TEM.	Data	on	respirator	use	(by	type)	were	also	
collected	[Maxim	et	al.	1998].
As	 background	 for	 the	 consent	 agreement	
monitoring	plan,	baseline	(now	referred	to	as	
historical)	 information	 about	 airborne	 fiber	
concentrations	was	obtained	through	personal	
sampling	 of	 workers	 at	 RCF	 manufacturing	
facilities	from	January	1989	to	May	1993.	Ex-
posure	monitoring	strategies	used	during	 the	
baseline	 period	 (1989–1993)	 provided	 the	
framework	for	 the	consent	agreement	(1993–
1998)	 monitoring	 protocol.	 Table	 4–3	 pres-
ents	AM	and	geometric	mean	 (GM)	concen-
trations	 of	 RCF	 exposures	 determined	 from	
historical	data	(1989–1993)	by	 functional	 job	
category.	 Table	 4–4	 contains	 these	 summary	
statistics	for	all	5	years	of	RCF	consent	agree-
ment	monitoring	data.	Table	4–5	summarizes	
data	 from	 samples	 collected	 during	 the	 5th	
year	of	the	consent	agreement	only	(June	1997	
to	May	1998).	Table	4–6	presents	 the	average	
airborne	fiber	concentrations	 for	 the	baseline	
(1989–1993)	and	consent	agreement	monitor-
ing	(1993–1998)	periods	by	manufacturing	and	
end-use	sectors.
A	comparison	of	values	 from	Tables	4–4,	4–5,	
and	4–6	with	those	in	Table	4–3	indicates	that	
average	airborne	concentrations	for	1993–1998	
were	 lower	 than	 those	 for	 the	preceding	base-
line	 sampling	 period	 (1989–1993).	 However,	
a	comparison	of	values	 in	Tables	4–5	and	4–6	
shows	that	average	concentrations	for	the	entire	
5-year	 consent	 agreement	 monitoring	 period	
(1993–1998)	 are	 equal	 to	 those	of	 year	5	 (i.e.,	
no	change).
After	the	first	3	years	(1993–1996)	of	the	con-
sent	agreement	monitoring	period,	Maxim	et	al.	
[1997]	performed	interim	analyses	of	these	data	
combined	with	historical	data	from	the	baseline	
monitoring	period	(1989–1993).	The	following	
conclusions	 about	 RCF	 exposures	 were	 based	
on	 these	 analyses	 of	 data	 from	 1,600	 baseline	
samples	and	3,200	consent	agreement	samples:
■	 Airborne	 concentrations	 of	 RCFs	 are	
generally	decreasing	in	the	workplace.
■	Ninety	 percent	 of	 airborne	 concentra-
tions	of	RCFs	in	the	workplace	are	below	
1	f/cm3.
■	 RCF	 concentrations	 have	 an	 approxi-
mately	log-normal	distribution.
■	 Significant	differences	exist	in	workplace	
concentrations	by	facility.	
■	Workplace	concentrations	vary	with	func-
tional	job	category.
■	 Respirator	usage	varies	with	the	worker’s	
functional	 job	 category	 and	 the	 associ-
ated	average	fiber	concentration.
■	Workplace	samples	have	a	lower	ratio	of	
respirable	 nonfibrous	 particles	 to	 fibers	
than	samples	used	in	initial	animal	inha-
lation	 studies	 [Mast	 et	 al.	 1995a,b;	Mc-
Connell	et	al.	1995].
Functional	job	categories	with	the	highest	aver-
age	TWA	fiber	concentrations	include	removal	
(AM=1.2	f/cm3),	finishing	(AM=0.8	f/cm3),	and	
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Table 4–3 . TWA* concentrations of airborne RCFs in personal samples collected during 
the baseline sampling period (1989–1993),† by functional job category
Functional job category
Manufacturing (primary production) End use (secondary processing)
No . 
samples
AM GM No .  
samples
AM GM
f/cm3 SD f/cm3 GSD f/cm3 SD f/cm3 SD
Assembly	 120 0.5 0.92 0.22 3.94 130 0.29 0.36 0.13 4.08
Auxiliary 119 0.15 0.18 0.07 4.01 26 1.1 2.26 0.2 6.33
Fiber 438 0.52 0.79 0.22 4.17 — — — — —
Finishing 127 0.76 0.63 0.49 3.11 84 1.57 5.72 0.47 4.18
Installation — — — — — 201 0.69 1.09 0.3 4.31
Mixing	forming 89 0.27 0.34 0.15 3.23 47 0.41 0.55 0.17 4.71
Other 129 0.33 0.86 0.09 4.25 57 0.38 0.69 0.14 4.88
Removal — — — — — 49 1.36 2.97 0.28 6.48
Total 1,022 0.46 0.74 0.19 4.37 594 0.75 2.49 0.23 4.85
*Abbreviations:	AM=arithmetic	mean;	GM=geometric	mean;	GSD=geometric	standard	deviation;	RCF=refractory	ceramic	fibers;	
	SD=standard	deviation;	TWA=time-weighted	average.
†Data	collected	from	August	1989	to	May	1993	[RCFC	1993].
Table 4–4 . TWA* concentrations of airborne RCFs in personal samples collected during the 
5-year consent agreement monitoring period, 1993–1998,† by functional job category
Functional job category
Manufacturing (primary production) End use (secondary processing)
No . 
samples
AM GM
No . 
samples
AM GM
f/cm3 SD f/cm3 GSD f/cm3 SD f/cm3 GSD
Assembly 362 0.28 0.27 0.18 2.76 369 0.31 0.4 0.14 4.1
Auxiliary 237 0.12 0.19 0.05 3.87 311 0.19 0.37 0.07 4.68
Fiber 421 0.26 0.47 0.14 3.27 — — — — —
Finishing 359 0.65 0.56 0.47 2.44 622 0.99 2.09 0.35 4.5
Installation — — — — — 456 0.42 0.51 0.2 3.83
Mixing	forming 379 0.28 0.27 0.17 2.96 332 0.31 0.47 0.17 3.07
Other 167 0.14 0.21 0.07 3.22 385 0.17 0.46 0.04 4.66
Removal — — — — — 176 1.92 2.85 0.82 4.22
Total 1,925 0.31 0.42 0.16 3.65 2,651 0.56 1.39 0.16 5.22
Source:	Maxim	et	al.	[1999a].
*Abbreviations:	AM=arithmetic	mean;	GM=geometric	mean;	GSD=geometric	standard	deviation;	RCF=refractory	ceramic	fibers;	
SD=standard	deviation;	TWA=time-weighted	average.
†Data	collected	from	June	1993	to	May	1998.
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installation	(AM=0.4	f/cm3).	The	remainder	of	
the	functional	job	categories	had	average	TWA	
concentrations	 near	 or	 below	 0.3	 f/cm3.	 Al-
though	different	jobs	and	activities	are	associ-
ated	with	the	three	higher	exposure	functional	
job	categories,	similarities	exist	that	contribute	
to	exposure	concentrations.	First,	removal	and	
installation	activities	are	performed	at	remote	
jobsites	where	implementing	fixed	engineering	
controls	may	be	difficult	or	impractical	for	re-
ducing	airborne	fiber	concentrations.	Removal	
requires	 more	 mechanical	 energy	 and	 may	
involve	 fracturing	 the	 structure	 of	 the	 RCF	
product,	 resulting	 in	 fiber	 release	 and	 higher	
concentrations	 of	 airborne	 fibers.	 Finish-
ing	activities	are	performed	at	fixed	 locations	
where	it	is	possible	to	implement	engineering	
controls,	but	they	also	involve	mechanical	en-
ergy	to	shape	RCF	products	by	drilling,	sand-
ing,	and	sawing.	These	processes	also	result	in	
the	dispersal	of	airborne	fibers.
Regarding	particle-to-fiber	ratio,	Maxim	et	al.	
[1997]	 found	 average	workplace	 values	 to	 be	
much	 lower	(0.53;	n=10;	range	not	reported)	
than	the	average	ratio	(9.1;	n=7)	in	the	samples	
used	 in	 a	 series	 of	 animal	 inhalation	 toxicity	
studies	with	RCFs	 [Mast	 et	 al.	 1995a,b,	2000;	
McConnell	et	al.	1995].	
Monitoring	performed	during	the	baseline	pe-
riod	(August	1989–May	1993)	and	the	5-year	
consent	 agreement	 period	 (June	 1993–May	
1998)	provided	data	from	nearly	6,200	air	sam-
ples	 in	 the	domestic	RCF	 industry.	Table	4–6	
presents	 the	 summary	 statistics	 of	workplace	
RCF	exposure	concentrations	for	the	baseline	
(historical)	 and	 consent	 agreement	monitor-
ing	data.	The	data	suggest	that	(1)	the	AMs	and	
GMs	 of	 RCF	 concentrations	 were	 higher	 for	
workers	during	the	baseline	period	than	dur-
ing	the	more	recent	(consent	monitoring	data)	
period,	and	(2)	AM	and	GM	exposure	concen-
trations	were	lower	for	workers	in	manufactur-
ing	facilities	than	at	end-use	sites.
Table 4–5 . TWA* concentrations of airborne RCFs in personal samples collected during 
year 5 of the consent agreement monitoring period, June 1997 to May 1998
Functional job category
Manufacturing (primary production) End use (secondary processing)
No . 
samples
AM GM No . 
samples
AM GM
f/cm3 SD f/cm3 GSD   f/cm3 SD  f/cm3 GSD
Assembly	 78 0.28 0.25 0.19 2.48 92 0.28 0.39 0.1 5.32
Auxiliary 44 0.16 0.21 0.08 4.05 89 0.18 0.36 0.06 4.98
Fiber 85 0.29 0.29 0.18 2.85 — — — — —
Finishing 77 0.6 0.57 0.44 2.11 126 0.93 1.49 0.37 4.43
Installation — — — — — 81 0.34 0.49 0.17 3.54
Mixing	forming 75 0.23 0.24 0.14 2.78 69 0.28 0.31 0.18 2.65
Other 39 0.22 0.34 0.12 3 70 0.05 0.12 0.02 3.07
Removal — — — — — 39 2.3 3.9 0.58 6.15
Total 398 0.31 0.37 0.18 3.12 566 0.54 0.14 0.13 5.83
Source:	Maxim	et	al.	[1999a].
*Abbreviations:	AM=arithmetic	mean;	GM=geometric	mean;	GSD=geometric	standard	deviation;	RCF=refractory	ceramic	
fibers;	SD=standard	deviation;	TWA=time-weighted	average.
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4.5.4  Exposures During Installation 
and Removal of RCF Furnace 
Insulation
To	 evaluate	 exposures	 to	 airborne	 dust	 as-
sociated	with	 removing	RCF	 furnace	 insula-
tion,	Gantner	[1986]	conducted	surveys	with	
air	 sampling	 at	 five	 sites.	 The	 surveys	 were	
performed	 at	 sites	 where	 workers	 removed	
modules	 or	 blanket-type	 insulation	 manu-
ally	using	knives	or	 trowels.	During	removal	
activities,	workers	wore	disposable,	single-use	
respirators,	disposable	protective	clothing	or	
their	 own	 personal	 clothing,	 and	 (in	 some	
cases)	 goggles	 or	 other	 protective	 eyewear.	
Personal	 sampling	 was	 performed	 for	 total	
dust	concentration	as	well	as	 respirable	dust	
concentration	using	 a	 cyclone.	Area	 samples	
were	 collected	 in	 the	 center	 of	 work	 zones	
(industrial	 furnaces)	 at	 9	 ft	 above	 the	 floor,	
which	was	at	 the	breathing	zone	 level	of	 the	
workers,	who	were	on	scaffolding.	A	total	of	
24	 air	 samples	 were	 collected,	 including	 14	
personal	 samples	 (9	 for	 respirable	 dust	 and	
5	 for	 total	 dust	 concentrations)	 and	 10	 area	
samples	 (3	 for	 respirable	 dust	 and	 7	 for	 to-
tal	 dust	 concentrations).	Bulk	 samples	 of	 the	
insulation	materials	were	 analyzed	 for	 cristo-
balite	content,	which	ranged	between	0%	and	
21%.	 In	 area	 air	 samples,	 cristobalite	 content	
ranged	 from	 4%	 to	 15%.	 Personal	 respirable	
dust	 concentrations	 averaged	 4.99	 mg/m3	
(range=0.12	to	16.9	mg/m3),	and	personal	total	
dust	samples	averaged	13.95	mg/m3	(range=0.31	
to	35.8	mg/m3).	Concentrations	in	area	samples	
were	 lower,	averaging	1.61	mg/m3	(range=0.1	
to	3.4	mg/m3)	for	respirable	dust	and	8.98	mg/m3	
(range=0.96	to	36.2	mg/m3)	for	total	dust.	As	
expected,	 the	 highest	 cristobalite	 concentra-
tions	 in	bulk	samples	were	 found	on	the	 face	
of	 insulation	 materials	 closest	 to	 high	 tem-
peratures	 in	 furnaces	 (threshold	 temperature	
near	1,700	oF).	Results	of	the	surveys	indicated	
that	 concentrations	 of	 respirable	 cristobalite	
exceeded	 the	ACGIH	TLV	 (then	 [10	mg/m3]/	
[%	SiO
2
	 +	 2]/2)	 in	 75%	 of	 the	 samples,	 al-
though	all	sampling	times	were	short	because	
the	removal	task	lasts	only	26	to	183	min.	The	
TLV	for	cristobalite	has	since	been	lowered	to	
0.05	mg/m3	as	an	8-hr	TWA	[ACGIH	2005].
Table 4–6 . TWA* concentrations RCFs in personal samples collected at manufacturing 
facilities and end-use site during the baseline (1989–1993) monitoring periods
Type of site
 No . 
samples
Baseline data (1989–1993)† 
No . 
samples
Consent monitoring data 
(1993–1998)‡
AM GM AM GM
f/cm3 SD f/cm3 GSD f/cm3 SD f/cm3 GSD
Manufacturing	(primary	
				production)
1,022 0.46 0.74 0.19 4.37 1,527 0.31 0.42 0.16 3.65
End-use	(secondary		
			processing)
594 0.75 2.49 0.23 4.85 2,085 0.56 1.39 0.16 5.22
Total 1,616 0.56 1.63 0.2 4.56 4,576 0.46 1.1 0.16 4.53
Sources:	RCFC	[1993]	and	Maxim	et	al.	[1999a].
*Abbreviations:	AM=arithmetic	mean;	GM=geometric	mean;	GSD=geometric	standard	deviation;	RCFs=refractory	ceramic	
fibers;	SD=standard	deviation;	TWA=time-weighted	average.	
†Data	collected	from	August	1989	to	May	1993	[RCFC	1993].
§Data	collected	from	June	1993	to	May	1998	[Maxim	et	al.	1999a].
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Cheng	et	al.	[1992]	studied	exposures	to	RCFs	
during	 the	 installation	 and	 removal	 of	 RCF	
insulation	 in	13	 furnaces	at	6	refineries	and	2	
chemical	 plants.	 Air	 samples	 were	 collected	
and	 analyzed	 according	 to	 NIOSH	 Method	
7400	 (A	 rules);	 sampling	 times	 ranged	 from	
15	 to	 300	min.	 Samples	 collected	 during	mi-
nor	maintenance	and	 inspection	tasks	(n=27)	
showed	GM	concentrations	of	0.08	to	0.39	f/cm3	
(range=0.02	to	17	f/cm3).	Sampling	performed	
during	 installation	 of	 RCF	 insulation	 (n=59)	
revealed	 GM	 concentrations	 of	 0.14	 to	 0.62	
f/cm3	 (range=0.02	 to	 2.6	 f/cm3).	 The	 highest	
exposures	 were	 observed	 in	 samples	 collect-
ed	during	 removal	of	RCF	 insulation	 (n=32),	
with	GM	concentrations	of	0.02	 to	1.3	 f/cm3	
(range=<0.01	 to	 17	f/cm3).	 Workers	 work-
ing	outside	of	enclosed	spaces	(furnaces)	were	
rarely	 exposed	 to	 more	 than	 0.2	 f/cm3.	 One	
sample	 of	 after-service	 RCF	 insulation	 was	
analyzed	for	fiber	diameter	and	length:	median	
diameter	was	reported	as	1.6	µm	(range=0.5	to	
6	µm),	and	 length	 ranged	 from	5	 to	220	µm.	
Of	100	fibers	randomly	selected	and	analyzed	
from	the	air	sample,	87%	were	within	the	re-
spirable	size	range.	Four	personal	samples	were	
collected	during	removal	of	after-service	RCF	
modules	and	fire	bricks	and	were	analyzed	for	
respirable	crystalline	silica	(cristobalite).	Sam-
ples	 revealed	 concentrations	 ranging	 from	
0.03	mg/m3	to	0.2	mg/m3	(GM=0.06	mg/m3).
At	a	Dutch	oil	 refinery,	van	den	Bergen	et	al.	
[1994]	performed	personal	air	monitoring	for	
airborne	fibers	to	assess	worker	exposures	dur-
ing	the	removal	of	RCF	insulation	from	expan-
sion	seams	in	a	heat-treating	furnace.	The	8-hr	
TWA	exposures	for	5	workers	sampled	ranged	
from	 9	to	 50	 f/cm3	 (GM=16	 f/cm3).	 Sweeney	
and	Gilgrist	[1998]	also	monitored	worker	ex-
posures	to	airborne	RCFs	and	respirable	silica	
during	 the	 removal	 of	 RCF	 materials	 from	
furnaces.	 Personal	 samples	 from	 two	 work-
ers	 taken	 during	 the	 removal	 of	 after-service	
RCF	insulation	revealed	exposures	of	0.15	and	
0.16	f/cm3.	Exposures	to	total	particulate	(18.3	
and	22.4	mg/m3	as	8-hr	TWAs)	were	above	the	
OSHA	PEL	of	15	mg/m3.	Exposure	concentra-
tions	for	respirable	dust	containing	crystalline	
silica	 (2.4%	 and	 4.3%)	 were	 also	 above	 the	
OSHA	 PEL.	 The	 elevated	 concentrations	 of	
respirable	and	total	dust	were	associated	with	
removal	of	 conventional	 refractory	 lining	us-
ing	 jackhammers,	 crowbars,	 and	hammers.	A	
worker	performing	routing	to	install	new	RCF	
insulation	 was	 exposed	 at	 1.29	 f/cm3	 (8-hr	
TWA).	Personal	samples	from	another	worker	
using	a	bandsaw	to	cut	new	RCF	insulation	re-
vealed	concentrations	of	1.02	f/cm3	as	an	8-hr	
TWA.
In	 the	RCF	 industry,	worker	exposures	 to	 re-
spirable	 crystalline	 silica	 (including	 quartz,	
cristobalite,	and	tridymite)	may	occur	during	
the	use	of	silica	in	manufacturing,	removal	of	
after-service	 insulation,	 and	 waste	 disposal.	
Focusing	 on	 exposures	 of	 workers	 who	 in-
stall,	use,	or	remove	RCF	insulation,	Maxim	et	
al.	[1999a]	collected	158	personal	air	samples	
analyzed	for	respirable	quartz,	cristobalite,	and	
tridymite	over	 the	RCFC/EPA	5-year	 consent	
agreement	monitoring	period	(1993–1998).	A	
total	of	42	removal	projects	were	sampled.	For	
small	 jobs,	 all	 workers	 engaged	 in	 insulation	
removal	were	 sampled;	 for	 larger	 jobs,	work-
ers	were	selected	at	random	for	sampling.	Air	
sampling	and	analysis	were	performed	accord-
ing	to	NIOSH	Method	7500	for	crystalline	sili-
ca	by	X-ray	diffraction;	sampling	times	ranged	
from	37	 to	588	min	 (AM=260	min,	 standard	
deviation	[SD]=129	min).	Short	sampling	times	
reflected	 the	short	duration	of	RCF	 insulation	
removal	tasks	(a	benefit	over	time-intensive	re-
moval	 of	 conventional	 refractories).	Removal	
of	RCF	blankets	and	modules	is	performed	by	
using	knives,	pitchforks,	rakes,	and	water	lanc-
es,	 or	 by	 hand-peeling.	 The	 study	 noted	 that	
most	 (>90%)	workers	wear	 respirators	 (with	
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protection	factors	from	10	to	50	or	more)	when	
removing	 insulation.	Analysis	of	158	 samples	
found	the	following:
■	 Fourteen	 samples	 had	 task-time	 respi-
rable	quartz	concentrations	ranging	from	
0.01	to	0.44	mg/m3	(equivalent	8-hr	TWA	
range=0.004	to	0.148	mg/m3);	the	remain-
der	of	samples	were	below	the	LOD.
■	 Three	samples	had	detectable	concentra-
tions	of	cristobalite	 that	were	below	the	
NIOSH	REL	of	0.05	mg/m3.
■	One	sample	contained	tridymite	(0.2	mg/m3)	
at	a	concentration	exceeding	the	NIOSH	
REL	of	0.05	mg/m3.
4.5.5  International (Canadian, Swedish, 
and Australian) Surveys of RCF 
Exposure
Perrault	 et	 al.	 [1992]	 reported	 on	 the	 charac-
teristics	of	fiber	exposures	that	occurred	during	
the	use	of	synthetic	fiber	insulation	materials	on	
construction	sites	in	Canada.	Fiber	dimensions	
were	measured	from	bulk	samples	of	insulation	
materials	used	at	five	construction	sites.	Area	air	
samples	were	also	collected	during	the	installa-
tion	of	 composite	RCF	and	glass	wool	 insula-
tion,	glass	wool	alone,	 rock	wool	 (both	blown	
and	sprayed	on),	and	RCFs	alone.	
Respirable	 fiber	 concentrations	 were	 highest	
during	removal	and	installation	of	RCFs	(0.39	
to	 3.51	 f/cm3)	 compared	with	 concentrations	
measured	 during	 installation	 of	 rock	 wool	
(0.15	to	0.32	f/cm3),	composite	RCF	and	glass	
wool	(0.04	f/cm3),	and	glass	wool	alone	(0.01	
f/cm3).	Diameters	of	fibers	in	bulk	samples	dif-
fered	significantly	from	diameters	in	airborne	
fibers.	RCFs	had	the	smallest	GM
D
	of	fibers	in	
bulk	samples	(0.38	to	0.55	µm)	compared	with	
glass	wool	(0.93	µm)	and	rock	wool	(1.1	to	3.9	
µm).	 For	 airborne	 fibers,	 rock	wool	 (sprayed	
on)	had	a	GM
D
	of	2.0	µm,	 followed	by	RCFs	
(1.1	µm),	composite	RCFs	and	glass	wool	(0.71	
µm),	glass	wool	(0.5	µm)	and	blown	rock	wool	
(0.5	µm).	Elemental	analysis	and	comparison	
of	 bulk	 samples	 with	 air	 samples	 revealed	 a	
greater	concentration	of	fibers	with	oxides	of	
silicon	and	aluminum	in	air	samples.	For	sites	
with	either	glass	wool	or	rock	wool	insulation,	
airborne	 samples	 contained	 fewer	fibers	with	
silicon	oxide	as	the	sole	constituent	than	bulk	
samples.	The	authors	concluded	that	airborne	
fiber	concentrations	were	affected	by	the	type	
of	 fiber	 material	 used	 and	 the	 confinement	
of	worksites.	The	authors	also	concluded	that	
characterization	of	fibers	in	bulk	samples	is	not	
a	good	representation	of	physical	and	chemical	
parameters	of	the	airborne	fibers.
A	 report	 by	 the	 Swedish	 National	 Institute	
for	Occupational	Health	 [Krantz	 et	 al.	 1994]	
describes	 exposure	 to	 RCFs	 in	 smelters	 and	
foundries	based	on	industrial	hygiene	surveys	
and	 sampling	 at	 4	 facilities:	 a	 specialty	 steel	
foundry	 (2,500	 workers),	 a	 metal	 smelting	
plant	 (1,500	workers),	 an	 aluminum	 foundry	
(450	workers),	and	an	iron	foundry	(450	work-
ers).	RCF	products	were	used	in	these	plants	in	
ladles,	 tapping	 spouts,	 holding	 furnaces,	 heat	
treatment	furnaces,	and	spill	protection	mats.	
Workers	and	contractors	were	placed	into	three	
exposure	 categories,	 depending	 on	 their	 po-
tential	for	exposure	(as	determined	by	distance	
from	a	fiber	source).	The	highest	exposures	to	
airborne	ceramic	fibers	(category	1)	had	medi-
an	concentrations	of	0.26	to	1.2	f/cm3	and	in-
volved	about	3%	(n=160)	of	the	workers	at	the	
plants	surveyed.	Secondary	exposures	(catego-
ries	2	and	3)	involved	another	33%	(n=1,650)	of	
the	workers	and	had	median	concentrations	
of	0.03	to	0.24	f/cm3.	During	certain	opera-
tions	such	as	removal	or	demolition	of	RCF	
materials	 in	 enclosed	 spaces,	 concentrations	
of	up	to	210	f/cm3	were	measured.	Total	dust	
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concentrations	 increased	 with	 fiber	 concen-
tration	and	were	as	high	as	600	mg/m3	during	
demolition	and	60	mg/m3	during	reinsulation.	
Median	fiber	diameters	from	bulk	samples	an-
alyzed	by	electron	microscopy	ranged	from	0.6	to	
1.5	µm,	which	was	comparable	to	the	diameters	
of	airborne	fibers.	On	the	basis	of	air	sampling	
data,	fiber dose	(assuming	a	working	lifetime	of	
40	years	[fiber	concentration	×	exposure	time	
per	year	×	40	years])	was	estimated	for	8	oc-
cupations	with	category	1	exposures.	Dose	es-
timates	ranged	from	0.05	fiber-years/cm3	for	a	
cleaner	to	85	fiber-years/cm3	for	a	bricklayer	or	
contractor.	Dose	estimates	for	the	6	other	oc-
cupations	 ranged	 from	0.6	 fiber-years/cm3	 to	
3.1	fiber-years/cm3.	
Researchers	at	 the	Australian	National	Occupa-
tional	Health	and	Safety	Commission	established	
a	technical	working	group	to	investigate	typi-
cal	exposures	in	SVF	manufacturing	and	user	
industries	[Rogers	et	al.	1997].	The	RCF	man-
ufacturing	 industry	 is	relatively	small	 in	Aus-
tralia:	2	plants	employing	roughly	40	workers	
have	been	manufacturing	RCFs	since	1976	and	
1977.	 Since	 the	 plants	 began	 manufacturing	
RCFs,	152	persons	have	been	involved	with	pro-
duction.	Airborne	fiber	concentrations	in	both	
plants	decreased	over	time	as	a	result	of	(1)	the	
introduction	of	 a	national	 exposure	 standard	
of	0.5	f/cm3	for	synthetic	fibers	and	a	second-
ary	standard	of	2	mg/m3	for	inspirable	dust,	(2)	
the	use	of	various	controls	and	handling	tech-
nologies,	and	(3)	 increased	awareness	of	dust	
suppression	by	the	workforce.	GM	concentra-
tions	 of	 airborne	 fibers	 before	 implementa-
tion	 of	 the	 synthetic	 fiber	 exposure	 standard	
(1983–1990)	measured	 0.52	f/cm3	 (geometric	
standard	deviation	[GSD]=3.9)	and	0.29	f/cm3	
(GSD=2.5)	 for	 plants	1	and	 2,	 respectively.	
GM	concentrations	for	the	subsequent	period	
(1991–1996)	dropped	to	0.11	f/cm3	(GSD=4.1)	
at	plant	1	and	0.27	f/cm3	(GSD=3.3)	at	plant	2.
4.5.6  Johns Hopkins University 
Industrial Hygiene Surveys 
A	report	of	RCF	end-user	exposure	data	pre-
pared	 for	 the	 Thermal	 Insulation	 Manufac-
turers	 Association	 (TIMA)	 showed	 that	 us-
ing	 blanket,	 bulk,	 and	 vacuum-formed	 RCFs	
during	 certain	operations	 resulted	 in	high	fi-
ber	concentrations	[Corn	et	al.	1992].	For	ex-
ample,	25	personal	air	samples	collected	from	
workers	 installing	 RCF	 blanket	 modules	 had	
an	AM,	8-hr	TWA	concentration	of	1.36	f/cm3	
(SD=1.15).	The	fibers	were	collected	and	ana-
lyzed	 using	 NIOSH	 Method	 7400	 (B	 rules).	
Seventeen	 vacuum	 formers	 had	 AM	 expo-
sure	 concentrations	 of	 0.71	 f/cm3	 (SD=0.83)	
while	using	bulk	RCF	products.	Twenty-eight	
workers	with	the	job	title	vacuum-formed RCF 
cast finisher	 had	AM	 exposures	 of	 1.55	f/cm3	
(SD=1.51).	 Table	 4–7	 summarizes	 exposure	
data	collected	for	the	17	occupations	sampled	
during	 the	 study.	 Scanning	 electron	 micros-
copy	(SEM)	was	used	to	measure	dimensions	
of	approximately	3,500	fibers	from	selected	air	
samples	of	the	17	occupations.	GM	fiber	diam-
eters	ranged	from	0.9	to	1.5	µm,	and	GM	fiber	
lengths	ranged	from	20.4	to	36.1	µm.	Fiber	as-
pect	ratios	based	on	these	data	ranged	between	
16:1	and	30:1.
4.5.7  NIOSH HHEs and Additional 
 Sources of RCF Exposure Data 
NIOSH	has	conducted	HHEs	involving	poten-
tial	 exposures	 to	RCFs	 at	 the	 following	work	
places:	an	RCF	manufacturing	facility	[Lyman	
1992],	 a	 steel	 foundry	 [O'Brien	 et	 al.	 1990],	
a	 power	plant	 [Cantor	 and	Gorman	1987],	 a	
foundry	 [Gorman	 1987],	 and	 a	 railroad	 car	
wheel	 and	 axle	 production	 facility	 [Hewett	
1996].	Table	4–8	summarizes	data	on	airborne	
fiber	 concentrations	 and	 dimensions	 from	
these	studies.		
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Table 4–7 . Summary of 8-hr TWA* RCF exposures for workers using RCF insulation products
PCM (f/cm3) SEM (f/cm3)
Gravimetric 
(mg/m3)
RCF product Occupation n AM SD n AM SD n AM SD
RCF	blanket Module	fabricator 5 0.44 0.4 7 0.54 0.8 4 6.26 6.5
Module	installer 25 1.36 1.15 23 1.19 0.8 11 14.2 18.7
Blanket	installer 8 0.37 0.29 9 0.33 0.24 4 1.42 1.2
Investment	caster 20 0.73 0.88 18 0.65 0.57 6 3.59 3.75
General	fabricator 20 0.55 0.55 19 0.46 0.55 7 0.86 0.49
Fabrication	maintenance — — — — — — — — —
RCF	bulk Vacuum	former 17 0.71 0.83 13 0.6 0.57 7 1.1 0.7
Vacuum	maintenance — — — — — — — — —
Vacuum	warehouse — — — — — — — — —
Sprayer 1 1.53 — 1 1.15 — — — —
Spray	feeder 1 0.24 — 1 0.21 — — — —
Vacuum-formed	RCFs General	fabricator 2 0.52 0.58 2 0.2 0.05 2 0.57 0.35
Paper	fabricator — — — — — — — — —
Paper	finisher — — — — — — — — —
Cast	finisher 28 1.55 1.51 32 1.17 1.17 8 4.05 5.42
Finishing	maintenance 1 0.12 — 2 0.07 0.01 1 0.75 —
Board	installer 9 0.78 0.84 9 0.66 0.67 1 6.09 —
Source:		Corn	et	al.	[1992].
*Abbreviations:	AM=arithmetic	mean;	PCM=phase	contrast	microscopy;	RCF-refractory	ceramic	fiber;	SD=standard	deviation;	
		SEM=scanning	electron	microscopy;	TWA=time-weighted	average.
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Table 4–8 . NIOSH Health Hazard Evaluations involving investigation of exposures to RCFs*
Reference Worksite
Samples Concentration
Fiber dimensionNo . Type f/cm3 SD
Lyman	[1992] RCF	manufacturing 286 Breathing	zone 0.69 — —
	 4 Breathing	zone 4.02 1.82 —
	 126 Breathing	zone 0.81 — AMD=0.6	µm
	 — — AML=13.8	µm
	 24 Breathing	zone 1.65 — —
O’Brien	et	al.	[1990] Steel	foundry 48 Fibers	in	an	insu-
lating	blanket
— — D=<1.5	µm	(81%	of	fibers)
— — L=	4-64	µm	(77%	of	fibers)
54 Fibers	in	settled	
dust
— — D=<0.5	µm	(73%	of	fibers)
— — L=4-64	µm	(62%	of	fibers)
Cantor	and	Gorman	
[1987]
Power	plant 4 Breathing	zone 0.26 0.08 D=0.5-2.0	µm	(73%	of	
fibers)
2 Area 0.08 0.01 L=>20	µm	(60%	of	fibers)
Gorman	[1987] Foundry 7 Breathing	zone 0.1 0.06 D=<2	µm	(96%	of	fibers)
5 Area 0.4 0.26 L=<20	µm	(80%	of	fibers)
Hewett	[1996] Railroad	car	wheel	
and	axle	manufac-
turer
6 Breathing	zone	
near	heat	
treatment	
plant
0.024 0.012
—
14 Breathing	zone		
during	RCF	
removal
1.44 0.84
—
1 Breathing	zone 3.04† — —
1.7‡ — Mean	D=0.71	(SD=0.44)
— — Mean	L=11.9	(SD=11.3)
*Abbreviations:		AMD=arithmetic	mean	diameter;	AML=arithmetic	mean	length;	D=diameter;	L=length;	RCFs=refractory	ceramic	
fibers;	SD=standard	deviation.
†Measured	by	phrase	control	optical	microscopy	(PCM).
‡Measured	by	transmission	electron	microscopy	(TEM).
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4.5.8  Discussion
Recent	and	historical	environmental	monitor-
ing	data	[Esmen	et	al.	1979;	Cantor	and	Gor-
man	1987;	Gorman	1987;	O=Brien	et	al.	1990;	
Cheng	et	al.	1992;	Brown	1992;	Corn	et	al.	1992;	
Lyman	1992;	Allshouse	1995;	Hewett	1996]	in-
dicate	 that	 airborne	 concentrations	 of	 RCFs	
include	 fibers	 in	 the	 thoracic	 and	 respirable	
size	range	(<3.5	µm	in	diameter	and	<200	µm	
long	 [Timbrell	 1982;	 Lippmann	 1990;	 Baron	
1996]).	Workers	are	exposed	to	these	concen-
trations	 during	 primary	RCF	manufacturing,	
secondary	 manufacturing	 or	 processing,	 and	
end-use	 activities	 such	 as	 RCF	 installation	
and	 removal.	 Sampling	 data	 from	 studies	 of	
domestic	 primary	 RCF	 manufacturing	 sites	
indicate	that	average	airborne	fiber	concentra-
tions	have	steadily	declined	by	nearly	2	orders	
of	magnitude	over	the	past	2	decades.	Rice	et	
al.	 [1997]	 report	an	estimated	maximum	air-
borne	 concentration	 of	 10	 f/cm3	 associated	
with	 an	 RCF	 manufacturing	 process	 in	 the	
1950s.	Esmen	et	al.	[1979]	recognized	average	
exposure	concentrations	ranging	from	0.05	to	
2.6	 f/cm3	 in	 RCF	 manufacturing	 facilities	 in	
the	mid-	to	late-1970s.	During	the	late	1980s,	
Rice	et	al.	 [1994,	1996,	1997]	calculated	aver-
age	airborne	concentrations	in	manufacturing	
facilities	that	ranged	from	<LOD	to	0.66	f/cm3.	
Maxim	 et	 al.	 [1994,	 1997,	 2000a]	 report	 that	
from	the	late	1980s	through	1997,	concentra-
tions	ranged	from	an	AM	of	<0.3	to	0.6	f/cm3	
(GM0.2	f/cm3).	
For	many	RCF	manufacturing	processes,	 re-
ductions	 in	 exposure	 concentrations	 have	
been	 realized	 through	 improved	 ventilation,	
engineering	 or	 process	 changes,	 and	 prod-
uct	 stewardship	 programs	 [Rice	 et	 al.	 1996;	
Maxim	 et	 al.	 1999b].	 Several	 functional	 job	
categories	 continue	 to	 be	 associated	with	fi-
ber	 concentrations	 that	 exceed	 the	 average;	
these	 include	 finishing	 operations	 during	
manufacturing,	 removal	 operations,	 and	 in-
stallation	 performed	by	 end	users.	Activities	
in	 these	 three	 categories	 require	 additional	
mechanical	 energy	 in	 handling	 RCF	 prod-
ucts	(e.g.,	 sawing,	drilling,	cutting,	sanding),	
which	 increases	 the	 generation	 of	 airborne	
fibers.	Removal	and	installation	activities	are	
performed	at	remote	sites	where	conventional	
engineering	 strategies	 and	fixed	 controls	 are	
more	difficult	to	implement.	For	certain	oper-
ations	in	which	airborne	fiber	concentrations	
are	greater	(such	as	removal	of	RCF	products	
from	furnaces),	jobs	are	performed	for	short	
periods	and	almost	universally	with	the	use	of	
respiratory	protection	[Maxim	et	al.	1998].
One	 additional	 consideration	 during	 work	
involving	 RCF	 exposure	 is	 the	 potential	 for	
exposure	 to	 respirable	 silica	 in	 the	 forms	 of	
quartz,	 tridymite,	 and	 cristobalite.	 Although	
the	 potential	 for	 such	 exposure	 exists	 in	 pri-
mary	manufacturing	(because	silica	is	a	major	
component	of	RCFs),	monitoring	data	indicate	
that	these	exposures	are	generally	low	[Rice	et	
al.	 1994].	Maxim	 et	 al.	 [1999a]	 reported	 that	
many	 airborne	 silica	 samples	 collected	 to	 as-
sess	exposures	during	installation	and	removal	
of	RCF	products	contain	concentrations	below	
the	LOD,	with	average	concentrations	of	respi-
rable	 silica	 ranging	 from	 0.01	 to	 0.44	mg/m3	
(equivalent	 8-hr	 TWA	 range=0.004	 to	 0.148	
mg/m3).	Other	studies	indicate	a	greater	poten-
tial	for	exposure	to	respirable	silica	(especially	
in	the	form	of	cristobalite)	during	removal	of	
after-service	 RCF	 materials	 [Gantner	 1986;	
Cheng	et	al.	1992;	Perrault	et	al.	1992;	van	den	
Bergen	et	al.	1994;	Sweeney	and	Gilgrist	1998].	
Processes	associated	with	high	concentrations	
of	airborne	fibers	generally	generate	high	con-
centrations	of	total	and	respirable	dust	as	well	
[Esmen	et	al.	1979;	Krantz	et	al.	1994].
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Animal	studies	report	the	concentration(s)	to	
which	the	animals	were	exposed.	The	distinc-
tion	 between	 administered	 exposure	 concen-
tration	 and	 received	 dose	 is	 important	when	
analyzing	these	studies.	The	dose	affecting	the	
target	tissues	is	known	only	when	the	amount	
of	 fiber	 present	 in	 the	 lung	 is	measured	 and	
reported.	To	analyze	 the	 results	of	RCF	stud-
ies,	the	number	of	fibers	per	exposure,	their	di-
mensions,	durabilities,	and	the	delivered	dose	
should	be	considered	for	making	comparisons	
and	conclusions	regarding	potential	and	rela-
tive	toxicity.	
5.1.1 Intrapleural, Intraperitoneal, 
and Intratracheal Studies
Instillation	 and	 implantation	 studies	 deliver	
fibers	directly	to	the	trachea,	pleural	cavity,	or	
peritoneal	cavity,	bypassing	some	of	the	defense	
and	clearance	mechanisms	that	act	on	inhaled	
fibers.	 Implantation	 of	 fibers	 into	 either	 the	
pleural	or	abdominal	cavities	delivers	fibers	di-
rectly	to	the	pleural	or	abdominal	mesothelium,	
bypassing	some	or	all	of	the	normal	defense	and	
clearance	mechanisms	of	the	respiratory	tract.	
Intratracheal	instillation	delivers	fibers	directly	
to	the	trachea,	bypassing	the	upper	respiratory	
tract.	 These	 exposure	methods	 do	 not	mimic	
an	occupational	inhalation	exposure	of	several	
hours	 per	 day	 for	 several	 days	 per	week	 over	
an	 extended	 period.	 However,	 one	 advantage	
of	 these	 studies	 is	 that	 they	 allow	 the	 admin-
istration	of	a	precise	dose	of	fibers	that	can	be	
replicated	 between	 animals.	 They	 also	 permit	
the	administration	of	higher	doses	than	may	be	
obtainable	by	inhalation	exposure.	
5.1 Health Effects in 
Animals (In Vivo Studies)
The	health	effects	of	RCF	exposures	have	been	
evaluated	 in	animal	 studies	using	 intrapleural,	
intraperitoneal,	 intratracheal,	 and	 inhalation	
routes	of	exposure.	All	of	these	routes	have	dem-
onstrated	 the	 carcinogenic	 potential	 of	 RCFs.	
Chronic	inhalation	studies	provide	information	
that	is	most	relevant	to	the	occupational	route	
of	exposure	and	human	risk	assessment.	Mech-
anistic	information	about	fiber	toxicity	may	also	
be	derived	from	other	types	of	studies.	Studies	
investigating	the	cellular	effects	of	RCFs	in	vitro	
are	reviewed	in	Section	5.2	and	Appendix	C.
When	comparing	the	effects	of	a	fiber	dose	 in	
animal	studies,	 it	 is	possible	 to	compare	fibers	
on	a	gravimetric	basis	 (effect	per	unit	weight)	
or	 a	 fiber	 basis	 (effect	 per	 number	 of	 fibers).	
The	 same	 gravimetric	 dose	 of	 different	 fiber	
types	may	contain	vastly	different	numbers	of	
fibers	 because	 of	 differences	 in	 their	 dimen-
sions.	RCF1	is	a	relatively	thick	fiber	compared	
with	many	types	of	asbestos,	such	as	chrysotile,	
a	fiber	commonly	used	as	a	positive	control	in	
pulmonary	carcinogenesis	experiments	 in	ani-
mals	 (see	Table	 2–2	 for	 descriptions	 of	RCF1,	
RCF2,	RCF3,	and	RCF4).	A	gravimetric	dose	of	
RCF1	usually	contains	far	fewer	fibers	than	the	
same	gravimetric	dose	of	chrysotile	asbestos	fi-
bers,	making	a	direct	comparison	of	their	effects	
difficult	 when	 the	 number	 of	 fibers	 per	 unit	
weight	 is	not	 reported.	Comparison	on	a	per-	
fiber	basis	 rather	 than	a	weight	basis	provides	
information	 most	 applicable	 to	 occupational	
risk	assessment.
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Although	 the	 results	 of	 implantation	 and	 in-
stillation	studies	may	not	be	directly	applicable	
to	 occupational	 exposure	 and	 human	 health	
effects,	 they	 provide	 important	 information	
about	 the	 potential	 toxicity	 of	 RCFs.	 Experi-
ments	that	control	fiber	dimensions	and	other	
variables	provide	information	about	the	physi-
ological	 characteristics	 relevant	 to	 fiber	 tox-
icity.	 They	 provide	 a	 less	 expensive,	 quicker	
means	to	screen	the	potential	toxicity	of	a	fiber	
than	inhalation	studies.
Many	of	the	implantation	and	instillation	stud-
ies	reviewed	here	report	the	administered	fiber	
dose	on	a	gravimetric	basis	rather	than	on	a	per-	
fiber	 basis.	 Some	 studies	 assess	 the	 toxicity	 of	
both	RCFs	 and	 asbestos	 independently,	which	
allows	 for	 the	comparison	of	 these	fibers	on	a	
gravimetric	basis	but	not	on	a	per-fiber	basis.
5.1.1.1	 Intraperitoneal	Implantation	Studies
In	intraperitoneal	studies,	fibers	are	implanted	
directly	 into	 the	 abdominal	 cavity,	 bypassing	
the	 respiratory	 system	 defense	 and	 clearance	
mechanisms	 that	 act	 on	 inhaled	 fibers.	 Al-
though	the	implanted	fibers	act	on	some	of	the	
same	target	cell	types	as	the	fibers	of	an	inhala-
tion	exposure	(such	as	 the	mesothelium),	 the	
effects	elicited	in	the	abdominal	mesothelium	
cannot	 be	 assumed	 to	 be	 identical	 to	 the	 re-
sponse	of	the	pleural	mesothelium.	Table	5–1	
summarizes	the	results	of	three	RCF	intraperi-
toneal	implantation	studies	[Davis	et	al.	1984;	
Smith	et	al.	1987;	Pott	et	al. 1987].	A	brief	de-
scription	of	these	studies	follows.
Davis	et	al.	[1987]	dosed	Wistar	rats	with	25	mg	
ceramic	 aluminum	 silicate	 dust	 by	 intraperi-
toneal	injection.	Tumors	were	induced	in	3	of	
32	rats:	2	fibrosarcomas	and	1	mesothelioma.	
Smith	 et	 al.	 [1987]	 dosed	 Osborne	 Mendel	
(OM)	 rats	 and	 Syrian	 hamsters	 with	 25	 mg	
RCFs	 by	 intraperitoneal	 injection.	 Abdomi-
nal	 mesothelioma	 induction	 rates	 were	 83%	
(19/23)	in	OM	rats	and	13%	(2/15)	and	24%	
(5/21)	 in	 two	 groups	 of	male	 hamsters.	Cro-
cidolite	asbestos	at	25	mg	induced	abdominal	
mesotheliomas	in	80%	(20/25)	of	OM	rats	and	
32%	(8/25)	of	hamsters.	The	difference	in	tu-
mor	incidence	reported	by	Davis	et	al.	[1984]	
and	Smith	et	al.	[1987]	may	be	explained	in	part	
by	differences	in	fiber	length.	Eighty-three	per-
cent	of	RCF	fibers	used	by	Smith	et	al.	[1987]	
had	 a	 length	 >10	 µm;	 86%	 had	 a	 diameter	
<2.0	µm.	Ninety	percent	of	the	ceramic	alumi-
num	silicate	material	used	by	Davis	et	al.	[1984]	
had	a	length	<3	µm	and	a	diameter	<0.3	µm.	
Pott	et	al.	[1987]	dosed	female	Wistar	rats	by	
intraperitoneal	injection	with	9	or	15	mg/week	
for	 5	weeks	 with	 2	ceramic	 (aluminum	 sili-
cate)	wool	fibers,	Fibrefrax	(RCFs),	and	MAN	
(Manville	RCFs);	total	doses	of	45	and	75	mg	
were	 administered,	 respectively.	 Fifty	 percent	
of	Fibrefrax	fibers	had	a	 length	<8.3	µm	and	
diameter	<0.91	µm.	Exposure	 to	Fibrefrax	fi-
bers	 induced	 abdominal	 tumors	 (sarcomas,	
mesotheliomas,	or	carcinomas)	in	68%	of	the	
rats.	Fifty	percent	of	MAN	fibers	had	a	length	
<6.9	µm	and	diameter	<1.1	µm.	The	number	
of	fibers	in	different	length	categories	was	not	
reported.	Exposure	to	MAN	fibers	induced	ab-
dominal	tumors	in	22%	of	the	rats.	Chrysotile	
(UICC/B)	injected	intraperitoneally	at	a	single	
dose	of	0.05,	0.25,	or	1.00	mg	induced	abdomi-
nal	 tumors	 in	 19%,	 62%,	or	 86%	of	 rats,	 re-
spectively.	Fifty	percent	of	chrysotile	fibers	had	
a	length	<0.9	µm	and	diameter	<0.11	µm.	The	
number	of	fibers	per	dose	was	not	reported	for	
the	ceramic	fibers	and	asbestos.	Saline	induced	
tumors	in	2%	of	rats.	
5.1.1.2 Intrapleural Implantation Studies
Intrapleural	 implantation	 studies	 permit	 the	
investigation	 of	 the	 effect	 of	 RCFs	 directly	
on	the	pleural	mesothelium	while	controlling	
variables	such	as	inhalation	kinetics	and	trans-
location.
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Table	 5–2	 summarizes	 the	 results	 of	 the	 in-
trapleural	 study	 of	Wagner	 et	 al.	 [1973].	 In-
trapleural	injection	of	20	mg	of	ceramic	fiber	
(unspecified	 type)	 or	 20	mg	 for	 each	 of	 two	
samples	of	chrysotile	produced	mesotheliomas	
in	10%	(3/31),	64%	(23/36),	and	66%	(21/32)	
of	Wistar	rats,	respectively.	The	mean	ceramic	
fiber	diameter	was	0.5	to	1.0	µm.	The	lengths	
of	the	chrysotile	fibers	were	mostly	<6	µm.	The	
chrysotile	fiber	diameter,	RCF	fiber	length,	and	
number	of	fibers	per	dose	were	not	reported,	
making	 a	 direct	 comparison	 of	 the	 samples	
difficult.
5.1.1.3 Intratracheal Instillation Studies
The	technique	of	intratracheal	instillation	has	
the	advantage	of	affecting	the	same	target	tis-
sues	 (other	 than	 the	 upper	 respiratory	 tract)	
as	 an	 inhalation	 exposure.	Other	 advantages,	
compared	 with	 inhalation	 exposure,	 include	
a	simpler	technique,	lower	cost,	accurate	dos-
ing,	 and	 the	ability	 to	deliver	materials	 (such	
as	 long	 fibers)	 that	may	 not	 be	 respirable	 to	
rodents	[Driscoll	et	al.	2000].	The	 faster	dose	
rate	and	bolus	delivery	of	tracheal	instillation	
may	 affect	 the	 response	 of	 the	 lung	 defense	
mechanisms,	 resulting	 in	differences	 in	clear-
ance	and	biopersistence	 relative	 to	an	 inhala-
tion	 exposure.	 Intratracheal	 instillation	 may	
also	produce	a	clumping	of	fibers	with	a	result-
ing	 effect	 on	fiber	 distribution	 and	 clearance	
[Davis	et	al.	1996;	Driscoll	et	al.	2000].	Intra-
tracheal	 instillation	results	 in	a	heavier,	more	
centralized	distribution	pattern;	inhalation	ex-
posure	results	in	a	more	evenly	and	widely	dis-
tributed	pattern	[Brain	et	al.	1976].	Table	5–3	
summarizes	 the	 results	 of	 two	 RCF	 intratra-
cheal	 instillation	 studies	 [Smith	 et	 al.	 1987;	
Manville	 1991].	 A	 brief	 description	 of	 these	
studies	follows.	
In	 the	 study	 by	 Smith	 et	 al.	 [1987],	 Syrian	
golden	hamsters	and	OM	rats	were	dosed	with	
2	mg	of	RCFs	suspended	in	saline	(Fibrefrax)	
by	 intratracheal	 instillation	 once	 a	week	 for	
5	weeks	(10	mg	total).	The	animals	were	main-
tained	for	the	rest	of	their	lives.	Approximately	
50%	of	the	RCFs	were	<20	µm	long	with	a	mean	
fiber	diameter	of	1.8	µm.	No	primary	lung	tu-
mors	developed	in	RCF-exposed	animals.	These	
animals	did	not	have	an	increased	incidence	of	
pulmonary	fibrosis	or	tumor	production	com-
pared	with	controls;	however,	the	rats	had	a	sta-
tistically	significant	increase	in	bronchoalveolar	
metaplasia.	The	median	 lifespan	was	479	days	
for	 hamsters	 and	 736	 days	 for	 rats.	 Hamsters	
(median	 lifespan	 657	 days)	 and	 rats	 (median	
lifespan	663	days)	exposed	to	the	same	dosing	
schedule	with	2	mg	crocidolite	 asbestos	had	a	
statistically	significant	increase	in	bronchoalve-
olar	lung	tumors	in	20	of	27	(74%)	and	2	of	25	
(8%)	 animals,	 respectively.	The	fiber	numbers	
per	dose	were	not	reported.
Manville	[1991]	reported	a	statistically	signifi-
cant	increase	in	lung	tumors	in	Fischer	rats	ex-
posed	intratracheally	to	2	mg	of	RCF1,	RCF2,	
RCF3,	and	RCF4	in	saline	[Manville	1991].	An-
imals	were	 terminally	 sacrificed	 at	 128	weeks	
with	interim	sacrifices	at	13,	26,	52,	78,	and	104	
weeks.	RCF1,	RCF2,	RCF3,	and	RCF4	exposure	
resulted	 in	 adenomas	 or	 adenocarcinomas	
in	6	of	109	(5.5%),	4	of	107	(3.7%),	4	of	109	
(3.7%),	and	7	of	108	(6.5%)	rats,	respectively.	
One	mesothelioma	was	identified	in	a	rat	ex-
posed	to	RCF2.	Exposure	to	0.66	mg	chrysotile	
asbestos	resulted	in	8	primary	lung	tumors	in	
8	of	55	rats	(14.5%).	The	fiber	dimensions	and	
numbers	per	dose	were	not	reported.
5.1.2	 Chronic	Inhalation	Studies
In	 animal	 bioassays,	 administering	 RCFs	 by	
chronic	 inhalation	 most	 closely	 mimics	 the	
occupational	 route	 of	 exposure.	 Exposure	 to	
RCFs	over	a	time	period	that	approximates	the	
lifespan	of	the	animal	provides	the	most	accu-
rate	prediction	of	 the	potential	pathogenicity	
and	carcinogenicity	of	these	fibers	in	animals.	
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Table 5–2 . Intrapleural study of RCFs* in animals
Reference Species
Number 
per group† Fiber dose
Fiber dimensions 
(µm) Tumor incidence
Wagner	et	al.	
	 [1973]
Wistar	rats	 31
	
35
	
35
 
 
35
	
36
	
32
20	mg	ceramic	fibers		
	 (aluminum	silicate)	
20	mg	aluminum	oxide
	
20	mg	fiberglass
	
	
20	mg	glass	powder	
	
20	mg	Canadian	chrysotile
	
20	mg	Canadian	chrysotile	
	 D=0.5–1.0
	
	
	 Area	D=<10
	
	 L=60%>20	
	 D=55%	2.5–7	
	
	 Area	D=<8
	
	 L=92%	<6	
	
	 L=92%	<6
3	mesotheliomas
	
	
1	mesothelioma
	
0	mesotheliomas
	
	
1	mesothelioma
	
23	mesotheliomas
	
21	mesotheliomas
*Abbreviations:	D=diameter;	L=length;	RCFs=refractory	ceramic	fibers.	
†The	sex	ratio	for	all	groups	was	approximately	2	male	rats	to	1	female	rat.
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5  ■		Effects of Exposure
The	 effects	 seen	 in	 animals	 may	 be	 used	 to	
predict	 the	 effects	 of	 these	 fibers	 in	 humans,	
although	 interspecies	 differences	 exist	 in	 re-
spiratory	anatomy,	physiology,	and	tissue	sen-
sitivity.	Chronic	inhalation	studies	provide	the	
best	means	to	predict	the	critical	disease	end-
points	of	cancer	induction	and	nonmalignant	
respiratory	disease	that	may	occur	in	humans	
because	 of	 fiber	 exposure	 [McConnell	 1995;	
Vu	et	al.	1996].
Five	chronic	RCF	inhalation	studies	have	been	
conducted	 on	 rats	 or	 hamsters	 [Davis	 et	 al.	
1984;	Smith	et	al.	1987;	Mast	et	al.	1995a,b;	Mc-
Connell	et	al.	1995].	These	studies	are	summa-
rized	in	Tables	5–4	and	5–5	and	are	described	
below.
Davis	 et	 al.	 [1984]	 exposed	 Wistar	 rats	 by	
whole-body	inhalation	to	10	mg/m3	(95	f/cm3)	
ceramic	 (aluminum	 silicate	 glass)	 dust	 for	
7	 hr/day,	 5	 days/week	 for	 12	months.	Ninety	
percent	of	the	exposure	fibers	were	short	(<3	
µm)	and	thin	(<0.3	µm).	The	particle	ratio	of	
nonfibrous	particulate	to	fibers	was	4:1.	Eight	
of	 48	 exposed	 rats	 (17%)	 developed	 pulmo-
nary	neoplasms:	1	adenoma,	3	bronchial	carci-
nomas,	and	4	histiocytomas.	Interstitial	fibro-
sis	was	observed.	No	pulmonary	tumors	were	
observed	in	control	animals.	
Smith	et	al.	[1987]	exposed	OM	rats	and	Syr-
ian	 golden	 hamsters	 by	 nose-only	 inhala-
tion	 to 10.8±3.4	 mg/m3	 (200	 f/cm3)	 ceramic	
fiber	(Fibrefrax)	for	6	hr/day,	5	days/week	for	
24	months.	The	ratio	of	nonfibrous	particulate	
to	fibers	was	33:1.	Exposure	 to	RCFs	did	not	
induce	pulmonary	 tumors	 in	 rats.	One	RCF-
exposed	rat	and	one	chamber	control	 rat	de-
veloped	primary	lung	tumors.	Rats	exposed	to	
RCFs	had	more	severe	pulmonary	lesions	than	
hamsters,	and	a	greater	percentage	of	rats	had	
fibrosis	than	hamsters	(22%	versus	1%,	respec-
tively).	Under	similar	conditions,	exposure	 to	
7	 mg/cm3	 (3,000	 f/cm3)	 crocidolite	 asbestos	
produced	 pulmonary	 tumors	 in	 3	 of	 57	 rats,	
including	 1	 mesothelioma	 and	 2	 bronchoal-
veolar	 tumors.	 No	 pulmonary	 tumors	 were	
observed	in	crocidolite-exposed	hamsters.	Ex-
posure	 to	 slag	wool	 at	 10	mg/m3	 (200	f/cm3)	
and	several	fibrous	glasses	at	similar	gravimet-
ric	concentrations	did	not	result	in	pulmonary	
neoplasms	(not	shown	in	Table	5–4).	
Mast	 et	 al.	 [1995a]	 exposed	 Fischer	 344	 rats	
by	nose-only	inhalation	to	30	mg/m3	(187±53	
WHO	f/cm3	RCF1,	220±52	WHO	f/cm3	RCF2,	
182±66	WHO	 f/cm3	 RCF3,	 153±49	WHO	
f/cm3	RCF4)	of	one	of	four	types	of	RCFs	for	
6	hr/day,	5	days/week	for	24	months	and	held	
until	sacrifice	at	30	months.	Groups	of	3	to	6	
animals	 were	 sacrificed	 at	 3,	 6,	 9,	 12,	 15,	 18,	
and	24	months	to	examine	lesions	and	deter-
mine	fiber	 lung	burdens.	Other	animals	were	
removed	 from	 exposure	 at	 the	 same	 time	
points	 and	 held	 until	 sacrifice	 at	 24	months.	
Positive	control	rats	were	exposed	to	10	mg/m3	
(1.06±1.14×104	WHO	f/cm3)	chrysotile	under	
similar	exposure	conditions.	RCF	fibers	with	a	
mean	diameter	of	1	µm	and	mean	length	of	20	
to	30	µm	were	selected.	A	particle	ratio	of	non-
fibrous	particulate	to	fiber	of	1.02–1.88:1	was	
reported.	Interstitial	fibrosis	was	first	observed	
at	6	months	with	RCF1,	RCF2,	and	RCF3	and	
at	 12	 months	 with	 RCF4	 exposure.	 Pleural	
fibrosis	 was	 first	 observed	 at	 9	 months	 with	
RCF1,	RCF2,	and	RCF3	and	at	12	months	with	
RCF4	exposure.	A	progression	 in	 the	 severity	
of	pleural	fibrosis	was	seen	in	animals	exposed	
to	30	mg/m3	for	24	months	and	examined	at	6	
months	post	exposure.	The	incidence	of	total	
lung	 tumors	was	 significantly	 increased	 from	
controls	 after	 exposure	 to	 RCF1,	 RCF2,	 and	
RCF3	but	not	RCF4.	Neoplastic	disease,	includ-
ing	adenomas	and	carcinomas,	was	observed	in	
all	treatment	groups:	with	RCF1,	in	16	of	123	
rats	(13%);	RCF2,	9	of	121	(7.4%);	RCF3,	19	of	
121(15.7%);	RCF4,	4	of	118	(3.4%);	and	chrys-
otile,	 13	 of	 69	 (18.5%).	Mesotheliomas	 were	
induced	in	some	rats	in	all	treatment	groups:	2	
with	RCF1;	3	with	RCF2;	2	with	RCF3;	1	with	
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RCF4;	and	1	in	the	chrysotile	exposure	group.	
All	mesotheliomas	were	detected	at	or	after	24	
months	of	exposure.	Most	RCF	fibers	recovered	
in	the	lung	were	5	to	10	µm	long	regardless	of	
exposure	time	and	recovery	time.	An	80%	re-
duction	in	fiber	 lung	burden	was	seen	in	rats	
allowed	to	recover	 for	21	months	following	3	
months	of	RCF	exposure.
Mast	et	al.	[1995b]	exposed	Fischer	344	rats	by	
nose-only	inhalation	to	0	(air),	3,	9,	or	16	mg/m3	
(0,	26±12,	75±35,	or	120±35	WHO	f/cm3)	RCF1	
for	 6	hr/day,	 5	days/week	 for	 24	months	 and	
held	them	until	sacrifice	at	30	months.	Fibers	
were	selected	by	size	as	in	Mast	et	al.	[1995a].	
A	particle	ratio	of	nonfibrous	particulate	to	fi-
bers	of	0.9–1.5:1	was	reported.	Groups	of	3	to	6	
animals	were	sacrificed	at	3,	6,	9,	12,	18,	and	24	
months	 to	examine	 lesions	and	determine	fi-
ber	lung	burdens.	Other	animals	were	removed	
from	exposure	at	the	same	time	points	and	held	
until	sacrifice	at	24	months.	Interstitial	fibrosis	
was	observed	after	12	months	of	exposure	in	the	
9-	and	16-mg/m3	exposure	groups.	Pulmonary	
fibrosis	was	first	observed	after	12	months	with	
16	mg/m3	exposure	and	after	18	months	with	
9	mg/m3	exposure.	The	mean	Wagner	grades	of	
pulmonary	cellular	change	and	fibrosis	in	rats	
exposed	to	0,	3,	9,	16,	and	30	mg/m3	of	RCFs	
for	24	months	were	1.0,	3.2,	4.0,	4.2,	and	4.0,	
respectively.	Rats	exposed	at	the	same	range	of	
doses	for	24	months	and	allowed	to	recover	for	
6	months	had	mean	Wagner	grades	of	1.0,	2.9,	
3.8,	4.0,	and	4.3.	The	severity	of	interstitial	and	
pleural	fibrosis	was	similar	between	those	ani-
mals	sacrificed	at	24	months	and	those	allowed	
6	months	of	recovery	following	the	24	months	
of	exposure.	The	incidence	of	pulmonary	neo-
plasms	was	not	statistically	different	from	the	
controls	 in	 all	 exposure	 groups.	 One	 pleural	
mesothelioma	 was	 observed	 in	 the	 9-mg/m3	
exposure	 group.	 A	 dose-related	 increase	 oc-
curred	in	fiber	lung	burden.	Fiber	lengths	of	5	
to	10	µm	were	most	prevalent	in	the	lung	fibers	
recovered	after	3	months		of	exposure	followed	
by	21	months	of	recovery,	after	12	months	of	
exposure,	and	after	24	months	of	exposure	to	
all	doses	of	RCFs.	Animals	exposed	for	3	or	6	
months	and	then	allowed	to	recover	until	sac-
rifice	at	24	months	had	lung	burdens	reduced	
by	96%	to	97%	compared	with	animals	not	al-
lowed	recovery	time.
McConnell	et	al.	[1995]	exposed	Syrian	golden	
hamsters	by	nose-only	inhalation	to	30	mg/m3	
RCF1	 (256±58	WHO	 f/cm3)	 for	 6	 hr/day,	 5	
days/week	for	18	months	and	held	them	until	
sacrifice	at	20	months.	Positive	control	animals	
were	exposed	to	10	mg/m3	(8.4±9.0×104	WHO	
f/cm3)	 chrysotile	 asbestos.	 Groups	 of	 3	 to	 6	
animals	were	 sacrificed	at	 3,	 6,	 9,	 12,	 15,	 and	
18	months	 to	 examine	 lesions	 and	determine	
fiber	 lung	 burdens.	 Other	 animals	 were	 re-
moved	from	exposure	at	the	same	time	points	
and	held	until	sacrifice	at	20	months.	Intersti-
tial	and	pleural	fibrosis	were	first	observed	after	
6	months	 of	 exposure	 in	RCF-exposed	 ham-
sters.	 No	 pulmonary	 neoplasms	 developed.	
Forty-two	 of	 102	 (41.2%)	 RCF-exposed	 ani-
mals	 developed	 pleural	mesotheliomas.	Most	
mesotheliomas	developed	after	 18	months	of	
exposure.	 Animals	 exposed	 to	 chrysotile	 de-
veloped	a	more	severe	 interstitial	fibrosis	and	
pleural	 fibrosis	 than	 those	 exposed	 to	 RCFs.	
No	neoplasms	were	 observed	 in	 the	 lungs	 or	
pleura	of	the	chrysotile-exposed	or	air	control	
animals.	The	 greatest	 percentage	of	 retained	
fibers	had	 lengths	of	5	 to	10	µm	and	diam-
eters	<5	µm	in	the	lungs	after	6	months	of	ex-
posure	followed	by	12	months	of	recovery.
McConnell	et	al.	[1999]	conducted	a	multidose	
chronic	study	of	the	effects	of	amosite	inhala-
tion	 in	 hamsters.	 The	 data	 can	 be	 compared	
with	the	effects	of	RCF1.	Syrian	golden	ham-
sters	were	exposed	to	0.8	(36±23	WHO	f/cm3),	
3.7	(165±61	WHO	f/cm3),	or	7	mg/m3	(263±90	
WHO	f/cm3)	amosite	asbestos.	Pleural	meso-
thelioma	incidences	of	3.6%,	25.9%,	and	19.5%,	
respectively,	were	reported.	The	aerosol	mean	
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diameter	of	the	amosite	asbestos	was	0.60	µm	
±0.25;	 its	 aerosol	 mean	 length	 was	 13.4	 µm	
±16.7.	 The	 dimensions	 of	 this	 asbestos	 fiber	
were	more	similar	to	those	of	the	RCFs	used	in	
the	chronic	inhalation	studies	of	McConnell	et	
al.	[1995]	than	the	chrysotile	asbestos	used	as	
the	positive	control	in	that	same	study.
NIOSH	[Dankovic	2001]	analyzed	the	hamster	
data	from	the	RCF	[McConnell	et	al.	1995]	and	
amosite	studies	[McConnell	et	al.	1999].		A	dose-
response	model	was	developed	for	amosite	and	
was	used	to	predict	the	amosite	response	at	the	
one	and	only	dose	at	which	RCFs	were	tested	in	
hamsters.	The	modeled	amosite	response	was	
compared	 with	 the	 observed	 RCF	 response.	
These	results	are	presented	in	Figures	5–1	and	
5–2.	 Log-probit,	 log-logistic,	 multistage,	 and	
unrestricted	 Weibull	 models	 were	 analyzed.	
The	 transformation	 for	 the	 log-probit	 and	
log-logistic	 models	 was	 log	 (fibers/cm3	 +1).	
The	dose	metric	of	the	multistage	and	Weibull	
models	was	fibers/cm3,	as	they	did	not	require	
a	log-transformation.	Results	of	the	log-probit	
model	 analysis	 of	 these	 data	 indicated	 RCF/
amosite	relative	potency	estimates	of	1.85	and	
1.19,	using	WHO	fibers	and	fibers	>20	µm	as	
the	 dose	 metric,	 respectively.	 The	 model	 fits	
were	poor	when	the	amosite	high-dose	group	
and	20	µm-fiber	dose	were	included.	Sensitivity	
analyses	in	which	the	high-dose	amosite	group	
was	dropped	suggest	that	the	relative	potency	
of	 RCFs	 to	 amosite	 could	 be	 as	 low	 as	 0.66	
based	on	 the	 log-probit	model.	Results	 using	
the	log-logistic,	multistage,	and	Weibull	mod-
els	were	 similar	 to	 those	using	 the	 log-probit	
model,	with	an	overall	 range	of	RCF/amosite	
relative	 potency	 estimates	 from	 these	models	
using	all	 four	amosite	dose	groups	of	1.03	 to	
1.89.	Although	no	clear	toxicologic	basis	exists	
for	 disregarding	 the	 high-dose	 amosite	 data,	
sensitivity	 analyses	 based	 on	 excluding	 these	
data	suggest	that	the	potency	of	RCFs	relative	
to	amosite	could	be	as	low	as	0.47,	based	on	the	
multistage	model.	These	models	 indicate	that	
the	 plausible	 carcinogenic	 potency	 estimates	
for	RCFs	relative	to	amosite,	based	on	hamster	
mesotheliomas,	range	from	about	half	to	near-
ly	twice	the	carcinogenicity	of	amosite.	
5.1.3	 Discussion	of	RCF	Studies	
in	Animals
The	intrapleural,	intraperitoneal,	and	intratra-
cheal	RCF	studies	have	demonstrated	the	car-
cinogenicity	of	RCFs.	Because	of	the	nonphysi-
ologic	delivery	of	fibers	by	these	methods,	it	is	
difficult	 to	 compare	 their	 results	 with	 those	
of	 an	 inhalation	 exposure.	Although	 tracheal	
instillation	 may	 result	 in	 different	 distribu-
tion	patterns	than	an	inhalation	exposure,	this	
route	of	exposure	 is	useful	as	a	screening	test	
for	relative	toxicity	and	to	compare	the	toxicity	
of	 new	materials	with	 the	 toxicity	 of	materi-
als	for	which	data	already	exist	[Driscoll	et	al.	
2000].	Tracheal	instillation	also	is	useful	when	
testing	fibers	respirable	by	humans	but	not	ro-
dents.	Chronic	 inhalation	studies	provide	 the	
data	most	relevant	to	occupational	exposure	to	
RCFs.
The	 RCF	 chronic	 animal	 inhalation	 studies	
described	 above	 allow	 for	 the	 comparison	 of	
health	effects	of	exposure	to	different	doses	of	
RCF1,	different	 types	of	RCFs,	and	 the	 inter-
species	susceptibility	of	the	rat	and	hamster	to	
RCF	exposure.	
Results	 of	 the	 multidose	 chronic	 inhalation	
testing	of	RCF1	 in	rats	 indicate	 the	pathogen-
ic	potential	of	RCFs	at	high	doses	[Mast	et	al.	
1995a,b].	 The	 incidence	 of	 total	 lung	 tumors	
was	 significantly	 increased	 from	 controls	 after	
exposure	to	30	mg/m3	RCF1,	RCF2,	and	RCF3	
but	not	RCF4.	A	dose-response	relationship	was	
demonstrated	 for	 nonneoplastic	 pulmonary	
changes	in	rats	exposed	to	3,	9,	and	16	mg/m3	
RCFs.	The	severity	of	interstitial	and	pleural	fi-
brosis	was	similar	between	those	animals	sacri-
ficed	at	24	months	and	those	allowed	6	months	
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Exposure concentration (f/cm3)
Exposure concentration (f/cm3)
Figure 5–1 .	Proportion	of	hamsters	with	mesotheliomas	following	exposure	to	amosite	or	RCFs.	Con-
centrations	are	based	on	fibers	>20µm	long.	The	95%	confidence	limits	are	based	on	assuming	a	bi-
nomial	distribution.	Dashed	lines	represent	the	log-probit	model	fitted	to	the	amosite	data	[Dankovic	
2001].	(Source:	McConnell	et	al.	[1995,	1999].)
Figure 5–2 .	Proportion	of	hamsters	with	mesotheliomas	following	exposure	to	amosite	or	RCFs.	Con-
centrations	are	based	on	WHO	fiber	dimension	criteria.	The	95%	confidence	limits	are	based	on	as-
suming	a	binomial	distribution.	Dashed	lines	represent	the	log-probit	model	fitted	to	the	amosite	data	
[Dankovic	2001].	(Source:	McConnell	et	al.	[1995,	1999].)
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of	recovery	following	the	24-month	exposure.	
Spontaneous	primary	pulmonary	mesothelio-
mas	are	rare	in	rats	[Analytical	Sciences	Incor-
porated	1999].	Therefore,	the	presence	of	any	
mesothelioma	in	treated	animals	is	biologically	
significant	and	warrants	caution.
Comparing	 the	 chronic	 effects	 of	 RCF1	with	
its	positive	control,	chrysotile	asbestos,	 in	the	
hamster	 is	difficult	because	of	 the	differences	
in	dose,	dimensions,	and	durability	of	the	two	
fibers	tested	[McConnell	et	al.	1995].	More	re-
cent	 dose-response	 data	 on	 amosite	 asbestos	
provide	 a	 comparison	 because	 these	 amosite	
fiber	dimensions	more	closely	resemble	those	
of	 RCF1	 [McConnell	 et	 al.	 1999].	 The	mean	
lengths	 of	 the	 RCFs	 and	 amosite	 asbestos	 fi-
bers	 were	 22.1	 (±16.7)	 and	 13.4	(±16.7)	 µm,	
respectively.	 Forty-three	 percent	 of	 RCF	 fi-
bers	 and	 ~26%	 of	 amosite	 asbestos	 fibers	
were	longer	than	20	µm.	The	mean	diameters	
of	 the	RCFs	and	amosite	asbestos	fibers	were	
0.94	(±0.63)	and	0.60	(±0.25)	µm,	respectively.	
Interstitial	and	pleural	fibrosis	were	seen	much	
earlier	with	 amosite	 exposure	 than	with	RCF	
exposure.	 RCF	 exposure	 at	 215	 (±56)	WHO	
f/cm3	resulted	 in	mesotheliomas	 in	42	of	102	
(41%)	hamsters.	Amosite	asbestos	exposure	at	
263	(±90)	WHO	f/cm3	resulted	in	mesothelio-
mas	 in	17	of	87	 (19.5%)	hamsters.	Modeling	
of	 these	data	 indicates	 that	 the	plausible	 car-
cinogenic	potency	estimates	 for	RCFs	relative	
to	amosite,	based	on	hamster	mesotheliomas,	
range	from	about	half	to	nearly	twice	the	car-
cinogenicity	of	amosite	[Dankovic	2001].	Dif-
ferences	 in	 the	 physical	 characteristics	 and	
biopersistence	 of	 RCF1	 and	 amosite	 asbestos	
must	be	considered	before	extrapolating	these	
animal	data	to	human	risk.
Hamsters	 showed	 a	 greater	 susceptibility	 to	
mesothelioma	induction	after	RCF1	exposure	
than	 did	 rats	 under	 similar	 exposure	 condi-
tions	[Mast	et	al.	1995a;	McConnell	et	al.	1995].	
Chronic	inhalation	studies	of	amosite	asbestos	
in	hamsters	showed	no	pulmonary	neoplasms,	
but	high	incidences	of	mesothelioma	occurred	
at	doses	of	125	and	250	f/cm3	[McConnell	et	al.	
1999].	Many	of	the	mesotheliomas	in	the	more	
recent	hamster	studies	were	identified	only	on	
microscopic	 examination	 [Mast	 et	 al.	 1995a;	
McConnell	et	al.	1995,	1999].	Previous	studies	
reporting	mesotheliomas	only	by	macroscopic	
identification	 may	 have	 underestimated	 the	
mesothelioma	 incidence.	 Recent,	 short-term	
inhalation	 studies	 indicate	 that	 hamster	 me-
sothelial	 cells	 may	 have	 a	 more	 pronounced	
inflammatory	 and	 proliferative	 response	 to	
RCF1	exposure	than	those	of	rats	[Everitt	1997;	
Gelzleichter	et	al.	1996a,b,	1999].	The	reasons	
for	this	species	difference	in	response	to	RCFs	
have	not	been	explained.	The	results	of	 these	
animal	studies	indicate	the	need	for	the	inclu-
sion	of	the	hamster	as	a	sensitive	test	species	in	
those	studies	in	which	pleural	mesothelioma	is	
an	endpoint	of	concern.
Results	 from	Mast	et	al.	[1995a]	 indicate	that	
under	 the	 conditions	 studied,	 exposure	 to	
RCF4	may	 have	 a	 less	 pronounced	 effect	 on	
pulmonary	pathology	than	exposure	to	RCF1,	
RCF2,	 and	 RCF3.	 Rats	 exposed	 to	 RCF4	 did	
not	have	a	significant	increase	in	total	lung	tu-
mors	 compared	with	 controls;	 those	 exposed	
to	 RCF1,	 RCF2,	 and	 RCF3	 did.	 Exposure	 to	
RCF4	produced	a	less	severe	fibrosis	than	was	
seen	in	the	other	RCF	exposure	groups.	Differ-
ences	in	the	dimensions	or	physical	properties	
of	RCF4	may	 explain	 its	different	 respiratory	
effects	 from	 RCF1,	 RCF2,	 and	 RCF3.	 RCF4	
was	 produced	 by	 heating	 RCF1	 in	 a	 furnace	
at	2,400	ºF	for	24	hr.	This	Aafter-service@	fiber	
contained	 approximately	 27%	 free	 crystal-
line	 silica.	 Silicotic	 nodules	were	 observed	 in	
the	RCF4-exposed	 animals.	RCF4	fibers	were	
shorter	 (~34%	 between	 5	 and	 10	 µm	 )	 and	
thicker	(~35%	<0.5	µm)	than	those	of	RCF1,	
RCF2,	and	RCF3.	
The	particle	content	of	 the	RCF	 test	material	
may	have	been	responsible	for	some	of	the	re-
spiratory	pathology	observed	in	these	studies.	
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However,	an	analysis	of	the	ratio	of	nonfibrous	
to	fibrous	particulates	in	the	reviewed	studies	
does	 not	 indicate	 a	 correlation	 between	 the	
particulate	content	and	observed	effects.	Smith	
et	al.	[1987]	performed	testing	with	the	high-
est	 particulate	 to	 fiber	 ratio	 at	 33:1	 and	 did	
not	 report	 a	 high	 tumor	 incidence.	Compar-
ing	 studies	 based	 on	 the	 ratio	 of	 nonfibrous	
particulates	to	fibers	is	complicated	by	differ-
ences	among	the	studies	 in	fiber	preparation,	
doses	 tested,	 fiber	 dimensions,	 and	 methods	
of	 fiber	 analysis.	 The	 techniques	 used	 to	 de-
tect	and	measure	nonfibrous	particulates	have	
improved	over	time	so	that	the	comparison	of	
recent	and	older	 studies	may	reflect	 these	 in-
consistencies.
These	chronic	RCF	inhalation	studies	indicate	
the	ability	of	RCFs	to	induce	cancer	in	two	lab-
oratory	 species—mesotheliomas	 in	 hamsters	
and	pulmonary	tumors	in	rats.	The	late	onset	
of	tumors	indicates	the	importance	of	chronic	
studies	on	the	effects	of	RCF	exposure.	Short-
term	intraperitoneal,	intrapleural,	intratrache-
al,	 and	 inhalation	 studies	 provide	 important	
information	about	the	action	of	fibers,	the	fi-
ber	characteristics	associated	with	toxicity,	and	
potential	toxicity.	Currently	it	is	only	through	
lifespan	toxicologic	testing	of	animals	that	the	
respiratory	and	other	chronic	health	effects	of	
RCFs	can	be	accurately	assessed.	
5.1.4		Lung	Overload		
Argument	Regarding		
Inhalation	Studies	in	Animals
Mast	et	al.	[2000]	published	a	review	interpret-
ing	the	results	of	chronic	inhalation	studies	of	
RCF1	in	rats	and	hamsters	[Mast	et	al.	1995a,b;	
McConnell	et	al.	1995].	In	the	review,	the	au-
thors	suggest	the	possibility	that	the	maximum	
tolerated	dose	(MTD)	may	have	been	exceeded	
and	that	lung	overload	may	have	compromised	
the	 pulmonary	 clearance	mechanisms	 of	 test	
animals.	Building	on	the	concept	of	lung	over-
load	 (first	 advanced	 by	Bolton	 et	 al.	 [1983]),	
Mast	et	al.	[2000]	considered	particulate	coex-
posure	(i.e.,	nonfibrous	particulate	or	shot)	to	
be	a	confounding	 factor	 that	may	have	had	a	
major	 effect	on	 the	observed	chronic	 adverse	
effects.	The	authors	propose	that	the	MTD	was	
exceeded	at	the	highest	exposure	concentration	
of	30	mg/m3	for	RCF1	in	the	rat	bioassay.	
The	 concept	 of	 pulmonary	 overload	 in	 the	
Fischer	344	rats	is	based	on	the	recognition	that	
excessive	particulate	 exposures	 (>1,500	µg/rat,	
according	 to	 Bolton	 et	 al.	 [1983])	 eventually	
reduce	the	clearance	effectiveness	of	the	lungs,	
causing	the	normal	linear	clearance	kinetics	to	
follow	a	nonlinear	pattern.	On	a	cellular	 level,	
the	overload	 conditions	may	 result	 in	 alveolar	
macrophages	 becoming	 engorged	 with	 par-
ticulate,	 pulmonary	 and	 alveolar	 inflamma-
tion,	increased	translocation	of	particles	to	the	
interstitium	and	lymph,	granuloma	formation,	
pulmonary	fibrosis,	and	lung	tumors,	depend-
ing	 on	 the	 time	 and	 severity	 of	 the	 overload	
[Mast	et	al.	2000].	Ambiguity	about	the	defini-
tion	of	MTD	for	chronic	inhalation	studies	with	
animals	was	also	a	concern	expressed	by	the	au-
thors.	One	reference	[Morrow	1986]	recognizes	
the	 MTD	 as	 that	 which	 causes	 “a	 significant	
functional	impairment	of	lung	clearance.”	At	a	
National	Toxicology	Program	(NTP)	workshop	
on	establishing	exposure	concentrations	for	in-
halation	 studies	 in	 animals,	 it	 was	 concluded	
that	the	highest	exposure	concentration	should	
produce	only	minimal	changes	in	lung	defense	
mechanisms	 as	measured	 by	 clearance	 [Lewis	
et	al.	1989].	At	a	similar	workshop	convened	by	
the	EPA,	it	was	proposed	that	the	MTD	for	fi-
ber	inhalation	studies	is	equivalent	to	the	lung	
dose	produced	at	the	maximum	achievable	con-
centration	 (MAC)	 [Vu	 et	 al.	 1996].	The	MAC	
is	calculated	as	the	highest	fiber	concentration	
based	on	a	90-day	study	that	results	in	signifi-
cant	 changes	 in	 alveolar	 macrophage	 clear-
ance	rates,	lung	burden	normalized	to	exposure	
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concentration,	cell	proliferation,	inflammation,	
lung	weight,	and	other	measures.	
The	methodology	described	for	the	RCF	chron-
ic	inhalation	studies	involved	procedures	(i.e.,	
wet	cyclone	separation	technology)	for	remov-
ing	 the	 nonfibrous	 particulate	 fraction	 from	
the	commercial	fiber	(RCF1)	used	for	the	 in-
halation	exposures	[Mast	et	al.	1995a,b	2000;	
McConnell	 et	al.	1995].	This	process	 resulted	
in	an	aerosol	with	a	9.1:1	particle-to-fiber	ratio	
[Maxim	et	al.	1997;	Mast	et	al.	2000],	compared	
with	a	study	by	Smith	et	al.	[1987],	which	re-
ported	 33	 nonfibrous	 particles	 per	 fiber	 in	
airborne	exposures.	Results	from	Esmen	et	al.	
[1979]	indicate	that	despite	a	poor	correlation	
between	mass	of	total	airborne	dust	and	fiber	
concentration	in	RCFs	measured	in	manufac-
turing,	fibers	generally	constitute	only	a	small	
portion	of	the	total	dust.	This	finding	is	con-
sistent	with	other	reported	measures	of	occu-
pational	 exposures	 to	 airborne	RCFs	 [Krantz	
et	 al.	 1994;	 Trethowan	 et	 al.	 1995].	However,	
Maxim	 et	 al.	 [1997]	 reported	 an	 average	
particle-to-fiber	 ratio	 of	 0.53:1	 (n=10,	 range	
not	reported),	or	roughly	1	particle	to	2	fibers	
in	RCF	manufacturing	facilities.	
Muhle	and	Bellmann	[1996]	conducted	a	5-day	
inhalation	study	with	Fischer	344	rats	to	mea-
sure	the	biopersistence	of	RCF1	(with	the	9:1	
particulate-to-fiber	 ratio)	 and	 RCF1a	 (RCF1	
that	 is	 further	 processed	 to	 reduce	 particu-
late	mass).	The	study	showed	a	1.5-fold	longer	
time-weighted	half-life	for	RCF1	(t
1/2
=78	days)	
compared	 with	 RCF1a	 (t
1/2
=54	 days).	 That	
study	also	involved	a	3-week	inhalation	experi-
ment	with	Fischer	344	rats,	in	which	the	clear-
ance	of	RCF1	(t
1/2
=103	days)	was	almost	twice	
as	long	as	that	of	RCF1a	(t
1/2
=54	days).
In	 a	 follow-up	 study	 by	 Brown	 et	 al.	 [2000],	
female	Wistar	rats	were	exposed	to	RCF1	and	
RCF1a	by	inhalation	for	3	weeks	and	followed	
for	12	months	to	evaluate	alveolar	macrophage	
clearance	 and	 inflammation.	 The	 exposure	
concentrations	were	130	fibers/ml	>20	µm	for	
RCF1	 and	 125	 fibers/ml	 >20	 µm	 for	 RCF1a.	
The	nonfibrous	content	of	RCF1	was	approxi-
mately	 25%,	whereas	 the	 nonfibrous	 content	
of	RCF1a	was	2%.	The	mean	diameter	of	the	
nonfibrous	particles	was	2	to	3	µm.	The	aero-
sol	exposure	to	RCF1	contained	twice	as	many	
short	fibers	(<20	µm)	as	RCF1a	and	twice	the	
amount	of	dust	(fibers	and	nonfibrous	dust/	
mg	·	m3)	as	RCF1a	(51	versus	25.8	mg/m3).	At	the	
end	of	the	inhalation	period,	animals	exposed	
to	RCF1a	had	a	higher	pulmonary	concentra-
tion	of	long	fibers	but	lower	concentrations	of	
short	fibers	and	nonfibrous	particles.	The	dif-
ference	in	particle	content	was	enhanced	in	the	
lungs—15	times	more	particles	were	found	in	
the	 lungs	 of	 the	RCF1-exposed	 animals	 than	
in	those	exposed	to	RCF1a.	In	the	aerosol	ex-
posure,	only	an	eightfold	difference	was	found	
in	the	number	of	particles	between	RCF1	and	
RCF1a.	 The	 RCF1a-exposed	 animals	 had	 a	
half-time	alveolar	clearance	of	80	days	(71–91)	
compared	with	 60	 days	 (49–77)	 for	 the	 con-
trols;	 clearance	 half-time	 for	 exposed	 RCF1	
animals	 was	 1,200	 days	 (573-infinity)	 com-
pared	with	66	 (58–88)	 for	 the	 corresponding	
controls.	 To	 evaluate	 respiratory	 inflamma-
tion,	 bronchoalveolar	 lavage	 (BAL)	measure-
ments	(lactose	dehyrdogenase	[LDH],	γ-gluta-
myltransferase	[γ	–GT],	total	protein,	reduced	
glutathione	 [GSH])	were	 taken	 at	 the	 end	of	
the	3-week	study	period	and	at	subsequent	in-
tervals	over	the	next	12	months.	Immediately	
following	the	3-week	inhalation	study,	all	BAL	
measurements	 were	 statistically	 elevated	 in	
both	RCF1	and	RCF1a	animals.	However,	after	
91	days	of	recovery,	the	BAL	measurements	for	
RCF1a	animals	returned	to	normal.	Indications	
of	 inflammation	 continued	 for	RCF1	 through	
the	entire	observation	period.	The	greater	and	
more	persistent	inflammation	seen	with	RCF1	
was	attributed	to	the	greater	mass	of	material	
or	to	increased	activity	of	the	nonfibrous	par-
ticles,	although	the	high	concentration	of	short	
fibers	 in	 RCF1	 (twice	 that	 of	 RCF1a)	 could	
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have	 contributed	 to	 the	 observed	 impedance	
in	alveolar	macrophage	clearance	and	inflam-
mation.	
Tran	et	al.	 [1997]	examined	how	overloading	
the	alveolar	macrophage	defense	system	affects	
the	clearance	of	fibers	versus	that	of	nonfibrous	
particles.	 Modeling	 was	 performed	 based	 on	
data	for	rats	exposed	by	inhalation	to	titanium	
dioxide	 (TiO
2
)	 at	 1,	 10,	 and	 50	mg/m3	 or	 to	
glass	wool	(MMVF10)	at	3,	16,	and	30	mg/m3.	
Lung	 burdens	 and	 clearance	 kinetics	 during	
exposure	(0	to	100	weeks)	were	compared	with	
those	at	3,	10,	and	38	days	post-exposure.	The	
models	showed	that	overloading	of	the	lung	by	
fibers	or	nonfibrous	particles	are	similar	when	
fibers	 are	 short	 (<15	µm).	 This	 observation	
is	plausible,	as	nonfibrous	particles	and	short	
fibers	smaller	than	the	diameter	of	 the	alveo-
lar	macrophage	are	most	readily	engulfed	and	
cleared	 via	 the	 macrophages.	 When	 this	 de-
fense	 is	overwhelmed	(lung	burden	≥10	mg),	
these	 particles	 are	 cleared	 less	 effectively.	 For	
fibers	longer	than	15	µm,	phagocytosis	by	alve-
olar	macrophage	is	reduced.	As	fiber	length	in-
creases,	fibers	tend	to	be	cleared	by	dissolution	
and	disintegration	of	 long	fibers	 into	 shorter	
fibers	 or	 fragments.	 Therefore,	 clearance	 of	
long	fibers	is	not	affected	by	the	overloading	of	
macrophage-mediated	 defenses	 with	 shorter	
fibers	or	nonfibrous	particles.	
The	 exposure	 concentrations	 for	 the	 RCF	
chronic	 inhalation	 bioassays	 were	 measured	
and	reported	as	mass	in	mg/m3.	Monitoring	of	
exposures	as	performed	by	gravimetric	analy-
sis	does	not	distinguish	fibers	from	nonfibrous	
particulate,	 although	 fiber	 concentration	 and	
dimensions	were	also	checked	by	phase	contrast	
and	electron	microscopy	[Mast	et	al.	1995a,b].	
Consequently,	the	particulate	fraction	was	in-
cluded	 in	 the	 dose	 measurements.	 This	 fact	
does	complicate	efforts	to	compare	the	relative	
toxicity	 of	 fibers,	 nonfibrous	 particulate,	 and	
total	 combined	 particulate,	 especially	 regard-
ing	the	lung	overload	hypothesis.	During	pro-
duction	of	RCFs	and	RCF	products,	however,	
the	 nonfibrous	 particulate	 fraction	 is	 associ-
ated	with	the	fiber,	as	shown	in	Table	2–1	(i.e.,	
20%	to	50%	of	RCFs	by	weight	is	nonfibrous	
particulate).	 This	 suggests	 that	 occupational	
exposures	to	airborne	RCFs	necessarily	involve	
coexposures	 to	 a	 fraction	 of	 nonfibrous	 par-
ticulate,	a	suggestion	that	has	been	supported	
by	 exposure	 assessment	 studies	 [Esmen	 et	 al.	
1979;	Krantz	et	al.	1994;	van	den	Bergen	et	al.	
1994;	Trethowan	et	al.	1995;	Maxim	et	al.	1997;	
Mast	et	al.	2000].	
5.2		Cellular	and	Molecular	
Effects	of	RCFs	(In Vitro	
Studies)	
The	cellular	and	molecular	effects	of	RCF	ex-
posures	have	been	 studied	with	 two	different	
objectives.	One	purpose	of	these	in	vitro	stud-
ies	is	to	provide	a	quicker,	less	expensive,	and	
more	controlled	alternative	to	animal	toxicity	
testing.	These	experiments	are	best	 interpret-
ed	by	comparing	their	results	with	those	of	in	
vivo	 experiments.	The	 second	objective	 of	 in	
vitro	studies	 is	 to	provide	data	 that	may	help	
to	 explain	 the	 pathogenesis	 and	mechanisms	
of	action	of	RCFs	at	the	cellular	and	molecu-
lar	 levels.	These	cytotoxicity	and	genotoxicity	
studies	are	best	 interpreted	by	comparing	the	
effects	of	RCFs	with	those	of	other	SVFs	and	
asbestos	fibers.	In	vitro	studies	serve	as	screen-
ing	tools	and	provide	insights	into	the	molecu-
lar	mechanisms	of	fibers.	They	are	an	impor-
tant	complement	to	animal	studies.	Currently	
it	is	not	possible	to	use	these	data	to	derive	the	
NIOSH	REL	for	RCFs.	For	 this	reason,	a	dis-
cussion	of	in	vitro	studies	is	included	here,	but	
the	more	comprehensive	summaries	of	studies	
are	included	in	Appendix	C.
The	 toxicity	 of	 fibers	 has	 been	 attributed	 to	
their	dose,	dimensions,	and	durability.	Any	test	
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system	that	is	designed	to	assess	the	potential	
toxicity	 of	 fibers	 must	 address	 these	 factors.	
Durability	 is	 difficult	 to	 assess	 using	 in	 vitro	
studies	 because	 of	 their	 acute	 time	 course.	
However,	in	vitro	studies	provide	an	opportu-
nity	 to	study	 the	effects	of	varying	doses	and	
dimensions	 of	 fibers	 in	 a	 quicker,	more	 effi-
cient	method	than	animal	testing.	They	do	not	
currently	provide	data	that	can	be	extrapolated	
to	occupational	risk	assessment.	
The	association	between	fiber	dimension	and	
toxicity	 has	 been	 documented	 and	 reviewed	
[Stanton	 et	 al.	 1977,	 1981;	 Pott	 et	 al.	 1987;	
Warheit	1994].	RCFs	may	have	different	toxici-
ties,	depending	on	 the	fiber	 length	relative	 to	
macrophage	size.	Longer	fibers	are	more	toxic.	
Fiber	length	has	been	correlated	with	the	cyto-
toxicity	of	glass	fibers	[Blake	et	al.1998].	Man-
ville	 code	 100	 (JM–100)	 fiber	 samples	 with	
average	lengths	of	3,	4,	7,	17,	and	33	µm	were	
assessed	for	their	effects	on	LDH	activity	and	
rat	alveolar	macrophage	function.	The	greatest	
cytotoxicity	was	reported	in	the	17-	and	33-µm	
samples,	 indicating	 that	 length	 is	 an	 impor-
tant	factor	in	the	toxicity	of	this	fiber.	Multiple	
macrophages	 were	 observed	 attached	 along	
the	length	of	long	fibers.	Relatively	short	fibers	
(<20	 µm)	 were	 usually	 phagocytized	 by	 one	
rat	 alveolar	 macrophage	 [Luoto	 et	 al.	 1994].	
Longer	 fibers	 were	 phagocytized	 by	 two	 or	
more	macrophages.	 Incomplete	 or	 frustrated	
phagocytosis	may	play	a	role	 in	the	 increased	
toxicity	 of	 longer	 fibers.	 Long	 fibers	 (17	 µm	
average	length)	were	a	more	potent	inducer	of	
tumor	necrosis	 factor	 (TNF)	production	 and	
transcription	 factor	 activation	 than	 shorter	
fibers	 (7	 µm	 average	 length)	 [Ye	 et	 al.	 1999].	
These	studies	demonstrate	the	important	role	
of	length	in	fiber	toxicity	and	suggest	that	the	
capacity	for	macrophage	phagocytosis	may	be	
a	critical	factor	in	determining	fiber	toxicity.
Several	 of	 the	 in	 vitro	 RCF	 studies	 (summa-
rized	in	Appendix	C)	reported	a	direct	associa-
tion	between	a	longer	fiber	length	and	greater	
cytotoxicity.	 Hart	 et	 al.	 [1992]	 reported	 the	
shortest	fibers	to	be	the	least	cytotoxic.	Brown	
et	 al.	 [1986]	 reported	an	association	between	
length,	but	not	diameter,	and	cytotoxic	activity.	
Wright	et	al.	[1986]	reported	that	cytotoxicity	
was	correlated	with	fibers	>8	µm	long.	Yegles	et	
al.	[1995]	reported	that	the	longest	and	thickest	
fibers	were	the	most	cytotoxic.	The	four	most	
cytotoxic	fibers	had	GM	lengths	≥13	µm	and	
GM	diameters	>0.5	µm.	The	production	of	ab-
normal	 anaphases	 and	 telophases	was	 associ-
ated	with	Stanton	fibers	with	a	 length	>8	µm	
and	diameter	<0.25	µm.	Hart	et	al.	[1994]	re-
ported	that	cytotoxicity	increased	with	increas-
ing	 average	 fiber	 lengths	 from	 1.4	 to	 22	 µm,	
but	did	not	increase	with	average	lengths	from	
22	to	31	µm.
Additional	 studies	 assessing	 the	 cytotoxicity	
of	specific	RCF	fiber	lengths	are	needed.	Such	
studies	will	help	to	describe	the	association	be-
tween	fiber	 length	 and	 toxicity	 for	RCFs	 and	
may	allow	determination	of	a	threshold	length	
above	 which	 toxicity	 increases	 significantly.	
In	addition	 to	providing	data	on	 the	correla-
tion	between	fiber	length	and	toxicity,	in	vitro	
studies	have	provided	data	on	the	relative	tox-
icity	 of	RCFs	 compared	with	 other	 fibers,	 al-
though	some	uncertainties	remain	in	the	inter-
pretation	of	these	studies	because	of	differences	
in	 fiber	 doses,	 dimensions,	 and	 durabilities.	
RCFs	 have	 direct	 and	 indirect	 effects	 on	 cells	
and	alter	 gene	 function	 in	 similar	ways.	They	
are	capable	of	inducing	enzyme	release	and	cell	
hemolysis.	They	may	decrease	cell	viability	and	
inhibit	 proliferation.	 RCFs	 affect	 the	 produc-
tion	of	TNF	and	reactive	oxygen	species	(ROS)	
and	affect	cell	viability	and	proliferation.	They	
induce	necrosis	in	rat	pleural	mesothelial	cells.	
They	may	 also	 induce	 free	 radicals,	micronu-
clei,	 polynuclei,	 chromosomal	 breakage,	 and	
hyperdiploid	cells	in	vitro.
In	vitro	studies	provide	an	excellent	opportu-
nity	for	investigating	the	pathogenesis	of	RCFs.	
However,	 comparisons	 are	 difficult	 to	 make	
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between	 in	 vitro	 studies	based	on	differences	
in	 fiber	 doses,	 dimensions,	 preparations,	 and	
compositions.	 Important	 information	 such	
as	 fiber	 length	 distribution	 is	 not	 always	 de-
termined.	 Even	 when	 comparable	 fibers	 are	
studied,	the	cell	line	or	conditions	under	which	
they	are	tested	may	vary.	Much	of	the	research	
to	date	has	been	done	in	rodent	cell	lines	and	
in	cells	that	are	not	related	to	the	primary	tar-
get	 organ.	 In	 vitro	 studies	 using	 human	pul-
monary	cell	lines	should	provide	pathogenesis	
data	most	relevant	to	human	health	risk	assess-
ment.
Short-term	 in	 vitro	 studies	 cannot	 take	 into	
account	the	influence	of	fiber	dissolution	and	
fiber	 compositional	 changes	 that	 may	 occur	
over	 time.	 In	 an	 in	 vivo	 exposure,	 fibers	 are	
continually	 modified	 physically,	 chemically,	
and	structurally	by	components	of	the	lung	en-
vironment.	This	 complex	 set	 of	 conditions	 is	
difficult	to	recreate	in	vitro.	Just	as	it	is	unlikely	
that	only	one	factor	is	an	accurate	predictor	of	
fiber	toxicity,	it	is	unlikely	that	any	one	in	vitro	
test	is	able	to	predict	fiber	toxicity.
5.3 Health Effects in Humans
5.3.1 Morbidity and Mortality Studies
Two	major	research	efforts	evaluated	the	mor-
bidity	of	RCF-exposed	workers—one	conduct-
ed	in	U.S.	plants	and	one	in	European	plants.	
Table	 5–6	describes	 the	populations	 analyzed	
for	both	studies.	The	objective	of	these	research	
efforts	was	to	evaluate	the	relationship	between	
occupational	 exposure	 to	RCFs	and	potential	
adverse	health	 effects.	These	 studies	 included	
standardized	respiratory	and	occupational	his-
tory	 questionnaires,	 chest	 radiographs,	 and	
pulmonary	 function	 tests	 (PFTs)	 of	 workers,	
as	well	as	air	sampling	to	estimate	worker	ex-
posures.	The	studies	of	European	plants	began	
in	1986.	Study	subjects	 included	only	current	
workers	 at	 seven	 RCF	 manufacturing	 plants	
[Rossiter	 et	 al.	 1994;	 Trethowan	 et	 al.	 1995;	
Burge	et	al.	1995].	A	followup	cross-sectional	
study	 conducted	 in	 1996	 evaluated	 the	 same	
medical	endpoints	in	workers	from	six	of	these	
seven	 European	 manufacturing	 plants	 (one	
plant	had	ceased	operation)	[Cowie	et	al.	1999,	
2001].	 Current	 and	 former	 workers	 were	 in-
cluded	as	study	subjects	in	the	followup	study.	
The	 studies	of	U.S.	plants	began	 in	1987	and	
involved	evaluations	of	current	workers	at	five	
RCF	manufacturing	plants	and	former	work-
ers	at	two	RCF	manufacturing	plants	[Lemas-
ters	et	al.	1994,	1998;	Lockey	et	al.	1993,	1996,	
1998,	2002].	
In	 the	 United	 States,	 the	 earliest	 commercial	
production	of	RCFs	and	RCF	products	began	
in	1953;	in	Europe,	RCF	production	began	in	
1968.	The	demographics	 of	 the	U.S.	 and	Eu-
ropean	 populations	 were	 similar	 at	 the	 time	
they	 were	 studied,	 although	 the	 average	 age	
of	U.S.	workers	was	 slightly	 higher	 than	 that	
of	 the	workforce	 in	 the	1986	European	 stud-
ies	because	of	 the	earlier	development	of	 this	
industry	 in	 the	United	 States.	 The	mean	 age	
for	the	European	RCF	workers	was	37.7	in	the	
1986	 study	 [Trethowan	 et	 al.	 1995]	 and	 42.0	
for	males	 and	39.4	 for	 female	workers	 in	 the	
1996	 study	 [Cowie	 et	 al.	 1999].	 In	 the	 U.S.	
RCF	manufacturing	 industry,	 the	average	age	
is	 40	for	 current	 workers	 and	 45	 for	 former	
workers	[Lemasters	et	al.	1994].	The	mean	du-
ration	of	employment	in	the	European	cohort	
was	10.2	years	(range	7.2	to	13.8	years)	in	1986	
[Trethowan	et	al.	1995]	and	13.0	years	in	1996	
[Cowie	et	al.	1999].	The	U.S.	study	reports	the	
mean	duration	of	employment	for	23	workers	
with	pleural	plaques	as	13.6	years	 (±9.8);	 the	
median	 is	 11.2	 years	 (range	 1.4	 to	 32.7)	 [Le-
masters	et	al.	1994].	
The	 following	 text	 and	Table	 5–7	 summarize	
findings	from	the	U.S.	and	European	research	
efforts,	 organized	 according	 to	 results	 from	
radiographic	examinations,	respiratory	symp-
toms,	 and	 PFTs.	 Discussion	 of	 two	 related	
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Table 5–6 . Cited studies of populations with occupational exposures to RCFs*
Population analyzed Outcome measures
Study Design
Employment 
status Number
% male 
workers
% female 
workers      Radiography PFT Symptoms
European:
Burge	et	al.	1995‡ Cross-sectional Current§ 532 100 0 N Y Y
Rossiter	et	al.	1994‡ Cohort	morbidity Current** 543 100 0 Y N N
Trethowanet	al.	1995‡ Cross-sectional Current 628 91 9 Y Y Y
Cowie	et	al.	1999†† Cross-sectional Current 695 90 10 Y Y Y
Former 79 85 15
United States:‡‡
Lemasters	et	al.	1994 Cross-sectional Current 627 83 17 Y N 	N
Lemasters	et	al.	1994 Cross-sectional Former§§ 220 91 9
Lockey	et	al.	1993: Cohort	mortality Current	
and	former	
684	(including	
46	deceased	
and	5	lost	to	
followup)***
100 0 N N 										N		
(Cause	of	
death)
Cohort	morbidity Current	
and	former	
801	(par-
ticipants;	
99%	provided	
respiratory	
history,	94%	
provided	
PFTs,	and	90%	
provided	chest	
X-rays	[radi-
ography])
85 15 Y Y Y
Lockey	et	al.	1996 Cohort	morbidity	 Current 370 NA NA Y N N
Former 282††† NA NA NA NA 		NA
Nested	
case-control
Both	(17	cases	
with	3	controls	
each	matched	
on	current	
versus	former	
status)
NA NA Y Y N N
Lockey	et	al.	1998 Cross-sectional	
and	longitudinal
Current 361‡‡‡ 100 0 N Y N
See	footnotes	on	next	page.
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*Abbreviations:	N=number;	NA=not	available	from	published	citation;	PFT=pulmonary	function	test;	RCFs=refractory	ceramic	
fibers;	Y=yes.
†Current	versus	former	(and	leaver)	worker	status	at	an	RCF	manufacturing	plant	as	determined	at	time	of	survey.	
‡Study	included	current	workers	at	seven	ceramic	fiber	manufacturing	plants	in	three	European	countries.
		 §From	a	possible	708	current	workers,	628	eligible	participants	were	identified	and	596	had	chest	X-ray	examinations;	51	female	
workers	and	13	unexplained	others	were	excluded	from	analysis.
				**From	a	possible	708	current	workers,	628	eligible	participants	were	identified	and	596	had	chest	X-ray	examinations;	2	
							unreadable	films	and	those	of	51	female	workers	were	excluded	from	the	analysis.
††Study	included	current	workers	at	six	ceramic	fiber	manufacturing	plants	in	three	European	countries	as	well	as	leavers	from	
the	first	three	European	studies	[Burge	et	al.	1995;	Rossiter	et	al.	1994;	Trethowan	et	al.	1995]	(one	of	the	seven	plants	in-
cluded	earlier	had	ceased	operation).
    ‡‡Studies	included	current	and	former	workers	at	five	RCF	manufacturing	plants	in	the	United	States.
§§From	a	possible	1,030	eligible	current	and	former	workers,	183	were	either	deceased,	not	located,	or	did	not	agree	to	chest	X-
ray	examinations.
***From	a	possible	729	eligible	current	and	former	workers	at	2	plant	sites	for	whom	individual	work	histories	were	available,	45	
							were	excluded	on	the	basis	of	insufficient	exposures	to	fibers	or	insufficient	data	regarding	fiber	exposures.
†††From	a	possible	868	eligible	current	and	former	workers	at	2	plant	sites,	148	were	eliminated	for	lack	of	exposure	
							characterization	data	and	loss	to	followup.	Of	the	remaining	720	workers,	68	did	not	agree	to	chest	X-ray	examinations.		
‡‡‡From	a	possible	963	eligible	current	workers	at	five	plant	sites,	209	female	workers	were	excluded	as	well	as	393	male	workers	
with	fewer	than	5	PFT	sessions.
mortality	 studies	 is	 also	 presented	 in	 Sec-
tion	 5.3.5	 [Lockey	 et	 al.	 1993;	 Lemasters	 et	
al.	2003].	Two	HHEs	of	workplaces	involving	
workers	exposed	to	RCFs	are	also	described	in	
Section	5.3.6	[Kominsky	1978;	Lyman	1992].
5.3.2 Radiographic Analyses
In	 both	 the	 European	 and	 U.S.	 studies	 cited	
in	 Table	 5–6,	 the	 study	 populations	 includ-
ed	workers	 at	multiple	plants	 involved	 in	 the	
manufacture	of	RCFs	or	RCF	products.	As	part	
of	the	investigation	of	potential	effects	of	expo-
sure	to	airborne	RCFs,	chest	radiography	was	
performed.	 In	 all	 studies,	 chest	 radiographs	
were	 read	 independently	by	 three	 readers	us-
ing	the	International	Labour	Office	(ILO)	1980 
International Classification of the Radiographs 
of Pneumoconioses	 [ILO	 1980].	 Identifiers	 on	
films	were	masked	to	ensure	a	blind	review	by	
readers,	and	quality	control	measures	and	tests	
of	 agreement	were	used	 to	 check	 consistency	
among	the	readers.	For	each	type	of	abnormal-
ity	analyzed,	the	median	of	the	three	readings	
for	each	film	was	used.	
5.3.2.1 Pleural abnormalities
In	the	1986	study	of	European	RCF	workers,	re-
sults	of	the	chest	radiography	indicated	a	preva-
lence	of	2.8%	(15/543)	 for	pleural	abnormali-
ties	among	male	workers	[Rossiter	et	al.	1994].	
Of	 the	 15	 cases	 with	 pleural	 abnormalities,	 4	
had	bilateral	diffuse	thickening	(1	with	calcifi-
cation),	1	showed	bilateral	pleural	calcification	
only,	7	presented	with	unilateral	diffuse	 thick-
ening,	and	3	showed	costophrenic	angle	blunt-
ing	only.	The	possibility	for	confounding	effects	
was	 recognized	 because	 of	 other	 exposures:	
52%	 of	 workers	 reported	 previous	 employ-
ment	 in	dusty	 jobs,	 including	4.5%	with	prior	
asbestos	exposures	and	7%	with	prior	MMMF	
exposures.	When	female	workers	were	included	
in	the	same	population,	Trethowan	et	al.	[1995]	
reported	 a	 prevalence	 of	 2.7%	 (16/592)	 for	
pleural	abnormalities.	Two	cases	were	known	to	
have	previous	exposure	to	asbestos,	and	the	pos-
sibility	for	exposure	to	other	respiratory	hazards	
was	acknowledged	for	other	persons	with	pleural	
abnormalities.	Cowie	et	al.	[1999,	2001]	reported	
pleural	 abnormalities	 in	 10%	 (78/774)	 and	
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Ev
al
u
at
io
n
 m
et
h
od
s
R
es
u
lt
s
C
om
m
en
ts
R
os
si
te
r	
et
	a
l.	
19
94
(E
u
ro
p
ea
n
	s
tu
dy
)
C
oh
or
t m
or
b
id
it
y 
 
st
u
dy
: 
		6
28
	c
u
rr
en
tl
y	
w
or
k-
in
g	
em
pl
oy
ee
s	
in
	
se
ve
n
	E
u
ro
p
ea
n
	
R
C
F	
pr
od
u
ct
io
n
	
pl
an
ts
.	5
43
	m
al
e	
w
or
ke
rs
	w
h
o	
h
ad
	
re
ad
ab
le
	c
h
es
t	
ra
di
og
ra
ph
s	
w
er
e	
in
cl
u
de
d	
in
	t
h
e	
an
al
ys
is
	(
59
6	
of
	
62
8	
w
or
ke
rs
	[
95
%
]	
h
ad
	c
h
es
t	
ra
di
o-
gr
ap
h
s;
	5
1	
w
om
en
	
an
d	
2	
u
n
re
ad
ab
le
	
fi
lm
s	
w
er
e	
ex
-
cl
u
de
d)
.
H
ea
lt
h:
C
he
st
	r
ad
io
gr
ap
hs
	a
nd
	
qu
es
ti
on
na
ir
e	
w
er
e	
ad
m
in
is
te
re
d.
	D
at
a	
fo
r	
14
	d
es
cr
ip
tiv
e	
	v
ar
i-
ab
le
s	
w
er
e	
co
lle
ct
ed
	
fo
r	
ea
ch
	w
or
ke
r	
as
	
fo
llo
w
s:
	p
ro
du
ct
io
n
	
pl
an
t;	
ag
e;
		y
ea
rs
	s
in
ce
	
fir
st
	e
m
pl
oy
m
en
t	a
t	
pl
an
t;	
ye
ar
s	
si
nc
e	
fir
st
	
ex
po
se
d	
to
	R
C
Fs
;	y
ea
rs
	
of
	e
m
pl
oy
m
en
t	i
n	
th
e	
	
pl
an
t;	
cu
rr
en
t	r
es
pi
-
ra
bl
e	
fib
er
	e
xp
os
ur
e;
	
cu
rr
en
t	n
on
re
sp
ir
ab
le
	
fib
er
	e
xp
os
ur
e;
	c
ur
-
re
nt
	in
sp
ir
ab
le
	m
as
s	
ex
po
su
re
;	c
um
ul
a-
tiv
e	
re
sp
ir
ab
le
	fi
be
r	
ex
po
su
re
;	c
um
ul
at
iv
e	
no
nr
es
pi
ra
bl
e	
fib
er
	
ex
po
su
re
;	c
um
ul
at
iv
e	
in
sp
ir
ab
le
	m
as
s	
	e
xp
o-
su
re
;	n
um
be
r	
of
	jo
bs
	a
t	
th
e	
pl
an
t	w
it
h	
as
be
st
os
	
ex
po
su
re
;	p
ri
or
	a
sb
es
-
to
s	
ex
po
su
re
.
R
ad
io
gr
ap
h
ic
 a
n
al
ys
is
			
			
E
ff
ec
t 
   
   
  P
re
va
le
n
ce
P
le
u
ra
l	c
h
an
ge
s	
2.
8%
	(
15
/5
43
)	
La
rg
e	
op
ac
it
ie
s	
0
Sm
al
l	o
pa
ci
ti
es
	
7.
0%
	(
38
/5
43
)
Ir
re
gu
la
r	
5.
5%
R
ou
n
de
d	
3.
5%
M
ix
ed
	
5.
2%
St
at
is
ti
ca
l a
n
al
ys
is
:
Pr
ev
al
en
ce
 o
f p
le
ur
al
 c
ha
ng
es
 (
n=
15
) 
as
-
so
ci
at
ed
 w
ith
 a
ge
 (
χ2
 =
18
.8
5,
 P
=
0.
00
08
).
 
Pr
ev
al
en
ce
 o
f c
as
es
 o
f s
m
al
l o
pa
ci
ty
 p
ro
fu
-
si
on
 (
n=
38
) 
re
la
te
d 
to
pr
od
uc
ti
on
	p
la
nt
	(
χ2
=
	2
2.
10
,	P
<
0.
00
01
);
	
sm
ok
in
g	
ye
ar
s	
si
nc
e	
fir
st
	e
m
pl
oy
m
en
t,	
ye
ar
s	
of
	e
m
pl
oy
m
en
t,	
pr
io
r	
as
be
st
os
	e
xp
os
ur
e,
	
cu
rr
en
t	n
on
re
sp
ir
ab
le
	fi
be
r	
ex
po
su
re
	(
no
	 χ
2 	
re
po
rt
ed
,	 P
≤0
.0
5)
.
Pr
ev
al
en
ce
 o
f c
as
es
 w
ith
 m
os
tly
 r
ou
nd
ed
 
op
ac
it
ie
s (
n=
23
) 
re
la
te
d 
to
he
av
y	
sm
ok
in
g	
(χ
2 =
2.
18
,	P
=
0.
14
);
	a
sb
es
to
s	
ex
po
su
re
	w
it
hi
n	
th
e	
R
C
F	
pl
an
ts
	
(χ
2 =
3.
08
	w
it
h	
co
nt
in
ui
ty
	c
or
re
ct
io
n,
	
P=
0.
08
);
	b
ut
	n
ot
	a
ge
	(
χ2
=
1.
25
,	P
=
0.
87
)	
or
	
pr
od
uc
ti
on
		p
la
nt
	(
χ2
=
	5
.1
3,
	P
=
0.
53
).
Pr
ev
al
en
ce
 o
f c
as
es
 w
ith
 m
os
tly
 ir
re
gu
la
r 
op
ac
it
ie
s (
n=
15
) 
re
la
te
d 
to
ag
e	
(χ
2 =
	3
8.
9,
	P
<
0.
00
01
);
	c
ur
re
nt
	n
on
-
re
sp
ir
ab
le
	fi
be
r	
le
ve
ls
	(
χ2
=
5.
2,
	P
=
0.
07
);
	
ye
ar
s	
si
nc
e	
fir
st
	R
C
F	
em
pl
oy
m
en
t	(
χ2
=
8.
16
,	
P=
0.
09
);
		y
ea
rs
	o
f		
R
C
F	
em
pl
oy
m
en
t	
(χ
2 =
8.
70
,	P
=
0.
07
);
	b
ut
	n
ot
	p
la
nt
	(
P=
0.
23
).
P
le
ur
al
	c
ha
n
ge
s	
(n
=
15
)	
in
cl
ud
ed
	
fo
ur
	c
as
es
	w
it
h	
bi
la
te
ra
l	d
if
fu
se
			
	
th
ic
ke
n
in
g	
(o
n
e	
w
it
h	
ca
lc
ifi
ca
-	
ti
on
);
	o
n
e	
w
it
h	
bi
la
te
ra
l	p
le
u-
	
ra
l	c
al
ci
fi
ca
ti
on
	o
n
ly
;	s
ev
en
	w
it
h
	
un
ila
te
ra
l	d
if
fu
se
	th
ic
ke
n
in
g;
	
th
re
e	
w
it
h	
co
st
op
hr
en
ic
	a
n
gl
e	
bl
un
ti
n
g	
on
ly
.	P
re
va
le
n
ce
	o
f	
pl
eu
ra
l	c
ha
n
ge
s	
w
as
	a
ss
oc
ia
te
d	
w
it
h	
ag
e.
Ir
re
gu
la
r	
op
ac
it
ie
s	
w
er
e	
re
la
te
d	
to
	
ag
e,
	c
ur
re
n
t	n
on
re
sp
ir
ab
le
	fi
be
r	
co
n
ce
n
tr
at
io
n
s,
	a
n
d	
du
ra
ti
on
	
an
d	
la
te
n
cy
	o
f	
R
C
F	
	e
m
pl
oy
-
m
en
t.	
O
ve
ra
ll,
	a
	s
lig
ht
	a
ss
oc
ia
-
ti
on
	w
as
	n
ot
ed
	fo
r	
pr
ev
al
en
ce
	o
f	
sm
al
l	o
pa
ci
ti
es
	a
n
d	
w
or
ki
n
g	
in
	
ce
ra
m
ic
	fi
be
r	
pr
od
uc
ti
on
	(
i.e
.,	
R
C
F	
em
pl
oy
m
en
t	l
at
en
cy
	a
n
d	
du
ra
ti
on
).
	T
he
	r
es
ea
rc
he
rs
	c
on
-
cl
ud
ed
	it
	w
as
	u
n
lik
el
y	
th
at
	fi
be
r	
ex
po
su
re
	w
as
	th
e	
m
ai
n
	c
au
se
	o
f	
ra
di
og
ra
ph
ic
	a
bn
or
m
al
it
ie
s.
T
he
	p
os
si
bi
lit
y	
fo
r	
co
n
fo
un
di
n
g	
ef
fe
ct
s	
du
e	
to
	o
th
er
	e
xp
os
ur
es
	
is
	r
ec
og
n
iz
ed
:	5
2%
	o
f	
w
or
ke
rs
	
re
po
rt
ed
	p
re
vi
ou
s	
em
pl
oy
m
en
t	
in
	in
du
st
ri
es
	w
it
h	
po
te
n
ti
al
		
ex
po
su
re
	to
	d
us
ts
,	i
n
cl
ud
in
g	
as
be
st
os
	(
5%
),
	s
to
n
e	
qu
ar
ry
in
g	
(2
%
),
	ir
on
/s
te
el
	fo
un
dr
ie
s	
(6
%
),
	
re
fr
ac
to
ry
	b
ri
ck
	w
or
k	
(1
0%
),
	a
n
d	
m
an
-m
ad
e	
m
in
er
al
	fi
be
rs
	(
8%
).
(C
on
ti
nu
ed
)
* A
bb
re
vi
at
io
n
s.
	N
=
n
u
m
be
r;
	P
=
pr
ob
ab
ili
ty
;	R
C
Fs
=
re
fr
ac
to
ry
	c
er
am
ic
	fi
be
rs
.
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u
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n
d
 E
u
ro
p
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n
 M
or
b
id
it
y 
st
u
d
ie
s 
w
it
h
 R
C
Fs
*
R
ef
er
en
ce
St
u
dy
 d
es
ig
n
 
an
d
 p
op
u
la
ti
on
Ev
al
u
at
io
n
 m
et
h
od
s
R
es
u
lt
s
C
om
m
en
ts
Tr
et
h
ow
an
	
et
	a
l.	
19
95
(E
u
ro
p
ea
n
	s
tu
dy
)
C
ro
ss
-s
ec
ti
on
al
 re
sp
ir
a-
to
ry
 m
or
bi
di
ty
 st
ud
y:
62
8	
cu
rr
en
t	
w
or
ke
rs
	
in
	s
ev
en
	E
u
ro
p
ea
n
	
R
C
F	
m
an
u
fa
ct
u
ri
n
g	
pl
an
ts
.
M
ea
n
	a
ge
	=
	3
7.
7	
ye
ar
s.
M
ea
n
	d
u
ra
ti
on
	o
f	
em
pl
oy
m
en
t	
=
	1
0.
2	
ye
ar
s.
91
%
	w
er
e	
m
al
e	
w
or
ke
rs
	a
n
d	
9%
	
w
er
e	
fe
m
al
e	
w
or
ke
rs
.
44
%
	w
er
e	
cu
rr
en
t	
sm
ok
er
s.
H
ea
lt
h
:
A
	s
el
f-
ad
m
in
is
te
re
d	
	q
ue
st
io
n
n
ai
re
	
w
as
	u
se
d	
to
	o
bt
ai
n
	in
fo
rm
at
io
n
	
ab
ou
t	r
es
pi
ra
to
ry
,	n
as
al
,	e
ye
,	a
n
d	
sk
in
	s
ym
pt
om
s,
	p
lu
s	
de
ta
ils
	o
f	
su
b -
je
ct
s=
	o
cc
up
at
io
n
al
	h
is
to
ry
.	P
FT
	w
as
	
al
so
	p
er
fo
rm
ed
,	a
n
d	
ch
es
t	X
-r
ay
s	
w
er
e	
ob
ta
in
ed
	fr
om
	5
92
	s
ub
je
ct
s.
E
xp
os
u
re
 a
ss
es
sm
en
t:
14
0	
jo
bs
	w
er
e	
id
en
ti
fi
ed
	a
n
d	
cl
as
si
-
fi
ed
	in
to
	s
ev
en
	m
ai
n
	g
ro
up
s.
Fu
ll-
sh
if
t	
p
er
so
n
al
	a
ir
	s
am
pl
es
	w
er
e	
co
lle
ct
ed
	fo
r	
ra
n
do
m
ly
	s
el
ec
te
d	
w
or
ke
rs
	in
	e
ac
h
	o
f	
th
e	
se
ve
n
	m
ai
n
	
gr
ou
ps
.	
In
sp
ir
ab
le
	d
u
st
	m
on
it
or
in
g	
w
as
	
p
er
fo
rm
ed
	a
cc
or
di
n
g	
to
	a
n
	A
C
G
IH
	
m
et
h
od
.
R
es
pi
ra
bl
e	
fi
be
r	
co
n
ce
n
tr
at
io
n
	w
as
	
m
ea
su
re
d	
ac
co
rd
in
g	
to
	a
	W
H
O
/
E
U
R
O
	[
19
85
]	
re
fe
re
n
ce
	m
et
h
od
	fo
r	
M
M
M
Fs
.		
(R
es
pi
ra
bl
e	
fi
be
r	
is
	d
e -
fi
n
ed
	a
s	
<
5µ
m
	lo
n
g	
w
it
h
	a
n
	a
sp
ec
t	
ra
ti
o	
>
3:
1	
an
d	
a	
di
am
et
er
	 ≤
3µ
m
.)
St
at
is
ti
ca
l a
n
al
ys
is
:
P
u
lm
on
ar
y	
fu
n
ct
io
n
	in
di
ce
s	
w
er
e	
co
m
pa
re
d	
fo
r	
cu
m
u
la
ti
ve
	e
xp
os
u
re
	
gr
ou
ps
.	S
ym
pt
om
s	
w
er
e	
in
ve
st
i -
ga
te
d	
by
	lo
gi
st
ic
	r
eg
re
ss
io
n
,	a
n
d	
pu
lm
on
ar
y	
fu
n
ct
io
n
	b
y	
lin
ea
r	
re
gr
es
si
on
.	M
od
el
s	
w
er
e	
co
n
tr
ol
le
d	
fo
r	
ef
fe
ct
s	
of
	a
ge
,	s
ex
,	s
m
ok
in
g	
h
ab
it
s,
	a
n
d	
pr
ev
io
u
s	
ex
p
os
u
re
	to
	
re
sp
ir
at
or
y	
h
az
ar
ds
.
R
ad
io
gr
ap
h
ic
 a
n
al
ys
is
   
   
   
   
   
E
ff
ec
t 
P
re
va
le
n
ce
P
le
u
ra
l	c
h
an
ge
s	
2.
7%
	(
16
/5
92
)
La
rg
e	
op
ac
it
ie
s	
0
Sm
al
l	o
pa
ci
ti
es
	
13
%
Ir
re
gu
la
r	
5.
1%
R
ou
n
de
d	
3.
2%
M
ix
ed
	
4.
7%
Sy
m
p
to
m
 a
n
al
ys
es
   
   
 C
u
rr
en
t 
re
sp
ir
ab
le
 f/
cm
3  
E
ff
ec
t 
[O
R
†  (
95
%
 C
I)
]
<
0.
2	
B
as
el
in
e
0.
2	
to
	<
0.
6	
D
ry
	c
ou
gh
	
[2
.5
3	
(1
.2
5,
	5
.1
1)
]
	
St
u
ff
y	
n
os
e	
[2
.0
6	
(1
.2
5,
	3
.3
9)
]
	
E
ye
	ir
ri
ta
ti
on
	
[2
.1
6	
(1
.3
2,
	3
.5
4)
]
≥0
.6
	
D
ry
	c
ou
gh
	
[2
.0
1	
(1
.0
5,
	3
.8
4)
]
	
D
ys
pn
ea
	 ≥
2	
[2
.6
6	
(1
.3
1,
	5
.4
2)
]
	
E
ye
	ir
ri
ta
ti
on
	
[2
.6
3	
(1
.7
,	4
.0
8)
]
	
Sk
in
	ir
ri
ta
ti
on
	[
3.
18
	(
2.
01
,	5
.0
3)
]
P
re
va
le
n
ce
	o
f	
sm
al
l	o
pa
ci
ti
es
in
cr
ea
se
d	
w
it
h
	a
ge
,	s
m
ok
-
in
g,
	a
n
d	
pr
ev
io
u
s	
ex
po
su
re
	to
	
as
be
st
os
,	b
u
t	
n
ot
	w
it
h
	c
u
m
u
la
-
ti
ve
	e
xp
os
u
re
s	
to
	c
er
am
ic
	
fi
be
rs
.	N
o	
de
sc
ri
pt
io
n
	o
f	
th
is
	
an
al
ys
is
	is
	p
ro
vi
de
d.
Sy
m
pt
om
s	
pr
es
en
t	
in
	t
h
e
st
u
dy
	p
op
u
la
ti
on
	w
er
e	
re
la
te
d	
to
	e
xp
os
u
re
	to
	r
es
pi
ra
bl
e	
fi
be
rs
.		
St
at
is
ti
ca
lly
	s
ig
n
ifi
ca
n
t		
in
cr
ea
s -
es
	w
er
e	
n
ot
ed
	in
	t
h
e	
pr
ev
al
en
ce
	
of
	d
ys
pn
ea
	(
bo
th
	g
ra
de
s)
	w
it
h
	
in
cr
ea
si
n
g	
cu
m
u
la
ti
ve
	fi
be
r	
ex
po
su
re
	g
ro
u
ps
.
Lu
n
g	
fu
n
ct
io
n
	te
st
s	
sh
ow
ed
	a
si
gn
ifi
ca
n
t	
re
la
ti
on
	b
et
w
ee
n
	in
-
cr
ea
si
n
g	
cu
m
u
la
ti
ve
	e
xp
os
u
re
	
to
	r
es
pi
ra
bl
e	
fi
be
rs
	a
n
d	
de
cr
e -
m
en
ts
	in
	F
E
V
1	a
n
d	
FE
F 2
5-
75
	in
	
cu
rr
en
t	
sm
ok
er
s,
	a
n
d	
FE
V
1	
in
	fo
rm
er
	s
m
ok
er
s.
	A
m
on
g	
n
ev
er
	s
m
ok
er
s,
	a
n
	in
cr
ea
se
	
(n
ot
	s
ta
ti
st
ic
al
ly
	s
ig
n
ifi
ca
n
t)
	
oc
cu
rr
ed
	in
	p
u
lm
on
ar
y	
fu
n
c -
ti
on
	m
ea
su
re
s	
w
it
h
	in
cr
ea
si
n
g	
cu
m
u
la
ti
ve
	fi
be
r	
ex
po
su
re
.
O
ve
ra
ll,
	1
9%
	o
f	
th
e
po
pu
la
ti
on
	h
ad
	w
or
ke
d	
in
	
du
st
y	
oc
cu
pa
ti
on
s	
ou
ts
id
e	
th
e	
pr
od
u
ct
io
n
	o
f	
ce
ra
m
ic
	fi
be
rs
.
N
ot
e:
	I
n
	c
al
cu
la
ti
n
g	
cu
m
u
la
ti
ve
	
ex
po
su
re
s,
	t
h
e	
re
se
ar
ch
er
s	
as
-
su
m
e	
pa
st
	e
xp
os
u
re
	c
on
ce
n
tr
a -
ti
on
s	
w
er
e	
eq
u
al
	to
	c
u
rr
en
t	
ex
po
su
re
	c
on
ce
n
tr
at
io
n
s.
* A
bb
re
vi
at
io
n
s:
	A
C
G
IH
	=
	A
m
er
ic
an
	C
on
fe
re
n
ce
	o
f	
G
ov
er
n
m
en
ta
l	I
n
du
st
ri
al
	H
yg
ie
n
is
ts
;	C
I	
=
	c
on
fi
de
n
ce
	in
te
rv
al
;	M
M
M
Fs
	=
	m
an
-m
ad
e	
m
in
er
al
	
			
	fi
be
rs
;	O
R
	=
	o
dd
s	
ra
ti
o;
	P
FT
=
pu
lm
on
ar
y	
fu
n
ct
io
n
	te
st
;	R
C
Fs
=
re
fr
ac
to
ry
	c
er
am
ic
	fi
be
rs
.
† A
dj
u
st
ed
	fo
r	
th
e	
ef
fe
ct
s	
of
	a
ge
,	s
ex
,	s
m
ok
in
g,
	a
n
d	
pr
ev
io
u
s	
ex
p
os
u
re
s	
to
	r
es
pi
ra
to
ry
	h
az
ar
ds
.
(C
on
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n
u
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)
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Ta
bl
e 
5–
7 
(C
on
ti
n
u
ed
) .
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 .S
 . a
n
d
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u
ro
p
ea
n
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or
b
id
it
y 
st
u
d
ie
s 
w
it
h
 R
C
Fs
*
R
ef
er
en
ce
St
u
dy
 d
es
ig
n
an
d
 p
op
u
la
ti
on
Ev
al
u
at
io
n
 m
et
h
od
s
R
es
u
lt
s
C
om
m
en
ts
Tr
et
h
ow
an
	e
t	
al
.	1
99
5,
			
	c
on
ti
n
u
ed
(E
u
ro
p
ea
n
	s
tu
dy
)
Lo
gi
st
ic
	r
eg
re
ss
io
n
	w
as
	u
se
d	
to
	a
n
al
yz
e	
th
e	
tr
en
d	
be
tw
ee
n
	
sy
m
pt
om
	p
re
va
le
n
ce
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5  ■		Effects of Exposure
pleural	plaques	in	5%	(40/774)	of	study	partic-
ipants.	In	the	U.S.	study,	23	cases	with	pleural	
abnormalities	 (all	 production	 workers)	 were	
identified	 from	847	male	and	 female	workers	
(686	production,	161	nonproduction)	[Lemas-
ters	et	al.	1994].	The	prevalence	of	pleural	ab-
normalities	 among	all	workers	was	2.7%	and	
for	production	workers	only,	3.4%.	Of	the	cas-
es,	21	were	classified	as	having	pleural	plaques	
and	 2	 as	 having	 diffuse	 pleural	 thickening.	
One	worker	reported	having	previously	diag-
nosed	kaolinosis	from	prior	employment	in	a	
kaolin	mine.	Lockey	et	al.	[1996]	conducted	a	
followup	report	based	on	review	of	652	chest	
films	from	current	and	former	workers	at	two	
of	the	U.S.	plants.	They	reported	a	prevalence	
of	pleural	changes	of	3.1%	(n=20),	 including	
19	pleural	plaque	cases	and	1	with	diffuse	pleu-
ral	thickening.	Pleural	plaques	were	present	in	
18	 (4.1%)	 production	 workers	 and	 2	 (0.9%)	
nonproduction	workers.	The	two	nonproduc-
tion	workers	with	pleural	plaques	had	worked	
with	 RCFs	 as	 laboratory	 technicians.	 From	
statistical	 analyses	 of	 pleural	 abnormalities,	
Rossiter	 et	 al.	 [1994]	 reported	 an	 association	
with	 age	 [χ2=18.85,	 P=0.0008].	 However,	 no	
attempt	was	made	 to	assess	whether	an	asso-
ciation	 existed	between	pleural	 abnormalities	
and	RCF	exposure.	Trethowan	et	al.	[1995]	also	
noted	 that	pleural	 abnormalities	were	 related	
to	age	but	not	independently	to	ceramic	fiber	
exposures.	Cowie	et	al.	 [1999,	2001]	reported	
pleural	 abnormalities	 to	 be	 associated	 with	
age,	 exposure	 to	 asbestos,	 and	body	mass	 in-
dex	(weight	divided	by	height	squared).	When	
the	data	were	unadjusted	 for	 age,	 an	associa-
tion	existed	between	pleural	changes	and	years	
worked	 at	 the	 plant.	 Lemasters	 et	 al.	 [1994]	
found	that	pleural	abnormalities	were	associ-
ated	with	time	since	first	RCF	exposure	(RCF	
latency)	after	adjusting	for	duration	of	asbes-
tos	exposure	and	time	since	first	asbestos	expo-
sure	(odds	ratio	 [OR]=2.9	[95%	CI=0.8–9.7]	
for	 >10	 to	 20	 years	 of	 RCF	 latency,	 and	 7.7	
[95%	 CI=2.0–29.1]	 for	 >20	 years	 of	 RCF	
latency,	when	compared	with	workers	having	
<10	years	of	RCF	latency).	Pleural	abnormali-
ties	remained	statistically	significant	(P<0.001)	
with	time	since	first	RCF	exposure	(latency)	af-
ter	adjustment	for	the	effects	of	smoking,	body	
weight,	 and	 latency	 and	 duration	 of	 asbestos	
exposure.	The	positive	association	persisted	af-
ter	 exclusion	 of	workers	 exposed	 to	 asbestos.	
In	multiple	logistic	regression	analyses,	an	as-
sociation	 between	 duration	 of	 RCF	 exposure	
and	pleural	abnormalities	remained	significant	
(χ2=7.75, P=0.005)	after	adjustment	for	asbes-
tos	latency,	asbestos	duration,	and	age	[Lemas-
ters	 et	 al.	 1994].	 In	 subsequent	 analyses	with	
adjustment	for	age,	researchers	found	that	as-
sociations	 persisted	 between	 pleural	 plaques	
and	 latency	 and	 duration	 of	 RCF	 exposure	
[Lockey	et	al.	1996].	In	three	separate	analyses,	
Lockey	 et	al.	 [1996]	 found	 that	prevalence	of	
pleural	plaques	related	to	the	following:
■	 	>20	years	of	RCF	latency	(OR=9.5	[95%	
CI=1.9–48.2])	
■	 >20	years	RCF	exposure	duration	in	pro-
duction	 jobs	 (OR=22.3	 [95%	 CI=3.6–
137.0])	
■	 Cumulative	RCF	exposure	in	the	highest	
exposure	 category	 (>135	 fiber-months/
cm3)	(OR=24.2	[95%	CI=2.6–224.9])
Results	 of	 a	 nested	 case-control	 study	 of	 the	
20	workers	with	pleural	 plaques	 (matched	 to	
3	controls	based	on	sex,	RCF	employment	sta-
tus,	and	production/nonproduction	category)	
support	 the	 associations	 of	 pleural	 changes	
with	 RCF	 latency,	 RCF	 exposure	 duration,	
and	 cumulative	 RCF	 exposure	 [Lockey	 et	 al.	
1996].	A	latency	validity	review	was	also	con-
ducted,	 involving	 analysis	 of	 205	 historical	
chest	 radiographs	 available	 for	 workers	 with	
pleural	 changes.	 The	 purpose	 of	 the	 review	
was	 to	 confirm	 that	 for	persons	with	pleural	
plaques,	a	biologically	plausible	latency	period	
(≥5	 years)	 existed	 between	 initial	 RCF	 expo-
sure	and	appearance	of	a	pleural	plaque.	Of	18	
pleural	plaque	cases	for	which	historical	chest	
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radiographs	were	available,	only	1	had	a	latency	
period	of	<5	years	from	initial	RCF	production	
to	recognition	of	a	pleural	plaque.
A	subsequent	analysis	by	Lockey	et	al.	[2002]	
included	 chest	 radiographs	 for	 625	 current	
workers	obtained	every	3	years	at	5	RCF	man-
ufacturing	 sites	 and	 383	 former	 workers	 at	
2	of	 the	 5	 sites.	Pleural	 changes	were	 seen	 in	
27	workers	(2.7%),	of	which	19	were	bilateral	
plaques	 (70%)	 and	 3	were	 unilateral	 plaques	
(11%).	Cumulative	RCF	exposure	(>135	fiber-
months/cm3)	was	significantly	associated	with	
pleural	changes	(OR	=	6.0,	95%	CI	=	1.4,	31.0).	
The	researchers	noted	an	increasing	but	non-
significant	trend	involving	interstitial	changes	
and	 RCF	 exposure	 duration	 in	 a	 production	
job	and	cumulative	RCF	exposure.	
5.3.2.2 Parenchymal Opacities
In	 the	 1987	 European	 study,	 Rossiter	 et	 al.	
[1994]	found	that	7%	(38/543)	of	the	current	
male	 workers	 had	 small	 parenchymal	 opaci-
ties	with	median	profusion	of	1/0	or	more.	No	
large	 parenchymal	 opacities	 were	 observed.	
Both	predominantly	rounded	(n=23,	or	4.2%)	
and	predominantly	irregular	(n=15,	or	2.8%)	
small	 parenchymal	 opacities	 were	 identified.	
Prevalence	 of	 rounded,	 small	 opacities	 was	
not	 associated	with	 age	 (P=0.87)	 or	 produc-
tion	plant	(P=0.53).	However,	with	prevalence	
of	opacities,	stronger	associations	existed	with	
asbestos	 exposure	 in	 RCF	 production	 plants	
(P=0.08)	and	heavy	smoking	(P=0.14)	[Rossit-
er	et	al.	1994].	Predominantly	irregular,	small	
opacities	were	associated	with	age	(P<0.0001)	
but	 not	 with	 production	 plant	 (P=0.23).	Af-
ter	allowing	for	age,	associations	with	current	
nonrespirable	fiber	concentrations,	years	since	
first	 RCF	 employment,	 and	 duration	 of	 RCF	
employment	 approached	 statistical	 signifi-
cance	(P=0.07	to	0.09).	In	a	subsequent	analy-
sis	of	small	opacities	for	both	male	and	female	
workers,	Trethowan	et	al.	[1995]	noted	that	the	
prevalence	 of	 small	 opacities	 increased	 with	
age,	smoking,	and	previous	exposure	to	asbes-
tos	but	not	with	cumulative	RCF	exposure.	No	
description	of	the	analysis	was	provided.	Cow-
ie	et	al.	[1999]	reported	that	10	of	51	(19.6%)	
men	with	RCF	exposure	before	1971	had	small	
opacities	 of	 category	 1/0	 or	 greater.	 Eight	 of	
these	10	had	been	exposed	to	asbestos,	and	9	
were	either	current	or	ex-smokers.	In	the	U.S.	
study,	no	analyses	were	performed	to	assess	the	
relationship	between	small	opacities	and	RCF	
exposure	because	of	the	small	number	of	cas-
es	 (n=4)	 identified	by	Lemasters	 et	 al.	 [1994,	
1996].	
5.3.3 Respiratory Conditions and 
Symptom Analyses
Using	 respiratory	 health	 questionnaires,	 the	
U.S.	and	European	studies	sought	to	identify	re-
spiratory	conditions	and	symptoms	that	could	
be	 associated	with	 exposure	 to	RCFs.	 Lockey	
et	 al.	 [1993]	 administered	 to	 717	 subjects	 a	
standardized	 respiratory	 symptoms	question-
naire	 that	 included	 questions	 about	 the	 fol-
lowing	 symptoms	 and	 conditions:	 chronic	
cough,	 chronic	 phlegm,	 dyspnea	 grades	 1	
and	2	(described	in	the	Definitions	section	of	
this	 document),	 wheezing,	 asthma,	 pleurisy,	
and	 pleuritic	 chest	 pain.	 Logistic	 regression	
analyses	 were	 adjusted	 for	 age,	 sex,	 smoking	
(pack	 years),	 duration	 of	 asbestos	 exposure,	
duration	of	production	employment,	duration	
of	 other	 hazardous	 occupational	 respiratory	
exposure,	 and	 time	 since	 last	 RCF	 employ-
ment.	With	the	exception	of	asthma,	for	which	
self-selection	out	of	production	jobs	may	have	
occurred,	adjusted	ORs	for	respiratory	symp-
toms	were	significantly	elevated	in	production	
workers	compared	with	nonproduction	work-
ers.	Results	of	a	subsequent	analysis	with	742	
RCF	workers	by	Lemasters	 et	 al.	 [1998]	 indi-
cated	that	the	prevalence	of	respiratory	symp-
toms	and	conditions	(except	 for	asthma)	was	
approximately	 twofold	 to	 fivefold	 higher	 in	
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production	 than	 in	 nonproduction	 workers.	
The	 most	 frequently	 reported	 symptom	 for	
male	production	workers	was	dyspnea	grade	1	
(15.7%,	compared	with	2.5%	for	nonproduc-
tion),	followed	by	wheezing	(10.3%,	compared	
with	3.8%	 for	nonproduction).	Prevalence	of	
one	 or	more	 respiratory	 symptoms	 and	 con-
ditions	among	female	production	workers	was	
40.7%,	compared	with	20.3%	for	nonproduc-
tion	workers.
Trethowan	et	al.	[1995]	examined	the	relation-
ship	of	dry	cough,	chronic	bronchitis,	dyspnea	
(two	grades),	wheeze,	stuffy	nose,	eye	irritation,	
and	skin	 irritation	to	current	and	cumulative	
RCF	 exposure	 estimates	 among	 628	workers.	
Current	 exposures	 were	 based	 on	 air	 sam-
pling	measurements	taken	in	association	with	
the	respiratory	health	 survey.	The	researchers	
noted	eye	and	skin	irritation	were	frequent	in	
all	 plants	 and	 increased	 significantly,	 as	 did	
dyspnea	 and	wheeze,	with	 increasing	 current	
exposure	 concentrations	 (i.e.,	 0.2	 to	 0.6	 and	
≥0.6	 f/cm3)	after	controlling	 for	age,	 sex,	and	
smoking	 habits.	 The	 most	 frequent	 symp-
tom,	 nasal	 stuffiness	 (in	 55%	 of	 the	 group),	
showed	 no	 clear	 association	 with	 increasing	
current	 exposure.	 Chronic	 bronchitis,	 with	 a	
prevalence	of	12%	among	all	workers,	also	ap-
peared	unaffected	by	increasing	current	expo-
sure	concentration.	Dry	cough,	eye	 irritation,	
and	 skin	 irritation	 all	 seemed	 to	 be	 associat-
ed	with	 increasing	 exposure,	 especially	 at	 the	
highest	 exposure	 concentration	 (≥0.6	 f/cm3).	
Analyses	of	cumulative	exposure	to	respirable	
fibers	 showed	 statistically	 significant	 associa-
tions	 with	 dyspnea	 but	 no	 apparent	 associa-
tion	with	chronic	bronchitis	and	wheeze.	In	a	
separate	analysis	of	the	same	cohort,	Burge	et	
al.	[1995]	investigated	the	relative	importance	
of	 respirable	 RCF	 exposure	 versus	 inspirable	
dust	exposure	in	predicting	respiratory	symp-
toms	and	conditions.	The	study	 found	work-
ers=	current	exposures	to	both	inspirable	dust	
and	respirable	fibers	were	related	(P<0.05)	to	
dry	cough,	stuffy	nose,	eye	and	skin	irritation,	
and	breathlessness	(dyspnea)	after	adjustment	
for	the	effects	of	smoking,	sex,	age,	and	plant.	
Only	 skin	 irritation	 was	 significantly	 associ-
ated	 with	 current	 RCF	 exposure	 after	 con-
trolling	for	exposure	to	inspirable	dust.	Burge	
et	al.	 [1995]	 did	 not	 analyze	 the	 relationship	
between	 symptoms	 and	 cumulative	 exposure	
indices.	Cowie	et	al.	[1999,	2001]	reported	that	
recurrent	chest	illness	was	associated	with	esti-
mated	cumulative	exposure	to	respirable	fibers	
but	was	not	significantly	associated	with	recent	
exposure.	
5.3.4 Pulmonary Function Testing
Trethowan	 et	 al.	 [1995]	 analyzed	 spirometry	
test	 results	 from	 600	 of	 628	 current	 workers	
who	participated	at	7	European	RCF	produc-
tion	plants.	In	separate	multiple	linear	regres-
sion	analyses	for	male	workers	in	each	smoking	
category	(current,	former,	never),	the	authors	
controlled	for	age,	height,	and	past	exposures	
to	various	respiratory	hazards	(including	previ-
ous	employment	in	other	ceramic	fiber	plants).	
Results	 associated	 cumulative	RCFs	with	 sta-
tistically	 significant	 (P<0.05)	 decrements	 in	
FEV
1
	in	both	current	and	former	smokers	and	
with	decreases	 in	FEF
25-75
	 in	current	 smokers.	
In	never	smokers	(n=154),	all	regression	coef-
ficients	of	cumulative	RCF	exposure	in	relation	
to	lung	function	were	small,	positive,	and	not	
statistically	significant.
As	with	the	symptoms	data,	Burge	et	al.	[1995]	
further	 analyzed	 the	 spirometry	 data	 from	
the	 European	 study	 to	 discern	 whether	 the	
observed	 effects	 were	more	 highly	 associated	
with	 current	 respirable	 RCF	 exposure	 than	
with	concurrent	inspirable	dust	exposure.	In	a	
multiple	linear	regression	model	that	excluded	
cumulative	 inspirable	 dust	 exposure,	 statisti-
cally	 significant	 (P<0.05)	 decreases	 in	 FEV
1
	
and	FEF
25-75
	among	current	smokers	and	FEV
1	
among	 former	 smokers	 were	 associated	 with	
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cumulative	 exposure	 to	 respirable	RCFs.	 In	 a	
multiple	linear	regression	model	that	included	
variables	 for	 cumulative	dust	 and	 cumulative	
respirable	 RCFs,	 the	 only	 statistically	 signifi-
cant	 (P<0.05)	 association	 for	 these	 variables	
was	 for	 the	 decrease	 in	 FEV
1
	 among	 current	
smokers	associated	with	cumulative	respirable	
RCF	exposure.	No	cumulative	dust-associated	
coefficients	 remained	 statistically	 significant	
after	adjusting	for	the	effect	of	cumulative	RCF	
exposure.	Thus,	the	investigators	attributed	the	
adverse	pulmonary	function	effect	observed	in	
smokers	 to	 the	 fiber	 component	 of	 occupa-
tional	 dust	 exposures	 at	 RCF	manufacturing	
plants.	
Cowie	et	al.	 [1999,	2001]	observed	that	RCF-
exposed	 male	 workers	 (n=692)	 showed	 a	
decrease	 in	 FEV
1
	 and	 FVC	 only	 for	 current	
smokers,	 the	 strongest	association	being	with	
estimated	 cumulative	 exposure	 to	 respirable	
fibers.	The	average	estimated	decrease	in	FEV
1
	
and	FVC	was	mild,	approximately	100	ml.	Fe-
male	RCF-exposed	workers	(n=82)	had	a	de-
creased	 FEV
1
	 with	 increasing	 cumulative	 ex-
posure	to	respirable	fibers	and	respirable	and	
total	dust.	Among	the	female	workers,	cumu-
lative	exposure	to	total	dust	was	most	strongly	
associated	with	decreased	pulmonary	function	
measurements.
Lemasters	et	al.	[1998]	anaylzed	PFT	data	for	
736	male	 and	 female	 current	 workers	 at	 five	
U.S.	 RCF	 plants.	 They	 reported	 decreases	 in	
the	 percentage	 of	 predicted	 FVC	 and	 FEV
1
	
with	every	10	years	of	RCF	production	work.	
Although	 the	 decreases	 were	 greatest	 among	
current	male	smokers	and	former	male	smok-
ers,	they	were	greater	than	decreases	associated	
with	 smoking	 alone.	 No	 significant	 changes	
were	noted	in	pulmonary	function	of	RCF	pro-
duction	workers	who	never	smoked.	A	separate	
study	by	Lockey	et	al.	[1998]	involved	longitu-
dinal	analysis	of	data	from	a	cohort	of	361	cur-
rent	male	RCF	workers	hired	before	 June	30,	
1990,	who	had	participated	in	at	least	five	PFT	
sessions	between	1987	and	1994.	By	compari-
son,	nonparticipants	who	were	excluded	from	
the	 analysis	 according	 to	 the	 criteria	 above	
were	on	average	older,	smoked,	weighed	more,	
and	 had	 lower	 height-adjusted	 and	 percent-
predicted	lung	function	values.	Cross-sectional	
analysis	of	the	initial	pulmonary	function	ses-
sion	 in	 a	 regression	 model	 included	 coeffi-
cients	 for	 age,	≤7	 versus	 >7	RCF	 production	
years,	smoking	status	(pack	years,	current	ver-
sus	former	smoker),	weight,	and	plant	location	
(categorical).	The	analysis	 found	decreases	 in	
FVC	and	FEV
1
	for	workers	employed	>7	years	
in	production	compared	with	nonproduction	
workers.	 In	 longitudinal	 analyses	of	 followup	
production	years	(i.e.,	from	initial	PFT	to	final	
PFT)	and	followup	cumulative	exposure	(i.e.,	
from	initial	PFT	to	final	PFT),	neither	of	these	
variables	had	an	effect	on	FVC	or	FEV
1
.	These	
results	 led	 the	authors	 to	conclude	 that	more	
recent	 exposure	 concentrations	during	1980–
1994	 had	no	 adverse	 effect	 on	 the	 longitudi-
nal	 trend	 of	 pulmonary	 function	 [Lockey	 et	
al.	1998].	Decrements	in	FVC	and	FEV
1
	noted	
in	 initial	 cross-sectional	analyses	of	PFT	data	
were	believed	to	be	related	to	earlier	higher	ex-
posure	concentrations.
5.3.5 Mortality Studies
Table	5–8	presents	findings	from	a	cohort	mor-
tality	study	of	two	U.S.	RCF	production	plants	
reported	by	Lockey	et	al.	[1993].	The	study	is	
based	on	a	cohort	of	684	male	workers	at	two	
RCF	 production	 plants	 who	 were	 employed	
for	at	least	1	year	between	January	1,	1950,	and	
June	1,	1988.	Five	workers	were	lost	to	follow-
up	and	46	were	deceased.	Because	this	is	a	rela-
tively	new	 industry	 (40	years	 at	 the	 time	of	
the	study)	that	has	experienced	recent	growth	
of	the	workforce	at	the	plants	studied,	person-
years	 at	 risk	 were	 limited	 at	 higher	 latencies	
(for	 example,	 only	 126.37	 person-years	 with	
>30	years	since	first	RCF	job).	Using	standard-
ized	mortality	ratios	(SMRs),	the	authors	found	
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the	 combined-race	 cohort	 to	 have	 no	 signifi-
cant	 elevations	 associated	with	 specific	 causes	
of	death,	including	cancers	of	the	lung,	digestive	
organs	 and	 peritoneum,	 urinary	 organs,	 and	
pneumoconioses	and	other	respiratory	disease.	
The	 authors	 noted	 that	 the	 power	 to	 detect	 a	
significant	increase	in	mortality	for	any	specific	
cause	was	low	because	of	the	small	number	of	
deaths	in	the	cohort	and	generally	short	laten-
cies.	However,	a	statistically	significant	increase	
in	deaths	 from	pneumoconioses	and	other	re-
spiratory	disease	occurred	 in	Caucasian	males	
with	>30	years	RCF	 latency	 (n=2,	SMR=2,614	
[95%	CI=246–7,490]).	A	statistically	significant	
elevation	 in	deaths	 from	cancers	of	 the	diges-
tive	 organs	 and	 peritoneum	 also	 occurred	 for	
non-Caucasian	 males	 (n=2,	 SMR=913	 [95%	
CI=110–3,295]).	In	addition,	a	statistically	sig-
nificant	 elevation	 occurred	 in	 the	 number	 of	
deaths	 from	cancers	of	 the	urinary	organs	 for	
male	workers	with	>15	to	20	years	of	RCF	 la-
tency	(n=2,	SMR=3,306	[95%	CI=311–9,471]).	
Lemasters	et	al.	[2003]	published	a	subsequent	
analysis	of	current	and	former	male	workers	
employed	between	1952	and	2000	at	the	two	
RCF	 manufacturing	 facilities	 (942	 subjects)	
investigating	 a	 possible	 excess	 in	 mortality.	
The	mortality	analytic	methods	included	(1)	
standardized	mortality	ratios	comparing	this	
cohort	with	the	general	and	State	populations	
and	(2)	a	proportional	hazards	model	that	re-
lates	risk	of	death	to	the	 lifetime	cumulative	
fiber-months/cm3	 exposure	 among	 the	 RCF	
cohort,	adjusted	for	age	at	hire	and	for	race.	
The	analysis	found	no	excess	mortality	relat-
ed	 to	 all	 deaths,	 all	 cancers,	 or	malignancies	
or	diseases	of	the	respiratory	system	(includ-
ing	 mesothelioma)	 but	 found	 a	 statistically	
significant	 association	 with	 cancers	 of	 the	
urinary	organs	[SMR=344.8	(95%	confidence	
limits	 of	 111.6,	 805.4)].	 Based	 on	 the	 small	
size	 of	 the	 cohort,	 the	 young	 average	 age	
(51	 years),	 and	 a	mean	 latency	 of	 21	 years,	
the	 researchers	 concluded	 that	 the	 findings	
warrant	continued	surveillance	of	the	cohort	
mortality	registry.	
Walker	 et	 al.	 [2002]	 used	 the	 same	 cohort	 of	
male	RCF	production	workers	described	by	Le-
masters	et	al.	[2003].	Walker	et	al.	performed	a	
risk	analysis	comparing	the	lung	cancer	and	me-
sothelioma	in	the	cohort’s	accumulated	mortal-
ity	 experience	 to	 that	which	would	 have	 been	
expected	 if	 RCFs	 had	 a	 carcinogenic	 potency	
approximating	 various	 forms	 of	 asbestos.	 The	
authors	reported	that	deaths	from	lung	cancer	
in	the	RCF	cohort	were	statistically	significantly	
below	 that	 which	 would	 be	 expected	 if	 RCFs	
had	the	potency	of	either	crocidolite	or	amosite.	
The	mortality	was	also	lower	than	would	be	ex-
pected	 if	 RCFs	 had	 the	 potency	 of	 chrysotile,	
but	the	difference	is	not	statistically	significant.	
For	mesothelioma,	 the	 authors	 concluded	 the	
anticipated	 numbers	 of	 deaths	 under	 hypoth-
eses	of	asbestos-like	potency	are	too	small	to	be	
rejected	by	 the	zero	cases	 seen	 in	 the	RCF	co-
horts	 [Walker	et	al.	2002].	NIOSH	researchers	
noted	that	this	analysis	by	Walker	et	al.	was	not	
based	on	 the	most	current	update	of	 the	RCF	
cohort.	In	addition,	the	asbestos	risk	assessment	
models	used	by	Walker	et	al.	[2002]	were	fitted	
to	 studies	 with	 longer	 followup	 periods	 than	
the	cohort	of	RCF	workers.	Because	these	mod-
els	do	not	 specify	 length	of	 followup,	 it	 is	not	
possible	to	adjust	 for	these	differences.	Conse-
quently,	it	is	likely	that	the	RCF	cohort	has	not	
been	followed	for	a	sufficient	length	of	time	to	
demonstrate	the	risks	that	were	observed	in	the	
asbestos	 cohorts.	 NIOSH	 believes	 the	mortal-
ity	study	by	Lemasters	et	al.	[2003]	and	the	risk	
analysis	by	Walker	et	al.	[2002]	have	insufficient	
power	 for	detecting	 lung	cancer	 risk	based	on	
what	would	be	predicted	for	asbestos.	
5.3.6 NIOSH HHEs
As	part	of	its	mission	as	a	public	health	agen-
cy,	NIOSH	performs	HHEs	 at	 the	 request	 of	
workers,	employers,	or	 labor	organizations	 to	
investigate	 occupational	 hazards	 associated	
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with	a	workplace	or	work-related	activity.	One	
such	 HHE	 involved	 evaluating	 worker	 expo-
sures	to	ceramic	fibers	at	a	company	manufac-
turing	steel	 forgings	[Kominsky	1978].	At	the	
facility,	 furnaces	 for	heat-treating	 steel	 ingots	
were	lined	with	RCF	felt	and	batting,	and	this	
lining	 required	 regular	 maintenance	 and	 re-
placement.	 Among	 the	 workers	 interviewed	
were	six	bricklayers	involved	in	furnace	lining	
maintenance.	Four	of	the	bricklayers	reported	
having	experienced	 irritation	of	exposed	skin	
areas	 and	 of	 the	 throat	 during	 the	 handling	
and	installation	of	the	RCF-containing	insula-
tion.	On	 the	basis	 of	 the	 reported	 symptoms	
and	 their	 consistency	 with	 known	 effects	 of	
RCFs,	the	symptoms	of	irritation	were	attrib-
uted	to	RCF	exposure.	No	attempt	was	made	to	
measure	airborne	fiber	concentrations.	Anoth-
er	NIOSH	HHE	[Lyman	1992]	 resulted	 from	
an	OSHA	inspection	that	identified	18	cases	of	
occupational	lung	disease	recorded	in	1	year	at	
a	plant	manufacturing	fire	bricks,	ceramic	fiber	
products,	 and	 other	 thermal	 insulation	 com-
ponents	from	kaolin.	About	600	workers	were	
potentially	exposed	to	respiratory	hazards	that	
included	not	only	RCFs	but	 also	kaolin	dust,	
crystalline	 silica	 dust,	 and	 (for	 maintenance	
workers)	 asbestos.	 A	 total	 of	 38	workers	 had	
been	 referred	 to	 a	 pulmonary	 physician	 for	
evaluation	 based	 on	 2	 rounds	 of	 chest	X-ray	
screening	of	the	workforce	 in	1980	and	1986.	
Diagnoses	 were	 related	 to	 pleural	 thickening	
(n=10),	pleural	plaques	(n=3),	diffuse	pulmo-
nary	fibrosis	(n=21),	mesothelioma	(n=1),	and	
other	miscellaneous	conditions.	At	least	20	of	
these	 cases	were	 classified	 as	work-related	 by	
the	 pulmonologist	 who	 evaluated	 the	 cases.	
The	 nonoccupational	 classification	 of	 some	
of	the	remaining	18	cases	was	questioned	by	a	
NIOSH	physician	who	performed	a	retrospec-
tive	 record	 review.	 The	 38	 cases	 were	 reclas-
sified	 on	 the	 basis	 of	 job	histories	 into	 those	
who	were	likely	to	have	been	exposed	to	RCFs	
(n=19,	including	4	with	pleural	abnormalities	
and	8	with	diffuse	fibrosis)	and	those	unlikely	
to	have	been	exposed	to	RCFs	(n=19,	including	
9	with	pleural	abnormalities,	13	with	fibrosis,	
and	 1	 with	 mesothelioma).	 However,	 no	 at-
tempt	was	made	to	analyze	further	for	an	as-
sociation	of	 the	cases	with	exposure	to	RCFs.	
The	report	implied	that	occupational	exposure	
to	kaolin	dust	and	to	asbestos	caused	many	or	
all	of	the	job-related	conditions.
5.3.7 Discussion
The	radiographic	analyses	of	the	U.S.	and	1996	
European	worker	groups	 suggest	 an	associa-
tion	between	pleural	abnormalities,	including	
pleural	 plaques,	 and	 RCF	 exposure	 [Lemas-
ters	 et	 al.	 1994;	Lockey	 et	 al.	 1996;	Cowie	 et	
al.	1999].	From	Rossiter	et	al.	[1994]	it	is	less	
apparent	whether	such	an	association	was	in-
vestigated.	Trethowan	et	al.	[1995]	report	that	
pleural	abnormalities	were	not	independently	
related	to	RCF	exposure.	Differences	between	
the	findings	of	 the	U.S.	 studies	and	 those	of	
the	initial	European	studies	may	be	related	to	
the	long	latency	before	pleural	abnormalities	
are	 detectable,	 in	 particular,	 pleural	 plaques	
following	RCF	exposure.	Workers	exposed	to	
asbestos	developed	 asbestos-associated	pleu-
ral	plaques	after	a	latency	period	of	more	than	
15	years	after	initial	exposure	[Hillerdal	1994]	
and	in	some	cases,	after	30	to	57	years	[Begin	
et	al.	1996].	The	European	RCF	industry	de-
veloped	more	than	a	decade	after	the	U.S.	in-
dustry.	As	a	result,	workers	in	the	U.S.	group	
are	 slightly	 older	with	 a	 longer	 average	 em-
ployment	duration	in	RCF	manufacturing	and	
time	 since	first	 exposure	 to	RCFs.	Historical	
air	sampling	data	also	 indicate	that	airborne	
fiber	 concentrations	 were	 much	 higher	 in	
early	U.S.	RCF	manufacturing.	These	 factors	
might	 explain	 the	finding	of	RCF-associated	
pleural	abnormalities	in	the	U.S.	workers	but	
not	 in	the	European	workers.	A	further	pos-
sible	 explanation	may	 involve	 differences	 in	
the	radiographic	surveillance	methodologies.	
Both	the	U.S.	and	the	European	studies	used	
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the	1980	ILO	classification	systems	for	pneu-
monoconioses	to	review	posteroanterior	view	
chest	radiographs	for	study	subjects.	However,	
Lockey	et	al.	[2002]	began	to	supplement	these	
views	with	left	and	right	45o	oblique	view	films	
as	a	standard	practice	for	radiographic	surveil-
lance.	This	methodology,	known	as	a	film	tri-
ad,	was	evaluated	against	the	posteroanterior-
only	 view	 to	 determine	 reliability,	 sensitivity,	
and	specificity	of	each	method	[Lawson	et	al.	
2001].	The	 evaluation,	 involving	652	 subjects	
in	 the	RCF	 study,	 showed	 the	film	 triad	had	
considerably	 higher	 interreader	 reliabil-
ity	 (κ=0.59)	 than	 the	 posteroanterior-only	
method	(κ=0.44).	The	authors	concluded	that	
the	 film	 triad	method	 provides	 an	 optimum	
approach.	
The	 U.S.	 and	 1986	 European	 studies	 yielded	
little	evidence	of	an	association	between	radio-
graphic	parenchymal	opacities	and	RCF	expo-
sure.	In	the	U.S.	study,	small	opacities	were	rare	
[Lockey	et	al.	1996].	Small	opacities	of	profu-
sion	category	1/0	or	greater	were	more	frequent	
in	the	1986	European	study	[Trethowan	et	al.	
1995],	but	exposures	to	silica	and	other	dusts	
were	 believed	 to	 account	 for	 many	 of	 these	
cases.	 The	 results	 of	 statistical	 analyses	 did	
not	implicate	RCF	exposure	[Trethowan	et	al.	
1995]	or	yielded	results	only	slightly	suggestive	
of	an	RCF	exposure	effect	[Rossiter	et	al.	1994].	
In	the	1996	evaluation	of	the	European	cohort,	
small	opacities	of	category	1/0	or	greater	were	
positively	associated	with	RCF	exposures	that	
occurred	before	1971	[Cowie	et	al.	1999].	Ten	
of	the	51	(19.6%)	male	workers	exposed	before	
1971	developed	category	1/0	or	greater	opaci-
tiesC8	had	also	been	exposed	to	asbestos	and	9	
were	either	current	or	ex-smokers.
Both	the	U.S.	[Lockey	et	al.	1993;	Lemasters	
et	al.	1998]	and	the	European	[Trethowan	et	
al.	1995;	Burge	et	al.	1995;	Cowie	et	al.	1999]	
studies	 found	 that	 occupational	 exposure	
to	RCFs	is	associated	with	various	reported	
respiratory	symptoms	and	conditions,	after	
adjusting	for	the	effects	of	age,	sex,	and	smok-
ing.	 Exposure	 to	 RCF	 concentrations	 in	 the	
range	of	 0.2	 to	0.6	 f/cm3	was	 associated	with	
statistically	 significant	 increases	 in	 eye	 irrita-
tion	(OR=2.16,	95%	CI=1.32–3.54),	stuffy	nose	
(OR=2.06,	95%	CI=1.25–3.39),	and	dry	cough	
(OR=2.53,	95%	CI=1.25–5.11)	compared	with	
exposure	concentrations	 lower	than	0.2	f/cm3	
[Trethowan	et	al.	1995].	 Increasing	ORs	were	
demonstrated	 for	 RCF	 exposure	 concentra-
tions	greater	than	0.6	f/cm3	compared	with	ex-
posure	 concentrations	<0.2	 f/cm3	 for	wheeze	
(P<0.0001),	 dyspnea	 (P<0.05),	 eye	 irritation	
(P<0.0001),	skin	irritation	(P<0.0001),	and	dry	
cough	(P<0.05)	but	not	stuffy	nose	or	chronic	
bronchitis	 [Trethowan	 et	 al.	 1995].	 Lockey	 et	
al.	[1993]	found	that	dyspnea	was	significantly	
associated	with	exposure	to	>15	fiber-months/
cm3	(that	 is,	>1.25	fiber-years/cm3)	relative	to	
exposure	 to	 ≤15	 fiber	 months/cm3	 (dyspnea	
grade	 1COR=2.1,	 95%	 CI=1.3–3.3;	 dyspnea	
grade	2—OR=3.8,	95%	CI=1.6–9.4).	Lockey	et	
al.	[1993]	also	found	statistically	significant	as-
sociations	 between	 cumulative	RCF	 exposure	
and	chronic	cough	(OR=2.0,	95%	CI=1.0–4.0)	
and	pleurisy	(OR=5.4,	95%	CI=1.4–20.2).	Le-
masters	 et	 al.	 [1998]	 also	 noted	 associations	
(P<0.05)	 between	 employment	 in	 an	 RCF	
production	 job	 and	 increased	 prevalence	 of	
dyspnea	 and	 the	 presence	 of	 at	 least	 one	 re-
spiratory	 symptom	 or	 condition.	 Recurrent	
chest	illness	in	the	European	cohort	was	asso-
ciated	with	cumulative	exposure	to	respirable	
fibers	 and	was	most	 strongly	 associated	with	
cumulative	exposure	to	respirable	dust	[Cowie	
et	al.	1999].	
In	 cross-sectional	 analyses	 involving	 spiro-
metric	 testing,	 both	 the	 U.S.	 [Lockey	 et	 al.	
1998;	Lemasters	et	al.	1998]	and	1986	Europe-
an	[Trethowan	et	al.	1995;	Burge	et	al.	1995]	
studies	found	that	cumulative	RCF	exposure	
was	associated	with	pulmonary	function	dec-
rements	 among	 current	 and	 former	 smok-
ers.	 The	 1996	European	 study	 demonstrated	
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decrements	in	current	smokers	only	[Cowie	et	
al.	1999].	The	observed	decreased	pulmonary	
function	 in	 the	 European	 workers	 remained	
significantly	 associated	 with	 cumulative	 RCF	
exposure,	 even	 after	 controlling	 for	 cumula-
tive	 exposure	 to	 inspirable	 dust	 [Burge	 et	 al.	
1995].	 A	 longitudinal	 analysis	 of	 data	 from	
multiple	PFTs	by	Lockey	et	al.	 [1998]	 led	 the	
researchers	to	conclude	that	exposures	to	RCFs	
between	 1987	 and	 1994	 were	 not	 associated	
with	decreased	pulmonary	function.	The	find-
ings	from	the	U.S.	and	European	studies	sug-
gest	 that	 decrements	 in	 pulmonary	 function	
observed	in	current	and	former	smokers	result	
from	 an	 interactive	 effect	 between	 smoking	
and	RCF	exposure.
5.4 Carcinogenicity Risk  
Assessment Analyses
The	literature	contains	three	significant	 inde-
pendent	 risk	 analyses	 of	 occupational	 expo-
sure	 to	 RCFs	 and	 potential	 health	 effects.	 In	
each	of	 these	analyses,	health	effects	data	de-
rived	 from	multidose	 and	MTD	 studies	with	
rats	were	used	with	models	to	extrapolate	risks	
to	 human	 populations.	 The	 modeling	 of	 ef-
fects	observed	in	experimental	animal	studies	
was	necessitated	by	 the	 lack	of	adequate	data	
on	adverse	health	effects	 in	humans	with	oc-
cupational	exposures	to	RCFs.	The	three	stud-
ies,	described	in	detail	below	and	in	Table	5–9,	
include	 the	 following	 studies:	 Dutch	 Expert	
Committee	 on	Occupational	 Standards	 (DE-
COS)	 [1995],	Fayerweather	 et	 al.	 [1997],	 and	
Moolgavkar	et	al.	[1999].	
5.4.1 DECOS [1995]
In	1995,	DECOS	(a	workgroup	of	 the	Health	
Council	of	the	Netherlands)	published	a	report	
evaluating	 the	 health	 effects	 of	 occupational	
exposure	 to	SVFs.	The	purpose	of	 the	 report	
was	 to	 establish	 health-based	 recommended	
occupational	exposure	limits	for	specific	types	
of	 SVFs.	As	one	of	 the	 criteria	 for	determin-
ing	the	airborne	exposure	limits	for	six	distinct	
types	of	SVFs,	risk	assessments	were	performed	
for	 each	 fiber	 type,	 including	RCFs.	 The	 risk	
analysis	for	RCFs	was	based	on	the	assumption	
that	RCFs	are	a	potential	human	carcinogen	as	
indicated	by	the	positive	results	of	carcinoge-
nicity	testing	with	animals.	A	health-based	rec-
ommended	 occupational	 exposure	 limit	 was	
determined	using	the	following	rationale:
1.	If	 the	 carcinogenic	 potential	 of	RCFs	 is	
caused	 by	 a	 nongenotoxic	 mechanism,	
an	occupational	 exposure	 limit	 of	 1	 re-
spirable	f/cm3	as	an	8-hr	TWA	should	be	
recommended	 based	 on	 an	NOAEL	 of	
25	f/cm3	and	a	safety	factor	of	25.
2.	If	 the	 carcinogenic	 potential	 of	RCFs	 is	
linked	to	a	genotoxic	mechanism,	a	mod-
el	assuming	a	linear	relationship	between	
dose	and	the	response	(cancer)	should	be	
used	to	establish	the	occupational	expo-
sure	limit.	
The	model	indicated	that	an	excess	cancer	risk	
of	4	×10-3	 is	associated	with	a	TWA	exposure	
to	5.6	respirable	f/cm3	based	on	40	years	of	oc-
cupational	exposure.	A	cancer	risk	of	4×10-5	is	
associated	with	 exposure	 to	 0.056	 f/cm3,	 and	
a	 linear	 extrapolation	 indicated	 that	 occupa-
tional	exposure	to	1	respirable	f/cm3	as	an	8-hr	
TWA	 for	 40	 years	 is	 associated	with	 a	 cancer	
risk	of	7×10-4.	
The	DECOS	analysis	relied	on	the	data	from	a	
long-term	multidose	 study	with	 rats	 exposed	
to	kaolin	ceramic	fibers	[Bunn	et	al.	1993;	Mast	
et	 al.	 1995b].	 These	 data	 showed	 that	 expo-
sure	by	 inhalation	 to	25	 f/cm3	 (3	mg/m3)	 for	
24	months	 produced	 a	 negligible	 amount	 of	
fibrosis	 (mean	Wagner	 score	 of	 3.2).	 Conse-
quently,	the	Dutch	committee	viewed	25	f/cm3	
as	 the	 NOAEL	 for	 fibrosis.	 The	 report	 also	
notes	that	at	 the	time	of	publication,	no	data	
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existed	from	retrospective	cohort	mortality	or	
morbidity	and	case-control	studies	of	persons	
with	occupational	exposures	to	RCFs.	The	lin-
ear	modeling	approach	 in	 this	analysis	of	 the	
exposure-response	relationship	using	the	ani-
mal	data	does	not	take	into	consideration	pos-
sible	differences	in	dosimetry	and	lung	burden	
between	rats	and	humans.	
5.4.2 Fayerweather et al. [1997]
Fayerweather	 et	 al.	 [1997]	 conducted	 a	 study	
primarily	 focusing	 on	 the	 risk	 assessment	 of	
occupational	 exposures	 for	 glass	fiber	 insula-
tion	 installers.	 They	 performed	 risk	 analyses	
with	 several	 other	 types	 of	 SVFs,	 including	
RCFs.	Only	the	analysis	with	RCFs	is	present-
ed	 here.	 This	 analysis	 applied	 an	EPA	 linear-
ized	 multistage	 model	 (representing	 a	 linear	
nonthreshold	dose-response)	to	data	from	rat	
multidose	and	MTD	chronic	inhalation	bioas-
says	[Mast	et	al.	1995a,b]	 to	determine	expo-
sures	at	which	Ano	significant	risk@	occurs;	i.e.,	
no	more	 than	one	additional	 cancer	 case	per	
100,000	 exposed	 persons.	 Nonlinear	models	
were	 also	 used	 for	 comparison:	 the	 Weibull	
1.5-hit	nonthreshold	model	(representing	the	
nonlinear,	nonthreshold	dose-response	curve)	
and	Weibull	2-hit	threshold	model	(represent-
ing	 the	 nonlinear,	 threshold	 dose-response	
curve).	 Fiber	 inhalation	 by	 rats	 was	 equated	
to	 humans	 by	 determining	 the	 fibers/day·kg	
of	body	weight	 for	 the	 animals	 and	using	 an	
exposure	scenario	of	4	hr/day	(consistent	with	
insulation	installation	workers=	schedules),	for	
5	days/week	and	50	weeks/year	over	40	work-
ing	years	of	a	70-year	lifespan.	RCFC	interpret-
ed	the	results	of	the	analysis	with	the	linearized	
multistage	model	to	represent	a	risk	of	3.8×10-5	
for	 developing	 lung	 cancer	 over	 the	 work-
ing	 lifetime	 at	 an	 exposure	 concentration	 of	
1	 f/cm3	 [RCFC	 1998].	 Using	 the	 nonlinear	
models,	 estimates	 of	 nonsignificant	 expo-
sures	(i.e.,	a	working	lifetime	exposure	associ-
ated	with	 no	more	 than	 1	 additional	 cancer	
case/100,000	 exposed	persons)	were	2	 and	3	
orders	 of	 magnitude	 higher.	 Conversely,	 the	
risk	 estimates	 for	 exposure	 to	 1	f/cm3	 for	 a	
working	lifetime	were	lower	using	the	Weibull	
1.5-hit	nonthreshold	and	Weibull	2-hit	thresh-
old	models.	
5.4.3 Moolgavkar et al. [1999]
This	report	describes	a	quantitative	assessment	
of	 the	risk	of	 lung	cancer	associated	with	oc-
cupational	 exposure	 to	RCFs	 [Moolgavkar	 et	
al.	1999].	A	major	premise	underlying	the	risk	
assessment	is	that	humans	are	equally	suscep-
tible	to	RCFs	as	rats,	at	the	tissue	level.	The	risk	
analysis	 was	 performed	 using	 data	 from	 two	
chronic	 inhalation	bioassays	of	RCFs	 in	male	
Fischer	344	rats	[Mast	et	al.	1995a,b].	Dosim-
etry	in	the	risk	assessment	was	based	on	a	fiber	
deposition	and	clearance	model	developed	by	
Yu	et	al.	[1996]	that	was	used	to	estimate	the	
lung	burdens	of	fibers	 in	humans.	The	dose-
response	model	 used	 for	 the	 risk	 assessment	
was	the	two-mutation	clonal	expansion	model,	
commonly	referred	to	as	the	Moolgavkar-Ven-
zon-Knudson	(MVK)	model.	The	MVK	model	
was	fitted	to	the	rat	bioassay	data	to	estimate	
the	proportional	increase	in	the	rat	lung	tumor	
initiation	rate	in	RCF-exposed	rats,	relative	to	
the	background	initiation	rate	in	nonexposed	
rats.	An	MVK	model	 for	human	 lung	 cancer	
was	 then	 created	 by	 fitting	 the	model	 to	 the	
age-specific	lung	cancer	incidence	for	either	of	
two	human	 cohorts.	 Finally,	 the	human	 lung	
cancer	 rate	 for	 a	 given	 tissue	 dose	 was	 esti-
mated	by	 increasing	the	tumor	initiation	rate	
in	the	human	model	by	the	same	proportional	
amount	that	an	identical	tissue	dose	would	in-
crease	the	initiation	rate	in	the	MVK	model	for	
rats.	 The	 assumption	was	made	 that,	 for	 any	
given	tissue	dose,	the	proportional	increase	in	
the	 lung	 tumor	 initiation	rate	(relative	 to	 the	
background	rate)	is	the	same	in	humans	as	in	
rats.	The	two	human	cohorts	used	for	the	hu-
man	modeling	were	a	nonsmoking	American	
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Cancer	Society	(ACS)	cohort	[Peto	et	al.	1992]	
and	a	cohort	of	workers	from	the	steel	industry	
(not	exposed	to	coke	oven	emissions)	believed	
to	be	representative	of	industrial	workers.	Be-
cause	 of	 the	 difference	 in	 the	 baseline	 lung	
cancer	 risk,	 risk	 estimates	 based	 on	 the	 Steel	
Industry	 cohort	 were	 approximately	 4	 times	
higher	 than	 those	 based	 on	 the	 ACS	 cohort.	
Both	 central	 estimates	 (maximum	 likelihood	
estimates	[MLEs])	and	95%	upper	confidence	
limits	 (UCLs)	 were	 developed.	 Three	 equa-
tions	were	 tested	 to	 describe	 the	 relationship	
between	 initiation	 rate	 for	 lung	 cancer	 and	
lung	burden:	
I=A	exp(Bd)	 (exponential)	
I=A	+	Bd2	 (quadratic)	
I=A	+	Bd	 (linear)
where	d	=	lung	burden	in	fibers	per	milligram	
of	lung	(which	can	vary	with	time)	and	A	and	
B	 are	 constants	 (different	 for	 each	 model).	
With	 each	 equation,	 calculations	were	made	
to	determine	the	excess	risk	for	a	worker	aged	
20	 to	 50	 to	 develop	 lung	 cancer	 by	 age	 70	
when	exposed	to	RCFs	at	a	concentration	of	
1.0	fiber/cm3	for	8	hr/day,	5	days/week.
Using	the	exponential	model,	the	excess	risk	of	
lung	cancer	associated	with	1.0	f/cm3	was	esti-
mated	to	be	3.7×10-5	(MLE)	and	4.9×10-5	(95%	
UCL),	based	on	the	ACS	cohort.	For	the	same	
conditions	the	risk	of	lung	cancer	was	1.5×10-4	
(MLE)	and	1.8×10-4	(95%	UCL)	based	on	the	
Steel	Industry	cohort.	Using	a	quadratic	equa-
tion,	the	researchers	reported	slightly	lower	es-
timates	 of	 excess	 risk	 of	 4.1×10-6	 (MLE)	 and	
1.2×10-5	(95%	UCL)	for	the	ACS	cohort,	and	
1.4×10-5	 (MLE)	 and	4.3×10-5	 (95%	UCL)	 for	
the	 Steel	 Industry	 cohort.	 The	 highest	 esti-
mates	of	excess	risk	resulted	with	a	linear	equa-
tion:	2.7×10-4	(MLE)	and	1.5×10-3	(95%	UCL)	
for	 the	ACS	cohort,	and	1.1×10-3	(MLE),	and	
5.8×10-3	(95%	UCL)	for	the	Steel	Industry	co-
hort.	Additional	risk	estimates	were	calculated	
according	 to	 the	 conditions	 described	 above	
(i.e.,	ACS	cohort	versus	Steel	Industry	cohort;	
MLE	and	95%	UCL	for	exponential,	quadratic,	
and	linear	models)	but	with	different	exposure	
concentrations.	The	excess	risk	was	also	calcu-
lated	for	exposure	concentrations	of	0.75	f/cm3,	
0.5	f/cm3,	and	0.25	f/cm3.	These	risk	estimates	
are	presented	in	Table	5–10.
As	shown	in	Table	5–10,	the	highest	risk	esti-
mates	 at	 each	 of	 the	 three	 exposure	 concen-
trations	are	 associated	with	 the	 linear	model,	
followed	by	the	exponential	model.	The	lowest	
risk	estimates	are	associated	with	the	quadratic	
model.	At	each	exposure	concentration,	more	
conservative	risk	estimates	are	obtained	for	the	
ACS	cohort	than	the	Steel	Industry	cohort.	
At	the	recommended	exposure	guideline	estab-
lished	by	the	RCFC	(0.5	f/cm3),	the	highest	risk	
estimate	(linear	model,	Steel	Industry	cohort)	
is	 the	 MLE	 of	 5.3×10-4	 or	 5.3/10,000	 (95%	
UCL=2.9×10-3).	At	0.5	f/cm3,	the	risk	estimates	
for	the	steel	industry	cohort	are	roughly	1	order	
of	magnitude	(factor	of	10)	lower	with	the	ex-
ponential	model	 (MLE=7.3×10-5,	 95%	UCL=	
9.1×10-5),	 and	 2	 orders	 of	 magnitude	 lower	
using	 the	 quadratic	 model	 (MLE=3.5×10-6,	
95%	 UCL=1.1×10-5).	 At	 the	 lowest	 exposure	
concentration	 (0.25	 f/cm3),	 the	 highest	 risk	
estimate	(Steel	Industry	cohort,	linear	model)	
was	the	MLE	of	2.7×10-4	(95%	UCL=1.4×10-3).	
Again,	on	average,	the	risk	estimates	from	the	3	
models	using	the	steel	industry	cohort	are	3	to	
4	times	higher	than	for	corresponding	model	
values	with	the	ACS	cohort.
The	 authors	 concluded	 that	 the	 risk	 estimates	
based	on	the	two	cohorts	“represent	bounds	on	
risks	likely	to	be	seen	in	occupational	cohorts.”	
However,	an	occupational	cohort	is	unlikely	to	
share	the	nonsmoking	status	of	the	ACS	cohort.	
Therefore,	of	the	two	human	populations	used	
for	model	fitting	in	the	Moolgavkar	et	al.	[1999]	
risk	 assessment,	 the	 steel	 industry	 cohort	may	
be	 the	 preferable	 cohort	 to	 use	 for	 estimating	
the	risks	from	occupational	exposures	to	RCFs.
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The	Moolgavkar	et	al.	[1999]	report	also	indi-
cates	 airborne	 fiber	 concentrations	 estimated	
to	result	in	excess	lifetime	risk	for	cancer	of	10-4	
(1	in	10,000)	based	on	the	approaches	used	by	
DECOS	[1995]	and	Fayerweather	et	al.	[1997]	
and	using	 the	MVK	model	 for	both	 the	ACS	
cohort	 and	 the	 steel	 industry	 cohort.	 With	
the	 DECOS	 [1995]	 linearized,	 nonthreshold	
model	approach,	an	excess	lifetime	cancer	risk	
of	 10-4	 was	 calculated	 to	 result	 from	 a	 fiber	
concentration	of	0.14	f/cm3.	Using	the	linear-
ized,	multistage	model	approach	described	in	
Fayerweather	 et	 al.	 [1997],	 a	fiber	 concentra-
tion	of	2.6	f/cm3	was	estimated	to	correspond	
to	the	excess	lifetime	cancer	risk	of	10-4.	With	
the	MVK	exponential	model,	an	excess	lifetime	
cancer	 risk	 of	 10-4	 was	 determined	 for	 fiber	
concentrations	 of	 0.7	 f/cm3	 for	 the	 Steel	 In-
dustry	cohort	and	2.7	f/cm3	for	the	ACS	cohort	
[Moolgavkar	et	al.	1999].
5.4.4 Discussion
The	estimated	lung	fiber	burden	for	dosimetry	
in	 the	analysis	by	Moolgavkar	et	 al.	 [1999]	 is	
a	methodological	 improvement	 over	 the	 risk	
assessment	 for	 RCFs	 by	 Fayerweather	 et	 al.	
[1997],	which	was	based	solely	on	the	inhaled	
fiber	concentration.	Modeling	lung	burden	do-
simetry	should,	in	theory,	compensate	for	the	
known	 differences	 between	 rats	 and	 humans	
in	fiber	deposition	and	clearance.	Similarly,	us-
ing	an	MVK	model	for	dose-response	estima-
tion	 could	 compensate	 for	 differences	 in	 cell	
mutation	 and	 proliferation	 rates	 in	 rats	 and	
humans.	 However,	 some	 key	 parameter	 val-
ues	 in	 the	MVK	 and	 lung	 dosimetry	models	
are	poorly	known.	For	example,	the	dosimetry	
model	 for	 humans	 has	 been	 validated	 with	
only	 three	 human	 tissue	 samples	 taken	 from	
workers	 whose	 exposures	 to	 RCFs	 were	 not	
measured	[Yu	et	al.	1997].	
A	 review	 and	 comparison	 of	 risk	 modeling	
approaches	 for	 RCFs	 by	Maxim	 et	 al.	 [2003]	
describes	the	three	models	here	as	well	as	ad-
ditional	more	sophisticated	variations	of	quan-
titative	risk	analyses	for	RCFs.	Using	approach-
es	such	as	benchmark	dose	modeling,	Maxim	
et	al.	[2003]	produced	RCF	unit	potency	values	
ranging	from	1.4×10-4	to	7.2×10-4.
Table 5–10 . Estimates (MLE* and 95% UCL) of excess risk of lung cancer at three exposure concentrations 
using exponential, quadratic, and linear models for an ACS cohort and a steel industry cohort
Exposure
ACS cohort Steel industry cohort
 Exponential Quadratic Linear Exponential Quadratic Linear
0.75 f/cm3:	
MLE
	
2.8×10-5
	
2.3×10-6
	
2.0×10-4
	
1.1×10-4
	
7.9×10-6
	
8.0×10-4
95%	UCL 3.7×10-5 6.8×10-6 1.1×10-3 1.4×10-4 2.4×10-5 4.3×10-3
0.5	f/cm3:	
MLE
		
1.8×10-5
	
1.0×10-6
	
1.3×10-4
	
7.3×10-5
	
3.5×10-6
	
5.3×10-4
95%	UCL 2.5×10-5 3.0×10-6 7.3×10-4 9.1×10-5 1.1×10-5 2.9×10-3
0.25 f/cm3:	
MLE
		
9.2×10-6
	
2.5×10-7
	
6.7×10-5
	
3.6×10-5
	
8.8×10-7
	
2.7×10-4
95%	UCL 1.2×10-5 7.5×10-7 3.6×10-5 4.6	×10-5 2.7×10-6 1.4×10-3
Adapted	from	Moolgavkar	et	al.[	1999].
*Abbreviations:	ACS=American	Cancer	Society;	MLE=maximum	likelihood	estimate;	UCL=	95%	upper	confidence	limit.
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A	 common	weakness	 among	 all	 three	 of	 the	
risk	 analyses	 stems	 from	 uncertainty	 about	
possible	differences	in	the	sensitivity	of	human	
lungs	to	fibers,	as	compared	with	rat	lungs.	The	
possibility	of	such	a	difference	is	acknowledged	
in	the	report	by	Moolgavkar	et	al.	[1999],	but	
the	effect	of	 this	uncertainty	on	 the	risk	esti-
mates	is	not	explored	quantitatively.	As	an	ex-
ample,	Pott	et	al.	[1994]	estimated	that	in	the	
case	 of	 asbestos	 fibers,	 humans	 are	 approxi-
mately	 200-fold	more	 sensitive	 than	 rats,	 on	
the	basis	of	fiber	concentration	in	air.	Pott	et	al.	
[1994]	further	noted	that	a	crocidolite	inhala-
tion	study	that	was	negative	in	the	rat	resulted	
in	a	rat	lung	fiber	concentration	that	was	more	
than	1,000-fold	greater	than	the	fiber	concen-
trations	in	the	lungs	of	asbestos	workers	with	
mesotheliomas.	In	support	of	this	analysis,	re-
sults	of	a	study	by	Rödelsperger	and	Woitowitz	
[1995]	led	the	authors	to	conclude	that	humans	
are	at	least	6,000	times	more	sensitive	than	rats	
to	a	given	tissue	concentration	of	amphibole	fi-
bers.	Although	amphibole	asbestos	fibers	have	
physicochemical	 characteristics	 which	 differ	
from	those	of	RCFs,	these	findings	raise	ques-
tions	about	using	experimental	animal	data	for	
predicting	 human	 health	 effects	 and	 assum-
ing	that	target	tissues	 in	humans	and	rats	are	
equally	sensitive	to	RCF	toxicity.	
The	lung	cancer	risk	estimates	for	RCFs	derived	
by	Moolgavkar	et	al.	[1999]	may	also	be	under-
estimated	for	occupationally	exposed	workers	
because	 of	 several	 basic	 assumptions	 made	
in	 the	 lung	 tissue	 dosimetry.	 Tissue	 dosim-
etry	modeling	in	the	Moolgavkar	et	al.	[1999]	
risk	 assessment	 is	 based	 on	 the	 assumption	
that	a	worker	is	exposed	to	RCFs	for	8	hr/day,	
5	days/week,	52	weeks/year,	from	age	20	to	50	
[Moolgavkar	et	al.	1999].	An	alternative	analy-
sis,	 in	which	the	assumption	was	changed	to	
8	hr/day,	5	days/week,	50	weeks/year	from	age	
20	to	60,	was	also	described	but	not	presented	
in	detail.	 In	both	cases,	 the	breathing	rate	for	
light	work	was	assumed	to	be	13.5	liters/min-
ute.	Additional	 information	might	 be	 gained	
from	assuming	an	exposure	period	of	8	hr/day,	
5	days/week,	50	weeks/year,	from	age	20	to	65,	
with	 a	 breathing	 rate	 matching	 the	 Interna-
tional	Commission	on	Radiological	Protection	
“Reference	Man”	 value	 for	 light	work,	 which	
is	 20	 liters/minute	 [ICRP	 1994].	 In	 addition,	
the	cumulative	excess	risk	of	 lung	cancer	was	
calculated	only	through	age	70	[Moolgavkar	et	
al.	1999].	This	practice	may	underestimate	the	
lifetime	risk	of	lung	cancer	in	the	exposed	co-
hort,	since	a	substantial	fraction	of	the	cohort 
may	be	expected	to	survive	beyond	age	70.	The	
excess	risk	might	also	be	calculated	in	a	com-
peting-risks	 framework	using	actuarial	meth-
ods	until	most	or	all	of	the	cohort	is	presumed	
to	have	died	because	of	competing	risks	(gener-
ally	85	years).	Finally,	risk	estimates	derived	by	
Moolgavkar	et	al.	[1999]	were	based	solely	on	
data	from	studies with	rats,	ignoring	data	from	
studies	 of	 hamsters	 [McConnell	 et	 al.	 1995].	
Because	42%	of	the	hamsters	 in	these	studies	
developed	mesotheliomas,	using	this	database	
for	the	risk	assessment	would	produce	higher	
estimates	of	risk	than	the	analysis	based	on	the	
rat	data.	
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comparative	measures	of	toxicity	for	different	
agents.	 RCFs	 implanted	 into	 the	 pleural	 and	
abdominal	 cavities	 of	 various	 strains	 of	 rats	
and	 hamsters	 have	 produced	mesotheliomas,	
sarcomas,	and	carcinomas	at	the	sites	of	fiber	
implantation	[Wagner	et	al.	1973;	Davis	et	al.	
1984;	 Pott	 et	 al.	 1987].	 Similar	 tumorigenic	
responses	have	been	observed	following	intra-
tracheal	 instillation	 of	 RCFs	 [Manville	 Cor-
poration	1991].	These	data	provide	additional	
evidence	of	the	carcinogenic	effects	of	RCFs	in	
exposed	laboratory	animals.
Epidemiological	 data	 have	not	 associated	oc-
cupational	exposure	to	RCFs	under	current	ex-
posure	conditions	with	increased	incidence	of	
pleural	mesothelioma	or	 lung	cancer	[Lockey	
et	 al.	 1993;	 Lemasters	 et	 al.	 1998].	 However,	
in	 epidemiologic	 studies	 of	 workers	 in	 RCF	
manufacturing	facilities	[Lemasters	et	al.	1994;	
Lockey	 et	 al.	 1993,	 1996;	Rossiter	 et	 al.	 1994;	
Trethowan	et	al.	1995;	Burge	et	al.	1995;	Cowie	
et	al.	1999],	increased	exposures	to	airborne	fi-
bers	have	been	linked	to	pleural	plaques,	small	
radiographic	parenchymal	opacities,	decreased	
pulmonary	 function,	 respiratory	 symptoms	
and	conditions	(pleurisy,	dyspnea,	cough),	and	
skin	and	eye	irritation.
Many	of	the	respiratory	effects	showed	a	statis-
tically	 significant	association	with	RCF	expo-
sure	after	controlling	or	adjusting	for	potential	
confounders,	including	cigarette	smoking	and	
exposure	 to	nonfibrous	dust.	Yet	 in	PFTs,	 the	
interactive	 effect	 between	 smoking	 and	 RCF	
exposure	 was	 especially	 pronounced,	 based	
on	 the	 finding	 that	 RCF-associated	 decreases	
6.1  Significance of Studies 
with RCFs
Three	 major	 sources	 of	 data	 contributing	 to	
the	 literature	 on	 RCFs	 are	 (1)	 experimental	
studies	with	animals	and	in	vitro	bioassays,	(2)	
epidemiologic	studies	of	populations	with	oc-
cupational	 exposure	 to	RCFs	 (primarily	 dur-
ing	manufacturing),	 and	 (3)	 exposure	assess-
ment	 studies	 that	 provide	 quantitative	 and	
qualitative	measurements	of	exposures	as	well	
as	the	physical	and	chemical	characteristics	of	
airborne	RCFs.	Each	of	these	sources	of	infor-
mation	 is	 considered	 integral	 to	 this	 criteria	
document	 for	 providing	 a	more	 comprehen-
sive	 evaluation	 of	 occupational	 exposure	 to	
RCFs	and	their	potential	health	consequences.
Data	from	inhalation	studies	with	animals	ex-
posed	to	RCFs	have	demonstrated	statistically	
significant	 increases	 in	 the	 induction	of	 lung	
tumors	in	rats	and	mesotheliomas	in	hamsters	
[Mast	 et	 al.	 1995a,b;	McConnell	 et	 al.	 1995].	
Other	 inhalation	 studies	 with	 RCFs	 have	
shown	pathobiologic	 inflammatory	responses	
in	 lung	and	pleural	 tissues	[Gelzleichter	et	al.	
1996a,b].	Implantation	and	instillation	meth-
ods	 have	 also	 been	 used	 in	 animal	 studies	
with	 RCFs	 to	 determine	 the	 potential	 effects	
of	these	fibers	on	target	tissues.	These	studies	
have	recognized	limitations	for	interpreting	re-
sults	 because	 the	 exposure	 techniques	 bypass	
the	natural	defense	and	clearance	mechanisms	
associated	with	the	normal	route	of	exposure	
(i.e.,	 inhalation).	However,	they	are	useful	for	
demonstrating	 mechanisms	 of	 toxicity	 and	
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in	 pulmonary	 function	 were	 limited	 to	 cur-
rent	and	 former	 smokers	 [Lockey	et	al.	1998;	
Lemasters	 et	 al.	 1998;	 Trethowan	 et	 al.	 1995;	
Burge	 et	 al.	 1995].	 The	 interactive	 effect	 be-
tween	 exposure	 to	 airborne	 fibers	 and	 ciga-
rette	 smoke	has	been	previously	documented	
(e.g.,	 Selikoff	 et	 al.	 [1968]	 ).	However,	unlike	
male	workers,	nonsmoking	female	workers	did	
show	statistically	 significant	decreases	 in	PFT	
results	associated	with	RCF	exposure	[Lemas-
ters	et	al.	1998].	Analyses	of	data	from	multiple	
PFT	sessions	[Lockey	et	al.	1998]	have	led	re-
searchers	to	conclude	that	decreases	in	pulmo-
nary	 function	were	more	 strongly	 influenced	
by	the	higher	exposures	to	airborne	RCFs	that	
occurred	 in	 the	 past.	 This	 conclusion	 seems	
plausible,	since	historical	air-sampling	data	in-
dicate	that	airborne	fiber	concentrations	were	
much	higher	in	the	first	decades	of	RCF	manu-
facturing	and	that	former	workers	had	poten-
tially	higher	exposures.
Multiple	studies	have	been	performed	to	char-
acterize	the	concentrations	and	characteristics	
of	 airborne	 exposures	 to	 RCFs	 in	 the	 work-
place.	 Current	 and	 historical	 environmental	
monitoring	 data	 [Esmen	 et	al.	 1979;	 Cantor	
and	Gorman	1987;	Gorman	1987;	O’Brien	et	al.	
1990;	Cheng	et	al.	1992;	Brown	1992;	Corn	et	
al.	1992;	Lyman	1992;	Allshouse	1995;	Hewett	
1996]	indicate	that	airborne	exposures	to	RCFs	
include	fibers	in	the	respirable	size	range	(<3.5	
μm	in	diameter	and	<200	μm	long	[Timbrell	
1965;	 Lippmann	 1990;	 Baron	 1996]).	 These	
exposures	occur	in	primary	RCF	manufactur-
ing	as	well	as	 in	secondary	 industries	 such	as	
RCF	 installation	 and	 removal.	 Sampling	data	
from	studies	of	domestic,	primary	RCF	manu-
facturing	 sites	 indicate	 that	 average	 airborne	
fiber	concentrations	have	steadily	declined	by	
nearly	2	orders	of	magnitude	over	 the	past	 2	
decades.	For	example,	Rice		et	al.	[1997]	report	
a	maximum	exposure	estimate	of	10	f/cm3	as-
sociated	with	an	RCF	manufacturing	process	in	
the	1950s,	and	Esmen		et	al.	[1979]	measured	
average	exposure	concentrations	ranging	from	
0.05	to	2.6	f/cm3	in	RCF	facilities	in	the	middle	
to	late	1970s.	Rice	et	al.	[1994,	1996,	1997]	sug-
gest	average	concentrations	in	manufacturing	
ranging	 from	<LOD	to	0.66	 f/cm3	 in	 the	 late	
1980s,	 and	Maxim	 et	 al.	 [1994,	 1997,	 2000a]	
report	that	concentrations	from	the	late	1980s	
through	1997	ranged	 from	an	AM	of	<0.3	 to	
0.6	f/cm3	(GM0.2	f/cm3).	For	many	manufac-
turing	processes,	even	greater	reductions	in	ex-
posures	have	been	realized	through	improved	
ventilation,	 engineering	 or	 process	 changes,	
and	product	stewardship	programs	[Rice	et	al.	
1996;	Maxim	et	al.	1999b].
Although	the	potential	exists	for	exposure	to	re-
spirable	crystalline	silica	in	the	forms	of	quartz,	
tridymite,	 and	 cristobalite	 during	 work	 with	
RCFs,	 exposure	monitoring	 data	 indicate	 that	
these	 exposures	 are	 generally	 low	 [Rice	 et	 al.	
1994].	Maxim	et	 al.	 [1999b]	 report	 that	many	
airborne	 samples	 of	 crystalline	 silica	 collected	
during	 the	 installation	 and	 removal	 of	 RCF	
products	 contain	 concentrations	 below	 the	
LOD,	with	average	concentrations	of	respirable	
crystalline	 silica	 per	 measurable	 task	 ranging	
from	0.01	to	0.44	mg/m3	(equivalent	8-hr	TWA	
range=0.004	 to	 0.148	mg/m3).	 Other	 studies	
have	shown	greater	potential	for	exposure	to	re-
spirable	crystalline	silica	(especially	in	the	form	
of	 cristobalite)	 during	 the	 removal	 of	 after-
service	RCF	materials	[Gantner	1986;	Cheng	et	
al.	1992;	Perrault	et	al.	1992;	van	den	Bergen	et	
al.	1994;	Sweeney	and	Gilgrist	1998].	For	pro-
cesses	associated	with	higher	concentrations	of	
airborne	respirable	fibers,	there	are	also	general-
ly	greater	concentrations	of	total	and	respirable	
dusts	[Esmen	et	al.	1979;	Krantz	et	al.	1994].	
6.2  Factors Affecting Fiber 
Toxicity
To	 accurately	 interpret	 the	 results	 of	 experi-
mental	and	epidemiologic	studies	with	RCFs,	
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it	 is	 important	 to	consider	recognized	 factors	
that	contribute	 to	fiber	 toxicity	 for	RCFs	and	
other	 SVFs	 in	 general.	 The	 major	 determi-
nants	of	fiber	 toxicity	have	been	 identified	as	
fiber	dose	(or	its	surrogate,	airborne	fiber	ex-
posure),	fiber	dimensions	(length	and	diame-
ter),	and	fiber	durability	(especially	as	it	affects	
fiber	 biopersistence	 in	 the	 lungs)	 [Bignon	 et	
al.	1994;	Bunn	et	al.	1992;	Bender	and	Hadley	
1994;	Christensen	et	al.	1994;	Lockey	and	Wi-
ese	1992;	Moore	et	al.	2001].	
6.2.1  Fiber Dose
The	measurement	of	airborne	fiber	concentra-
tions	 is	 frequently	used	as	a	 surrogate	 for	as-
sessing	dose	and	health	risk	to	workers.	Analy-
ses	of	historical	and	current	air	sampling	data	
indicate	 that	 occupational	 exposure	 concen-
trations	of	airborne	RCFs	have	decreased	dra-
matically	in	the	manufacturing	sector	[Maxim	
et	al.	1997;	Rice	et	al.	1997].	In	chronic	inhala-
tion	studies	of	RCFs	[Mast	et	al.	1995a,b;	Mc-
Connell	 et	 al.	 1995],	 both	 rats	 and	 hamsters	
were	exposed	to	a	range	of	size-separated	RCF	
concentrations	in	a	nose-only	inhalation	pro-
tocol.	When	airborne	RCFs	are	generated,	half	
or	more	of	 the	aerosol	 is	 composed	of	 respi-
rable	particles	of	unfiberized	material	that	was	
formerly	a	component	of	the	fiber	[Mast	et	al.	
1995a,b].	Because	of	the	nature	of	this	mixed	
exposure,	 it	 is	difficult	 to	determine	 the	 rela-
tive	 contributions	 of	 the	 airborne	 fibers	 and	
nonfibrous	 particulates	 to	 the	 adverse	 effects	
observed	in	humans	and	animals.	It	has	been	
postulated	that	the	nonfibrous	particulates	may	
have	 contributed	 to	 an	overload	 effect	 in	 the	
Mast	et	al.	[1995a,b]	animal	studies	with	RCFs	
[Yu	et	al.	1994;	Mast	et	al.	1995a,b;	Maxim	et	
al.	1997;	Brown	et	al.	2000].	Burge	et	al.	[1995]	
have	 suggested	 that	 the	health	 effects	 seen	 in	
RCF-exposed	 workers	 are	 a	 consequence	 of	
combined	particulate	and	fiber	exposure,	but	
the	 decrements	 in	 lung	 function	 are	more	 re-
lated	to	fiber	exposure	combined	with	smoking.	
Other	 studies	 have	 shown	 that	 for	 processes	
associated	with	 higher	 concentrations	 of	 air-
borne	 respirable	fibers,	 there	 is	 also	a	greater	
concentration	of	total	and	respirable	dust	[Es-
men	et	al.	1979;	Krantz	et	al.	1994].
6.2.2  Fiber Dimensions
Throughout	 the	 literature,	 studies	 support	
the	 theory	 that	 fiber	 toxicity	 is	 related	 to	 fi-
ber	 dimensions	 [Timbrell	 1982,	 1989;	Harris	
and	Timbrell	1977;	Stanton	et	al.	1977,	1981;	
Lippmann	 1988].	 Initially,	 fiber	 dimensions	
(length	and	diameter)	play	a	significant	role	in	
determining	the	deposition	site	of	a	fiber	in	the	
lungs.	Longer	and	thicker	(>3.5	µm	in	diam-
eter)	fibers	are	preferentially	deposited	 in	 the	
upper	 airways	 by	 the	mechanisms	 of	 impac-
tion	[Yu	et	al.	1986]	or	interception.	Timbrell	
[1965]	suggested	that	direct	interception	plays	
an	 important	role	 in	 the	deposition	of	fibers,	
as	the	fiber	comes	into	contact	with	the	airway	
wall	and	is	deposited.	Fibers	being	deposited	in	
the	larger	ciliated	airways	are	generally	cleared	
via	 the	 mucociliary	 escalator.	 Thinner	 fibers	
tend	to	maneuver	past	airway	bifurcations	into	
smaller	and	smaller	airways	until	their	dimen-
sions	 dictate	 deposition	 either	 by	 sedimenta-
tion	or	diffusion	[Asgharian	and	Yu	1989].	An-
other	factor	that	may	enhance	deposition	is	the	
electrostatic	charge	a	fiber	can	accumulate	dur-
ing	dust-generating	processes	in	occupational	
settings	[Vincent	1985].	The	fiber	charge	may	
affect	its	attraction	to	the	lung	surface,	causing	
the	fiber	 to	be	deposited	by	electrostatic	pre-
cipitation.			
Although	the	dimensional	characteristics	and	
geometry	 of	 a	 fiber	 influence	 its	 deposition	
in	the	respiratory	tract,	the	fiber’s	length	and	
chemical	properties	dictate	 its	 clearance	and	
retention	 once	 it	 has	 been	 deposited	 within	
the	alveolar	region.	For	the	fiber	that	traverses	
the	respiratory	airways	and	is	deposited	in	the	
gas	 exchange	 region,	 possible	 fates	 include	
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dissolution,	clearance	via	phagocytic	cells	(al-
veolar	macrophages)	 in	 the	 alveoli,	 or	 trans-
location	 through	membranes	 into	 interstitial	
tissues.	 Both	 test	 animals	 and	 workers	 have	
been	exposed	to	RCFs	of	similar	length	and	di-
ameter	[Allshouse	1995],	and	these	exposures	
include	 fibers	 of	 respirable	 dimensions	 [Es-
men	et	al.	1979;	Lockey	et	al.	1990;	Cheng	et	al.	
1992].	Since	rats	and	other	rodents	are	obligate	
nasal	breathers,	fibers	greater	than	about	1	µm	
in	diameter	are	too	large	for	deposition	in	their	
alveoli	 [Jones	1993].	By	comparison,	humans	
can	inhale	and	deposit	fibers	up	to	3.5	µm	in	
diameter		in	the	thoracic	and	gas	exchange	re-
gions	of	the	lung.	This	physiological	difference	
prevents	the	evaluation	of	fibers	with	diameters	
of	about	1	 to	3.5	µm	(which	would	have	hu-
man	relevance)	in	rodent	inhalation	studies.
The	role	of	fiber	size	in	inducing	biological	ef-
fects	 is	well	documented	and	reviewed	 in	 the	
literature	[Stanton	et	al.	1977,	1981;	Pott	et	al.	
1987;	Warheit	1994].	Stanton	et	al.	[1977]	hy-
pothesized	 that	glass	fibers	 longer	 than	8	µm	
with	diameters	thinner	than	0.25	µm	had	high	
carcinogenic	potential.	In	a	review	of	the	sig-
nificance	of	fiber	size	to	mesothelioma	etiol-
ogy,	Timbrell	[1989]	concluded	that	the	thin-
ner	 fibers	 with	 an	 upper	 diameter	 limit	 of	
0.1	µm	are	more	potent	for	producing	diseases	
of	the	parietal	pleura	(e.g.,	mesothelioma	and	
pleural	plaques)	than	thicker	fibers.	That	value	
for	fiber	diameter	is	cited	by	Lippmann	[1988]	
in	his	asbestos	exposure	 indices	 for	mesothe-
lioma.	Oberdörster	 [1994]	 studied	 the	 effects	
of	both	long	(>10–16	μm)	and	short	(<10	μm)	
fibers	on	alveolar	macrophage	functions,	con-
cluding	that	both	will	lead	to	inflammatory	re-
actions—although	 a	 distinct	 difference	 exists	
in	the	long-term	effects	because	of	differential	
clearance	 of	 fibers	 of	 different	 sizes.	Alveolar	
macrophages	constitute	the	first	line	of	defense	
against	particles	deposited	in	the	alveoli;	 they	
migrate	to	sites	where	fibers	are	deposited	and	
phagocytize	them.	The	engulfed	fibers	are	then	
moved	by	the	macrophages	toward	the	muco-
ciliary	escalator	and	removed	 from	the	 respi-
ratory	 tract.	 The	 ability	 of	 the	 macrophages	
to	 clear	 fibers	 is	 size-dependent.	 Short	 fibers	
(<15	 µm	 long)	 can	 usually	 be	 phagocytized	
by	 one	 rat	 alveolar	macrophage	 [Luoto	 et	 al.	
1994;	 Morgan	 et	 al.	 1982;	 Oberdörster	 et	 al.	
1988,	Oberdörster	1994],	whereas	longer	fibers	
may	be	engulfed	by	two	or	more	macrophages.	
Blake	et	al.	[1998]	have	suggested	that	incom-
plete	or	frustrated	phagocytosis	may	play	a	role	
in	the	increased	toxicity	of	longer	fibers.	Fiber	
length	has	been	correlated	with	the	cytotoxicity	
of	glass	fibers	[Blake	et	al.	1998],	with	greatest	
cytotoxicity	for	fibers	17	and	33	µm	long	com-
pared	with	 shorter	fiber	 samples.	 Long	fibers	
(17	μm	average	length)	tend	to	be	a	more	po-
tent	inducer	of	TNF	production	and	transcrip-
tion	 factor	activation	than	short	fibers	(7	μm	
average	length)	[Ye	et	al.	1999].	
When	comparing	the	dimensions	of	airborne	
fibers	with	those	found	in	the	 lungs,	 it	 is	 im-
portant	 to	 consider	 the	preferential	 clearance	
of	 shorter	fibers	as	well	as	 the	effects	of	fiber	
dissolution	and	breakage.	Yu	et	al.	[1996]	eval-
uated	 these	 factors	 in	 a	 study	 that	 led	 to	 the	
development	of	a	clearance	model	for	RCFs	in	
rat	lungs.	Results	of	that	study	confirmed	that	
fibers	10	to	20	µm	long	are	cleared	more	slowly	
than	those	<10	µm	long	because	of	the	incom-
plete	 phagocytosis	 of	 long	 fibers	 by	 macro-
phages.	The	preferential	clearance	of	shorter	fi-
bers	has	also	been	documented	in	studies	with	
chrysotile	asbestos	and	other	mineral	fibers,	in	
which	the	average	length	of	retained	fibers	in-
creased	during	a	discrete	period	following	de-
position	[Coin	et	al.	1992;	Churg	1994].	This	
increase	might	 also	 be	 explained	 by	 the	 lon-
gitudinal	 cleavage	 pattern	 of	 asbestos	 fibers,	
which	 results	 in	 longer	 fibers	 of	 decreasing	
diameters	[Coin	et	al.	1992].	By	contrast,	any	
breakage	of	RCFs	would	occur	perpendicular	
to	 the	 longitudinal	plane,	resulting	 in	shorter	
fibers	of	the	same	diameter.	For	the	clearance	
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model	 developed	 by	Yu	 et	 al.	 [1996],	 the	 ef-
fect	 of	 fiber	 breakage	was	 also	 assessed	 from	
experimental	 data	 and	 incorporated	 into	 the	
model.	The	authors	concluded	that	the	simul-
taneous	effect	of	fiber	breakage	and	differential	
clearance	leads	only	to	a	small	change	in	fiber	
size	 distribution	 in	 the	 lung.	This	 result	 sug-
gests	that	the	dimensions	of	fibers	in	the	lung	
are	closely	related	to	the	dimensions	of	fibers	
measured	 in	 the	 airborne	 samples	 (adjusted	
for	deposition);	thus,	most	short	fibers	in	the	
lungs	originated	as	short	fibers	in	airborne	ex-
posures.
The	 dimensions	 of	 airborne	 fibers	 have	 also	
been	 characterized	 for	 workers	 with	 occupa-
tional	exposure	to	RCFs.	One	study	of	domes-
tic	RCF	manufacturing	facilities	found	that	ap-
proximately	90%	of	airborne	fibers	were	<3	μm	
in	diameter,	and	95%	of	airborne	fibers	were	
<4	μm	in	diameter	and	<50	μm	long	[Esmen	
et	 al.	 1979].	The	 study	 showed	 that	 diameter	
and	 length	distributions	of	 airborne	fibers	 in	
the	facilities	were	consistent	with	a	GM
D
	of	0.7	
μm	and	a	GM
L
	of	13	μm.	Another	air	sampling	
study	of	domestic	RCF	manufacturing	sites	re-
ported	that	99.7%	of	the	fibers	had	diameters	
of	<3	μm	and	64%	had	lengths	>10	μm	[Alls-
house	1995].	Measurements	of	airborne	fibers	
in	the	European	RCF	manufacturing	industry	
are	comparable:	Rood	[1988]	reported	that	all	
fibers	observed	were	in	the	thoracic	and	respi-
rable	 size	 range	 (i.e.,	 diameter	 <3	μm),	 with	
median	diameters	 ranging	0.5	 to	1.0	μm	and	
median	 lengths	 from	8	 to	23	μm.	During	 re-
moval	 of	 RCF	 products,	 Cheng	 et	 al.	 [1992]	
found	that	87%	of	airborne	fibers	were	within	
the	respirable	size	range,	with	fiber	diameters	
ranging	 from	 0.5	 to	 6	 μm	 (median	 diame-
ter=1.6	μm)	and	fiber	lengths	ranging	from	5	
to	220	μm.	Another	study	[Perrault	et	al.	1992]	
of	 airborne	 fiber	 dimensions	 measured	 dur-
ing	installation	and	removal	of	RCF	materials	
in	industrial	furnaces	reported	GM
D
	values	of	
0.38	and	0.57	μm,	respectively.
6.2.3 Fiber Durability
Biopersistence	 (and	 specifically	 the	 retention	
time	 of	 the	 fiber	 in	 the	 lungs)	 is	 considered	
to	be	an	important	predictor	of	fiber	toxicity.	
Fiber	 solubility	 affects	 the	 biopersistence	 of	
fibers	 deposited	within	 the	 lung	 and	 is	 a	 key	
determinant	of	fiber	toxicity.	Bender	and	Had-
ley	[1994]	suggest	that	some	of	the	important	
considerations	 of	 fiber	 durability	 include	 the	
following:
■	 Fiber	 size—particularly	 length	 as	 it	 re-
lates	 to	 the	 dimensions	 of	 the	 alveolar	
macrophages
■	 Fiber	dissolution	rate
■	Mechanical	 properties	 of	 the	 fibers,	 in-
cluding	partially	dissolved	and/or	digest-
ed	fibers
■	Overloading	 of	 the	 normal	 clearance	
mechanisms	of	the	lung
Bignon	et	al.	[1994]	argue	that	fibers	that	are	
biopersistent	in	vivo	and	in	vitro	are	more	bio-
logically	active	than	less	durable	fibers.	
The	durability	of	RCFs	[Hammad	et	al.	1988;	
Luoto	et	al.	1995]	provides	a	basis	for	suggest-
ing	that	these	fibers	might	persist	long	enough	
to	induce	biological	effects	similar	to	those	of	
asbestos.	 In	 vitro	durability	 tests	 have	 shown	
RCFs	to	be	highly	resistant	to	dissolution	in	bi-
ologically	 relevant	mixtures	 such	as	Gamble’s	
solution	[Scholze	and	Conradt	1987].	The	per-
sistence	of	RCFs	in	both	the	peritoneal	cavity	
[Bellman	et	al.	1987]	and	the	lung	[Hammad	
et	al.	1988]	has	been	recognized	in	experimen-
tal	 studies.	 Hammad	 et	 al.	 [1988]	 sacrificed	
rats	 exposed	 to	 either	 slag	 wool	 or	 ceramic	
fibers	 via	 inhalation	 at	 5,	 30,	 90,	 180,	 or	 270	
days	after	exposure.	The	lungs	of	the	animals	
were	 ashed	 in	 a	 low-temperature	 asher,	 and	
the	fiber	content	of	the	lungs	was	evaluated	by	
PCM.	The	researchers	 found	that	24%	of	 the	
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deposited	RCFs	persisted	 in	 the	 lungs	of	 rats	
sacrificed	270	days	following	exposure.	In	the	
same	 study,	 the	 lungs	 of	 rats	 exposed	 to	 slag	
wool	contained	only	6%	of	the	slag	wool	fibers	
270	days	after	exposure	compared	with	 those	
sacrificed	 5	 days	 following	 inhalation.	 From	
these	 results,	 it	was	concluded	 that	RCFs	 fol-
low	 a	 clearance	 pattern	 of	 relatively	 durable	
fibers	that	persist,	translocate,	or	are	removed	
by	 some	 mechanism	 other	 than	 dissolution.	
Similar	 results	were	obtained	 in	 the	 study	by	
Mast	 et	 al.	 [1995b],	 which	 shows	 that	 RCFs	
are	persistent	 in	 the	 lungs	of	 rats	 exposed	by	
inhalation.	Specifically,	compared	with	the	fi-
ber	burden	in	the	lungs	of	animals	sacrificed	3	
months	after	exposure	(recovery),	the	lungs	of	
animals	sacrificed	after	21	months	of	recovery	
contained	approximately	20%	of	the	deposited	
fibers.	Of	 the	 retained	 fibers	 (measured	with	
both	SEM	and	TEM	techniques)	54%	to	75%	
had	diameters	<0.5	µm,	 and	more	 than	90%	
were	5	to	20	µm	long.
Researchers	have	suggested	that	fibers	depos-
ited	 in	 the	gas	 exchange	 region	with	 lengths	
less	 than	the	diameter	of	an	alveolar	macro-
phage	 are	 phagocytized	 and	 cleared	 via	 the	
mucociliary	 system	 or	 the	 lymph	 channels.	
Dissolution	of	fibers	within	the	AlM	occurs	if	
the	fibers	are	not	resistant	to	the	acidic	intra-
cellular	conditions	or	a	pH~5	[Nyberg	et	al.	
1989].	Fibers	that	are	not	engulfed	by	alveo-
lar	macrophages	are	subjected	to	a	pH	of	7.4	
in	the	extracellular	fluid	of	the	lung.	A	study	
of	SVF	durability	in	rat	alveolar	macrophages	
reports	that	RCFs	are	much	less	soluble	than	
glass	wool	and	rock	wool	fibers	based	on	the	
amounts	 of	 silicon	 (Si)	 and	 iron	 (Fe)	 dis-
solved	 from	 the	 fibers	 in	 vitro	 [Luoto	 et	 al.	
1995].	RCFs	 in	 rat	alveolar	macrophage	cul-
ture	dissolved	 less	 than	10	mg	Si/m2	of	fiber	
surface	area	and	less	than	1	mg	Fe/m2	of	fiber	
surface	area.	Glass	wool	dissolved	more	than	
50	mg	Si/m2,	and	rock	wool	dissolved	nearly	
2	mg	Fe/m2	when	measured	over	comparable	
time	periods.	However,	degradation	and	dis-
solution	 of	 deposited	 RCFs	 may	 still	 occur,	
based	 on	 the	 findings	 of	 higher	 dissolution	
of	aluminum	(Al)	from	RCFs	(0.8	to	2.4	mg	
Al/m2)	 in	 alveolar	 macrophages	 than	 from	
the	other	SVFs	[Luoto	et	al.	1995].	In	another	
study,	SEM	analysis	of	fibers	recovered	 from	
the	lungs	of	rats	6	months	after	inhalation	of	
RCFs	revealed	an	eroded	appearance,	causing	
the	 researchers	 to	 conclude	 that	 dissolution	
of	 Si	 in	 the	 fibers	 is	 a	 plausible	mechanism	
for	 long-term	 fiber	 clearance	 [Yamato	 et	 al.	
1994].
SVFs	in	general	are	less	durable	than	asbestos	
fibers.	RCFs	are	more	durable	than	many	other	
SVFs,	with	a	dissolution	rate	somewhat	higher	
than	chrysotile	asbestos.	Under	the	extracellu-
lar	conditions	in	the	lung,	chrysotile—the	most	
soluble	form	of	asbestos—has	a	dissolution	rate	
of	<1	to	2	ng/cm2/hr.	RCFs	have	a	similar	dis-
solution	rate	of	about	1	to	10	ng/cm2/hr	under	
conditions	experienced	in	pulmonary	intersti-
tial	fluid.	Other	more	soluble	SVFs	can	be	10	
to	1,000	times	less	durable	[Scholze	and	Con-
radt	 1987;	Christensen	 et	 al.	 1994;	Maxim	 et	
al.	1999b;	Moore	et	al.	2001].	At	the	measured	
solubility	rate,	an	RCF	with	a	1-µm	diameter	
would	 take	more	 than	 1,000	 days	 to	 dissolve	
completely	[Leineweber	1984].
6.3  Summary of RCF Toxicity 
and Exposure Data
In	 addition	 to	 the	 main	 determinants	 of	 fi-
ber	toxicity	(dose,	dimension,	and	durability),	
other	 factors	 such	 as	 elemental	 composition,	
surface	 area,	 and	composition	can	also	 influ-
ence	the	toxicity	of	the	fiber.	Thus,	it	is	difficult	
to	predict	a	fiber’s	potential	for	human	toxicity	
based	solely	on	in	vitro	or	in	vivo	tests.	Based	
on	 consideration	 of	 these	 factors,	 the	 major	
findings	 from	 the	 RCF	 animal	 and	 human	
studies	are	as	follows:
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■	 Toxicologic	evidence	 from	experimental	
inhalation	 studies	 indicates	 that	 RCFs	
are	 capable	 of	 producing	 lung	 tumors	
in	laboratory	rats	and	mesotheliomas	in	
hamsters	 [Mast	 et	 al.	 1995a,b;	McCon-
nell	 et	 al.	 1995].	 However,	 interpreting	
these	studies	with	regard	to	RCF	potency	
and	its	implication	for	occupationally	ex-
posed	human	populations	is	complicated	
by	the	 issue	of	coexposure	to	fibers	and	
nonfibrous	respirable	particulate.			
■	 The	durability	of	RCFs	contributes	to	the	
biopersistence	of	these	fibers	both	in	vivo	
and	in	vitro	[Bellmann	et	al.	1987;	Schol-
ze	and	Conradt	1987;	Lockey	and	Wiese	
1992].
■	 Cytotoxicity	and	genotoxicity	studies	in-
dicate	that	RCFs
—	are	 capable	 of	 inducing	 enzyme	 re-
lease	and	cell	hemolysis	[Wright	et	al.	
1986;	Fujino	et	al.	1995;	Leikauf	et	al.	
1995;	Luoto	et	al.	1997],	
—	affect	mediator	release	[Morimoto	et	
al.	1993;	Ljungman	et	al.1994;	Fujino	
et	al.	1995;	Leikauf	et	al.	1995;	Hill	et	
al.	1996;	Cullen	et	al.	1997;	Gilmour	
et	al.	1997;	Luoto	et	al.	1997;	Wang	et	
al.	1999],
—	may	 decrease	 cell	 viability	 and	 in-
hibit	proliferation	[Yegles	et	al.	1995;	
Okayasu	et	al.	1999;	Hart	et	al.	1992],
—	affect	 cell	 viability	 and	 proliferation	
[Hart	et	al.	1992],	and	
—	may	 induce	 free	 radicals,	 micronu-
clei,	polynuclei,	chromosomal	break-
age,	and	hyperdiploid	cells	[Brown	et	
al.	1998;	Dopp	et	al.	1997;	Hart	et	al.	
1992].
■	 Exposure	 monitoring	 results	 indicate	
that	airborne	fibers	measured	in	both	the	
manufacturing	 and	 end-use	 sectors	 of	
the	RCF	 industry	 have	 dimensions	 that	
fall	 within	 the	 thoracic	 and	 respirable	
size	ranges	[Esmen	et	al.	1979;	Lockey	et	
al.	1990;	Cheng	et	al.	1992].
■	 Epidemiologic	studies	of	workers	 in	the	
RCF	manufacturing	 industry	 report	 an	
association	between	increased	exposures	
to	 airborne	 fibers	 and	 the	 occurrence	
of	 pleural	 plaques,	 other	 radiographic	
abnormalities,	 respiratory	 symptoms,	
decreased	 pulmonary	 function,	 and	 eye	
and	skin	irritation	[Lemasters	et	al.	1994,	
1998;	Lockey	et	al.	1996;	Trethowan	et	al.	
1995;	Burge	et	al.	1995].	Current	occupa-
tional	exposures	 to	RCFs	have	not	been	
linked	 to	 decreases	 in	 pulmonary	 func-
tion	of	workers	[Lockey	et	al.	1998].	
■	Worker	exposure	to	airborne	fiber	in	the	
RCF	 industry	 over	 the	 past	 20	 years	 or	
more	 have	 decreased	 substantially,	 re-
portedly	as	the	result	of	increased	hazard	
awareness	and	the	design	and	implemen-
tation	of	engineering	controls	[Rice	et	al.	
1997;	Maxim	et	al.	1997].	
These	 observations	 warrant	 concern	 for	 the	
continued	 control	 and	 reduction	 of	 occupa-
tional	exposures	to	airborne	RCFs.
96	 Refractory Ceramic Fibers
7 Existing Standards and  Recommendations
lengths	≥10	µm	for	up	 to	10	hr/day	during	a	
40-hr	 workweek.	 NIOSH	 also	 recommended	
that	airborne	concentrations	determined	as	to-
tal	fibrous	glass	be	limited	to	a	5	mg/m3	of	air	
as	a	TWA.	At	that	time,	NIOSH	concluded	that	
exposure	 to	 glass	fibers	 caused	 eye,	 skin,	 and	
respiratory	 irritation.	NIOSH	also	 stated	 that	
until	more	information	became	available,	this	
recommendation	 should	 be	 applied	 to	 other	
SVFs.
The	Agency	for	Toxic	Substances	and	Disease	
Registry	 (ATSDR)	 calculated	 an	 inhalation	
minimal	 risk	 concentration	 of	 0.03	 f/cm3	 for	
humans	 based	 on	 extrapolation	 from	 animal	
studies	[ATSDR	2002].	The	Agency	used	mac-
rophage	aggregation,	the	most	sensitive	indica-
tor	of	inflammation	from	RCFs,	as	the	basis	for	
this	value.	Calculation	of	this	value	is	based	on	
exposure	assumptions	for	general	public	health	
that	differ	from	those	used	in	models	for	deter-
mining	occupational	exposure	limits.	
ACGIH	proposed	a	TLV	of	0.1	f/cm3	as	an	8-hr	
TWA	 for	 RCFs	 under	 its	 notice	 of	 intended	
changes	to	the	1998	TLVs	[ACGIH	1998].	On	
further	review,	this	concentration	was	revised	
to	0.2	f/cm3	[ACGIH	2000].	ACGIH	also	clas-
sifies	RCFs	 as	 a	 suspected	human	 carcinogen	
(A2	designations)	[ACGIH	2005].	On	the	ba-
sis	 of	 a	 weight-of-evidence	 carcinogenic	 risk	
assessment,	the	EPA	[1993]	classified	RCFs	as	
a	Group	B2	carcinogen	(probable	human	car-
cinogen	based	on	sufficient	animal	data).
ACGIH	 and	 EPA	 designations	 are	 consistent	
with	 that	of	 the	 International	Agency	 for	Re-
search	 on	 Cancer	 (IARC),	 which	 classified	
Standards	and	guidelines	for	controlling	work-
er	exposures	to	RCFs	vary	in	the	United	States.	
Other	governments	and	international	agencies	
have	also	developed	recommendations	and	oc-
cupational	exposure	limits	that	apply	to	RCFs.	
Table	7–1	presents	a	summary	of	occupational	
exposure	 limit	 standards	 and	 guidelines	 for	
RCFs.	
Within	 the	United	States,	 the	RCFC	 formally	
established	 a	 recommended	 exposure	 guide-
line	of	0.5	 f/cm3	as	an	element	of	 its	product	
stewardship	 program	 known	 as	 PSP	 2002,	
which	was	endorsed	by	OSHA	as	a	5-year	vol-
untary	program	[OSHA	2002].	As	part	of	that	
program,	the	RCFC	recommends	that	workers	
wear	respirators	whenever	the	workplace	fiber	
concentration	 is	 unknown	 or	 when	 airborne	
concentrations	exceed	0.5	f/cm3.	This	exposure	
guideline	was	established	by	the	RCFC	on	Oc-
tober	 31,	 1997,	 and	 replaces	 the	previous	 ex-
posure	guideline	of	1	f/cm3	set	by	the	RCFC	in	
1991.
Before	this	agreement,	the	OSHA	General	In-
dustry	Standard	was	most	applicable	to	RCFs,	
requiring	that	a	worker’s	exposure	to	airborne	
dust	 containing	<1%	quartz	 and	no	 asbestos	
be	limited	to	an	8-hr	PEL	of	5	mg/m3	for	respi-
rable	dust	and	15	mg/m3	for	total	dust	[29	CFR	
1910.1000].
NIOSH	 has	 not	 previously	 commented	 on	
occupational	 exposure	 to	 RCFs.	 However,	 in	
addressing	 health	 hazards	 for	 another	 SVF	
(fibrous	glass),	NIOSH	[1977]	 recommended	
an	exposure	limit	(REL)	of	3	f/cm3	as	a	TWA	
for	 glass	 fibers	 with	 diameters	 ≤3.5	 µm	 and	
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Table 7–1 . Occupational exposure limits and guidelines pertaining to RCFs*, by country
Country  Regulated substance Exposure limit†
Australia Synthetic	mineral	fibers 0.5	f/cm3
Inspirable	dust 2	mg/m3
Austria Total	dust		(lists	superfine	fibers	as	suspected	carcinogen) 10	mg/m3
Canada RCFs 0.5	f/cm3
Denmark Manmade	mineral	fibers 1	f/cm3
Total	dust	(nonstationary	work	site) 5	mg/m3
Finland Glass	wool	and	mineral	wool 10	mg/m3
France General	dust,	mineral	wool 10	mg/m3
Germany Synthetic	vitreous	fibers 	0.5	f/cm3	
Netherlands RCFs 1	f/cm3
New	Zealand Synthetic	mineral	fibers 1	f/cm3
Norway Synthetic	mineral	fibers 1	f/cm3
Poland Glass	wool 2	f/cm3
Total	dust 4	mg/m3
Sweden Synthetic	inorganic	fibers	 1	f/cm3
United	Kingdom	[HSE	2004] Machine-made	mineral	fibers	(except	RCFs	and	special-
purpose	fibers)	
2	f/cm3
RCFs 1	f/cm3
Total	dust	(gravimetric	limit) 5	mg/m3
United	States:	
ACGIH RCFs 0.2	f/cm3
ATSDR	[2002]‡ RCFs 0.03	f/cm3
NIOSH§ RCFs 0.5	f/cm3
Glass	fibers,	other	SVFs	[NIOSH	1977] 3	f/cm3
Total	fibrous	glass 5	mg/m3
OSHA	[2002] RCFs 0.5	f/cm3
Respirable	dust	(<1%	quartz,	no	asbestos) 	5	mg/m3
Total	dust	(<1%	quartz,	no	asbestos) 	15	mg/m3
Source:	Adapted	and	updated	from	U.S.	Navy	[DOD	1997].	
*Abbreviations:	ACGIH=American	Conference	of	Governmental	Industrial	Hygienists;	ATSDR=Agency	for	Toxic	Substances	Disease	
Registry;	NIOSH=National	Institute	for	Occupational	Safety	and	Health;	OSHA=Occupational	Safety	and	Health	Administration;	
RCFs=refractory	ceramic	fibers;	REL=recommended	exposure	limit;	TWA=time-weighted	average.
†8-hr	TWA	unless	otherwise	specified.
‡
Inhalation	minimal	risk	level	based	on	general	public	health	assumptions,	not	occupational	exposure.
§
The	NIOSH	REL	is	established	as	a	TWA	for	up	to	a	10-hr	work	shift	in	a	40-hr	workweek.
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ceramic	fibers,	including	RCF,	as	“possibly	car-
cinogenic	to	humans	(Group	2B)”	[IARC	1988,	
2002].	 The	 IARC	 characterization	 was	 based	
on	“sufficient	evidence	for	the	carcinogenicity	
of	ceramic	fibers	in	experimental	animals”	and	
a	lack	of	data	on	the	carcinogenicity	of	ceramic	
fibers	to	humans	[IARC	1988,	2002].	DECOS	
[1995]	determined	that	“RCFs	may	pose	a	car-
cinogenic	 risk	 for	humans,”	 and	 set	 a	health-
based	 recommended	 occupational	 exposure	
limit	of	1	f/cm3.	
The	German	Commission	for	the	Investigation	
of	Health	Hazards	of	Chemical	Compounds	in	
the	Work	Area	 published	 a	 review	 of	 fibrous	
dusts	[Pott	1997]	classifying	RCFs	as	category	
IIIA2,	citing	“positive	results	(for	carcinogenic-
ity)	 from	 inhalation	 studies	 (often	 supported	
by	the	results	of	other	studies	with	intraperito-
neal,	intrapleural,	or	intratracheal	administra-
tion).”
In	the	United	Kingdom,	the	Health	and	Safety	
Commission	of	 the	Health	and	Safety	Execu-
tive	has	established	a	maximum	exposure	limit	
for	RCFs	of	1.0	f/ml	of	air,	with	the	additional	
advisory	 to	reduce	exposures	 to	 the	 lowest	as	
reasonably	 practicable	 concentration	 based	
on	the	category	2	carcinogen	classification	for	
RCFs	[HSE	2004].
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ditions	(including	dyspnea,	wheezing,	coughing,	
and	pleurisy)	observed	 in	RCF	workers	 to	be	
adverse	health	effects	associated	with	exposure	
to	airborne	RCFs	[Lemasters	et	al.	1998;	Lock-
ey	et	al.	1993;	Trethowan	et	al.	1995;	Burge	et	
al.	1995;	Cowie	et	al.	1999].	
An	association	between	inhaling	RCFs	and	fi-
brotic	or	 carcinogenic	 effects	has	been	docu-
mented	 in	 animals,	 but	 no	 evidence	 of	 such	
effects	has	been	found	in	workers	 in	the	RCF	
manufacturing	 industry.	 The	 lack	 of	 such	 an	
association	 could	 be	 influenced	 by	 the	 small	
population	of	workers	in	this	industry,	the	long	
latency	 period	 between	 initial	 exposure	 and	
development	of	measurable	effects,	the	limited	
number	 of	 persons	 with	 extended	 exposure	
to	 elevated	 concentrations	 of	 airborne	fibers,	
and	declining	occupational	 exposure	concen-
trations.	 However,	 the	 evidence	 from	 animal	
studies	 suggests	 that	RCFs	 should	 be	 consid-
ered	a	potential	occupational	carcinogen.	This	
classification	is	consistent	with	the	conclusions	
of	ACGIH,	EPA,	DECOS,	and	IARC.	(See	dis-
cussion	in	Chapter	7.)	
Given	 these	 considerations,	 the	 NIOSH	 ob-
jective	 in	 developing	 an	 REL	 for	 RCFs	 is	 to	
reduce	 the	 possible	 risk	 of	 lung	 cancer	 and	
mesothelioma.	 In	 addition,	 maintaining	 ex-
posures	below	the	REL	will	also	help	to	pre-
vent	other	adverse	effects,	including	irritation	
of	the	skin,	eyes,	and	respiratory	tract	 in	ex-
posed	workers.	To	establish	an	REL	for	RCFs,	
NIOSH	took	into	account	not	only	the	animal	
and	 human	 health	 data	 but	 also	 exposure	
8.1 Background
In	the	Occupational	Safety	and	Health	Act	of	
1970	(Public	Law	91–96),	Congress	mandated	
that	NIOSH	develop	and	recommend	criteria	
for	identifying	and	controlling	workplace	haz-
ards	that	may	result	in	occupational	illness	or	
injury.	 In	 fulfilling	this	mission,	NIOSH	con-
tinues	 to	 investigate	 the	 potential	 health	 ef-
fects	 of	 exposure	 to	 naturally	 occurring	 and	
synthetic	 airborne	 fibers.	 This	 interest	 stems	
from	 the	 results	 of	 research	 studies	 confirm-
ing	asbestos	fibers	as	human	carcinogens.	Sig-
nificant	 increases	 in	 the	 production	 of	 RCFs	
during	the	1970s	and	concerns	about	potential	
health	 effects	 led	 to	 experimental	 and	 epide-
miological	studies	as	well	as	worker	exposure	
monitoring.	Chronic	 animal	 inhalation	 stud-
ies	demonstrated	the	carcinogenic	potential	of	
RCFs,	with	a	statistically	significant	increase	in	
the	incidence	of	lung	cancer	or	mesothelioma	
in	 two	 laboratory	 species—rats	and	hamsters	
[Bunn	et	al.	1993;	Mast	et	al.	1995a;	McConnell	
et	 al.	 1995].	 Evidence	 of	 pleural	 plaques	 ob-
served	in	persons	with	occupational	exposures	
to	 airborne	 RCFs	 is	 clinically	 similar	 to	 that	
observed	in	asbestos-exposed	persons	after	the	
initial	 years	 of	 their	 occupational	 exposures	
to	 asbestos	 [Hourihane	 et	 al.	 1966;	 Becklake	
et	al.	1970;	Dement	et	al.	1986].	NIOSH	con-
siders	the	discovery	of	pleural	plaques	in	U.S.	
studies	 of	 RCF	manufacturing	workers	 to	 be	
a	significant	finding	because	the	plaques	were	
correlated	with	RCF	exposure	[Lemasters	et	al.	
1994;	Lockey	et	al.	1996].	In	addition,	NIOSH	
considers	 the	respiratory	symptoms	and	con-
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information	 describing	 the	 extent	 to	 which	
RCF	 exposures	 can	 be	 controlled	 at	 differ-
ent	 workplaces.	 On	 the	 basis	 of	 this	 evalua-
tion,	NIOSH	 considers	 an	 REL	 of	 0.5	 f/cm3	
(as	a	TWA	for	up	to	10	hr/day	during	a	40-hr	
workweek)	 to	 be	 achievable	 for	most	 work-
places	where	RCFs	or	RCF	products	are	man-
ufactured,	used,	or	handled.	Maintaining	ex-
posures	at	the	REL	will	minimize	the	risk	for	
lung	cancer	and	reduce	 the	risk	of	 irritation	
of	the	eyes	and	upper	respiratory	system.	The	
residual	 risks	 of	 lung	 cancer	 at	 the	 REL	 are	
estimated	 to	be	0.073	 to	1.2	per	1,000	based	
on	extrapolations	of	risk	models	from	Mool-
gavkar	et	al.	 [1999]	and	Yu	and	Oberdörster	
[2000].
The	 risk	 for	 mesothelioma	 at	 the	 REL	 of	
0.5	 f/cm3	 is	 not	 known	 but	 cannot	 be	 dis-
counted.	Evidence	from	epidemiologic	studies	
showed	 that	 higher	 exposures	 in	 the	 past	 re-
sulted	in	pleural	plaques	in	workers,	indicating	
that	RCFs	do	reach	pleural	tissue.	Both	implan-
tation	studies	in	rats	and	inhalation	studies	in	
hamsters	have	shown	that	RCF	fibers	can	cause	
mesothelioma.	 Because	 of	 limitations	 in	 the	
hamster	data,	the	risk	of	mesothelioma	cannot	
be	quantified.	However,	the	fact	that	no	meso-
thelioma	has	been	found	in	workers	and	that	
pleural	plaques	appear	 to	be	 less	 likely	 to	oc-
cur	in	workers	with	lower	exposures	suggests	a	
lower	risk	for	mesothelioma	at	the	REL.
Because	 residual	 risks	 of	 cancer	 (lung	 can-
cer	 and	 pleural	 mesothelioma)	 and	 irrita-
tion	 may	 exist	 at	 the	 REL,	 NIOSH	 further	
recommends	 that	 all	 reasonable	 efforts	 be	
made	to	work	toward	reducing	exposures	to	
less	than	0.2	f/cm3.	At	this	concentration,	the	
risks	of	lung	cancer	are	estimated	to	be	0.03	
to	 0.47	 per	 1,000	 based	 on	 extrapolations	
of	 risk	 models	 from	 Sciences	 International	
[1998],	Moolgavkar	et	al.	[1999],	and	Yu	and	
Oberdörster	[2000].
Maintaining	airborne	RCF	concentrations	at	or	
below	the	REL	requires	the	implementation	of	a	
comprehensive	safety	and	health	program	that	in-
cludes	routine	monitoring	of	worker	exposures,	
installation	and	routine	maintenance	of	engi-
neering	controls,	and	worker	training	in	good	
work	 practices.	 To	 ensure	 that	 worker	 expo-
sures	are	routinely	maintained	below	the	REL,	
NIOSH	recommends	that	an	AL	of	0.25	f/cm3	
be	part	of	the	workplace	exposure	monitoring	
strategy	to	ensure	that	all	exposure	control	ef-
forts	(e.g.,	engineering	controls	and	work	prac-
tices)	 are	 in	place	and	working	properly.	The	
purpose	of	the	AL	is	to	indicate	when	worker	
exposures	 to	 RCFs	 may	 be	 approaching	 the	
REL.	Exposure	measurements	at	or	above	the	
AL	indicate	a	high	degree	of	certainty	that	con-
centrations	 of	RCFs	 exceed	 the	REL.	The	AL	
is	a	statistically	derived	concept	permitting	the	
employer	 to	have	 confidence	 (e.g.,	 95%)	 that	
if	 exposure	measurements	 are	 below	 the	AL,	
only	 a	 small	 probability	 exists	 that	 the	 expo-
sure	concentrations	are	above	the	REL.	When	
exposures	 exceed	 the	 AL,	 employers	 should	
take	 immediate	 action	 (e.g.,	 determine	 the	
source	of	exposure,	identify	measures	for	con-
trolling	exposure)	to	ensure	that	exposures	are	
maintained	below	the	exposure	limit.	NIOSH	
has	concluded	that	an	AL	allows	for	the	peri-
odic	 monitoring	 of	 worker	 exposures	 in	 the	
workplace	so	that	resources	do	not	need	to	be	
devoted	 to	 conducting	 daily	 exposure	 mea-
surements.	The	AL	concept	has	been	an	inte-
gral	 element	 of	 recommended	 occupational	
standards	 in	 NIOSH	 criteria	 documents	 and	
in	 comprehensive	 standards	 promulgated	 by	
OSHA	and	MSHA.	
8.2		Rationale	for	the	REL
The	recommendation	to	limit	occupation-
al	exposures	to	airborne	RCFs	to	a	TWA	of	
0.5	f/cm3	is	based	on	data	from	animal	and	
human	 studies,	 risk	 assessments,	 and	 the	
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availability	of	methods	to	control	RCF	ex-
posures	 at	 the	 REL	 in	 many	 workplaces.	
Establishing	the	REL	for	RCFs	is	consistent	
with	 the	mission	 of	 NIOSH	mandated	 in	
the	Occupational	Safety	and	Health	Act	of	
1970.	 This	Act	 states	 that	NIOSH	 is	 obli-
gated	to	“develop	criteria	dealing	with	toxic	
materials	and	harmful	physical	agents	and	
substances	 which	 will	 describe	 exposure	
levels	 that	 are	 safe	 for	 various	 periods	 of	
employment,	 including	but	not	 limited	 to	
the	 exposure	 levels	 at	which	no	 employee	
will	 suffer	 impaired	 health	 or	 functional	
capacities	or	diminished	life	expectancy	as	
a	result	of	his	work	experience.”	The	carci-
nogenicity	findings	from	the	chronic	nose-
only	inhalation	assays	of	RCF1	in	rats	and	
hamsters	 [Mast	 et	 al.	 1995a,b;	McConnell	
et	 al.	 1995]	 warrant	 concern	 about	 pos-
sible	 health	 effects	 in	 workers	 exposed	 to	
RCFs.	 Although	 no	 increase	 in	 lung	 can-
cer	 or	 mesothelioma	 mortality	 has	 been	
observed	 in	 worker	 populations	 exposed	
to	RCFs,	radiographic	analyses	indicate	an	
association	 between	 pleural	 changes	 (in-
cluding	 pleural	 plaques)	 and	 RCF	 expo-
sure	 [Lemasters	 et	 al.	 1994;	 Lockey	 et	 al.	
1996;	 Cowie	 et	 al.	 1999,	 2001].	 Both	 the	
U.S.	 [Lockey	 et	 al.	 1993;	 Lemasters	 et	 al.	
1998]	and	 the	European	[Trethowan	et	al.	
1995;	Burge	et	al.	1995;	Cowie	et	al.	1999,	
2001]	 studies	 have	 found	 RCF-associated	
respiratory	 symptoms,	 pulmonary	 func-
tion	reductions,	and	pleural	abnormalities	
among	RCF	production	workers.
Several	independent	evaluations	have	quantita-
tively	estimated	the	risk	of	lung	cancer	for	work-
ers	exposed	to	RCFs	at	various	concentrations	
[DECOS	1995;	Fayerweather	et	al.	1997;	Mool-
gavkar	et	al.	1999].	NIOSH	evaluated	these	stud-
ies	to	determine	whether	an	appropriate	quali-
tative	or	quantitative	assessment	of	lung	cancer	
risk	 could	be	 achieved.	 In	 addition,	 exposure	
information	 was	 collected	 during	 the	 5-year	
monitoring	period	covered	under	the	consent	
agreement	between	RCFC	and	EPA	[Maxim	et	
al.	 1994,	1997,	1998].	NIOSH	used	 the	 expo-
sure	 information	to	evaluate	 the	 feasibility	of	
controlling	workplace	 exposures	 at	manufac-
turing	and	end-use	 facilities	where	RCFs	and	
RCF	products	are	handled.
8.2.1 Carcinogenesis in 
 Animal Studies
Chronic	inhalation	studies	with	RCFs	demon-
strate	significant	increases	in	the	incidence	of	
mesothelioma	in	hamsters	and	lung	cancer	in	
rats.	Tables	8–1	through	8–4	present	a	synop-
sis	of	the	major	findings	of	these	studies	[Mast	
et	al.	1995a,b;	McConnell	et	al.	1995].	Results	
from	 chronic	 animal	 inhalation	 studies	 with	
chrysotile	and	amosite	are	also	presented	(i.e.,	
results	 for	 the	positive	 control	 groups);	 these	
data	provide	a	reference	point	for	determining	
the	relative	toxicity	of	RCFs	[Mast	et	al.	1995a;	
McConnell	et	al.	1999].
Chronic	 inhalation	 exposure	 to	 RCF1	 at	
30	 mg/m3	 (187	 WHO	 f/cm3)	 induced	 a	
13%	(16/123)	incidence	of	lung	tumors	in	F344	
rats	[Mast	et	al.	1995a].	The	incidence	of	lung	
cancer	at	 lower	doses	did	not	show	a	statisti-
cally	significant	difference	from	the	unexposed	
control	group.	Lung	fiber	burdens	in	the	multi-
dose	chronic	rat	study	revealed	a	dose-response	
relationship	 [Mast	 et	 al.	 1995b].	 In	 the	 rat,	
16	 mg/m3	 (120	 WHO	 f/cm3)	 appeared	 to	
be	 the	NOAEL	 for	 lung	 cancer	 and	 3	mg/m3	
(26	WHO	 f/cm3)	 appeared	 to	 be	 the	NOAEL	
for	 fibrosis.	 Although	 it	 has	 been	 suggested	
that	fibrosis	in	animals	is	a	precursor	to	carci-
nogenesis,	a	definite	link	has	not	been	shown	
for	RCFs	or	other	fibers.	No	lung	cancers	were	
found	in	hamsters	exposed	to	RCF1	[McCon-
nell	et	al.	1995].	
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Table 8–1 .  Doses and dimensions of RCFs* in chronic inhalation studies with F344 rats
Dose 
(mg/m3)
WHO Total % Fibers 
>20 µm 
long
Mean fiber 
diameter†
Mean fiber 
length†
Reference Fiber type
 
f/cm3	 SD
 
f/cm3	 SD
 
	 µm	 SD µm      SD
	
Mast	et	al.				
	 1995a
	
RCF1
	
	 30
	
	187	 53
	
	234	 35
	
						43
	
0.98	 0.61
	
22.3	 17.0
Mast	et	al.	
	 1995b
RCF1 	 6
	 9
	 3
	 0
	120	 35
	 75	 35
	 26	 12
	 0	 —
	162	 37
	 91	 34
	 36	 17
	 0	 —
						43	
						—	
						—	
						—
0.98	 0.61	
		—						—	
		—						—	
		—						—
22.3	 17.0	
		—							—	
		—							—	
		—							—
Mast	et	al.	
	 1995a
Chrysotile	
	 asbestos
	 10 				1.06			+1.14	×	10			4 1	×	10			5 					NR 0.10	 0.15 	 2.2	 3.0
*Abbreviations:	NR=not	reported;	RCFs=refractory	ceramic	fibers;	SD=standard	deviation;	WHO=World	Health	Organization.
†Arithmetic	mean.
Table 8–2 . Results of RCF* chronic inhalation studies with F344 rats
Dose 
(mg/m3)
Time of first  
occurrence  (months)            Lung 
      neoplasms 
Pleural 
mesotheliomasWHO Interstitial 
fibrosis
Pleural 
fibrosisReference Fiber type   f/cm3	 SD 	 Number	 %    Number	 %
 
Mast	et	al.	
	 1995a
	
RCF1
	
	 30
	
	 187	 53
	
	 6	
	
	 9
	
	16/123	 13
	
	 2/123	 1.6
Mast	et	al.	
	 1995b
RCF1 	 16
	 	 9
	 3
	 0
	 120	 35
	 75	 35
	 26	 12
	 0	 —
	 12
	 12
	 None
					None
	 12
	 18
None
None
	 2/124	 1.6
	 5/127	 3.9
	 2/123	 1.6
	 1/129	 0.8
	 0																—
	 1/127	 0.8
	 0	 —
	 0	 —
Mast	et	al.	
	 1995a
Chrysotile	
	 asbestos
	 10 	 1.06			+1.14	×	10	4 	 3 	 9 	 13/69	 18.8 	 1/69	 1.4
*Abbreviations:	RCF=refractory	ceramic	fiber;	SD=standard	deviation;	WHO=World	Health	Organization.
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Table 8–3 .  Doses and dimensions of RCF* in chronic inhalation studies with Syrian golden hamsters
Dose 
(mg/m3)
WHO Total
% Fibers 
>20 µm long
Mean fiber 
diameter†
Mean fiber 
length†
 Reference Fiber type 	 f/cm3	 SD    f/cm3          SD 	 %	 f/cm3	 SD   µm     SD   µm       SD
	
McConnell	
	 et	al.	1995
	
		RCF1
	
	 30
	
	 215	 56
	
	 256	 58
	
	 43	 —	 —
	
		0.94			0.63
	
22.1	 16.7
McConnell	
	 et	al.	1995
		Chrysotile	
	 asbestos
	 10 3.0	×	10	3	 1.4	×	10	3 8.4	×	10	4					9.0	×	10	4 	 NR	 —	 — 		0.09			0.06 	 1.68	 2.71
McConnell									
	 et	al.	1999
		Amosite	
	 asbestos
	 7.1	
	 3.7	
	 0.8
	 263	 90	
	 165	 61	
	 36	 23
	 NR	 —	
	 —	 —	
	 —	 —				
	 ~26	 69	 24	
		~23							38						14	
		~28							10								6		
		0.60			0.25	
			—								—	
			—								—
13.4	 16.7	
		—								—	
		—								—
*Abbreviations:	NR=not	reported;	RCFs=refractory	ceramic	fibers;	SD=standard	deviation;	WHO=World	Health	Organization.	
†Arithmetic	mean.
Table 8–4 .  Results of RCF* chronic inhalation studies with Syrian golden hamsters
Time of first occurrence   
Dose 
(mg/m3)
WHO Interstitial 
fibrosis
Pleural 
fibrosis
Hamsters with pleural 
mesotheliomas†
  Reference Fiber type 	 f/cm3	 SD Number	 %
	
McConnell	
	 et	al.	1995
	
RCF1
	
	 30
	
	 215	 56
	
6	months
	
6	months
	
	42/123	 41.6
	
McConnell	
	 et	al.	1995
	
Chrysotile				
	 asbestos
	
	 10
	
	 3.0	×	10	3	 1.4	×	10	3
	
3	months
	
6	months
	
	 0	 —
	
McConnell
	
Amosite
	
	 7.1
	
	 263	 90
	
13	weeks
	
13	weeks
	
	 17/87	 19.5
	 et	al.	1995 	 asbestos 	 3.7 	 165	 61 13	weeks 13	weeks 	 22/85	 25.9
0.8 	 36	 23 13	weeks 13	weeks 	 3/83	 3.6
*Abbreviations:	RCF=refractory	ceramic	fiber;	SD=standard	deviation;	WHO=World	Health	Organization.	
†No	lung	neoplasms	were	detected.
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Chronic	 inhalation	 exposure	 to	 RCF1	 at	
30	mg/m3	 induced	 a	 41%	 (42/102)	 incidence	
of	 mesotheliomas	 in	 Syrian	 golden	 ham-
sters	 [McConnell	 et	 al.	 1995].	 Determining	
a	 dose-response	 relationship	 for	 inducing	
mesothelioma	is	not	possible	based	on	current-
ly	available	data	because	of	the	single	exposure	
dose	tested	in	the	hamster	and	because	of	the	
low,	 sporadic	 occurrence	of	mesothelioma	 in	
the	exposed	rats	[Mast	et	al.	1995a].	Yet	the	oc-
currence	of	mesotheliomas	in	the	rat	and	the	
high	incidence	in	the	hamster	are	biologically	
significant	because	the	spontaneous	incidence	
of	mesotheliomas	in	rats	and	hamsters	has	his-
torically	been	very	low	[Analytical	Sciences	In-
corporated	1999].
To	assess	the	significance	of	the	mesothelioma	
incidence	 observed	 in	 RCF-exposed	 ham-
sters,	 these	 results	were	 compared	with	 those	
obtained	from	hamsters	that	were	exposed	to	
chrysotile	 asbestos	 and	were	 used	 as	 positive	
controls	for	the	study	[McConnell	et	al.	1995]	
(see	Tables	8–3	and	8–4).	However,	the	chrysotile-
exposed	hamsters	failed	to	develop	any	tumors	
and	 therefore	 could	 not	 be	 considered	 true	
positive	controls.	Based	on	these	results,	a	po-
tency	ranking	could	not	be	assigned	for	RCFs	
relative	to	chrysotile,	since	the	carcinogenic	re-
sponse	rate	for	the	latter	was	zero	in	this	study.	
The	two	fibers	tested	also	differed	with	regard	
to	their	dose	and	fiber	dimension.
The	McConnell	et	al.	[1999]	study	of	hamsters	
exposed	 to	 amosite	 asbestos	 provides	 dose-
response	data	 for	 comparison	with	 the	RCF1	
data	of	McConnell	et	al.	[1995]	(See	Tables	8–3	
and	8–4.).	These	separate	studies	examined	the	
effects	of	RCF1	or	amosite	asbestos	in	hamsters	
using	 relatively	 similar	 exposure	 conditions,	
experimental	conditions,	and	fiber	dimensions	
[McConnell	 et	 al.	 1995,	 1999].	 Exposure	 to	
263	 WHO	 f/cm3	 and	 165	 WHO	 f/cm3	 of	
amosite	 asbestos	 induced	 pleural	 mesothe-
liomas	 in	 20%	 and	 26%	 of	 the	 hamsters,	
respectively	[McConnell	et	al.	1999].	A	concen-
tration	of	215	RCF1	WHO	f/cm3	induced	me-
sotheliomas	in	41%	of	hamsters	[McConnell	et	
al.	1995].	Interstitial	and	pleural	fibrosis	were	
first	 observed	 at	 13	 weeks	 following	 amosite	
asbestos	 exposure	 and	at	 6	months	 following	
RCF1	exposure.	Although	average	fiber	dimen-
sions	for	the	RCF1	and	amosite	asbestos	sam-
ples	were	similar,	the	RCF1	sample	contained	a	
higher	percentage	of	fibers	longer	than	20	μm	
[McConnell	 et	 al.	 1995,	 1999].	 Longer	 fibers	
have	been	associated	with	increased	toxicity	in	
experimental	animal	studies	[Davis	et	al.	1986;	
Pott	et	al.	1987;	Davis	and	Jones	1988;	Warheit	
1994;	Blake	et	al.	1998].	
Results	from	a	dose-response	analysis	using	the	
mesothelioma	data	from	the	RCF	and	amosite	
asbestos	hamster	studies	[McConnell	et	al.	1995,	
1999]	 indicated	 that	 the	 carcinogenic	 potency	
estimates	 for	RCFs	 ranged	 from	about	half	 to	
two	times	the	carcinogenic	potency	estimates	for	
amosite	asbestos	[Dankovic	2001]	(see	Section	
5.1.2).	This	analysis	may	not	predict	the	meso-
thelioma	risk	in	humans,	since	RCF1	contained	
a	greater	percentage	of	fibers	longer	than	20	µm	
and	 because	 of	 differences	 in	 fiber	 durability.	
Amosite	asbestos	is	a	more	durable	fiber	with	a	
longer	in	vivo	half-life	than	RCF1	[Maxim	et	al.	
1999b;	Hesterberg	et	al.	1993]	(see	Table	8–5).	
Yet	RCFs	are	more	durable	and	less	soluble	than	
many	other	types	of	SVFs	that	have	not	demon-
strated	carcinogenicity	in	experimental	studies.	
This	characteristic	is	significant,	as	the	durabil-
ity	of	asbestos	and	SVFs	(including	RCFs)	may	
be	linked	to	the	risk	of	lung	cancer	in	animals	
chronically	exposed	to	these	fibers	[Bignon	et	al.	
1994;	Bender	and	Hadley	1994;	Hammad	et	al.	
1988;	Luoto	et	al.	1995].	Because	of	the	long	la-
tency	period	for	the	development	of	mesothelio-
mas	in	humans,	Berry	[1999]	hypothesized	that	
fibers	of	sufficient	durability	are	needed	to	cause	
this	disease	in	humans.	Extrapolation	of	the	RCF	
dose-response	data	 for	 lung	cancer	and	meso-
thelioma	 in	exposed	rodents	 should	 take	 into	
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Table 8–5 .  Dissolution constant (K
dis
) and weighted in vivo half-life (t
0 .5
) 
of amosite asbestos and RCF1 
 Fiber type K
dis
 (ng/cm2 per hr) t
0 .5
(days)
	
RCF1
	
	 7.6
	
	 89.6
Amosite	asbestos 	 1.3 	 418.0
Source:	Adapted	from	Maxim	et	al.	[1999].
*Abbreviation:	RCF=refractory	ceramic	fiber.
account	 the	 durability	 of	 RCFs	 in	 humans.	
Some	evidence	indicates	that	rats	are	less	sen-
sitive	than	humans	to	the	development	of	lung	
cancer	and	mesothelioma	from	exposure	to	as-
bestos	and	may	therefore	represent	an	inappro-
priate	model	for	human	risk	assessment.	Pott	et	
al.	[1994]	hypothesized	that	in	chronic	inhala-
tion	studies,	rats	may	have	a	lower	sensitivity	to	
inorganic	fiber	toxicity	than	humans.	The	lung	
cancer	risk	from	inhaling	asbestos	may	be	two	
orders	of	magnitude	lower	in	rats	than	in	hu-
mans,	and	the	mesothelioma	risk	from	inhaling	
asbestos	may	be	three	orders	of	magnitude	low-
er	for	rats.	Rödelsperger	and	Woitowitz	[1995]	
measured	 amphibole	 fiber	 concentration	 in	
the	lung	tissues	of	humans	with	mesothelioma	
and	 compared	 the	 results	 with	 fiber	 burdens	
reported	 in	rats.	A	significantly	 increased	OR	
(OR=4.8,	 95%;	 CI=1.05–21.7)	 for	 mesothe-
lioma	 was	 seen	 in	 humans	 with	 amphibole	
concentrations	 between	 0.1	 and	 0.2	 fiber/μg	
of	 dried	 lung	 tissue.	 The	 lowest	 tissue	 con-
centration	 reported	 to	 produce	 a	 significant	
carcinogenic	 response	 in	 rat	 inhalation	 stud-
ies	of	amphiboles	(specifically	crocidolite)	was	
1,250	fibers/μg	of	dried	lung	tissue.	By	compar-
ing	these	results,	Rödelsperger	and	Woitowitz	
[1995]	estimated	that	humans	are	at	least	6,000	
times	more	sensitive	than	rats	to	a	given	tissue	
concentration	of	amphibole	fibers.
This	 work	 is	 refuted	 by	 other	 scientists	 who	
favor	the	rat	as	an	appropriate	model	for	eval-
uating	 the	 risk	 evaluation	 of	 lung	 cancer	 in	
humans	[Maxim	and	McConnell	2001].	Limi-
tations	 of	 the	 Rödelsperger	 and	 Woitowitz	
[1995]	and	Pott	[1994]	analyses	(discussed	ear-
lier)	include	the	lack	of	a	dose-response	analy-
sis,	 analysis	 of	 only	 one	 epidemiologic	 study,	
inadequate	comparisons	of	exposure	duration,	
lack	of	accounting	for	the	potentially	multipli-
cative	effect	of	smoking	and	asbestos	exposure,	
lack	of	consideration	of	latency	and	clearance,	
and	different	fiber	measurement	techniques.	
In	 summary,	 multiple	 factors	 affecting	 the	
comparability	of	different	fiber	types	and	ani-
mal	models	reported	in	the	literature	make	it	
difficult	to	determine	whether	the	carcinogen-
ic	potency	of	RCFs	in	animals	is	similar	to	that	
in	 humans.	 Extrapolation	 of	 the	 animal	 data	
to	humans	is	further	complicated	by	a	limited	
understanding	of	the	mechanisms	of	fiber	tox-
icity.	 Consequently,	 any	 extrapolation	 of	 the	
cancer	risk	found	in	animals	exposed	to	RCFs	
must	account	for	differences	between	humans	
and	 rodents	 with	 regard	 to	 fiber	 deposition	
and	clearance	patterns,	uncertainty	about	 the	
role	of	RCF	durability	for	potentiating	an	ad-
verse	effect,	and	possible	species	differences	in	
sensitivity	to	fibers.
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8.2.2 Health Effects Studies of  
 Workers Exposed to RCFs
Two	 major	 research	 efforts	 evaluated	 the	
morbidity	of	workers	exposed	to	airborne	fi-
bers	in	the	RCF	manufacturing	industry.	One	
study	was	conducted	in	the	United	States	and	
the	other	in	Europe.	The	objective	of	each	was	
to	evaluate	the	relationship	between	occupa-
tional	 exposure	 to	 RCFs	 and	 potential	 ad-
verse	 health	 effects.	 These	 studies	 contained	
multiple	components	including	standardized	
respiratory	 and	 occupational	 history	 ques-
tionnaires,	 chest	 radiographs,	 pulmonary	
function	tests	of	workers,	and	air	sampling	to	
estimate	 worker	 exposures.	 The	 first	 studies	
of	 European	 plants	were	 conducted	 in	 1986	
and	 included	 current	 workers	 at	 seven	 RCF	
manufacturing	 plants	 [Rossiter	 et	 al.	 1994;	
Trethowan	 et	 al.	 1995;	 Burge	 et	 al.	 1995].	A	
followup	 cross-sectional	 study	 conducted	 in	
1996	 evaluated	 the	 same	medical	 endpoints	
in	workers	from	six	of	these	seven	European	
manufacturing	plants	 (one	plant	had	 ceased	
operation)	 [Cowie	 et	 al.	 1999,	 2001].	 Cur-
rent	as	well	as	former	workers	were	included	
as	 study	 subjects	 in	 the	 followup	 study.	The	
studies	of	U.S.	plants	began	 in	1987	and	 in-
volved	evaluations	of	current	workers	at	five	
RCF	manufacturing	plants	and	former	work-
ers	at	two	of	the	plants	[Lemasters	et	al.	1994,	
1998,	 2003;	 Lockey	 et	 al.	 1993,	 1996,	 1998,	
2002].	In	the	United	States,	the	earliest	com-
mercial	 production	of	RCFs	 and	RCF	prod-
ucts	began	in	1953. In	Europe,	RCF	produc-
tion	began	in	1968.	The	demographics	of	the	
U.S.	 and	European	populations	were	 similar	
at	 the	 time	 they	were	 studied,	 but	 the	 aver-
age	age	and	duration	of	employment	for	the	
U.S.	workers	were	slightly	higher	than	for	the	
workforce	 in	 the	 1986	 European	 studies	 be-
cause	 of	 the	 earlier	 development	 of	 this	 in-
dustry	in	the	United	States.
8.2.2.1 Pleural changes in humans
The	radiographic	analyses	of	the	U.S.	and	1996	
European	 populations	 in	 RCF	 manufactur-
ing	 detected	 an	 association	 between	 pleural	
changes	 and	 RCF	 exposure	 [Lemasters	 et	 al.	
1994;	 Lockey	 et	 al.	 1996;	 Cowie	 et	 al.	 1999,	
2001].	 In	 the	 initial	 European	 studies,	 Tre-
thowan	et	al.	[1995]	found	pleural	abnormali-
ties	 in	 a	 small	 number	 of	 RCF	workers	 who	
had	 other	 confounding	 exposures	 that	 did	
not	 include	 asbestos.	Differences	 observed	 in	
pleural	 abnormalities	 between	 the	 U.S.	 and	
European	worker	populations	may	be	 related	
to	 the	 latency	 of	 exposure	 required	 to	 cause	
specific	pleural	changes	[Hillerdal	1994;	Begin	
et	al.	1996],	especially	 the	 formation	of	pleu-
ral	plaques,	which	were	first	observed	in	stud-
ies	 of	 the	 U.S.	 RCF	 manufacturing	 industry,	
with	 its	 longer	 latency	 period.	 Historical	 air	
sampling	data	also	indicate	that	airborne	fiber	
concentrations	were	much	higher	in	early	U.S.	
RCF	 manufacturing.	 Therefore,	 in	 addition	
to	 their	 longer	overall	 latency,	RCF	manufac-
turing	workers	 in	 the	United	 States	 probably	
had	 generally	 higher	 exposures	 in	 the	 early	
years	of	the	industry	than	did	their	European	
counterparts.	These	factors	might	explain	the	
appearance	of	RCF-associated	pleural	plaques	
in	 the	 U.S.	 studies	 before	 their	 detection	 in	
the	European	 studies.	The	U.S.	 and	1986	Eu-
ropean	studies	yielded	little	evidence	of	an	as-
sociation	 between	 radiographic	 parenchymal	
opacities	and	RCF	exposure.	In	the	U.S.	study,	
small	opacities	were	rare,	with	only	three	cases	
noted	 in	one	 report	 [Lockey	 et	 al.	 1996]	 and	
only	 one	 case	 (with	 small	 rounded	 opacities	
of	profusion	category	3/2	attributable	to	prior	
kaolin	mine	work)	noted	in	the	other	[Lemas-
ters	 et	 al.	 1994].	 Small	 opacities	of	profusion	
category	1/0	or	greater	were	more	frequent	in	
the	European	study	by	Trethowan	et	al.	[1995],	
but	 confounding	 exposures	 were	 believed	
to	 account	 for	 many	 of	 these	 cases.	 The	 re-
sults	of	statistical	analyses	indicated	either	no	
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association	with	RCF	exposure	[Trethowan	et	
al.	 1995]	 or	 an	 association	 slightly	 suggestive	
of	an	RCF	exposure	effect	[Rossiter	et	al.	1994].	
In	a	more	comprehensive	evaluation	of	the	Eu-
ropean	 study	 population,	 small	 opacities	 of	
category	1/0	or	greater	were	positively	associ-
ated	with	RCF	exposures	that	occurred	before	
1971	[Cowie	et	al.	1999].
8.2.2.2 Respiratory symptoms, irritation,   
 and other conditions in humans
In	both	the	U.S.	[Lockey	et	al.	1993;	Lemasters	et	
al.	1998]	and	the	European	[Trethowan	et	al.	1995;	
Burge	et	al.	1995;	Cowie	et	al.	1999,	2001]	stud-
ies,	occupational	exposure	to	RCFs	was	associated	
with	 various	 reported	 respiratory	 conditions	 or	
irritation	symptoms	after	adjusting	for	the	effects	
of	smoking.	Worker	exposure	to	RCFs	at	concen-
trations	 of	 0.2	 to	 0.6	 f/cm3	was	 associated	with	
statistically	 significant	 increases	 in	 eye	 irritation	
(OR=2.16,	 95%	 CI=1.32–3.54),	 stuffy	 nose	
(OR=2.06,	 95%	 CI=1.25–3.39),	 and	 dry	 cough	
(OR=2.53,	 95%	 CI=1.25–5.11)	 compared	 with	
exposure	to	concentrations	lower	than	0.2	f/cm3	
[Trethowan	et	 al.	 1995].	Between	 the	0.2	 to	
0.6	 f/cm3	and	>0.6	f/cm3	RCF	exposure	groups,	
a	 statistically	 significant	 increase	 occurred	 in	
ORs	 for	wheezing	 (P<0.0001),	 grade	2	dyspnea	
(P<0.05),	eye	 irritation	(P<0.0001),	and	skin	ir-
ritation	(P<0.0001)—but	not	for	stuffy	nose	[Tre-
thowan	et	al.	1995].	Lockey	et	al.	[1993]	found	that	
dyspnea	was	significantly	associated	with	cumula-
tive	exposure	to	>15	fiber-months/cm3	(i.e.,	>1.25	
fiber-year/cm3)	relative	to	cumulative	exposure	to	
≤15	fiber-months/cm3	(dyspnea	grade	1–OR=2.1,	
95%	CI	1.3–3.3;	dyspnea	grade	2–OR=3.8,	95%	
CI	1.6–9.4)	after	adjusting	for	smoking	and	other	
potential	 confounders.	Lockey	 et	 al.	 [1993]	 also	
found	 a	 statistically	 significant	 association	 be-
tween	 cumulative	 RCF	 exposure	 and	 pleurisy	
(OR=5.4,	95%	CI=1.4–20.2),	and	an	elevated	but	
nonsignificant	 association	 between	 cumulative	
RCF	 exposure	 and	 chronic	 cough	 (OR=2.0,	
95%	CI=1.0–4.0).	Lemasters	et	al.	[1998]	also	
noted	 associations	 (P<0.05)	 between	 employ-
ment	in	an	RCF	production	job	and	increased	
prevalence	 of	 dyspnea	 and	 the	 presence	 of	 at	
least	 one	 respiratory	 symptom	 after	 adjusting	
the	data	for	confounders.	Recurrent	chest	illness	
in	 the	European	 study	population	was	 associ-
ated	with	the	estimated	cumulative	exposure	to	
thoracic-sized	fibers	but	was	more	strongly	as-
sociated	with	estimated	cumulative	exposure	to	
thoracic-sized	dust	[Cowie	et	al.	1999,	2001].	
In	cross-sectional	analyses,	both	the	U.S.	[Lock-
ey	 et	 al.	 1998;	 Lemasters	 et	 al.	 1998]	 and	 the	
1986	European	[Trethowan	et	al.	1995;	Burge	
et	al.	1995]	studies	found	that	cumulative	RCF	
exposure	 is	 associated	with	 pulmonary	 func-
tion	 decrements	 among	 current	 and	 former	
smokers.	 Lemasters	 et	 al.	 [1998]	 also	 found	
statistically	 significant	 deficits	 in	 pulmonary	
function	 measures	 for	 nonsmoking	 female	
workers.	 The	 decreased	 pulmonary	 function	
in	 the	 European	 study	 population	 remained	
significantly	 associated	 with	 cumulative	 RCF	
exposure,	even	after	controlling	for	cumulative	
dust	 exposure	 [Burge	 et	 al.	 1995].	 The	 1996	
European	 study	 found	 pulmonary	 function	
decrements	 only	 in	 current	 smokers	 [Cowie	
et	 al.	 1999,	 2001].	 In	 a	 longitudinal	 analysis	
of	data	from	multiple	serial	pulmonary	func-
tion	tests,	Lockey	et	al.	[1998]	concluded	that	
the	more	recent	RCF	concentrations	occurring	
after	1987	were	not	associated	with	decreased	
pulmonary	function;	rather,	decreases	 in	pul-
monary	function	were	more	closely	related	to	
typically	 higher	 concentrations	 that	 occurred	
before	this	time	period.	The	U.S.	and	European	
studies	suggest	that	decrements	in	pulmonary	
function	 observed	 primarily	 in	 current	 and	
former	smokers	are	evidence	of	an	interactive	
effect	between	smoking	and	RCF	exposure.	
8.2.3 Carcinogenic Risk in Humans
Moolgavkar	et	al.	[1999]	derived	risk	estimates	
for	lung	cancer	in	humans	on	the	basis	of	the	
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results	from	the	two	chronic	bioassays	of	RCFs	
in	male	Fischer	344	rats	[Mast	et	al.	1995a,b].	
Several	 models	 (linear,	 quadratic,	 exponen-
tial)	were	used	to	estimate	and	compare	risks	
using	 reference	 populations	 comprised	 of	 ei-
ther	a	nonsmoking	ACS	cohort	or	a	cohort	of	
steel	workers	not	exposed	to	coke	oven	emis-
sions	 (see	Table	5–10	 for	 risk	estimates).	The	
exponential	model	provided	the	best	statistical	
fit	of	the	data.	The	linear	model	provided	the	
highest	estimates	of	human	 lung	cancer	 risks	
from	 exposure	 to	 RCFs	 when	 used	 with	 the	
referent	 steel	 workers	 cohort	 (considered	 to	
be	most	representative	of	workers	exposed	to	
RCFs	 because	 it	 includes	 blue	 collar	 workers	
who	smoke).	Lung	cancer	risk	estimates	were	
calculated	using	each	model	at	exposure	con-
centrations	of	0.25	f/cm3,	0.5	f/cm3,	0.75	f/cm3,	
and	1.0	f/cm3.	The	RCF-related	lung	cancer	risk	
determined	from	the	linear	model	for	the	low-
est	concentration	(0.25	 f/cm3)	was	0.27/1,000	
for	the	cohort	of	steel	workers	compared	with	
0.036/1,000	using	 the	exponential	model	 and	
0.00088/1,000	 for	 the	 quadratic	model	 when	
using	the	same	referent	population.
The	 risk	 estimates	 incorporated	 multiple	 as-
sumptions,	 including	a	human	breathing	rate	
of	 13.5	L/min	 (considered	 light	 work)	 and	
multiple	 criteria	 for	 defining	 the	 length	 of	
time	a	worker	could	be	exposed	to	RCFs	over	
a	working	lifetime.	Higher	risk	estimates	could	
be	 expected	 if	 the	 assumptions	 more	 closely	
represented	those	used	by	NIOSH	and	OSHA:	
(1)	 a	human	breathing	 rate	 of	 20	L/min	 and	
(2)	 a	 worker	 exposure	 duration	 of	 8	 hr/day,	
5	days/wk,	 50	 wk/yr,	 from	 age	 20	 to	 65	 with	
the	risk	calculated	beyond	age	70	(e.g.,	to	age	
85).	Furthermore,	the	calculated	risk	estimates	
could	be	an	underestimation	of	the	lung	cancer	
risk	 to	 humans	 because	 the	models	 assumed	
that	the	tissue	sensitivity	to	RCFs	in	the	rat	is	
equal	 to	 that	 in	 humans.	 Although	 the	 lung	
cancer	risk	estimates	derived	from	the	rat	data	
are	 reason	 for	 concern,	 estimates	 of	 human	
risk	for	mesothelioma	from	the	high	incidence	
(41%)	of	mesothelioma	in	hamsters	cannot	be	
appropriately	modeled	since	only	a	single	ex-
posure	was	administered	in	the	study.	Primar-
ily	 on	 the	 basis	 of	 chronic	 animal	 inhalation	
studies	 [Mast	et	al.	1995a,b;	McConnell	 et	al.	
1995],	NIOSH	concludes	that	RCFs	are	a	po-
tential	occupational	carcinogen.	Furthermore,	
the	evidence	of	pleural	plaques	 [Lemasters	et	
al.	1994;	Lockey	et	al.	1996]	observed	 in	per-
sons	with	occupational	exposures	to	airborne	
RCFs	is	clinically	similar	to	that	observed	in	as-
bestos-exposed	persons	after	the	initial	years	of	
their	occupational	asbestos	exposures	[Houri-
hane	et	al.	1966;	Becklake	et	al.	1970;	Dement	
et	al.	1986].	NIOSH	considers	the	discovery	of	
pleural	plaques	in	U.S.	studies	of	RCF	manu-
facturing	 workers	 to	 be	 a	 significant	 finding	
because	the	plaques	were	correlated	with	RCF	
exposure	 [Lemasters	 et	al.	 1994;	Lockey	 et	 al.	
1996].	 In	 addition,	 NIOSH	 considers	 the	 re-
spiratory	symptoms	and	conditions	(including	
dyspnea,	wheeze,	cough,	and	pleurisy)	[Lemas-
ters	et	al.	1998;	Lockey	et	al.	1993;	Trethowan	
et	al.	1995;	Burge	et	al.	1995;	Cowie	et	al.	1999]	
in	RCF	workers	to	be	adverse	health	effects	that	
have	been	associated	with	exposure	to	airborne	
fibers	of	RCFs.	
Insufficient	 evidence	 exists	 to	 document	 an	
association	 between	 fibrotic	 or	 carcinogenic	
effects	and	the	inhalation	of	RCFs	by	workers	
in	 the	 RCF	 manufacturing	 industry	 though	
these	 effects	 have	 been	 demonstrated	 in	 ani-
mal	 studies.	The	 lack	of	an	observed	associa-
tion	between	RCF	 exposure	 and	 these	 effects	
among	 workers	 could	 be	 affected	 by	 one	 or	
more	factors,	 including	several	relating	to	the	
study	 population:	 the	 relatively	 small	 cohort,	
the	 proportion	 of	 workers	 with	 short	 tenure	
relative	to	what	might	be	expected	(on	the	ba-
sis	of	an	asbestos	analogy)	in	terms	of	disease	
latency,	 and	workers	with	 limited	 cumulative	
exposures	to	RCFs.	
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8.2.4 Controlling RCF Exposures in 
the Workplace
Table	 8–6	 summarizes	 exposure	 monitoring	
data	 collected	 by	 the	 RCFC	 under	 a	 consent	
agreement	with	the	EPA	[Everest	1998;	Maxim	
et	al.	1997].	These	data	indicate	that	exposures	
to	 RCFs	 during	 1993–1998	 had	 an	AM	 fiber	
concentration	 of	 about	 0.3	 f/cm3	 for	 manu-
facturing	 and	 nearly	 0.6	 f/cm3	 for	 end	 users.	
Maxim	et	al.	[1997,	1999a]	reported	results	for	
both	 manufacturing	 and	 end-use	 sectors	 in	
which	 airborne	 fiber	 concentrations	 through	
1997	were	reduced	to	an	AM	<0.3–0.6	f/cm3.
The	exposure	monitoring	data	collected	as	part	
of	 the	RCFC/EPA	consent	agreement	provide	
assurance	 that	when	 appropriate	 engineering	
controls	and	work	practices	are	used,	airborne	
exposure	to	RCFs	can	be	maintained	for	most	
functional	job	categories	(FJCs)	at	the	REL	of	
0.5	f/cm3.	For	many	manufacturing	processes,	
reductions	in	exposures	have	resulted	from	the	
improved	 ventilation,	 engineering	 or	 process	
changes,	 and	 product	 stewardship	 programs	
[Rice	 et	 al.	 1996;	Maxim	et	 al.	 1999b].	These	
data	provide	the	basis	for	the	NIOSH	determi-
nation	that	a	REL	of	0.5	f/cm3	as	a	TWA	can	be	
achieved.
Although	many	RCF	manufacturing	and	end-
user	job	tasks	have	exposures	to	RCFs	at	con-
centrations	 below	 0.5	 f/cm3,	 exposure	moni-
toring	data	also	indicate	that	not	all	FJCs	may	
be	 able	 to	 achieve	 these	 RCF	 concentrations	
consistently.	 FJCs	 that	 currently	 experience	
airborne	AM	fiber	 concentrations	>0.5	 f/cm3	
include	finishing	(manufacturing	and	end	use)	
and	removal	(end	use).	Typical	processing	dur-
ing	finishing	operations	(e.g.,	sawing,	drilling,	
cutting,	 sanding)	 often	 requires	 high-energy	
sources	that	tend	to	generate	larger	quantities	
of	airborne	dust	and	fibers.	For	RCF	insulation	
removal,	 activities	 are	 performed	 at	 remote	
sites	where	conventional	engineering	controls	
and	fixed	ventilation	systems	are	more	difficult	
to	 implement.	 For	 some	 operations,	 such	 as	
removal	of	RCF	insulation	tiles	from	furnaces,	
the	 release	 of	 high	 airborne	 fiber	 concentra-
tions	can	occur.	However,	removal	of	RCF	in-
sulation	tiles	is	not	routine	and	is	generally	ac-
complished	in	a	short	period	of	time.	Workers	
almost	 universally	 wear	 PPE	 and	 respiratory	
protection	during	these	job	tasks	[Maxim	et	al.	
1997,	1998]. 
NIOSH	acknowledges	that	the	frequent	use	of	
PPE,	 including	 respirators,	 may	 be	 required	
for	some	workers	handling	RCFs	or	RCF	prod-
ucts.	The	frequent	use	of	PPE	may	be	required	
during	 job	 tasks	 for	which	(1)	routinely	high	
airborne	 concentrations	 of	 RCF	 (e.g.,	 finish-
ing,	insulation	removal)	exist,	(2)	the	airborne	
concentration	 of	RCF	 is	 unknown	or	 unpre-
dictable,	and	(3)	job	tasks	are	associated	with	
highly	 variable	 airborne	 concentrations	 be-
cause	of	environmental	conditions	or	the	man-
ner	 in	which	the	 job	task	 is	performed.	In	all	
work	environments	where	RCFs	or	RCF	prod-
ucts	are	handled,	control	of	exposure	through	
the	engineering	controls	should	be	the	highest	
priority.
8.3	Summary
The	 following	 summarize	 the	 relevant	 infor-
mation	used	as	the	basis	for	the	NIOSH	assess-
ment	of	occupational	exposures	to	RCFs:
■	 Airborne	 concentrations	 of	 RCFs	 have	
been	 characterized	 as	 containing	 fibers	
of	dimensions	in	the	thoracic	and	respi-
rable	 size	 ranges.	 RCFs	 are	 among	 the	
most	 durable	 types	 of	 SVFs.	 In	 tests	 of	
solubility,	RCFs	are	nearly	as	durable	as	
chrysotile	 asbestos	 but	 significantly	 less	
durable	 than	 amphibole	 asbestos	 fibers	
such	as	amosite.
■	 Chronic,	 nose-only	 inhalation	 studies	
with	RCFs	in	animals	show	a	statistically	
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Table 8–6 . Airborne fiber concentrations in the RCF* industry during 1993–1998, by 
functional job category and production status† (f/cm3 as TWA)
Functional job category          
and production status
Minimum 
value
First 
quartile Median
Geometric 
mean
Arithmetic  
mean
Third  
quartile
Maximum 
value
Total:	
							Manufacturing	
							End	use
	
0.001	
0.002
	
0.070	
0.052
	
0.186	
0.173
	
0.16	
0.16
	
0.313	
0.560
	
0.407	
0.524
	
	 7.700	
	 30.000
Assembly:	
							Manufacturing	
							End	use
	
0.001	
0.002
	
0.110	
0.050
	
0.208	
0.159
	
0.18	
0.14
	
0.281	
0.316
	
0.366	
0.402
	
2.154	
2.837
Auxiliary:	
							Manufacturing	
							End	use
	
0.001	
0.002
	
0.019	
0.021
	
0.038	
0.066
	
0.05	
0.07
	
0.112	
0.198
	
0.132	
0.198
	
1.347	
2.678
Fiber:	
							Manufacturing	
							End	use
	
0.004	
—
	
0.063	
—
	
0.145	
—
	
0.14	
—
	
0.257	
—
	
0.299	
—
	
7.700	
—
Finishing:	
							Manufacturing	
							End	use
	
0.004	
0.006
	
0.316	
0.124
	
0.488	
0.383
	
0.47	
0.35
	
0.663	
0.991
	
0.803	
0.986
	
	 4.044	
	 30.000
Installation:	
							Manufacturing	
							End	use
	
—	
0.003
	
—	
0.084
	
—	
0.236
	
—	
0.20
	
—	
0.434
	
—	
0.559
	
—	
3.371
Mixing/forming:	
							Manufacturing	
							End	use
	
0.004	
0.010
	
0.090	
0.074
	
0.184	
0.159
	
0.17	
0.17
	
0.292	
0.319
	
0.364	
0.369
	
1.445	
4.109
Other:	
							Manufacturing	
							End	use
	
0.007	
0.003
	
0.027	
0.013
	
0.070	
0.030
	
0.07	
0.04
	
0.112	
0.194
	
0.177	
0.102
	
1.900					
6.400
Removal:	
							Manufacturing	
							End	use
	
—	
0.010
	
—	
0.373
	
—	
1.914
	
—	
0.82
	
—	
1.816
	
—	
2.340
			
								—	
	 16.000
Source:	Adapted	from	Everest	[1998].	
*Abbreviations:	RCF	=	refractory	ceramic	fiber;	TWA	=	time-weighted	average.	
†Fiber	concentrations	were	determined	during	monitoring	performed	over	a	5-year	period	(1993–1998)	under	the	Refractory			
				Ceramic	Fibers	Coalition/Environmental	Protection	Agency	(RCFC/EPA)	consent	agreement.		Concentrations	were		
				determined	by	NIOSH	method	7400	“B”	counting	rules.
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significant	 increased	 incidence	 of	 lung	
tumors	 in	 rats	 and	 pleural	 mesothelio-
mas	in	hamsters.	These	data	support	the	
NIOSH	 determination	 that	 RCFs	 are	 a	
potential	occupational	carcinogen.
■	 Epidemiologic	studies	of	workers	 in	the	
RCF	 manufacturing	 industry	 show	 an	
increased	 incidence	 of	 pleural	 plaques,	
respiratory	 symptoms	 (dyspnea	 and	
cough),	 skin	 and	eye	 irritation,	 and	de-
creased	 pulmonary	 function	 related	 to	
increasing	 exposures	 to	 airborne	 fibers.	
Some	 of	 these	 conditions	 are	 docu-
mented	for	exposure	concentrations	in	a	
range	as	low	as	0.2	to	0.6	f/cm3.	Studies	of	
workers	exposed	to	airborne	RCFs	show	
no	evidence	of	excess	risk	for	lung	cancer	
or	mesothelioma.	However,	the	inability	
to	detect	such	an	association	could	be	be-
cause	of	(1)	the	low	statistical	power	for	
detecting	an	effect,	(2)	the	short	latency	
period	 for	most	workers	 occupationally	
exposed,	and	(3)	the	historically	low	and	
decreasing	fiber	exposures	that	have	oc-
curred	in	this	industry.	
■	 Risk	assessment	analyses	using	data	from	
chronic	 inhalation	 studies	 in	 rats	 indi-
cate	 that	 the	 excess	 risk	 of	 developing	
lung	cancer	when	exposed	 to	RCFs	at	a	
TWA	of	0.5	f/cm3	for	a	working	lifetime	
is	 0.073	 to	 1.2/1,000.	 However,	 on	 the	
basis	of	the	assumptions	used	in	the	risk	
analyses,	NIOSH	concludes	that	this	risk	
estimate	is	more	likely	to	underestimate	
than	 to	 overestimate	 the	 risk	 to	 RCF-
exposed	workers.	Reduction	of	 the	RCF	
TWA	 concentration	 to	 0.2	 f/cm3	 would	
reduce	the	risk	for	lung	cancer	to	0.03	to	
0.47/1,000.	OSHA	 attempts	 to	 set	 PELs	
for	carcinogens	that	reflect	an	estimated	
risk	of	1/1,000	but	is	limited	by	consider-
ations	of	technologic	and	economic	fea-
sibility.
■ RCF	exposure	data	gathered	under	a	con-
sent	 agreement	 between	 RCFC	 and	 EPA,	
which	included	a	5-year	comprehensive	air	
monitoring	 program	 (1993–1998),	 indi-
cate	that	airborne	exposure	concentrations	
to	RCFs	have	been	decreasing.	Monitoring	
results	 show	that	75%	to	>95%	of	TWA	
exposure	concentration	measurements	in	
all	FJCs	(with	one	exception)	were	below	
1.0	f/cm3.	In	all	but	two	of	the	eight	FJCs,	
>70%	of	TWA	measurements	were	below	
the	RCFC	recommended	exposure	guide-
line	 of	 0.5	 f/cm3.	On	 the	 basis	 of	 the	 re-
view	of	these	data,	NIOSH	has	concluded	
that	the	REL	of	0.5	f/cm3	can	be	achieved	
in	most	work	places	where	RCFs	or	RCF	
products	are	manufactured	or	used.
■	 The	 combined	 effect	 of	mixed	 exposures	
to	fibers	and	nonfibrous	particulates	may	
contribute	to	increased	irritation	of	the	re-
spiratory	tract,	skin,	and	eyes.	Engineering	
controls	 and	 appropriate	 work	 practices	
used	to	keep	airborne	RCF	concentrations	
below	the	REL	should	help	to	minimize	air-
borne	exposures	to	nonfibrous	particulates	
as	well.	Because	the	ratio	of	fibers	to	non-
fibrous	 particulate	 in	 airborne	 exposures	
may	vary	among	job	tasks,	exposure	moni-
toring	should	include	efforts	to	characterize	
particulate	composition	and	to	control	and	
minimize	 airborne	 fibers	 and	 nonfibrous	
particulate	accordingly.
From	 the	 assessment	 described	 above	 and	
throughout	this	document,	NIOSH	concludes	
that	 on	 a	 continuum	 of	 fiber	 toxicity,	 RCFs	
relate	more	closely	to	asbestos	than	to	fibrous	
glass	and	other	SVFs	and	should	be	handled	ac-
cordingly.	NIOSH	considers	all	asbestos	types	
to	 be	 carcinogens	 and	 has	 established	 a	 REL	
of	0.1	 f/cm3	 for	airborne	asbestos	fibers.	This	
value	was	determined	on	the	basis	of	extensive	
human	and	animal	health	effects	data	and	the	
recognized	limits	of	analytical	methods.	
112	 Refractory Ceramic Fibers
8  ■		Basis for the Recommended Standard
Recognizing	that	RCFs	are	carcinogens	in	ani-
mal	studies	and	given	the	limitations	in	deriv-
ing	an	exposure	value	that	reflects	no	excess	risk	
of	 lung	 cancer	 or	mesothelioma	 for	 humans,	
NIOSH	recommends	that	every	effort	be	made	
to	keep	exposures	below	the	REL	of	0.5	f/cm3	
as	a	TWA	for	up	to	10	hr/day	in	a	40-hr	work-
week.	These	efforts	will	further	reduce	the	risk	
for	malignant	 respiratory	disease	 and	protect	
workers	 from	 conditions	 and	 symptoms	 de-
riving	from	irritation	of	 the	respiratory	tract,	
skin,	and	eyes.	
From	 the	 analysis	 of	 historical	 exposure	data	
(see	Chapter	4)	and	the	exposure	data	collect-
ed	as	part	of	the	RCFC/EPA	consent	agreement	
monitoring	program	(Table	8–6),	NIOSH	has	
determined	that	compliance	with	the	REL	for	
RCFs	is	achievable	in	most	manufacturing	and	
end-use	 job	 categories.	 Although	 routine	 at-
tainment	 of	 TWA	 exposures	 below	 the	 REL	
may	not	currently	occur	at	all	job	tasks,	it	does	
represent	 a	 reasonable	 objective	 that	 can	 be	
achieved	through	modification	of	the	job	task	
or	the	introduction	or	improvement	of	venti-
lation	controls.	
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■	 Establish	 procedures	 for	 reporting	 haz-
ards	 and	 giving	 feedback	 about	 actions	
taken	to	correct	them.	
■	 Instruct	 workers	 about	 using	 safe	 work	
practices	and	appropriate	PPE.
■	 Inform	workers	about	practices	or	oper-
ations	that	may	generate	high	concentra-
tions	of	airborne	fibers	(such	as	cutting	
and	 sanding	 of	 RCF	 boards	 and	 other	
RCF	products).
■	Make	workers	who	remove	refractory	in-
sulation	materials	aware	of	the	following:
—	Their	potential	for	exposure	to	respi-
rable	crystalline	silica
—	Health	effects	related	to	this	exposure
—	Methods	for	reducing	their	exposure
—	Types	 of	 PPE	 that	 may	 be	 required	
(including	respirators)
9.1.2 Labeling and Posting
Although	workers	should	have	received	train-
ing	about	RCF	exposure	hazards	and	methods	
for	protecting	themselves,	labels	and	signs	serve	
as	important	reminders	and	provide	warnings	
to	workers	who	may	not	ordinarily	work	in	the	
area.	Employers	should	do	the	following:
■	 Post	warning	labels	and	signs	about	RCF-
associated	 health	 risks	 at	 entrances	 and	
inside	work	areas	where	airborne	concen-
trations	of	RCFs	may	exceed	the	REL.	
The	following	guidelines	for	protecting	worker	
health	 and	 minimizing	 worker	 exposures	 to	
RCFs	 are	 considered	 minimum	 precautions	
that	should	be	adopted	as	a	part	of	a	site-specific	
safety	and	health	plan	to	be	developed	and	over-
seen	by	appropriate	and	qualified	personnel.
9.1 Informing Workers 
 about Hazards
9.1.1 Safety and Health Training 
 Program
Employers	should	establish	a	safety	and	health	
training	program	 for	 all	workers	who	manu-
facture,	 use,	 handle,	 install,	 or	 remove	 RCF	
products	or	perform	other	activities	that	bring	
them	 into	 contact	with	RCFs.	As	part	of	 this	
training	 program,	 employers	 should	 do	 the	
following:	
■	 Inform	all	potentially	exposed	workers	(in-
cluding	 contract	 workers)	 about	 RCF-
associated	 health	 risks	 such	 as	 skin,	 eye,	
and	respiratory	irritation	and	lung	cancer.
■	 Provide	MSDSs	on	site:	
—	Make	 MSDSs	 readily	 available	 to	
workers.
—	Instruct	workers	how	to	interpret	in-
formation	from	MSDSs.
■	 Teach	 workers	 to	 recognize	 and	 report	
adverse	respiratory	effects	associated	with	
RCFs.	
■	 Train	workers	to	detect	hazardous	situa-
tions.
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■	 State	the	need	to	wear	appropriate	respi-
ratory	protection	and	protective	clothing	
in	areas	where	airborne	RCFs	may	exceed	
the	REL.	
■	 If	respiratory	protection	is	required,	post	
the	following	statement:
9.2.1 Engineering Controls
Engineering	 controls	 should	 be	 the	 principal	
method	 for	minimizing	 exposure	 to	RCFs	 in	
the	workplace.	
9.2.1.1 Ventilation
Achieving	 reduced	 concentrations	 of	 air-
borne	RCFs	depends	on	adequate	engineering	
controls	such	as	local	exhaust	ventilation	sys-
tems	that	are	properly	constructed	and	main-
tained.	Local	exhaust	ventilation	systems	that	
employ	hoods	and	ductwork	to	remove	fibers	
from	 the	 workplace	 atmosphere	 have	 been	
used	by	RCF	manufacturers.	One	example	is	
a	 slotted-hood	dust	collection	system	placed	
over	a	mixing	tank	so	that	airborne	fibers	are	
captured	 and	 collected	 in	 a	 bag	 house	 with	
HEPA	filters	[RCFC	1996].	Other	types	of	lo-
cal	exhaust	ventilation	or	dust	collection	sys-
tems	may	be	used	at	or	near	dust-generating	
systems	to	capture	airborne	fibers.	Band	saws	
used	in	RCF	manufacturing	and	finishing	op-
erations	have	been	fitted	with	such	engineer-
ing	controls	to	capture	fibers	and	dust	during	
cutting	operations	and	thereby	reduce	expo-
sures	 for	 the	 band	 saw	 operator	 [Venturin	
1998].	 Disc	 sanders	 fitted	 with	 similar	 local	
exhaust	 ventilation	 systems	 are	 effective	 in	
reducing	 airborne	 RCF	 concentrations	 dur-
ing	sanding	of	vacuum-formed	RCF	products	
[Dunn	et	al.	2004].	For	quality	control	labora-
tories	or	laboratories	where	production	sam-
ples	are	prepared	for	analyses,	exhaust	venti-
lation	systems	should	be	designed	to	capture	
and	contain	dust.	For	guidance	 in	designing	
local	 exhaust	 ventilation	 systems,	 see	 Indus-
trial Ventilation—A Manual of Recommended 
Practice,	 25th	 edition	 [ACGIH	 2005],	 Rec-
ommended Industrial Ventilation Guidelines	
[Hagopian	and	Bastress	1976],	and	the	OSHA	
ventilation	standard	[29	CFR	1910.94].
RESPIRATORS REQUIRED 
IN THIS AREA.
■	 Print	all	labels	and	warning	signs	in	both	
English	 and	 the	 predominant	 language	
of	workers	who	do	not	read	English.
■	 If	workers	 are	unable	 to	 read	 the	 labels	
and	 signs,	 inform	 them	 verbally	 about	
the	hazards	and	instructions	printed	on	
the	labels	and	signs.	
9.2 Hazard Prevention and 
 Control
Proper	 use	 and	 maintenance	 of	 engineering	
controls,	work	practices,	and	PPE	are	essential	
for	 controlling	 concentrations	of	 airborne	fi-
bers	during	the	manufacturing,	use,	and	han-
dling	of	RCF	products.	Minimizing	 exposure	
to	RCFs	may	be	accomplished	through	a	com-
bination	 of	 the	 following	work	 practices	 and	
controls:	
■	 Engineering	controls	and	ventilation
■	 Product	reformulation
■	Worker	isolation
■	 PPE	 (such	 as	 protective	 clothing	 and	
equipment	and	respirators)
■	 Proper	 decontamination	 and	waste	 dis-
posal
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Additional	 engineering	 controls	 have	 been	
evaluated	 by	 the	 Bureau	 of	 Mines	 for	 mini-
mizing	airborne	dust	in	underground	mining	
operations	and	at	industrial	sand	plants.	These	
controls	 may	 also	 have	 applications	 for	 RCF	
finishing,	installation,	and	removal	operations.	
The	use	of	air	showers	(also	known	as	a	canopy	
air	curtain	or	an	overhead	air	supply	island)	in-
volves	positioning	an	air	supply	over	the	head	
of	a	worker	to	provide	a	flow	of	clean,	filtered	
air	 to	 the	worker’s	 breathing	 zone	 [Volkwein	
et	 al.	 1982,	 1988].	 Proper	 design	 and	 evalua-
tion	 are	 critical	 for	 ensuring	 that	filtration	 is	
adequate	 to	 remove	 airborne	 fibers	 from	 the	
air	supply.	Also,	selection	of	the	air	supply	flow	
rate	is	important	to	make	sure	that	the	velocity	
delivered	to	the	worker’s	breathing	zone	is	suf-
ficient	to	overcome	cross	drafts	and	maintain	a	
clean	air	flow.	
9.2.1.2 Tool selection and modification
The	RCFC	has	reported	that	using	hand	tools	
instead	of	powered	 tools	 can	 significantly	 re-
duce	 airborne	 concentrations	 of	 dust.	 How-
ever,	hand	tools	often	require	additional	physi-
cal	effort	and	time,	and	they	may	increase	the	
risk	 of	 musculoskeletal	 disorders.	 Employers	
should	 therefore	 use	 ergonomically	 correct	
tools	and	proper	workstation	design	 to	avoid	
ergonomic	hazards.
The	 additional	 physical	 effort	 required	 to	
use	hand	tools	may	also	increase	the	rate	and	
depth	of	breathing	and	may	consequently	af-
fect	 the	 inhalation	 and	 deposition	 of	 fibers.	
For	operations	such	as	cutting,	sawing,	grind-
ing,	drilling,	and	sanding,	the	high	level	of	me-
chanical	energy	applied	to	RCF	products	with	
power	tools	increases	the	potential	for	elevated	
concentrations	 of	 airborne	 fiber.	 Examples	
[Carborundum	 1992]	 of	 how	 airborne	 fiber	
concentrations	are	affected	by	 the	equipment	
used	to	process	RCF	products	include	the	fol-
lowing:
■	 A	 test	of	hand	 sawing	versus	 the	use	of	
a	powered	jigsaw	showed	an	81%	reduc-
tion	 in	 concentrations	 of	 airborne	 dust	
generated.
■	 A	 comparison	 of	 hand	 sanding	 versus	
power	sanding	showed	a	90%	reduction	
in	 concentrations	of	 airborne	dust	gen-
erated.
■	When	a	light	water	mist	is	applied	to	the	
surface	 of	 a	 vacuum-formed	 board	 be-
fore	 sanding,	 airborne	 dust	 concentra-
tion	is	reduced	by	89%	for	hand	sanding	
and	88%	for	powered	sanding.
■	 The	use	of	a	cork	bore	(core	drill)	versus	
an	electric	drill	with	a	twist	bit	for	cutting	
holes	 in	 RCF	 product	 forms	 reduces	 air-
borne	dust	concentrations	by		about	85%.
9.2.1.3 Engineering controls for RCF  
finishing operations
Researchers	at	NIOSH	have	been	working	with	
industrial	 hygienists	 at	 RCFC	member	 facili-
ties	 to	 study	 the	 effectiveness	 of	 engineering	
controls	designed	and	applied	to	RCF	finishing	
operations.	Because	hand	tools	are	not	always	
a	practical	solution	to	manufacturing	and	end-
use	 facilities	 requirements,	 engineering	 con-
trols	are	being	designed	and	evaluated	for	use	
with	powered	tools.	
A	joint	project	between	NIOSH	and	RCFC	was	
initiated	in	1998	and	involved	investigating	en-
gineering	controls	for	use	with	a	pedestal	belt/
disc	 sander	 [Dunn	 et	 al.	 2000,	 2004].	 These	
units	 are	 frequently	used	by	 the	manufactur-
ers	as	well	as	the	customer	facilities	to	produce	
vacuum-formed	 boards	 sized	 to	 the	 required	
dimensions.	A	continuous	misting	nozzle	and	
simple	 local	 exhaust	 ventilation	 system	 were	
integrated	for	use	on	the	pedestal	sanding	unit.	
The	mister	consisted	of	a	standard	atomization	
nozzle	that	was	set	for	a	low-water	flow	rate	to	
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minimize	part	degradation.	The	local	exhaust	
ventilation	 system	used	 two	hoods	or	pickup	
points	with	a	total	airflow	of	700	ft3/min.
During	production	of	vacuum-formed	boards,	
these	 two	 controls	 reduced	 fiber	 concentra-
tions	in	the	breathing	zone	as	follows:	
% decrease in airborne fibers: 
Disc	sanding	using	water	mist . 	. 	. 	. 	. 	. 	. 	88
Disc	sanding	using	local	exhaust	
			ventilation . 	. 	. 	. 	. 	. 	. 	. 	. 	. 	. 	. 	. 	. 	. 	. 	. 	99	
Belt	sanding	using	water	mist	 .	 .	 .	 .	 .	 .	 .		50
Belt	sanding	using	local	exhaust	
			ventilation . 	. 	. 	. 	. 	. 	. 	. 	. 	. 	. 	. 	. 	. 	. 	. 	. 	99
These	studies	highlight	 the	potential	 for	sig-
nificant	reductions	in	worker	exposure	using	
well	 designed	 and	 maintained	 engineering	
controls,	 but	 their	 effectiveness	 needs	 to	 be	
validated	in	the	field.	
9.2.1.4 Wet methods for dust 
suppression
Fiber	counts	are	 lower	 in	more	humid	atmo-
spheres.	Examples	of	using	water	 to	 suppress	
dust	concentrations	are	described	as	follows:
■	 At	one	RCF	 textile	 facility,	misters	have	
been	added	above	broad	looms	and	tape	
looms	to	decrease	fiber	concentrations.
■	Water	knives	are	high-pressure	water	jets	
that	are	used	to	cut	and	trim	edges	of	RCF	
blanket	while	suppressing	dust	and	limit-
ing	the	generation	of	airborne	fibers.
■	During	the	installation	of	RCF	modules	
in	 a	 furnace,	 a	 procedure	 called	 tamp-
ing	is	typically	performed.	After	modules	
are	put	in	place	on	the	furnace	wall,	the	
modules	 are	 compressed	 by	 placing	 a	
1-ft	 length	of	 2-	 by	 4-ft	 lumber	 against	
the	modules	 and	 tapping	 it	 lightly	with	
a	hammer.	The	process	helps	ensure	that	
the	RCF	modules	are	installed	tightly	in	
place.	When	a	light	water	spray	is	applied	
to	 the	 surface	 of	 the	 modules	 before	
tamping,	airborne	fiber	concentration	is	
reduced	 by	 about	 75%	 [Carborundum	
1993].	 The	water	 is	 applied	with	 a	 gar-
den-type	 sprayer	 that	 is	 set	on	mist	us-
ing	about	1	gal	of	water/100	ft2	of	surface	
area.	However,	caution	is	advised	regard-
ing	 the	dampening	of	 refractory-linings	
during	 installation.	 The	 introduction	
of	 water	 can	 damage	 refractory-lined	
equipment	during	heating	with	explosive	
spalling	from	the	generation	of	steam.
■	 After-service	 RCF	 insulation	 removed	
from	 furnaces	may	be	wetted	 to	 reduce	
the	release	of	fibers.	
9.2.1.5 Isolation
Some	 manufacturing	 processes	 may	 be	 en-
closed	 to	 keep	 airborne	 fibers	 contained	 and	
separated	from	workers.
■	When	possible,	 isolate	workers	from	di-
rect	 contact	 with	 RCFs	 by	 using	 auto-
mated	equipment	operated	from	a	closed	
control	booth	or	room.
■	Maintain	the	control	room	at	greater	air	
pressure	than	that	surrounding	the	pro-
cess	equipment	so	that	air	flows	out	rath-
er	than	in.
■	Make	 sure	workers	 take	 special	 precau-
tions	 (such	 as	 using	 PPE)	 when	 they	
must	enter	the	general	work	area	to	per-
form	process	checks,	adjustments,	main-
tenance,	assembly-line	tasks,	and	related	
operations.
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9.2.2 Product Reformulation
One	 factor	 that	 contributes	 to	 the	 toxicity	of	
an	 inhaled	 fiber	 is	 the	 durability	 of	 the	 fiber	
and	its	resistance	to	degradation	in	the	respira-
tory	tract.	The	chemical	characteristics	of	RCFs	
make	 them	one	of	 the	most	durable	 types	of	
SVFs.	As	a	result,	an	inhaled	RCF	of	specific	di-
mensions	will	persist	longer	in	the	lungs.	Mod-
ifying	 the	 physical	 characteristics	 of	 RCFs	 or	
reformulating	their	chemistry	to	produce	 less	
durable	 fibers	 are	 recommended	 options	 for	
reducing	the	hazard	for	exposed	workers.	Such	
an	approach	has	been	taken	by	one	RCF	manu-
facturer	in	developing	two	more	soluble	types	
of	SVF	[Maxim	et	al.	1999b].	However,	caution	
is	advised	for	developing	and	distributing	such	
modified	fibers.	Possible	adverse	health	effects	
of	newly	developed	fibers	should	be	evaluated	
before	 introducing	 them	 into	commerce.	Ap-
propriate	testing	of	these	fibers	should	be	per-
formed	to	provide	information	about	the	fiber	
toxicology	and	potential	adverse	health	effects	
associated	with	exposure	to	these	fibers.	
9.2.3 Work Practices and Hygiene
Use	good	work	practices	to	help	reduce	expo-
sure	to	airborne	fibers.	These	practices	include	
the	following:
■	 Limit	the	use	of	power	tools	unless	they	
are	equipped	with	 local	exhaust	or	dust	
collection	 systems.	 When	 possible,	 use	
hand	tools,	which	generate	less	dust	and	
fewer	airborne	particles.	
■	Use	HEPA-filtered	vacuums,	wet	sweeping,	
or	a	properly	enclosed	wet	vacuum	system	
for	cleaning	up	dust	containing	RCFs.
■	During	removal	of	RCF	products,	damp-
en	insulation	with	a	light	water	spray	to	
keep	fibers	and	dust	from	becoming	air-
borne.	
■	 Clean	work	 areas	 regularly	with	HEPA-
filtered	 vacuums	 or	 with	 wet	 sweeping	
methods	 to	minimize	 the	 accumulation	
of	debris.	
■	 Limit	access	to	areas	where	workers	may	
be	exposed	to	airborne	RCFs:	permit	only	
workers	who	are	essential	to	the	process	
or	operation.
Use	 good	 hygiene	 and	 sanitation	 to	 protect	
workers	 as	 well	 as	 people	 outside	 the	 work-
place	who	might	be	 contaminated	with	 take-
home	dust	and	fibers:	
■	Do	not	 allow	workers	 to	 smoke,	 eat,	 or	
drink	 in	work	 areas	where	 they	 contact	
RCFs.	
■	 If	RCFs	get	on	the	skin,	wash	with	warm	
water	and	mild	soap.
■	 Apply	skin	moisturizing	cream	as	needed	
to	 avoid	 dryness	 or	 irritation	 from	 re-
peated	washing.	
■	 Vacuum	 contaminated	 clothes	 with	 a	
HEPA-filtered	vacuum	before	leaving	the	
work	area.
—	Do	 not	 use	 compressed	 air	 to	 clean	
the	work	area	or	clothing.
—	Do	not	shake	clothes	to	remove	dust.
■	Do	not	wear	 contaminated	clothes	out-
side	the	work	area.	Instead,	take	the	fol-
lowing	measures	 to	prevent	 taking	con-
taminants	home:
—	Change	into	street	clothes	before	go-
ing	home.
—	Leave	 contaminated	 clothes	 at	 the	
workplace	to	be	laundered	by	the	em-
ployer.
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—	Store	 street	 clothes	 in	 separate	 areas	
of	 the	workplace	 to	 keep	 from	 con-
taminating	them.
■	 Provide	workers	with	 showers	and	have	
them	shower	before	leaving	work.	
■	 Prohibit	removal	of	contaminated	clothes	
or	other	items	from	the	workplace	[NIOSH	
1995b].
9.2.4 Personal Protective Equipment
Wear	 long	 sleeves,	 gloves,	 and	 eye	 protection	
when	 performing	 dusty	 activities	 involving	
RCFs.
9.2.5 Respiratory Protection
NIOSH	recommends	using	a	respirator	for	any	
task	involving	RCF	exposures	that	are	unknown	
or	have	been	documented	to	be	higher	than	the	
NIOSH	REL	of	0.5	 f/cm3	(TWA).	Respirators	
should	not	 be	 used	 as	 the	 primary	means	 of	
controlling	worker	exposures.	Instead,	NIOSH	
recommends	 using	 other	 exposure-reduction	
methods,	 such	 as	 product	 substitution,	 engi-
neering	 controls,	 and	 changes	 in	 work	 prac-
tices.	 However,	 respirators	 may	 be	 necessary	
when	available	engineering	controls	and	work	
practices	do	not	adequately	control	worker	ex-
posures	below	the	REL	for	RCFs.	NIOSH	rec-
ognizes	this	control	to	be	a	particular	challenge	
in	the	finishing	stages	of	RCF	product	manu-
facturing	as	well	as	during	the	installation	and	
removal	of	RCF	insulation	materials.
If	 respiratory	 protection	 is	 needed,	 the	 em-
ployer	 should	 establish	 a	 comprehensive	 re-
spiratory	 protection	program	 as	 described	 in	
the	 OSHA	 respiratory	 protection	 standard	
[29	CFR	1910.134].	Elements	of	a	respiratory	
protection	program	should	be	established	and	
described	 in	 a	written	plan	 that	 is	 specific	 to	
the	workplace.	This	 respirator	program	must	
include	the	following:
■	 Procedures	for	selecting	respirators
■	Medical	evaluations	of	workers	required	
to	wear	respirators
■	 Fit	testing	procedures
■	 Routine	 use	 procedures	 and	 emergency	
respirator	use	procedures
■	 Procedures	 and	 schedules	 for	 cleaning,	
disinfecting,	 storing,	 inspecting,	 repair-
ing,	discarding,	 and	maintaining	 respi-
rators
■	 Procedures	 for	 ensuring	 adequate	 air	
quality	for	supplied-air	respirators
■	 Training	in	respiratory	hazards
■	 Training	 in	 the	proper	use	 and	mainte-
nance	of	respirators
■	 Program	evaluation	procedures
■	 Procedures	 for	 ensuring	 that	 workers	
who	voluntarily	wear	respirators	(exclud-
ing	filtering	facepiece	respirators	known	
as	 dust	 masks)	 comply	 with	 the	 medi-
cal	evaluation	and	cleaning,	storing,	and	
maintenance	 requirements	 contained	 in	
Appendix	 D	 of	 the	 OSHA	 respiratory	
protection	standard	
■	 A	designated	program	administrator	who	
is	qualified	to	administer	the	respiratory	
protection	program
The	 written	 respiratory	 protection	 program	
should	be	updated	as	necessary	to	account	for	
changes	in	the	workplace	that	affect	respirator	
use.	All	equipment,	training,	and	medical	eval-
uations	required	under	the	respiratory	protec-
tion	program	should	be	provided	at	no	cost	to	
workers.	Workers	 should	use	only	 respirators	
that	have	been	certified	by	NIOSH	[2002].
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When	airborne	RCF	concentrations	exceed	the	
REL,	NIOSH	recommends	the	following	respi-
ratory	protection:
■	 At	 a	 minimum,	 use	 a	 half-mask,	 air-
purifying	 respirator	 equipped	 with	 a	
100	 series	 particulate	 filter	 (this	 res-
pirator	has	an	assigned	protection	factor	
(APF)	of	10.	
■	 For	 a	 higher	 level	 of	 protection	 and	 for	
prevention	 of	 facial	 or	 eye	 irritation,	 use	
a	 full-facepiece,	 air-purifying	 respirator	
(equipped	with	a	100	 series	filter)	or	 any	
powered,	air-purifying	respirator	equipped	
with	a	tight-fitting	full	facepiece.	
■	 For	greater	 respiratory	protection	when	
the	 work	 involves	 potentially	 high	 air-
borne	 fiber	 concentrations	 (such	 as	 re-
moval	 of	 after-service	 RCF	 insulation	
such	 as	 furnace	 insulation),	 use	 a	 sup-
plied-air	respirator	equipped	with	a	 full	
facepiece,	 since	 airborne	 exposure	 to	
RCFs	can	be	high	and	unpredictable.	
A	comprehensive	assessment	of	workplace	ex-
posures	should	always	be	performed	to	deter-
mine	the	presence	of	other	possible	contami-
nants	 (such	 as	 silica)	 and	 to	 ensure	 that	 the	
proper	respiratory	protection	is	used.	Table	9–1	
provides	additional	guidance	for	selecting	ap-
propriate	respiratory	protection	with	regard	to	
airborne	fiber	concentrations	and	the	NIOSH	
REL	for	RCFs.	
Workers	may	voluntarily	choose	to	use	respi-
ratory	 protection	 even	 when	 airborne	 fiber	
concentrations	 are	 below	 the	 NIOSH	 REL	
or	 other	 applicable	 Federal	 or	 State	 stan-
dards.	When	respirators	are	used	voluntarily	
by	workers,	employers	need	to	establish	only	
those	 respiratory	 protection	 program	 ele-
ments	necessary	to	assure	that	the	respirator	
itself	is	not	a	hazard	[29	CFR	1910.134].	The	
exception	is	that	filtering-facepiece	respirators	
(for	example,	any	95	or	100	series	filter)	can	be	
used	without	a	respirator	protection	program	
when	they	are	used	voluntarily.	
For	information	and	assistance	in	establishing	
a	respiratory	protection	program	and	selecting	
appropriate	 respirators,	 see	 the	OSHA	Respi-
ratory	Protection	Advisor	on	 the	OSHA	Web	
site	 at	 http://www.osha.gov.	Additional	 infor-
mation	 is	 available	 from	 the	NIOSH Respira-
tor Selection Logic	[NIOSH	2004]	document	at	
http://www.cdc.gov/niosh/docs/2005–100	 and	
the	NIOSH Guide to the Selection and Use of 
Particulate Respirators Certified under 42 CFR 
84	[NIOSH	1996].
9.3 Exposure Monitoring
9.3.1 Workplace Exposure Monitoring 
 Program
The	workplace	 exposure	monitoring	 program	
for	worksites	where	RCFs	or	RCF	products	are	
manufactured,	handled,	or	used	should	include	
routine	 environmental	 and	 personal	monitor-
ing	of	airborne	fiber	concentrations.	The	moni-
toring	 strategy	 should	 be	 designed	 to	 assess	
the	effectiveness	of	engineering	controls,	work	
practices,	 PPE,	 training,	 and	 other	 factors	 in	
controlling	 airborne	 fiber	 concentrations.	 The	
monitoring	 program	 should	 also	 be	 used	 to	
identify	areas	or	 tasks	 that	 are	associated	with	
higher	exposures	to	RCFs	and	that	therefore	re-
quire	additional	efforts	to	reduce	them.
The	 goal	 of	 an	 RCF	 exposure	 monitoring	
program	is	to	ensure	a	more	healthful	work	
environment	where	worker	 exposure	 (mea-
sured	by	full-shift	samples)	does	not	exceed	
the	REL.	Because	adverse	respiratory	health	
effects	can	occur	at	the	REL	for	RCFs,	achiev-
ing	 lower	concentrations	 is	desirable	when-
ever	 possible.	 For	 work	 involving	 potential	
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Table 9–1 . Respiratory protection for exposure to RCFs*
Airborne concentration of 
RCFs or conditions of use Minimum respiratory protection options
5.0	f/cm3	(10	×	REL) Any	air-purifying,	elastomeric	half-mask	respirator	equipped	with	
a	100	series	(NH,	R,	or	P)	filterI
Any	negative	pressure	(demand),	suppled-air	respirator	equipped	
with	a	half	mask
12.5	f/cm3	(25	×	REL) Any	powered,	air-purifying	respirator	equipped	with	a	hood	or	hel-
met	and	a	high-efficiency	particulate	air	filter	(HEPA	filter)
Any	continuous-flow,	supplied-air	respirator	equipped	with	a	hood	
or	helmet
25	f/cm3	(50	×	REL) Any	air-purifying,	full-facepiece	respirator	equipped	with	a	100	
series	(NH,	R,	or	P)	filterI
Any	powered,	air-purifying	respirator	equipped	with	a	tight-fitting	
facepiece	(half	or	full	facepiece)	and	a	HEPA	filter
Any	negative	pressure	(demand),	supplied-air	respirator	equipped	
with	a	full	facepiece
Any	continuous	flow,	supplied-air	respirator	equipped	with	a	tight-
fitting	facepiece	(half	or	full	facepiece)
Any	negative	pressure	(demand),	self-contained	respirator	
equipped	with	a	full	facepiece
500	f/cm3	(1,000	×	REL) Any	pressure	demand,	supplied-air	respirator	equipped	with	a	
half-mask
*Abbreviations:	APFs=assigned	protection	factors;	HEPA=high-efficiency	particulate	air;	NIOSH=National	Institue	for	Occupational	
Safety	and	Health;	RCFs=refractory	ceramic	fibers.	
HN-100	series	particulate	filters	should	not	be	used	in	environments	where	there	is	potential	for	exposure	to	oil	mists.
IAssigned	protection	factors	(APFs)	for	other	half-mask	and	full-facepiece	particulate	respirators	certified	under	42	CFR	Part	84	are	
being	studied	by	NIOSH.	Recommended	APFs	for	these	respirators	will	be	revised	accordingly.
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exposure	to	airborne	RCFs,	perform	the	expo-
sure	sampling	survey	as	follows:
■	 Collect	 representative	 personal	 samples	
for	 the	 entire	 work	 shift	 using	 NIOSH	
Method	 7400	 (B	 rules)	 [NIOSH	 1977a,	
1998].	
■	 Perform	 periodic	 sampling	 at	 least	 an-
nually	 and	whenever	 any	major	process	
change	takes	place	or	another	reason	ex-
ists	 to	 suspect	 that	 exposure	 concentra-
tions	may	have	changed.	
■	 Collect	 all	 routine	 personal	 samples	 in	
the	breathing	zones	of	the	workers.
■	 For	 workers	 exposed	 to	 concentrations	
above	 the	 REL,	 perform	more	 frequent	
exposure	 monitoring	 until	 at	 least	 two	
consecutive	 samples	 indicate	 that	 the	
worker’s	exposures	no	longer	exceed	the	
REL.	
■	Notify	all	workers	about	monitoring	re-
sults	 and	 any	 actions	 taken	 to	 reduce	
their	exposures.
■	Make	 sure	 that	 any	 sampling	 strategy	
considers	 variations	 in	 work	 and	 pro-
duction	schedules	as	well	as	the	inherent	
exposure	variability	 in	most	workplaces	
[NIOSH	1995a].	
9.3.2 Action Level
NIOSH	 has	 recommended	 an	 action	 level	
(AL)	of	 0.25	 f/cm3	for	determining	when	 ad-
ditional	 controls	 are	needed	or	when	admin-
istrative	 actions	 should	 be	 taken	 to	 reduce	
RCF	 exposures.	 The	 purpose	 of	 the	AL	 is	 to	
indicate	when	worker	exposures	to	RCFs	may	
be	approaching	the	REL.	Measurement	of	ex-
posure	concentrations	at	or	above	 the	AL	 in-
dicate	 that	 there	 is	 a	high	degree	of	 certainty	
that	RCF	concentrations	exceed	the	REL.	The	
AL	is	a	statistically	derived	concept	permitting	
the	employer	to	have	confidence	(for	example,	
95%)	that	if	the	measured	exposure	concentra-
tion	is	below	the	AL,	only	a	small	probability	
exists	that	the	exposure	concentration	is	above	
the	 REL.	NIOSH	 has	 concluded	 that	 the	 use	
of	 an	AL	permits	 employers	 to	monitor	RCF	
exposures	 in	 the	 workplace	 without	 devot-
ing	unnecessary	resources	to	conducting	daily	
exposure	measurements.	The	AL	 concept	has	
served	as	the	basis	for	defining	the	elements	of	
an	 occupational	 standard	 in	 NIOSH	 criteria	
documents	 and	 in	 comprehensive	 standards	
promulgated	 by	OSHA	 and	MSHA.	 Employ-
ers	should	determine	whether	the	use	of	an	AL	
of	0.25	f/cm3	provides	adequate	assurance	that	
worker	exposures	are	being	maintained	below	
the	REL.	In	some	work	environments,	the	high	
degree	 of	 exposure	 variability	 for	 certain	 job	
tasks	may	require	a	lower	AL	to	assure	that	ex-
posures	are	being	maintained	below	the	REL.	
Similar	 exposure	 monitoring	 strategies	 have	
been	espoused	by	the	American	Industrial	Hy-
giene	Association,	which	 recommends	 that	 if	
measured	exposures	are	 less	 than	10%	of	 the	
designated	 exposure	 limit	 (for	 example,	 REL	
or	PEL),	there	is	a	high	degree	of	certainty	that	
the	exposure	limit	will	not	be	exceeded.
9.3.3 Sampling Strategies
When	sampling	to	determine	whether	work-
er	 exposures	 are	 below	 the	 REL,	 a	 focused	
sampling	 strategy	 may	 be	 more	 practical	
than	random	sampling.	A	focused	sampling	
strategy	 targets	 workers	 perceived	 to	 have	
the	highest	exposure	concentrations	[Leidel	
and	Busch	1994].	A	focused	strategy	is	most	
efficient	for	identifying	exposures	above	the	
REL	if	maximum-risk	workers	and	time	pe-
riods	are	accurately	identified.	Focused	sam-
pling	may	help	identify	short-duration	tasks	
involving	high	airborne	fiber	concentrations	
that	could	result	in	elevated	exposures	over	a	
full	work	shift.	
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Sampling	 strategies	 such	 as	 those	 used	 by	
Corn	 and	 Esmen	 [1979],	 Rice	 et	 al.	 [1997],	
and	Maxim	et	al.	[1997]	have	been	derived	and	
used	in	RCF	manufacturing	facilities	to	moni-
tor	airborne	fiber	concentrations	by	 selecting	
representative	workers	for	sampling.	The	rep-
resentative	workers	 are	 grouped	 according	 to	
dust	zones,	uniform	job	titles,	or	functional	job	
categories.	 These	 approaches	 are	 intended	 to	
reduce	the	number	of	required	samples	while	
increasing	the	confidence	of	identifying	work-
ers	at	similar	risk.	
Area	sampling	may	also	be	useful	in	exposure	
monitoring	 for	 determining	 sources	 of	 air-
borne	RCF	exposures	and	assessing	the	effec-
tiveness	of	engineering	controls.
9.4 Medical Monitoring
NIOSH	recommends	periodic	medical	evalu-
ation,	or	medical	monitoring,	of	RCF-exposed	
workers	to	identify	potential	health	effects	and	
symptoms	that	may	be	related	to	contact	with	
airborne	fibers.	The	following	sections	describe	
the	objectives	of	medical	monitoring	and	the	
elements	of	a	medical	monitoring	program	for	
workers	exposed	to	RCFs.
The	 primary	 goals	 of	 a	 workplace	 medical	
monitoring	 program	 are	 (1)	 early	 identifi-
cation	 of	 adverse	 health	 effects	 that	may	 be	
related	to	exposures	at	work	and	(2)	possible	
health	trends	within	groups	of	exposed	work-
ers.	These	goals	are	based	on	the	premise	that	
early	 detection,	 subsequent	 treatment,	 and	
workplace	 interventions	 will	 ensure	 the	 con-
tinued	health	of	the	affected	workforce.	
9.4.1 Objectives of Medical Monitoring 
Medical	 monitoring	 and	 resulting	 interven-
tions	 represent	 secondary	 prevention	 and	
should	not	replace	primary	prevention	efforts	
to	minimize	worker	exposures	to	RCFs.	In	the	
case	of	RCFs,	medical	monitoring	is	especially	
important	because	achieving	compliance	with	
the	REL	of	 0.5	 f/cm3	does	not	 assure	 that	 all	
workers	will	be	free	from	the	risk	of	respiratory	
irritation	or	chronic	respiratory	disease	caused	
by	occupational	exposure.	Early	identification	
of	 respiratory	 system	 changes	 and	 symptoms	
associated	 with	 RCF	 exposures	 (such	 as	 de-
creased	 pulmonary	 function,	 irritation,	 dys-
pnea,	 chronic	 cough,	 wheezing,	 and	 pleural	
plaques)	may	signal	the	need	for	more	inten-
sive	medical	monitoring	and	the	assessment	of	
existing	controls	to	minimize	the	risk	of	long-
term	adverse	health	effects.	An	ongoing	medi-
cal	monitoring	program	also	serves	to	inform	
workers	of	potential	health	risks	and	promotes	
an	understanding	of	the	need	for	and	support	
of	exposure	control	activities.
A	medical	monitoring	program	serves	as	an	ef-
fective	 secondary	 prevention	method	 on	 two	
levels—screening	 and	 surveillance.	 Medical	
screening	in	the	workplace	focuses	on	the	early	
detection	 of	 health	 outcomes	 for	 individual	
workers	and	may	involve	an	occupational	his-
tory,	medical	examination,	and	application	of	
specific	medical	tests	to	detect	the	presence	of	
toxicants	 or	 early	 pathologic	 changes	 before	
the	worker	would	normally	 seek	 clinical	 care	
for	symptomatic	disease.	By	contrast,	medical	
surveillance	(described	in	Section	9.5)	involves	
the	ongoing	evaluation	of	the	health	status	of	
a	group	of	workers	through	the	collection	and	
aggregate	 analysis	of	health	data	 for	 the	pur-
pose	of	preventing	disease	and	evaluating	the	
effectiveness	of	intervention	programs.	
9.4.2 Criteria for Medical Screening
To	determine	whether	 tests	or	procedures	 for	
medical	screening	are	appropriate	and	relevant	
to	a	given	hazard	(in	this	case,	exposure	to	air-
borne	RCFs),	 the	 following	 factors	 should	be	
considered:
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■	 Prevalence	 of	 an	 associated	 disease	 or	
symptoms	in	the	population
■	 Risk	of	 toxicity	 associated	with	 the	ex-
posure
■	 Consequences	of	false	positive	test	results
■	 Sensitivity,	specificity,	and	predictive	val-
ue	of	the	screening	test(s)	to	be	used
■	 Reliability	 and	 validity	 of	 the	 screening	
test(s)
■	 Ability	of	the	screening	test(s)	to	identify	
disease	 early	 so	 that	 effective	 treatment	
or	 intervention	may	be	used	 to	 impede	
disease	progression
■	 Availability,	accessibility,	and	acceptabil-
ity	of	 followup,	 further	diagnostic	 tests,	
and	effective	management	of	the	disease
■	 Benefits	of	 the	screening	program	com-
pared	with	the	costs	[Wagner	1996].
On	 the	 basis	 of	 these	 criteria,	 NIOSH	 rec-
ommends	 a	 medical	 screening	 program	 for	
RCF-exposed	workers	 that	 require	 initial	 and	
periodic	medical	 examinations.	The	elements	
of	 the	program	should	 include	a	physical	 ex-
amination,	 occupational	 history,	 respiratory	
symptom	 questionnaire,	 spirometric	 test-
ing,	and	chest	radiograph	when	warranted.	If	
a	 particular	 medical	 screening	 test	 indicates	
the	 presence	 of	 exposure-related	 disease	 or	
the	 increased	probability	 that	disease	will	de-
velop,	 further	 evaluation	 and	diagnostic	 test-
ing	may	be	needed.	Recommended	guidelines	
and	schedules	for	specific	medical	tests	are	de-
scribed	 in	 Section	9.4.5	 (Recommended	Pro-
gram	Elements).
9.4.3 Worker Participation
All	 workers	 potentially	 exposed	 to	 RCFs,	 in	
both	 manufacturing	 and	 end-use	 industries,	
may	benefit	by	being	 included	 in	 an	occupa-
tional	medical	monitoring	program.	Workers	
should	 be	 provided	 with	 information	 about	
the	purposes	of	medical	monitoring,	the	health	
benefits	 of	 the	 program,	 and	 the	 procedures	
involved.	 The	 following	 hierarchy	 describes	
workers	who	should	be	included	in	a	medical	
monitoring	 program	 and	 who	 could	 receive	
the	greatest	benefit	from	medical	screening:
■	Workers	 exposed	 to	 elevated	 fiber	 con-
centrations	(for	example,	all	workers	ex-
posed	to	airborne	RCFs	at	concentrations	
above	the	AL	of	0.25	f/cm3	[described	in	
Section	9.3])	
■	Workers	 in	 areas	 or	 in	 jobs	 and	 activi-
ties	in	which,	regardless	of	airborne	fiber	
concentration,	one	or	more	workers	have	
recently	developed	symptoms	or	respira-
tory	 changes	 apparently	 related	 to	 RCF	
exposure
■	Workers	who	may	have	been	previously	
exposed	to	asbestos	or	other	respiratory	
hazards	 that	place	 them	at	an	 increased	
risk	of	respiratory	disease
■	Workers	with	potential	 exposure	 to	 air-
borne	RCFs	who	also	smoke	cigarettes	or	
other	tobacco	products	(see	Section	9.6,	
Smoking	Cessation).
9.4.4 Medical Monitoring Program 
 Director
Oversight	 of	 the	 medical	 monitoring	 pro-
gram	should	be	assigned	by	the	employer	 to	
a	qualified	physician	or	other	qualified	health	
care	 provider	 (as	 determined	 by	 appropriate	
State	 laws	 and	 regulations)	 who	 is	 informed	
and	knowledgeable	about	the	following:
■	 The	administration	and	management	of	
a	medical	monitoring	program	for	occu-
pational	hazards
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■	 The	establishment	of	a	respiratory	protec-
tion	program	based	on	an	understanding	
of	the	requirements	of	the	OSHA	respi-
ratory	protection	 standard	and	 types	of	
respiratory	 protection	 devices	 available	
at	the	workplace
■	 The	 identification	 and	 management	 of	
work-related	respiratory	effects	or	illnesses
■	 The	 identification	 and	 management	 of	
work-related	skin	diseases
9.4.5 Recommended Program 
 Elements 
Recommended	 elements	 of	 a	 medical	 moni-
toring	program	 for	workers	 exposed	 to	RCFs	
include	 provisions	 for	 an	 initial	 medical	 ex-
amination	and	periodic	medical	examinations	
at	regularly	scheduled	intervals.	Depending	on	
the	 findings	 from	 these	 examinations,	 more	
frequent	 and	 detailed	 medical	 examinations	
may	 be	 necessary.	 Worker	 education	 should	
also	be	included	as	a	component	of	the	medi-
cal	monitoring	program.	Specific	elements	of	
the	examinations	and	scheduling	are	described	
below	and	illustrated	in	the	flow	chart	diagram	
in	Figure	9–1.
9.4.5.1 Initial medical examination
An	 initial	 (baseline)	 examination	 should	 be	
performed	as	near	as	possible	to	the	date	of	be-
ginning	employment	(within	3	months).	The	
initial	medical	examination	should	include	the	
following:
■	 A	 physical	 examination	 of	 all	 systems,	
with	emphasis	on	the	respiratory	system	
and	the	skin	
■	 A	spirometric	test	(Anyone	administering	
spirometric	 testing	as	part	of	 the	medi-
cal	 monitoring	 program	 should	 have	
completed	 a	 NIOSH-approved	 training	
course	in	spirometry	or	other	equivalent	
training.)	
■	 A	chest	X-ray	(All	chest	X-ray	films	should	
be	 interpreted	 by	 a	 NIOSH-certified	 B	
reader	 using	 the	 standard	 International	
Classification	 of	 Radiographs	 of	 Pneu-
moconioses	[ILO	2000	or	the	most	recent	
equivalent].)	
■	Other	medical	tests	as	deemed	appropri-
ate	 by	 the	 attending	health	 care	 profes-
sional
■	 A	standardized	respiratory	symptom	ques-
tionnaire	such	as	the	American	Thoracic	
Society	Respiratory	Questionnaire	[Ferris	
1978	or	the	most	recent	equivalent]	with	
additional	questions	to	address	symptoms	
of	pleuritic	chest	pain	and	pleurisy	
■	 A	standardized	occupational	history	ques-
tionnaire	 that	 gathers	 (1)	 information	
about	all	past	jobs	(with	special	emphasis	
on	those	with	potential	exposure	to	dust),	
(2)	a	description	of	all	duties	and	poten-
tial	exposures	for	each	job,	and	(3)	a	de-
scription	of	all	protective	equipment	 the	
worker	has	used
9.4.5.2 Periodic medical examinations
Periodic	 examinations	 (including	 a	 physical	
examination	of	the	respiratory	system	and	the	
skin,	spirometric	testing,	a	respiratory	symptom	
update	 questionnaire,	 and	 an	 occupational	
history	 update	 questionnaire)	 should	 be	 ad-
ministered	at	 regular	 intervals	determined	by	
the	medical	monitoring	program	director.	The	
frequency	 of	 the	 periodic	 medical	 examina-
tions	 should	 be	 determined	 according	 to	 the	
following	guidelines:
■	 For	 workers	 with	 fewer	 than	 10	 years	
since	first	exposure	to	RCFs,	periodic	ex-
aminations	should	be	conducted	at	least	
once	every	5	years.
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I. Worker participation?
Work	involves	potential	for	exposure	to	RCFs,	especial-
ly	for	workers	who	are
■	 exposed	to	elevated	fiber	concentrations	(for	
example,	above	a	designated	AL),
■	 in	work	areas	where	one	or	more	workers	have	
recently	developed	respiratory	symptoms	or	
changes,
■	 previously	exposed	to	asbestos	or	other	respira-
tory	hazards
YES
II. Initial medical examination
(within	3	months	of	beginning	employment)
■	 Examination	of	respiratory	system	and	skin
■	 Spirometric	test
■	 Chest	X-ray
■	 Standardized	respiratory	symptom	question-
naire
■	 Standardized	occupational	history	question-
naire
III. Adverse symptoms/health outcomes?
■	 Respiratory	symptoms	(for	example,	chronic	
cough,	difficulty	breathing,	shortness	of	breath,	
wheezing)
■	 Recurrent	or	chronic	dermatitis
■	 Medically	significant	reason	for	additional	as-
sessment
YES
IV. More frequent or detailed medical 
     examination and treatment
(as	determined	by	program	director)
NO May	not	require	medical	monitoring
NO
V. Periodic medical examination
■	 Examination	of	respiratory	system	and	skin
■	 Spirometric	test
■	 Standardized	respiratory	symptom	update	
questionnaire
■	 Standardized	occupational	history	update	
questionnaire
YES
VI. Adverse symptoms/health outcomes?
(described	in	III.)
VII. Continue with guidance and schedule 
in V.
Figure 9–1 .	Flow	chart	of	medical	monitoring	guidelines	for	workers	exposed	to	RCFs.	This	flow	chart	is	intended	as	
a	simplified	representation	of	the	minimum	requirements	of	the	recommended	medical	monitoring	program	guide-
lines.	Administration	and	management	of	the	program	should	ultimately	rely	on	the	judgment	of	the	medical	moni-
toring	program	director.	Frequency	of	periodic	medical	examinations	are	as	follows:
■	 If	time	since	first	RCF	exposure	is	<10	years,	examinations	should	be	conducted	at	least	every	5	years.
■	 If	time	since	first	RCF	exposure	is	≥10	years,	then	examinations	should	be	conducted	at	least	every	2	years.
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■	 For	workers	with	10	or	more	years	since	
first	exposure	to	RCFs,	periodic	examina-
tions	 should	be	conducted	at	 least	once	
every	2	years.	
A	chest	X-ray	and	spirometric	testing	are	im-
portant	upon	initial	examination	and	may	also	
be	appropriate	medical	screening	tests	during	
periodic	 examinations	 for	 detecting	 respira-
tory	 system	 changes—especially	 in	 workers	
with	more	 than	 10	 years	 since	 first	 exposure	
to	 RCFs.	 The	 value	 of	 periodic	 chest	 X-rays	
in	 a	medical	monitoring	 program	 should	 be	
evaluated	by	a	qualified	health	care	provider	in	
consultation	with	the	worker	to	assess	whether	
the	 benefits	 of	 testing	warrant	 the	 additional	
exposure	 to	 radiation.	As	with	 the	 frequency	
of	 periodic	 examinations,	 the	 utility	 of	 the	
chest	X-ray	as	a	medical	 test	becomes	greater	
for	workers	with	more	than	10	years	since	first	
exposure	to	RCFs	(based	on	the	latency	period	
between	first	exposure	and	appearance	of	no-
ticeable	 respiratory	 system	 changes).	 Because	
persons	 with	 advanced	 fiber-related	 pleural	
changes	 experience	 difficulty	 in	 breathing	 as	
the	parietal	 and	 visceral	 surfaces	 become	 ad-
herent	and	lose	flexibility,	it	may	prove	benefi-
cial	to	detect	fibrotic	changes	in	the	early	stages	
so	steps	may	be	taken	to	prevent	further	lung	
damage.	Similar	 recommendations	have	been	
made	for	asbestos-exposed	workers	diagnosed	
with	pleural	fibrosis	or	pleural	plaques	to	pre-
vent	more	serious	types	of	respiratory	disease	
[Balmes	1990].
9.4.5.3 More frequent medical 
examinations
Any	worker	should	undergo	more	frequent	and	
detailed	medical	evaluation	if	he	or	she	has	any	
of	the	following	indications:
■	New	or	worsening	respiratory	symptoms	
or	findings	(for	example,	chronic	cough,	
difficulty	 breathing,	 wheezing,	 reduced	
lung	 function,	or	 radiographic	evidence	
of	pleural	plaques	or	fibrosis)
■	History	of	exposure	to	other	respiratory	
hazards	(for	example,	asbestos)
■	 Recurrent	or	chronic	dermatitis
■	Other	medically	significant	reason(s)	for	
more	detailed	assessment
9.4.5.4 Worker education
Workers	 should	 be	 provided	 with	 sufficient	
training	 to	 recognize	 symptoms	 associated	
with	 RCF	 exposures	 (such	 as	 chronic	 cough,	
difficulty	 breathing,	 wheezing,	 and	 skin	 irri-
tation).	Workers	 should	 also	be	 instructed	 to	
report	 these	 symptoms	 to	 designated	 safety	
and	health	personnel	and	a	physician	or	other	
qualified	health	care	provider	 for	appropriate	
diagnosis	and	treatment.	
9.4.6 Written Reports to the Worker
Following	initial	and	periodic	medical	exami-
nations,	the	physician	or	other	qualified	health	
care	provider	should	provide	each	worker	with	
a	written	report	containing	the	following:
■	 Results	 of	 any	 medical	 tests	 performed	
on	the	worker
■	Medical	opinion	in	plain	language	about	
any	 medical	 condition	 that	 would	 in-
crease	 the	 worker=s	 risk	 of	 impairment	
from	exposure	to	airborne	RCFs
■	 Recommendations	 for	 limiting	 the	
worker=s	 exposure	 to	 RCFs,	 which	may	
include	 the	 use	 of	 appropriate	 PPE,	 as	
warranted
■	 Recommendations	for	further	evaluation	
and	treatment	of	medical	conditions	de-
tected	
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9.4.7 Written Reports to the Employer
Following	initial	and	periodic	medical	exami-
nations,	the	physician	or	other	qualified	health	
care	provider	should	provide	a	written	report	
to	the	employer	containing	the	following:	
■	Occupationally	 pertinent	 results	 of	 the	
medical	evaluation
■	 A	 medical	 opinion	 about	 any	 medi-
cal	 condition	 that	 would	 increase	 the	
worker=s	risk	of	impairment	from	expo-
sure	to	airborne	RCFs
■	 Recommendations	 for	 limiting	 the	
worker=s	 exposure	 to	 RCFs	 (or	 other	
agents	in	the	workplace),	which	may	in-
clude	the	use	of	appropriate	PPE	or	reas-
signment	to	another	job,	as	warranted
■	 A	statement	 to	 indicate	 that	 the	worker	
has	 been	 informed	 about	 results	 of	 the	
medical	examination	and	about	the	med-
ical	condition(s)	that	should	have	further	
evaluation	or	treatment
Findings,	test	results,	or	diagnoses	that	have	no	
bearing	 on	 the	worker=s	 ability	 to	work	with	
RCFs	should	not	be	included	in	the	report	to	
the	 employer.	 Safeguards	 to	 protect	 the	 con-
fidentiality	 of	 the	 worker=s	 medical	 records	
should	be	enforced	in	accordance	with	all	ap-
plicable	regulations	and	guidelines.	
9.4.8 Employer Actions
The	employer	should	assure	that	the	qualified	
health	 care	 provider=s	 recommended	 restric-
tions	of	a	worker=s	exposure	to	RCFs	or	to	oth-
er	workplace	hazards	are	followed	and	that	the	
REL	for	RCFs	is	not	exceeded	without	requir-
ing	the	use	of	PPE.	Efforts	to	encourage	worker	
participation	 in	 the	medical	monitoring	pro-
gram	and	to	report	symptoms	promptly	to	the	
program	director	are	essential	for	the	program=s	
success.	Medical	evaluations	performed	as	part	
of	 the	 medical	 monitoring	 program	 should	
be	provided	by	the	employer	at	no	cost	to	the	
participating	workers.	If	the	recommended	re-
strictions	determined	by	the	medical	program	
director	 include	 job	 reassignment,	 such	 reas-
signment	should	be	implemented	with	the	as-
surance	of	economic	protection	for	the	worker.	
When	medical	removal	or	job	reassignment	is	
indicated,	the	affected	worker	should	not	suf-
fer	loss	of	wages,	benefits,	or	seniority.
The	employer	should	ensure	that	the	medical	
monitoring	 program	 director	 communicates	
regularly	with	the	employer=s	safety	and	health	
personnel	(such	as	 industrial	hygienists),	em-
ployee	 representatives,	 and	 safety	 and	 health	
committees	to	identify	work	areas	that	may	re-
quire	evaluation	and	implementation	of	con-
trol	measures	to	minimize	the	risk	from	expo-
sure	to	hazards.
9.5 Surveillance of Health 
 Outcomes
Standardized	 medical	 screening	 data	 should	
be	periodically	aggregated	and	evaluated	by	an	
epidemiologist	or	other	knowledgeable	person	
to	identify	patterns	of	worker	health	that	may	
be	linked	to	work	activities	and	practices	that	
require	additional	primary	prevention	efforts.	
Routine	 aggregate	 assessments	 of	 medical	
screening	data	should	be	used	in	combination	
with	evaluations	of	exposure	monitoring	data	
to	identify	changes	needed	in	work	areas	or	ex-
posure	conditions.	
One	example	of	 surveillance	using	analyses	of	
medical	 screening	 data	 is	 the	 ongoing	 epide-
miologic	study	of	RCF	workers	described	in	the	
RCFC	product	 stewardship	plan	referred	 to	as	
PSP	2000	[RCFC	2001].	Elements	of	 this	plan	
may	be	adapted	and	modified	by	other	employ-
ers	to	develop	medical	surveillance	programs	for	
workers	who	are	potentially	exposed	to	RCFs.
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9.6 Smoking Cessation
NIOSH	recognizes	a	synergistic	effect	between	
exposure	 to	RCFs	and	cigarette	 smoking	 that	
increases	the	risk	of	adverse	respiratory	health	
effects.	The	combined	effects	of	smoking	and	
dust	 exposures	 have	 been	 recognized	 as	 con-
tributing	 to	 the	 increased	 risk	 of	 respiratory	
diseases,	including	chronic	bronchitis,	emphy-
sema,	and	lung	cancer.	NIOSH	urges	employ-
ers	 to	 establish	 smoking	 cessation	 programs	
that	 (1)	 inform	 workers	 about	 the	 increased	
hazards	of	cigarette	smoking	and	exposure	to	
RCFs	and	 (2)	provide	 assistance	 and	encour-
agement	for	workers	who	want	to	quit	smok-
ing.	 NIOSH	 recommends	 that	 all	 workers	
who	are	potentially	 exposed	 to	airborne	RCF	
fibers	and	who	also	smoke	should	participate	
in	a	smoking	cessation	program.	With	regard	
to	smoking	 in	the	workplace,	NIOSH	recom-
mends	that	employers	do	the	following:
■	 Prohibit	 workers	 from	 smoking	 in	 the	
workplace.
■	Disseminate	 information	 about	 health	
promotion	 and	 the	 harmful	 effects	 of	
smoking.
■	Offer	smoking	cessation	programs	to	work-
ers	at	no	cost	to	participants.
■	 Collect	detailed	smoking	histories	as	part	
of	the	medical	monitoring	program.
■	Use	 training,	 employee	 assistance	 pro-
grams,	or	health	education	campaigns	to	
encourage	 activities	 promoting	 physical	
fitness	 and	 other	 healthy	 lifestyle	 prac-
tices	 that	 affect	 respiratory	 and	 cardio-
vascular	health.
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NIOSH	[1993]	has	developed	a	fiber	research	
strategy	that	proposes	the	following:
■	 Research	 into	 the	 mechanisms	 for	 hu-
man	fiber	disease
■	 Epidemiologic	 studies	 of	 fiber-exposed	
workers	 for	whom	 limited	or	no	health	
data	exist
■	 Toxicologic	 experiments	 with	 fibers	 for	
which	health	effects	have	not	been	estab-
lished
The	research	strategy	also	considers	the	useful-
ness	of	integrating	fiber	data	from	various	sci-
entific	 disciplines	 (toxicology,	 epidemiology,	
industrial	hygiene,	occupational	medicine)	 to	
elucidate	the	characteristics	of	fibers.
In	addition,	NIOSH	recommends	that	the	follow-
ing	steps	be	taken	with	regard	to	RCF	research:	
1.	 Conduct	basic	scientific	investigations,	
including	 in	 vitro	 and	 in	 vivo	 animal	
studies,	to	delineate	the	mechanism	of	
action	for	RCF	toxicity.
2.	 Conduct	 comparable	 studies	 for	 oth-
er	SVFs	and	natural	fibers	 so	 that	 the	
mechanistic	data	can	be	compared.	For	
instance,	Coffin	et	al.	[1992]	examined	
the	 ability	 of	 different	 synthetic	 and	
natural	fibers	to	induce	mesotheliomas.	
They	suggested	that	in	addition	to	fiber	
length	and	width,	currently	undefined	
intrinsic	 surface	 characteristics	 of	 the	
fibers	are	directly	related	to	their	meso-
thelioma	induction	potency.
3.	 Conduct	a	series	of	in	vitro	and	in	vivo	
animal	studies	to	ensure	that	fiber	tox-
icity	 studies	 share	 a	 consistent,	 stan-
dardized	 approach.	 Such	 studies	 will	
ensure	 comparability	 of	 results	 in	 a	
variety	of	experiments	that	all	use	well-
characterized,	 known	 concentrations	
of	 synthetic	or	natural	fibers.	A	 series	
of	controlled,	systematic	in	vitro	stud-
ies	of	the	factors	believed	to	be	involved	
in	RCF	pathogenicity	 should	 produce	
valuable	 data	 on	 their	 mechanism	 of	
action.	 In	vitro	studies	provide	an	ex-
cellent	opportunity	to	investigate	fiber	
toxicity	 factors	 such	 as	 dose,	 dimen-
sion,	 surface	 area,	 and	 physicochemi-
cal	 composition.	 This	 information	 is	
an	important	supplement	to	data	from	
chronic	inhalation	studies.
4.	 Assure	 that	an	 independent	agency	or	
testing	laboratory	assembles	and	keeps	
a	set	of	reference	samples	of	RCFs	(sim-
ilar	to	the	Union	Internationale	Contre	
le	 Cancer	 [UICC]	 asbestos	 samples).	
Well-characterized	RCF	material	repre-
sentative	of	that	found	in	occupational	
exposures	could	serve	as	an	important	
component	 of	 future	 animal	 toxicol-
ogy	 research	 into	 the	 mechanisms	 of	
fiber-induced	 disease.	 Additional	 SVF	
such	as	fibrous	glass,	mineral	wool,	and	
other	ceramic	fibers	should	also	be	rep-
resented	in	this	repository.
5.	 Initiate	 and	 continue	 occupational	
health	 surveillance	 for	 industries	 that	
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manufacture,	process,	install,	or	remove	
new	 fibrous	materials.	 Understanding	
of	this	emerging	industry	is	imperative	
so	 that	 exposures	 to	 synthetic	 fibrous	
materials	can	be	avoided	and	industry-
specific	controls	can	be	developed.
6.		 Continue	and	expand	surveillance	of	
RCF	 exposure	 in	 U.S.	 manufactur-
ing	 facilities.	 Continue	 monitoring	
of	airborne	fiber	and	total	particulate	
concentrations	 and	 analyze	 them	 to-
gether	with	 the	health	data	using	epi-
demiologic	 research	 methods.	 Extend	
surveillance	 efforts	 to	 include	 assess-
ments	of	worker	exposure	in	secondary	
facilities.
7.		 Assess	the	effects	of	variable	work	sched-
ules	(such	as	shifts	longer	than	8	hr)	on	
RCF	exposure	concentrations	and	health	
effects.
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Air Sampling Methods*
*Reprinted	from	NIOSH	Manual of Analytical Methods (NMAM),	Fourth	Edition,	8/15/94.
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Appendix B
Functional Job Categories 
for RCF Workers
Table B–1 . Functional job categories for RCF workers
Functional 
category Definition General examples Additional comments
Fiber	manufac-
turing
The	production	or	manu-
facture	of	RCF	bulk	
or	blanket,	except	in	a	
supervisory	capacity.		
Includes	all	job	func-
tions	on	the	production	
line,	from	mixing	the	raw	
ingredients	to	packaging	
the	finished	product	(bulk	
or	blanket)	at	the	end	of	
the	line.
Raw	materials,	furnace	man,	
furnace	operator,	or	assistant	
furnace	operator
Production	worker	or	relief
Blanket	line
Working	leader
Needler
Slit/cut/pack
Line	utility
Utility	operator
Chopper	operator
End	of	line,	bagging	of	bulk	RCF
End	of	line	trimming,	rolling,	
and	packaging	of	RCF	blanket
None	to	date
Finishing Cutting	or	machining	RCF	
materials	after	fiber	
manufacture.	Hand	or	
power	tools	may	be	used	
in	finishing	operations.
Operating	die	stamp	on	RCF	
blanket	or	paper	except	for	
automotive	applications
Sawing,	slotting,	trimming,	
or	filing	casting	tips	or	riser	
sleeves
Cutting	blanket	for	duct	wrap
Working	in	an	area	where	
finishing	is	taking	place	but	
not	personally	working	with	
RCFs	unless	in	a	supervisory	
capacity	or	in	other	auxiliary 
operations.
(Continued)
Adapted	from	Maxim	et	al.	1997.
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Table B–1 (Continued) . Functional job categories for RCF workers
Functional 
category Definition General examples Additional comments
Finishing	
(Continued)
Cutting	or	trimming	RCF	board	
or	other	vacuum-formed	RCF	
material	capacity
Sanding	RCF	board	or	other	
vacuum-formed	RCF	material
Loading	sander
Off-line	cutting	and	tandem	
rerolling	and/or	repackaging	
of	RCF	blanket
Cutting	or	trimming	RCF	mod-
ules	for	use	in	appliances
Milling	or	routing	RCF	board	
or	other	vacuum-formed	RCF	
material
Off-site	cutting	of	batten	strips	
from	RCF	blanket
EXAMPLE:	Unloading	dry	
forms	from	the	drying	
oven	and	taking	them	to	
the	finishing	area	for	final	
shaping,	or	packaging	shapes	
immediately	after	finishing	
would	be	considered	finish-
ing.	However,	unloading	dry	
forms	from	an	oven	and	tak-
ing	them	to	be	packaged,	or	
packaging	shapes	that	come	
directly	from	the	drying	
oven	would	be	considered	
auxiliary operations.
Installation Building	or	manufactur-
ing	industrial	furnaces	or	
boilers,	refinery	or	petro-
chemical	plant	equip-
ment,	kilns,	foundries,	
electric	power	generators,	
and	industrial	incinera-
tors	at	end	user	locations.		
Includes	furnace	mainte-
nance.	Does	not	include	
factory	manufacture	of	
industrial	furnace	compo-
nents.
Installing	hardware	or	modules
On-site	cutting	(trimming)	
modules	to	fit
Caulking	and	filling	gaps
Wrapping	molds	with	RCF
Spraying	or	pumping	RCF	cast-
able	material	inside	furnace
	Cutting	and	installing	laid-in	
blanket
Working	inside	furnace	dur-
ing	the	installation	of	RCF	
materials,	even	though	not	
working	directly	with	that	
material	(e.g.,	a	plumber	or	
electrician	working	inside	a	
furnace	during	an	installa-
tion)
Removal Removal	of	after-service	
RCF	material	from	an	in-
dustrial	furnace,	etc.,	that	
has	completed	its	eco-
nomic	life.	Includes	the	
removal	of	RCF	material	
during	furnace	mainte-
nance.
Unwrapping	and	knocking	out	
molds
Furnace	disassembly
Furnace	maintenance
Cleanup	and	disposal	of	re-
moved	material
Working	inside	furnace	dur-
ing	the	removal	of	RCF	
materials,	even	though	not	
working	directly	with	that	
material	(e.g.,	a	plumber	or	
electrician	working	inside	a	
furnace	during	a	removal)
Assembly		
operations
Combining	or	assembling	
RCF	material	with	other	
material	(RCF	or	other),	
except	automotive	appli-
cations.	Includes	factory	
assembly	of	industrial	
furnace	components.
Laminating
Cutting	material	for	modules
Encapsulating	RCF	blanket
Unpacking	blanket	and	loading	
into	module	folder
(Continued)
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Table B–1 (Continued) . Functional job categories for RCF workers
Functional 
category Definition General examples Additional comments
Assembly		
operations	
(Continued)
Installing	bands	around	modules
Packaging	modules	at	end	of	line
Trimming	modules	and	install-
ing		hardware
Assembling	appliances
Off-site	assembly	of	industrial	
furnace	components	(original				
equipment	manufacture)
Changing	RCF	gaskets,	etc.	in	
appliances
Cutting	and	assembling	material	
for	sound-proofing	exhaust	
ducts
Sewing	RCF	material
Stapling	RCF	material
Ball	milling	or	grinding	RCF	
material
Mixing	RCF	putties,	compounds,	
or	castables
Mixing/form-
ing
Wet	end	production	of	
vacuum-cast	shapes,	
board,	and	felt
Forming	RCF	board	or	shapes
Weighing,	batching,	or	mixing		
	materials	to	be	formed
Placing	wet	parts	on	conveyor
Operating	mixing	machine
Felting
Premixing	dry	materials	before	
adding	to	mix	tank
Auxiliary	op-
erations
Jobs	in	which	workers	are	
passively	exposed	to	RCFs	
while	performing	their	
normal	duties	and	whose	
exposures are not likely to 
parallel those of workers 
working directly with RCF 
materials.	Includes	certain	
jobs	in	which	RCFs	may	
be	handled	but	with	small	
probability	of	significant	
exposures	(e.g.,	ware-
house	worker	or	person	
unloading	completed	
parts	for	packaging).
Moving	RCF-wrapped	molds	
into	and	out	of	furnace
Warehouse	duties,	including	
dock	work,	loading	trucks,	
moving			materials
Supervising
Driving	forklift
Making	cartons	to	package	RCFs	
at	end	of	line
Quality	control	inspection
Packaging	dry	parts
Maintaining	or	repairing	equip-
ment	except	furnaces
(Continued)
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Table B–1 (Continued) . Functional job categories for RCF workers
Functional 
category Definition General examples Additional comments
Auxiliary	
operations	
(Continued)
Cleaning	furnaces	or	plant	areas	
where	RCFs	are	used
Removing	vacuum-formed	parts	
from	oven	and/or	packaging				
them	(no	finishing)
Other	(not				
elsewhere				
classisfied)
All	duties	performed	in	the	
production	of	RCF	paper,	
textiles,	and	automotive	
components	or	other	in-
dustry	sectors	not	covered	
in	any	of	the	foregoing	
categories.		Also,	expo-
sures	that	cannot	reason-
ably	be	included	in	the	
categories	listed	above	
(i.e.,	not	elsewhere	classi-
fied).	Industrial	hygienist	
personnel	should	explain	
tasks	and	industry	sectors	
as	fully	as	possible	for	ob-
servations	in	this	category.
Diecutting	parts	for	automotive	
airbag	filters,	gaskets,	mufflers,	
or	catalytic	converters
Wrapping	substrate	for	catalytic	
converter
Operating	former	to	make	rov-
ing
Operating	tape	loom
Operating	carding	machine
Papermaking
Wrapping	RCF	blanket	around	
a	hot	weld	so	the	weld	may	
cool	without	stress	between	
the	hot	seam	or	joint	and	the	
cooler	surrounding	metal	
(not	elsewhere	classified)
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human	 pulmonary	 cells.	 The	 human	 alveolar	
macrophage	has	a	volume	several	 times	greater	
than	that	of	the	rat	alveolar	macrophage	[Krom-
back	et	al.	1997].	Macrophage	size	and	volume	
may	affect	(1)	the	size	range	of	fibers	that	can	
be	phagocytized,	dissolved,	 and	cleared	by	 the	
lungs	and	(2)	the	resulting	pathogenicity	of	the	
fiber.	Even	the	use	of	a	human	lung	cell	line	does	
not	guarantee	that	in	vitro	results	will	be	directly	
applicable	 to	 the	 intact	 human	 response.	 The	
in	vivo	integration	of	stimuli	from	the	nervous,	
hormonal,	and	cardiovascular	systems	cannot	be	
reproduced	in	vitro.	
Another	point	to	consider	when	reviewing	these	
data	is	the	number	and	definitions	of	variables	
used	in	different	studies.	Variables	include	dif-
ferences	 in	fiber	type,	fiber	 length,	fiber	dose,	
cell	type,	and	length	of	exposure	tested,	among	
others.	Disparate	results	between	studies	make	
strong	conclusions	from	in	vitro	studies	diffi-
cult.	At	the	same	time,	these	studies	may	pro-
vide	important	data	regarding	the	mechanism	
of	action	of	RCFs	that	would	not	be	obtainable	
in	other	testing	venues.
RCFs	may	exert	their	effects	on	pulmonary	tar-
get	cells	via	direct	or	indirect	mechanisms.	Di-
rect	mechanisms	are	the	resultant	effects	when	
fibers	come	in	direct	physical	contact	with	cells.	
Direct	cytotoxic	effects	of	RCFs	include effects	
on	cell	viability,	responses,	and	proliferation.	
The	 cellular	 and	molecular	 effects	 of	RCF	 ex-
posures	 have	 been	 studied	 with	 two	 different	
objectives.	One	purpose	of	these	in	vitro	stud-
ies	 is	 to	provide	 a	 quicker,	 less	 expensive,	 and	
more	 controlled	 alternative	 to	 animal	 toxic-
ity	 testing.	These	 experiments,	which	 strive	 to	
act	 as	 screening	 tests	or	 alternatives	 to	 animal	
studies,	are	best	interpreted	by	comparing	their	
results	with	 those	of	 in	vivo	experiments.	The	
second	objective	of	in	vitro	studies	is	to	provide	
data	that	may	help	to	explain	the	pathogenesis	
and	mechanisms	of	action	of	RCFs	at	 the	cel-
lular	 and	 molecular	 levels.	 These	 cytotoxicity	
and	 genotoxicity	 studies	 are	 best	 interpreted	
by	comparing	the	effects	of	RCFs	with	those	of	
other	SVFs	and	asbestos	fibers.	In	vitro	studies	
serve	 as	 an	 important	 complement	 to	 animal	
studies	and	provide	important	tools	for	study-
ing	the	molecular	mechanisms	of	fibers.	It	is	not	
yet	possible	to	use	these	data	in	the	derivation	
of	an	REL.
Drawing	strong	conclusions	 relevant	 to	human	
health	based	on	these	in	vitro	studies	is	impossi-
ble.	One	point	to	consider	when	reviewing	these	
data	 is	 the	 relevance	 of	 the	 cell	 types	 studied.	
Many	studies	to	date	have	examined	the	effects	of	
RCFs	on	rodent	cell	lines.	The	cytotoxic	effects	of	
RCFs	may	vary	with	cell	size,	volume,	and	lineage.	
Effects	 observed	 in	 the	 cells	 from	organs	 other	
than	the	lung	or	effects	in	species	other	than	the	
human	may	not	be	similar	to	those	elicited	with	
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Indirect	cellular	effects	of	RCFs	involve	the	in-
teraction	of	fibers	with	inflammatory	cells	that	
may	 be	 activated	 to	 produce	 inflammatory	
mediators.	These	mediators	may	 affect	 target	
cells	directly	or	may	attract	other	cells	that	act	
on	target	cells.	An	inflammatory	cell	type	often	
used	in	RCF	in	vitro	studies	is	the	pulmonary	
macrophage.	Pulmonary	macrophages	are	the	
first	 line	 of	 defense	 against	 inhaled	 material	
that	deposits	 in	 the	alveoli,	 and	among	 func-
tions,	they	attempt	to	phagocytize	particles	de-
posited	in	the	lung.	Effects	of	RCF	exposure	on	
macrophages	and	other	inflammatory	cells	are	
assessed	by	the	measurement	of	inflammatory	
mediator	release	in	vitro.	
Three	important	groups	of	inflammatory	me-
diators	 are	 cytokines,	 ROS,	 and	 lipid	media-
tors	 (prostaglandins	 and	 leukotrienes).	 Some	
of	 the	cytokines	 that	have	been	 implicated	 in	
the	inflammatory	process	include	TNF	and	in-
terleukins	(ILs).	TNF	and	many	ILs	stimulate	
the	deposition	of	fibroblast	collagen,	an	initial	
step	 in	fibrosis,	 and	prostaglandins	 (PG)s	 in-
hibit	these	effects.	ROS	include	hydroxyl	radi-
cals,	hydrogen	peroxide,	and	superoxide	anion	
radicals.	Oxidative	stress	occurs	when	the	ROS	
level	in	a	cell	exceeds	its	antioxidant	level.	Oxi-
dative	stress	may	result	in	damage	to	deoxyribo	
nucelic	acid	(DNA),	lipids,	and	proteins.	
Either	 direct	 or	 indirect	 effects	 of	 RCFs	may	
result	in	genotoxic	effects	on	pulmonary	target	
cells.	Changes	 in	 the	genetic	material	may	be	
important	 in	 tumor	 development	 [Solomon	
et	al.	1991].	Genotoxic	effects	may	be	assessed	
through	 the	analysis	of	chromosome	changes	
or	alterations	in	gene	expression	following	ex-
posure	to	RCFs.
The	following	summary	of	RCF	in	vitro	stud-
ies	examines	their	direct	effects	on	cell	prolif-
eration	 and	 viability	 and	 indirect	 effects	 via	
release	of	TNF,	ROS,	and	other	inflammatory	
mediators.	 The	 genotoxic	 effects	 of	RCFs	 are	
also	examined	and	summarized.	Table	C–1	de-
scribes	RCF	cytotoxicity	studies	involving	their	
direct	effects	on	cells.	Table	C–2	describes	RCF	
cytotoxicity	 studies	 involving	 the	 release	 of	
mediators.	Table	C–3	summarizes	RCF	geno-
toxic	studies.
C.1 Direct Cytotoxic Effects 
 of RCFs
RCFs	may	have	a	direct	cytotoxic	effect	on	tar-
get	cells.	Measurements	of	cell	viability	and	cell	
proliferation	are	both	indications	of	cytotoxic	
effects.	Cell	 viability	 can	 be	 assessed	 through	
the	 detection	 of	 enzymes	 released	 by	 cells	 or	
dyes	taken	up	by	cells	that	indicate	altered	cell	
membrane	integrity	or	permeability.	Measure-
ment	of	cytoplasmic	LDH	and	trypan	blue	ex-
clusion	are	two	methods	used	to	assess	cell	via-
bility.	LDH	is	a	cytoplasmic	enzyme;	its	release	
indicates	 plasma	membrane	 damage.	 Trypan	
blue	is	a	dye	that	can	only	penetrate	damaged	
cell	membranes.	β-glucuronidase	is	a	lysosom-
al	 enzyme,	 it	 assesses	 lysosomal	 permeability	
and	membrane	viability.	It	may	also	be	released	
when	 alveolar	 macrophages	 are	 activated	 by	
frustrated	 phagocytosis.	 The	 cytotoxic	 effects	
of	RCFs	on	rat	pleural	mesothelial	cells,	por-
cine	 aortic	 endothelial	 cells,	 human-hamster	
hybrid	(A
L
)	cells,	human	macrophages,	macro-
phage-like	P388D1	 cells,	 and	human	 alveolar	
epithelial	 cells	 are	 summarized	 in	 Table	 C–1	
and	C–2	and	in	the	text	below.	
Luoto	 et	 al.	 [1997]	 evaluated	 the	 effects	 of	
RCFs,	 quartz,	 and	 several	 MMVFs	 on	 LDH	
levels	 in	rat	alveolar	macrophages	and	hemo-
lysis	in	sheep	erythrocytes.	RCF1,	RCF2,	RCF3,	
and	RCF4	at	1.0	mg/ml	induced	a	lower	release	
of	 LDH	 (less	 than	 20%	 of	 control)	 from	 rat	
alveolar	 macrophages	 compared	 with	 quartz	
(approximately	 40%	of	 control)	 [Luoto	 et	 al.	
1997].	RCF1	stimulated	the	lowest	amount	of	
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LDH	release	(less	than	10%	of	control),	lower	
even	 than	 TiO
2
	 (approximately	 15%	 of	 con-
trol).	 RCF1,	 RCF2,	 RCF3,	 RCF4,	 MMVF10,	
MMVF11,	 MMVF21,	 and	 MMVF22	 at	 0.5,	
2.5,	 and	 5.0	mg/ml	 induced	 a	 dose-depen-
dent	 increase	 in	 sheep	erythrocyte	hemolysis.	
RCF1	and	RCF3	induced	slightly	more	hemo-
lysis	than	other	MMVFs.	The	hemolytic	activ-
ity	of	MMVFs	was	similar	to	that	of	TiO
2
,	and	
much	less	than	that	of	quartz.
At	 doses	 of	 100,	 300,	 and	 1,000	 µg/ml	 RCFs	
(unspecified	type),	an	increased	release	of	LDH	
was	 induced	 from	 rat	 macrophages	 [Leikauf	
et	al.	1995].	At	equivalent	gravimetric	doses	of	
1,000	µg/ml,	the	effects	of	RCFs	were	much	less	
than	those	of	silica.	Ceramic	fibers	(unspecified	
type)	at	50	µg/ml	induced	no	difference	in	LDH	
levels	compared	with	negative	controls	in	rat	al-
veolar	macrophages	[Fujino	et	al.	1995].	Chrys-
otile,	crocidolite,	amosite,	and	anthophyllite	as-
bestos	all	induced	significant	increases	in	LDH	
and	β-glucuronidase	levels.	Ceramic	fibers	also	
induced	 a	 significant	 increase	 in	 β-glucuroni-
dase	but	much	less	than	that	induced	by	each	of	
the	asbestos	fiber	types.	
In	 the	 permanent	 macrophage-like	 cell	 line	
P388D1,	an	elutriated	ceramic	fiber	(unspeci-
fied	type)	at	10	or	50	µg/ml	after	24	or	48	hr	
had	 no	 significant	 effect	 on	 cell	 viability	 as	
measured	by	the	trypan	blue	assay	[Wright	et	
al.	1986].	The	elutriation	process	used	for	this	
experiment	provided	mainly	respirable	fibers.	
All	 other	 fibers	 examined,	 excluding	 short-
fiber	amosite,	 reduced	viability.	Although	 the	
specific	data	on	the	effect	of	exposure	to	fibers	
on	 enzyme	 release	 was	 not	 presented,	 an	 as-
sociation	between	decreasing	cell	viability	and	
increasing	loss	of	intracellular	glucosaminidase	
and	LDH	was	reported	under	most	conditions	
investigated.	Cytotoxicity	was	 correlated	with	
fiber	lengths	greater	than	8	µm	when	all	fiber	
types	were	combined.	
The	effect	of	 several	fibers	on	 the	viability	of	
rat	 pleural	 mesothelial	 cells	 was	 investigated	
[Yegles	 et	 al.	 1995].	 On	 a	 per	 weight	 basis,	
the	 rank	 order	 of	 cytotoxicity	 was	 National	
Institute	 for	 Environmental	 Health	 Sciences	
(NIEHS)	 chrysotile,	 RCF3,	 MMVF10	 and	
RCF1,	Calidria	chrysotile,	RCF4,	and	all	others.	
Based	on	the	total	number	of	fibers,	the	rank	
order	 of	 cytotoxicity	 was	 RCF3,	 MMVF10,	
RCF1,	 RCF4,	 MMVF11,	 NIEHS	 chrysotile,	
amosite,	 and	 all	 others.	 Cytotoxicity	 was	 de-
pendent	 on	 fiber	 dimensions	 as	 the	 longest	
(RCF3,	MMVF10,	RCF1,	MMVF11)	or	thick-
est	(RCF4,	RCF1,	MMVF11,	RCF3)	fibers	were	
the	most	cytotoxic.	
RCF1,	RCF2,	RCF3,	and	RCF4	were	found	to	
inhibit	 the	proliferation	and	colony-forming	
efficiency	 of	 Chinese	 hamster	 ovary	 cells	 in	
vitro	 [Hart	 et	 al.	 1992].	 The	 inhibition	 was	
concentration-dependent.	 RCF4	 was	 least	
cytotoxic,	RCF2	was	intermediate,	and	RCF1	
and	RCF3	were	the	most	cytotoxic.	A	correla-
tion	existed	between	average	fiber	length	and	
toxicity,	 with	 the	 shortest	 fibers	 being	 least	
cytotoxic.	LC
50
s	 for	 the	RCF	ranged	 from	10	
to	30	µg/cm2.	In	each	assay,	the	RCFs	were	less	
cytotoxic	 than	 those	of	 the	positive	 controls	
of	crocidolite	(LC
50
=5	µg/cm2)	and	chrysotile	
(LC
50
=1	µg/cm2)	asbestos.	
At	0	to	80	µg/cm2	RCF1,	tremolite,	and	erion-
ite	were	 significantly	 less	 cytotoxic	 to	human-
hamster	 hybrid	A
L
	 cells	 than	 chrysotile	 as	 de-
termined	by	 the	 surviving	 fraction	of	colonies	
after	fiber	exposure	[Okayasu	et	al.	1999].	RCF1,	
crocidolite	asbestos,	and	MMVF10	at	25	µg/cm2	
induced	 focal	necrosis	 in	 rat	pleural	mesothe-
lial	cells	after	24	hr	that	became	a	more	obvious	
necrosis	by	72	hr	[Janssen	et	al.	1994].	At	72	hr,	
the	qualitative	effects	of	25	µg/cm2	RCF1	were	
comparable	to	those	of	5	µg/cm2	crocidolite	as-
bestos.	 In	 contrast,	minimal	necrosis	was	 seen	
at	 25	 µg/cm2	 crocidolite	 asbestos,	 RCF2,	 and	
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MMVF10	fibers	in	hamster	tracheal	epithelial	
cells	at	24	hr;	no	necrosis	was	present	at	72	hr.
RCF1,	 RCF2,	 RCF3,	 and	 RCF4	 as	 well	 as	 as-
bestos	and	other	fibers	had	a	dose-dependent	
effect	on	cytotoxicity,	as	measured	by	cell	de-
tachment,	in	the	human	alveolar	epithelial	cell	
line	A549	[Cullen	et	al.	1997].	Cell	detachment	
is	associated	with	epithelial	damage,	an	impor-
tant	 step	 in	 the	 inflammatory	 process.	 These	
cells	 are	 a	 primary	 target	 of	 inhaled	 fibers.	
When	equivalent	doses	(10,	25,	50,	and	100	µg/
ml)	 were	 tested	with	 various	 fibers,	 all	 RCFs	
had	a	less	significant	effect	than	both	crocido-
lite	and	amosite	asbestos.	When	the	dose	data	
were	adjusted	for	the	number	of	fibers,	RCF1,	
RCF2,	 and	 RCF3	 were	 more	 cytotoxic	 than	
RCF4	and	crocidolite.	
In	an	assay	determining	the	ability	of	fibers	to	
induce	an	 increase	 in	the	diameter	of	human	
A549	cells,	an	elutriated	ceramic	fiber	(unspec-
ified	 type)	 had	 a	 midrange	 of	 activity	 when	
compared	 with	 12	 other	 fibers	 [Brown	 et	 al.	
1986].	It	was	more	active	than	most	varieties	of	
amosite	tested	(but	not	UICC	amosite)	but	less	
active	than	the	chrysotile	fibers.	An	association	
was	found	between	increasing	length	and	assay	
activity.	When	 these	 same	fiber	 samples	were	
tested	for	colony	 inhibition	 in	V79/4	Chinese	
hamster	lung	fibroblasts,	the	ceramic	fiber	had	
even	less	effect	than	the	TiO
2
	control.	Analysis	
of	all	fibers	upheld	the	association	between	in-
creasing	length	and	increased	activity.	In	both	
assays,	fiber	diameter	was	not	related	to	activ-
ity	in	most	cases.
Chrysotile	asbestos	at	10	µg/cm2	and	crocido-
lite	 asbestos	 at	 5	 µg/cm2	 altered	 porcine	 aor-
tic	endothelial	cell	morphology	and	increased	
neutrophil	 adherence	 [Treadwell	 et	 al.	 1996].	
RCF1	fibers	at	10	µg/cm2	did	not	change	cell	
morphology	or	increase	neutrophil	binding.
These	studies	suggest	that	RCFs	may	have	some	
similar	direct	cytotoxic	effects	to	asbestos.	They	
are	capable	of	inducing	enzyme	release	and	cell	
hemolysis.	They	may	decrease	cell	viability	and	
inhibit	 proliferation.	 In	most	 studies,	 the	 ef-
fects	of	RCFs	are	much	less	pronounced	than	
the	 effects	 of	 asbestos	 at	 similar	 gravimetric	
concentrations.	Fiber	length	was	demonstrated	
to	be	an	 important	 factor	 in	determining	 the	
cell	responses	in	many	studies.
C.2 Indirect Effects of RCFs:  
Effects on Inflammatory 
Cells
In	 addition	 to	 direct	 effects	 on	 target	 cells,	
RCFs	may	have	indirect	mechanisms	of	action	
by	acting	on	inflammatory	cells.	Inflammatory	
cells,	such	as	pulmonary	macrophages,	may	re-
spond	to	fiber	exposure	by	releasing	inflamma-
tory	mediators	that	initiate	the	process	of	pul-
monary	inflammation	and	fibrosis.	Cytokines	
and	ROS	are	among	the	inflammatory	media-
tors	released.	Many	studies,	summarized	below	
and	 in	 Table	 C–2,	 have	 investigated	 this	 link	
between	 fiber	 exposure	 and	mediator	 release	
to	try	to	elucidate	the	mechanism	of	action	of	
RCFs.	Cytokines	are	a	class	of	proteins	that	are	
involved	in	regulating	processes	such	as	cell	se-
cretion,	proliferation,	and	differentiation.	One	
of	 the	cytokines	most	 commonly	analyzed	 in	
RCF	cytotoxicity	studies	is	TNF.	TNF	has	been	
implicated	in	silica-	and	asbestos-induced	pul-
monary	 fibrosis	 [Piguet	 et	 al.	 1990;	 Lemaire	
and	Ouellet	1996].	TNF	and	many	ILs	are	as-
sociated	 with	 collagen	 deposition	 (an	 initial	
stage	of	fibrosis),	and	PGs	inhibit	these	effects.	
Experiments	on	the	effects	of	RCF	exposure	on	
TNF	production	in	various	cell	types	have	had	
differing	results.
TNF	secretion	has	been	associated	with	ex-
posure	to	asbestos	both	in	vitro	and	in	vivo	
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[Perkins	 et	al.	 1993].	 In	 vitro	 incubation	 of	
human	 alveolar	 macrophages	 from	 normal	
volunteers	 with	 25	µg/ml	 chrysotile	 asbestos	
resulted	 in	 increased	 levels	 of	TNF	 secretion.	
Alveolar	macrophages	from	6	human	subjects	
occupationally	 exposed	 to	 asbestos	 for	 more	
than	 10	 years	 secreted	 increased	 amounts	 of	
the	 cytokines	TNF,	 IL–6,	PGE
2
,	 and	 IL–1ß	 in	
vitro.	Five	human	subjects	occupationally	ex-
posed	for	 less	than	10	years	did	not	show	in-
creases	 in	 these	 cytokines.	 The	 two	 exposure	
groups	were	matched	for	age,	smoking	history,	
and	 diagnosis.	 The	 increased	 TNF	 secretion	
in	both	in	vitro	and	chronic	in	vivo	asbestos-
exposed	conditions	suggests	its	importance	in	
the	response	of	the	lung	to	fiber	exposure,	al-
though	the	small	exposure	group	sizes	warrant	
caution	in	drawing	strong	conclusions.	
When	 equal	 numbers	 (8.2	 	 106)	 of	 various	
fiber	types,	including	RCF1,	RCF2,	RCF3,	and	
RCF4,	 were	 incubated	 separately	 with	 rat	 al-
veolar	macrophages,	 silicon	 carbide	whiskers,	
amosite,	 and	 crocidolite	 asbestos	 stimulated	
the	 highest	 TNF	 release	 [Cullen	 et	 al.	 1997].	
RCF1,	RCF2,	RCF3,	and	RCF4	showed	no	sig-
nificant	increase	in	TNF	release	compared	with	
control.	
In	contrast,	ceramic	fibers	(unspecified	type)	at	
50	 µg/ml	 (1.72	 105	 f)	 significantly	 increased	
TNF	release	compared	with	controls	in	rat	al-
veolar	macrophages	 [Fujino	 et	 al.	 1995].	 Po-
tassium	 octatitanate	 whisker,	 chrysotile,	 and	
crocidolite	asbestos	 induced	the	greatest	TNF	
release.	 Alveolar	macrophages	 exposed	 to	 ei-
ther	300	or	1,000	µg/ml	RCFs	or	1,000	µg/ml	
asbestos	showed	a	significant	increase	in	TNF	
production	[Leikauf	et	al.	1995].	At	300	µg/ml	
RCFs,	a	 significant	elevation	occurred	 in	 leu-
kotriene	B
4
.	At	 1,000	 µg/ml	RCFs,	 significant	
elevations	occurred	in	leukotriene	B
4
	and	pros-
taglandin	 E
2
.	 Levels	 induced	 at	 lower	 doses	
were	not	different	from	controls.	At	equivalent	
doses,	the	effect	on	the	levels	of	all	mediators	
measured	was	 greater	 after	 asbestos	 exposure	
than	after	RCF	exposure.	
Chrysotile	A,	chrysotile	B,	crocidolite,	MMVF21,	
RCF1,	and	silicon	carbide	at	100	µg/ml	caused	a	
significantly	increased	synthesis	of	TNF	mRNA	
after	90	minutes	of	 incubation	with	rat	alveo-
lar	macrophages	[Ljungman	et	al.1994].	After	4	
hr	of	incubation,	chrysotile	A	still	had	a	signifi-
cantly	 increased	TNF	mRNA	production,	 and	
all	other	fibers	were	at	baseline	concentrations.	
None	 of	 the	 fibers	 studied	 increased	 TNF	 re-
lease	at	90	minutes.	However,	an	increased	TNF	
bioactivity	 occurred	 after	 4	 hr	 of	 incubation	
with	 chrysotile	 A,	 chrysotile	 B,	 crocidolite,	 or	
MMVF21.	RCF1	at	100	µg/ml	did	not	increase	
TNF	production	under	these	conditions.
Chrysotile	 asbestos	 and	 alumina	 silicate	 ce-
ramic	fibers	increased	in	vitro	alveolar	macro-
phage	TNF	production	in	rats	exposed	to	ciga-
rette	 smoke	 in	vivo	and	 in	 rats	unexposed	 to	
smoke	[Morimoto	et	al.	1993].	Asbestos	at	50	
and	100	µg/ml	induced	a	significantly	greater	
TNF	release	in	rats	exposed	to	cigarette	smoke	
versus	 unexposed	 rats.	 No	 significant	 differ-
ences	were	found	between	groups	at	all	doses	
of	 RCF	 fibers	 tested	 (25,	 50	 and	 100	 µg/ml).	
RCF	 exposure,	 in	 contrast	 to	 chrysotile,	 did	
not	 have	 a	 significant	 synergistic	 effect	 with	
cigarette	smoke	exposure.
In	addition	to	the	cytokines	such	as	TNF,	an-
other	 group	 of	 inflammatory	mediators	 that	
has	been	 studied	 in	vitro	 are	 the	ROS.	These	
mediators,	 also	 referred	 to	 as	 reactive	oxygen	
metabolites	 (ROMs)	 are	 normally	 produced	
during	the	process	of	cellular	aerobic	metabo-
lism	and	in	phagocytic	cells	in	response	to	par-
ticle	exposure.	One	molecular	effect	of	asbestos	
exposure	has	been	demonstrated	to	be	the	in-
duction	of	ROS	[Kamp	et	al.	1992].	Oxidative	
stress	occurs	when	the	ROS	level	 in	a	cell	ex-
ceeds	the	antioxidant	level.	ROS	may	result	in	
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damage	to	DNA,	lipids	and	proteins	and	have	
been	implicated	in	having	a	role	in	carcinogen-
esis	[Klaunig	et	al.	1998;	Vallyathan	et	al.	1998].	
This	research	has	suggested	that	free	radical	ac-
tivity	may	be	 involved	 in	 the	pathogenesis	of	
fiber-induced	lung	disease.
The	ability	of	RCFs	to	induce	the	release	of	free	
radicals	 has	 been	 studied	 in	 rodent	 alveolar	
macrophages.	RF1	and	RF2	(Japanese	ceramic	
fibers)	at	200	µg/ml	induced	a	significant	pro-
duction	of	superoxide	anion	and	a	significant	
increase	in	intracellular	free	calcium	in	guinea	
pig	 alveolar	macrophages	 [Wang	 et	 al.	 1999].	
Both	 superoxide	 anion	 and	 increased	 intra-
cellular	 calcium	are	 associated	with	oxidative	
stress.	Superoxide	anions	may	generate	hydro-
gen	 peroxide	 and	 hydroxyl	 radical,	 classified	
as	ROS	or	free	radicals.	RF2	exposure	resulted	
in	a	significant	depletion	of	glutathione.	Glu-
tathione	is	a	cellular	antioxidant	that	protects	
cells	against	oxidative	stress;	depletion	of	glu-
tathione	is	associated	with	oxidative	stress.	The	
RFs	did	not	affect	hydrogen	peroxide	produc-
tion.	In	each	test,	the	effects	of	chrysotile	were	
significantly	greater	than	those	of	the	RFs.	
RCF1,	MMVF10,	and	amosite	asbestos	at	8.24	×	
106	f/ml	induced	a	significant	depletion	of	intra-
cellular	glutathione	in	rat	alveolar	macrophages	
[Gilmour	et	al.	1997].	RCF1	had	similar	effects	
to	amosite	asbestos,	whereas	MMVF10	caused	
the	greatest	depletion	of	glutathione.
RCF1,	 RCF2,	 and	 RCF3	 induced	 a	 greater	
production	of	ROMs	in	human	polymorpho-
nuclear	cell	cultures	than	RCF4	and	chrysotile	
[Luoto	et	al.	1997].	A	dose-dependent	produc-
tion	of	ROMs	was	seen	in	all	RCFs	and	other	
MMVFs	tested	from	25	to	500	µg/ml.	Quartz	
had	a	greater	effect	on	ROM	production	than	
all	fibers	tested.
RCF1	had	a	high	binding	capacity	for	rat	im-
munoglobulin	 (IgG),	 a	 normal	 component	
of	lung	lining	fluid	[Hill	et	al.	1996].	At	doses	
>100	µg	RCF1,	fibers	coated	with	IgG	induced	
a	 significantly	 increased	 superoxide	anion	re-
lease.	This	supports	the	premise	that	lung	lin-
ing	fluid	 and	other	 substances	 that	fibers	 are	
exposed	 to	 in	vivo	may	 significantly	 alter	 the	
effect	of	fibers	on	cells.	 IgG-coated	 long	fiber	
amosite	 asbestos,	 in	 spite	 of	 a	 poor	 binding	
affinity	for	IgG,	induced	a	comparable	super-
oxide	anion	release	response	to	that	of	coated	
RCF1.
Brown	 et	 al.	 [1999]	 investigated	 the	 abil-
ity	of	RCF1,	amosite	asbestos,	silicon	carbide,	
MMVF10,	Cole	100/475	glass	fiber,	and	RCF4	
to	cause	translocation	of	the	transcription	fac-
tor	NF-κB	to	the	nucleus	in	A549	lung	epithe-
lial	 cells.	 RCF1,	 amosite	 asbestos,	 and	 silicon	
carbide	produced	a	significant	dose-dependent	
translocation	of	NF-κB	to	the	nucleus;	the	oth-
er	 fibers	 tested	 did	 not.	 Equal	 fiber	 numbers	
were	tested.
These	 cytotoxicity	 studies	 indicate	 that	 RCFs	
may	share	some	aspects	of	their	mechanism	of	
action	with	asbestos.	They	both	affect	the	pro-
duction	of	TNF	and	ROS	as	well	as	cell	viabil-
ity	and	proliferation.	The	effects	of	RCFs	have	
usually	been	less	pronounced	than	those	of	as-
bestos.	Results	of	in	vitro	studies	are	difficult	to	
compare,	even	within	studies	of	different	fiber	
types,	because	of	different	 study	designs,	dif-
ferent	fiber	concentrations	and	characteristics,	
and	different	endpoints.
C.3 Genotoxic Effects 
of RCFs
In	addition	 to	 research	assessing	 the	cytotox-
icity	 of	 RCFs,	 studies	 have	 also	 assessed	 the	
genotoxicity	of	RCFs.	Most	genotoxicity	assays	
assess	changes	 in	or	damage	 to	genetic	mate-
rial.	Methods	that	have	been	used	to	investigate	
the	genotoxicity	of	fibers	include	cell-free	or	in	
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vitro	 cell	 systems	 investigating	DNA	damage,	
studies	of	aneuploidy	or	polyploidy,	studies	of	
chromosome	damage	or	mutation,	 gene	mu-
tation	assays,	and	investigations	of	cell	growth	
regulation	[Jaurand	1997].	Several	studies,	de-
scribed	 below	 and	 in	 Table	 C–3,	 have	 exam-
ined	the	ability	of	RCFs	to	produce	genotoxic	
changes	in	comparison	with	asbestos.
Several	fibers,	including	RCF1	and	RCF4,	were	
assayed	for	free	radical	generating	activity	us-
ing	a	DNA	assay	and	a	salicylate	assay	[Brown	
et	 al.1998].	 The	 DNA	 plasmid	 assay	 showed	
only	amosite	asbestos	to	have	free	radical	activ-
ity.	The	salicylate	assay	showed	amosite	as	well	
as	RCF1	 to	have	 free	 radical	 activity.	Coating	
the	fibers	with	lung	surfactant	decreased	their	
hydroxyl	 radical	 generation.	 Differences	 in	
RCF1	results	in	the	two	assays	were	proposed	
to	 be	 a	 result	 of	 increased	 iron	 release	 from	
RCF1	 in	 the	 salicylate	assay.	An	 iron	chelator	
inhibited	 the	RCF	hydroxylation	of	 salicylate.	
RCF4	showed	no	free	radical	activity.
When	 equal	 fiber	 numbers	 were	 compared,	
RCF1,	 RCF2,	 RCF3,	 and	 RCF4	 had	 minimal	
free-	 radical-generating	 activity	 on	 plasmid	
DNA	compared	with	 crocidolite	 and	amosite	
asbestos	 [Gilmour	 et	 al.	 1995].	 RCFs	 and	
other	MMVF	produced	a	 small	but	 insignifi-
cant	 amount	 of	 DNA	 damage.	 This	 damage	
was	 mediated	 by	 hydroxyl	 radicals.	 No	 cor-
relation	was	 found	between	 iron	content	and	
free	radical	generation.	At	9.3	×	105	fibers	per	
assay,	amosite	produced	substantial	 free	radi-
cal	 damage	 to	 plasmid	 DNA	 [Gilmour	 et	 al.	
1997].	 Amosite	 significantly	 upregulated	 the	
transcription	 factors	 AP–1	 and	 NFkB;	 RCF1	
had	a	much	smaller	effect	on	AP–1	upregula-
tion	only.
SVFs,	 including	 ceramic	 fibers	 (unspecified),	
were	reported	to	form	hydroxyl	radicals	based	
on	 the	 formation	 of	 the	 DNA	 adduct	 8-hy-
droxydeoxyguanosine	(8-OH-dG)	from	2-de-
oxyguanosine	 (dG)	 in	 calf	 thymus	DNA	 and	
solution	 [Leanderson	 et	 al.	 1989;	 Leanderson	
and	Tagesson	1989].	Ceramic	and	glasswool	fi-
bers	had	poor	hydroxylating	capabilities	relative	
to	rockwool	and	slag	wool	fibers	[Leanderson	
et	al.	1989].	Hydroxyl	radical	scavengers,	such	
as	 dimethyl	 sulfoxide,	 decreased	 the	 hydrox-
ylation.	 Compounds	 that	 increase	 hydroxyl	
radical	formation,	such	as	hydrogen	peroxide,	
increased	hydroxylation.	Rockwool	 in	combi-
nation	with	cigarette	smoke	condensate	caused	
a	synergistic	 increase	in	8-OH-dG	formation;	
ceramic	and	glasswool	fibers	did	not	have	syn-
ergistic	effects	with	cigarette	smoke	[Leander-
son	and	Tagesson	1989].	
RCF1,	RCF2,	RCF3,	and	RCF4	induced	nucle-
ar	 abnormalities,	 including	 micronuclei	 and	
polynuclei,	 in	 Chinese	 hamster	 ovary	 cells	
[Hart	et	al.	1992].	Micronuclei	may	form	when	
chromosomes	 or	 fragments	 of	 chromosomes	
are	 separated	 during	mitosis.	 Polynuclei	may	
arise	when	cytokinesis	 fails	 after	mitosis.	The	
incidence	of	micronuclei	and	polynuclei	after	
exposure	to	20	µg/cm2	RCF	was	from	22%	to	
33%.	 At	 5	 µg/cm2,	 chrysotile	 and	 crocidolite	
induced	 nuclear	 abnormalities	 of	 49%	 and	
28%,	respectively.
Amosite,	 chrysotile,	 and	 crocidolite	 asbestos,	
and	ceramic	fibers	caused	a	significant	increase	
in	micronuclei	 in	human	amniotic	fluid	 cells	
[Dopp	 et	 al.	 1997].	 The	 response	 was	 dose-
dependent	 with	 asbestos	 fiber	 exposure	 but	
not	 with	 ceramic	 fiber	 exposure.	 Significant	
increases	 in	 chromosomal	 breakage	 and	 hy-
perdiploid	cells	were	noted	after	asbestos	and	
ceramic	fiber	exposure.	
RCF1,	 RCF3,	 and	 RCF4	 did	 not	 induce	 ana-
phase	 aberrations	 in	 rat	 pleural	 mesothelial	
cells	 [Yegles	 et	 al.	 1995].	 Of	 all	 fibers	 tested,	
UICC	chrysotile	was	the	most	genotoxic	on	the	
basis	of	weight,	number	of	fibers	with	a	length	
>4	 µm	 and	 number	 of	 fibers	 corresponding	
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to	Stanton=s	and	Pott=s	criteria	[Stanton	et	al. 
1981;	Pott et	al. 1987].
The	effect	of	fibers	on	the	mRNA	levels	of	c-
fos	and	c-jun	proto-oncogenes	and	ornithine	
decarboxylase	(ODC)	in	hamster	tracheal	epi-
thelial	 (HTE)	 cells	 and	 rodent	 pleural	meso-
thelial	(RPM)	cells	were	examined	[Janssen	et	
al.	1994].	ODC	is	a	rate-limiting	enzyme	in	the	
synthesis	of	compounds	involved	in	cell	prolif-
eration	and	tumor	promotion,	the	polyamines.	
In	HTE	cells,	crocidolite	induced	a	significant	
dose-dependent	increase	in	levels	of	c-jun	and	
ODC	mRNA	but	not	 c-fos	mRNA.	RCF1	 in-
duced	only	small	nondose-dependent	increases	
in	ODC	mRNA	levels.	In	RPM	cells,	crocidolite	
fibers	at	2.5	µg/cm2	significantly	elevated	 lev-
els	of	c-fos	and	c-jun	mRNA.	RCF1	increased	
proto-oncogene	expression	at	 cytotoxic	 levels	
of	25	µg/cm2;	no	significant	effect	was	seen	at	
concentrations	≤5	µg/cm2.	
RCF1	 fibers	 were	 nonmutagenic	 in	 the	 hu-
man-hamster	hybrid	cell	line	A
L	
[Okayasu	et	al.	
1999].	Chrysotile	was	a	significant	 inducer	of	
mutations	in	the	same	system.
These	 studies	 demonstrate	 that	 RCFs	 may	
share	some	similar	genotoxic	mechanisms	with	
asbestos	 including	 induction	 of	 free	 radicals,	
micronuclei,	polynuclei,	 chromosomal	break-
age,	and	hyperdiploid	cells.	Other	studies	have	
demonstrated	that,	using	certain	methods	and	
doses,	RCFs	did	not	 induce	anaphase	aberra-
tions	and	induced	proto-oncogene	expression	
only	 at	 cytotoxic	 concentrations.	 RCFs	 were	
nonmutagenic	in	human-hamster	hybrid	cells.	
C.4 Discussion of In Vitro 
 Studies
The	toxicity	of	fibers	has	been	attributable	to	
their	dose,	dimensions,	and	durability.	Any	test	
system	that	is	designed	to	assess	the	potential	
toxicity	 of	 fibers	 must	 address	 these	 factors.	
Durability	 is	 difficult	 to	 assess	 using	 in	 vitro	
studies	 because	 of	 their	 acute	 time	 course.	
However,	in	vitro	studies	provide	an	opportu-
nity	 to	study	 the	effects	of	varying	doses	and	
dimensions	of	fibers	in	a	quicker,	more	efficient	
method	 than	 animal	 testing.	 Although	 they	
provide	important	information	about	mecha-
nism	of	action,	they	do	not	currently	provide	
data	that	can	be	extrapolated	to	occupational	
risk	assessment.
The	association	between	fiber	dimension	and	
toxicity	 has	 been	 documented	 and	 reviewed	
[Stanton	et	al.	1977,	1981;	Pott	et	al.	1987;	War-
heit	 1994].	 Fiber	 length	 has	 been	 correlated	
with	the	cytotoxicity	of	glass	fibers	[Blake	et	al.	
1998].	Manville	code	100	(JM–100)	fiber	sam-
ples	of	average	lengths	of	3,	4,	7,	17,	and	33	µm	
were	 assessed	 for	 their	 effects	 on	LDH	activ-
ity	and	rat	alveolar	macrophage	function.	The	
greatest	cytotoxicity	was	reported	in	the	17	µm	
and	 33	 µm	 samples,	 indicating	 that	 length	 is	
an	important	factor	in	the	toxicity	of	this	fiber.	
Multiple	macrophages	were	observed	attached	
along	the	length	of	long	fibers.	Relatively	short	
fibers,	 <20	µm	 long,	 were	 usually	 phagocy-
tized	 by	 one	 rat	 alveolar	macrophage	 [Luoto	
et	 al.	 1994].	 Longer	 fibers	were	 phagocytized	
by	 two	or	more	macrophages.	 Incomplete,	or	
frustrated,	phagocytosis	may	play	a	role	in	the	
increased	toxicity	of	longer	fibers.	Long	fibers	
(17	 µm	 average	 length)	 were	 a	 more	 potent	
inducer	 of	 TNF	 production	 and	 transcrip-
tion	factor	activation	than	shorter	fibers	(7	µm	
average	length)	[Ye	et	al.	1999].	These	studies	
demonstrate	 the	 important	 role	 of	 length	 in	
fiber	toxicity	and	suggest	that	the	capacity	for	
macrophage	phagocytosis	may	be	a	critical	fac-
tor	 in	determining	fiber	 toxicity.	The	 toxicity	
of	 individual	fibers	of	the	same	type	of	RCFs	
may	differ	according	to	their	size	in	relation	to	
alveolar	macrophages.
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Several	 RCF	 in	 vitro	 studies	 reported	 a	 di-
rect	association	between	a	 longer	fiber	 length	
and	greater	cytotoxicity.	Hart	et	al.	[1992]	re-
ported	the	shortest	fibers	to	be	the	least	cyto-
toxic.	Brown	et	al.	[1986]	reported	an	associa-
tion	between	length	and	cytotoxic	activity	but	
not	 between	diameter	 and	 activity.	Wright	 et	
al.	 [1986]	 reported	 that	 cytotoxicity	was	 cor-
related	with	fibers	>8	µm	length.	Yegles	et	al.	
[1995]	 reported	 that	 the	 longest	 and	 thickest	
fibers	were	the	most	cytotoxic.	The	four	most	
cytotoxic	fibers	had	GM	lengths		≥13	µm	and	
GM	diameters	>0.5	µm.	The	production	of	ab-
normal	anaphases	and	telophases	was	associat-
ed	with	Stanton	fibers	with	a	length	>8	µm	and	
diameter	≤0.25	µm.	Hart	et	al.	[1994]	reported	
that	cytotoxicity	increased	with	fiber	length	up	
to	20	µm.	All	of	these	studies	demonstrate	the	
importance	of	fiber	dimensions	on	cytotoxicity.	
Other	studies	have	not	reported	the	length	dis-
tribution	of	fiber	samples	used.	When	studies	
are	done	with	RCFs	for	which	specific	lengths	
are	assessed	for	cytotoxicity	(such	as	has	been	
done	with	glass	fibers)	[Blake	et	al.	1998],	it	will	
be	possible	to	determine	the	strength	of	the	as-
sociation	between	RCF	fiber	length	and	toxic-
ity	and	determine	whether	a	threshold	length	
exists	above	which	toxicity	increases	steeply.	
In	addition	to	providing	data	on	the	correlation	
between	fiber	length	and	toxicity,	in	vitro	stud-
ies	have	provided	data	on	the	relative	toxicity	of	
RCFs	compared	with	asbestos.	Uncertainties	ex-
ist	in	the	interpretation	of	these	studies	because	
of	 differences	 in	 fiber	 doses,	 dimensions,	 and	
durabilities.	RCFs	do	appear	to	share	some	sim-
ilar	mechanisms	 of	 action	 with	 asbestos.	 (See	
references	in	Tables	C–1,	C–2,	and	C–3.)	They	
have	similar	direct	and	indirect	effects	on	cells	
and	 alter	 gene	 function	 in	 similar	ways.	 They	
are	 capable	 of	 inducing	 enzyme	 release	 and	
cell	hemolysis.	They	may	decrease	cell	viability	
and	 inhibit	proliferation.	They	both	 affect	 the	
production	of	tumor	necrosis	factor	and	ROS,	
and	affect	cell	viability	and	proliferation.	They	
induce	necrosis	in	rat	pleural	mesothelial	cells.	
They	also	may	induce	free	radicals,	micronuclei,	
polynuclei,	chromosomal	breakage,	and	hyper-
diploid	cells	in	vitro.
In	vitro	studies	also	provide	an	excellent	oppor-
tunity	for	investigating	the	pathogenesis	of	RCF.	
However,	comparisons	are	difficult	to	make	be-
tween	in	vitro	studies	because	of	differences	in	
fiber	doses,	dimensions,	preparations,	and	com-
positions.	Important	information,	such	as	fiber	
length	 distribution,	 is	 not	 always	 determined.	
Even	when	 comparable	 fibers	 are	 studied,	 the	
cell	line	or	conditions	under	which	they	are	test-
ed	may	vary.	Much	of	the	research	to	date	has	
been	done	in	rodent	cell	lines	and	in	cells	that	
are	not	related	to	the	primary	target	organ.	In	
vitro	studies	using	human	pulmonary	cell	lines	
should	provide	pathogenesis	data	most	relevant	
to	human	health	risk	assessment.
Short-term	 in	 vitro	 studies	 cannot	 take	 into	
account	the	influence	of	fiber	dissolution	and	
fiber	 compositional	 changes	 that	 may	 occur	
over	 time.	 In	 an	 in	 vivo	 exposure,	 fibers	 are	
continually	 modified	 physically,	 chemically,	
and	structurally	by	components	of	the	lung	en-
vironment.	This	 complex	 set	 of	 conditions	 is	
difficult	to	recreate	in	vitro.	Just	as	it	is	unlikely	
that	only	one	factor	will	be	an	accurate	predic-
tor	of	fiber	 toxicity,	 it	 is	much	more	unlikely	
that	any	one	in	vitro	test	will	be	able	to	predict	
fiber	toxicity.	Best	results	are	obtained	by	tox-
icity	assessment	in	several	in	vitro	tests	and	in	
comparison	with	in	vivo	results.	In	vitro	stud-
ies	provide	an	excellent	opportunity	to	inves-
tigate	 factors	 important	 to	fiber	 toxicity	 such	
as	dose,	dimension,	surface	area,	and	physico-
chemical	composition.	They	provide	the	abil-
ity	to	obtain	information	that	is	an	important	
supplement	 to	 the	data	of	 chronic	 inhalation	
studies.	They	do	not	 currently	provide	 infor-
mation	that	can	be	directly	applied	to	human	
health	risk	assessment	and	the	development	of	
occupational	exposure	limits.
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